assays_ASI,assays_SRASSI,assays_Descri,assays_ASSCA,assays_BAFO,assays_CHEI,assays_DOI,assays_ASSTI,assays_CURB,assays_SRI,assays_CI,assays_ASSUBCEFR,assays_Ti,assays_RELATY,assays_CONFSCO,assays_TISI,assays_VARII
7524,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,CHEMBL618647,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7525,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,CHEMBL618648,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7526,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,CHEMBL618649,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7527,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,CHEMBL618650,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7528,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,CHEMBL618651,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7529,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,CHEMBL876497,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7530,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,CHEMBL618652,9866,10116.0,Intermediate,1,,,50597,N,1,2048.0,
7531,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,CHEMBL618653,9866,10116.0,Intermediate,1,,,50597,N,1,2048.0,
7532,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,CHEMBL618654,9866,10116.0,Intermediate,1,,,50597,N,1,2048.0,
7533,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,BAO_0000218,CHEMBL618655,6351,10116.0,Intermediate,1,,,50597,N,1,,
7534,,Compound was tested for solubility in water,,BAO_0000218,CHEMBL618656,1465,10116.0,Intermediate,1,,,50597,N,1,,
7535,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,BAO_0000100,CHEMBL618657,5182,,Intermediate,1,,,22229,U,0,,
7536,,Solubility was determined,,BAO_0000218,CHEMBL618658,17847,10116.0,Intermediate,1,,,50597,N,1,,
7537,,solubility in water (ug/mL) at 37 degree C.,,BAO_0000218,CHEMBL618659,15339,10116.0,Intermediate,1,,,50597,N,1,,
7538,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,BAO_0000218,CHEMBL618660,5202,10116.0,Intermediate,1,,,50597,N,1,,
7539,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,BAO_0000218,CHEMBL618661,1088,10116.0,Intermediate,1,,,50597,N,1,,
7540,,Half life in rats,,BAO_0000218,CHEMBL873807,3169,10116.0,Intermediate,1,,,50597,N,1,,
7541,,Half life in Dawley rat,,BAO_0000218,CHEMBL618662,5353,10116.0,Intermediate,1,,,50597,N,1,,
7542,,Half life period after 3 mg/kg iv administration,,BAO_0000218,CHEMBL618663,2864,10116.0,Intermediate,1,,,50597,N,1,,
7543,,Half life period after 3 mg/kg iv administration in rat,,BAO_0000218,CHEMBL618664,2864,10116.0,Intermediate,1,,,50597,N,1,,
7544,,Half life period after 3 mg/kg iv administration in the rat,,BAO_0000218,CHEMBL618665,2864,10116.0,Intermediate,1,,,50597,N,1,,
7545,,Half life period in female Sprague-Dawley rats,,BAO_0000218,CHEMBL876498,6362,10116.0,Intermediate,1,,,50597,N,1,,
7546,,Half life period in rat,,BAO_0000218,CHEMBL618666,6249,10116.0,Intermediate,1,,,50597,N,1,,
7547,,Half-life in rats was determined,,BAO_0000218,CHEMBL620440,3169,10116.0,Intermediate,1,,,50597,N,1,,
7548,,Half-life in rats with metabolic oxidation,,BAO_0000218,CHEMBL620441,3169,10116.0,Intermediate,1,,,50597,N,1,,
7549,,Half-life in rats,,BAO_0000218,CHEMBL620442,3169,10116.0,Intermediate,1,,,50597,N,1,,
7550,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,CHEMBL620443,17260,10116.0,Intermediate,1,,,50597,N,1,,
7551,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,CHEMBL620444,17260,10116.0,Intermediate,1,,,50597,N,1,,
7552,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,CHEMBL620445,17260,10116.0,Intermediate,1,,,50597,N,1,,
7553,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,CHEMBL620446,17260,10116.0,Intermediate,1,,,50597,N,1,,
7554,,Biological half-life measured in plasma of rat,,BAO_0000218,CHEMBL620447,2879,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7555,,Biological half-life measured in plasma of rat; 22-25,,BAO_0000218,CHEMBL621129,2879,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7556,,Biological half-life measured in plasma of rat; 9-16,,BAO_0000218,CHEMBL621130,2879,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7557,,Compound was evaluated for its half life when administered intravenously in rat,,BAO_0000218,CHEMBL873808,3184,10116.0,Intermediate,1,,,50597,N,1,,
7558,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,BAO_0000218,CHEMBL876598,4891,10116.0,Intermediate,1,,,50597,N,1,,
7559,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,BAO_0000218,CHEMBL621131,429,10116.0,Intermediate,1,,,50597,N,1,,
7560,,Half life (T1/2) after oral administration in rat,,BAO_0000218,CHEMBL621132,5656,10116.0,Intermediate,1,,,50597,N,1,,
7561,,Half life of compound after iv administration of 20 mg/kg dose in rat,,BAO_0000218,CHEMBL621133,4413,10116.0,Intermediate,1,,,50597,N,1,,
7562,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL621312,3598,10116.0,Expert,1,,,50597,N,1,,
7563,,Half life of compound was determined in rat,,BAO_0000218,CHEMBL621313,17267,10116.0,Intermediate,1,,,50597,N,1,,
7564,,Half life of compound was determined in rat blood,,BAO_0000218,CHEMBL621314,4727,10116.0,Intermediate,1,,,50597,N,1,178.0,
7565,,Half life at 1 mg/kg was determined in rat,,BAO_0000218,CHEMBL621315,17651,10116.0,Intermediate,1,,,50597,N,1,,
7566,,Half life at 10 mg/kg was determined in rat,,BAO_0000218,CHEMBL621316,17651,10116.0,Intermediate,1,,,50597,N,1,,
7567,,Half life in rats,,BAO_0000218,CHEMBL621317,401,10116.0,Intermediate,1,,,50597,N,1,,
7568,,Half life in rats in hours,,BAO_0000218,CHEMBL621318,4942,10116.0,Intermediate,1,,,50597,N,1,,
7569,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,BAO_0000218,CHEMBL621319,17735,10116.0,Intermediate,1,,,50597,N,1,,
7570,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,BAO_0000218,CHEMBL621377,6056,10116.0,Intermediate,1,,,50597,N,1,,
7571,,Half life was determined,,BAO_0000218,CHEMBL621378,5213,10116.0,Intermediate,1,,,50597,N,1,,
7572,,Half life after i.v. administration,,BAO_0000218,CHEMBL876599,6616,10116.0,Intermediate,1,,,50597,N,1,,
7573,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,BAO_0000218,CHEMBL621379,5937,10116.0,Intermediate,1,,,50597,N,1,,
7574,,Half life in rat plasma,,BAO_0000218,CHEMBL621380,5819,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7575,,Half life in rat plasma; Not detected,,BAO_0000218,CHEMBL621381,5819,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7576,,Half life in rats,,BAO_0000218,CHEMBL618515,6803,10116.0,Intermediate,1,,,50597,N,1,,
7577,,Half life period of compound was determined after peroral administration,,BAO_0000218,CHEMBL618516,17804,10116.0,Intermediate,1,,,50597,N,1,,
7578,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,BAO_0000218,CHEMBL618517,17804,10116.0,Intermediate,1,,,50597,N,1,,
7579,,Half life period in rat,,BAO_0000218,CHEMBL618518,5948,10116.0,Intermediate,1,,,50597,N,1,,
7580,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,BAO_0000218,CHEMBL618519,1916,10116.0,Intermediate,1,,,50597,N,1,,
7581,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,BAO_0000218,CHEMBL618698,1916,10116.0,Intermediate,1,,,50597,N,1,,
7582,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,BAO_0000218,CHEMBL618862,1916,10116.0,Intermediate,1,,,50597,N,1,,
7583,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL618863,4890,10116.0,Intermediate,1,,,50597,N,1,,
7584,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,CHEMBL618864,17764,10116.0,Intermediate,1,,,50597,N,1,,
7585,,Half life time in rat the dose of 2 mg/kg,,BAO_0000218,CHEMBL618865,4727,10116.0,Intermediate,1,,,50597,N,1,,
7586,,Half-life 24 hr after 10 mg/kg iv administration in rats,,BAO_0000218,CHEMBL618866,17509,10116.0,Intermediate,1,,,50597,N,1,,
7587,,Half-life 24 hr after 2 mg/kg iv administration in rats,,BAO_0000218,CHEMBL618867,17509,10116.0,Intermediate,1,,,50597,N,1,,
7588,,Half-life consistent with the observed metabolic steady state in rats,,BAO_0000218,CHEMBL875828,6597,10116.0,Intermediate,1,,,50597,N,1,,
7589,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,BAO_0000218,CHEMBL618868,17735,10116.0,Intermediate,1,,,50597,N,1,,
7590,,Half-life for oxidative metabolic stability was determined using male human,,BAO_0000218,CHEMBL618869,6597,10116.0,Intermediate,1,,,50597,N,1,,
7591,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,CHEMBL618870,17670,10116.0,Intermediate,1,,,50597,N,1,,
7592,,Half-life in rat plasma,,BAO_0000218,CHEMBL618871,1696,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7593,,Half-life in rat plasma was determined,,BAO_0000218,CHEMBL618872,1742,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7594,,Half-life in rats was determined,,BAO_0000218,CHEMBL873816,17800,10116.0,Intermediate,1,,,50597,N,1,,
7595,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,BAO_0000218,CHEMBL618873,12923,,Autocuration,1,,,22224,U,0,,
7596,,Area under curve after oral dose of 0.1 mg//kg,,BAO_0000019,CHEMBL621602,11954,,Autocuration,1,,,22224,U,0,,
7597,,Area under curve after oral dose of 0.3 mg/kg,,BAO_0000218,CHEMBL621603,11954,,Autocuration,1,,,22224,U,0,,
7598,,Area under curve after oral dose of 1 mg/kg,,BAO_0000218,CHEMBL621604,11954,,Autocuration,1,,,22224,U,0,,
7599,,Area under curve after oral dose of 10 mg/kg,,BAO_0000218,CHEMBL621605,11954,,Autocuration,1,,,22224,U,0,,
7600,,Area under curve after oral dose of 23.4 mg/kg,,BAO_0000218,CHEMBL621606,11954,,Autocuration,1,,,22224,U,0,,
7601,,Area under curve after oral dose of 3 mg/kg,,BAO_0000218,CHEMBL621607,11954,,Autocuration,1,,,22224,U,0,,
7602,,Area under curve after oral dose of 3.87 mg/kg,,BAO_0000218,CHEMBL621608,11954,,Autocuration,1,,,22224,U,0,,
7603,,Area under curve was determined,,BAO_0000019,CHEMBL621609,5237,,Autocuration,1,,,22224,U,0,,
7604,,Area under curve at a dose of 10 mg/kg,,BAO_0000218,CHEMBL621610,4026,,Autocuration,1,,,22224,U,0,,
7605,,Area under curve was determined; ND=No data,,BAO_0000218,CHEMBL621611,5237,10116.0,Intermediate,1,,,50597,N,1,,
7606,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL621612,14793,10116.0,Intermediate,1,,,50597,N,1,,
7607,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,BAO_0000218,CHEMBL622308,14793,10116.0,Intermediate,1,,,50597,N,1,,
7608,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622309,14793,10116.0,Intermediate,1,,,50597,N,1,,
7609,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,BAO_0000218,CHEMBL622310,14793,10116.0,Intermediate,1,,,50597,N,1,,
7610,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622311,14793,10116.0,Intermediate,1,,,50597,N,1,,
7611,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,BAO_0000218,CHEMBL622312,14793,10116.0,Intermediate,1,,,50597,N,1,,
7612,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622931,14793,10116.0,Intermediate,1,,,50597,N,1,,
7613,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,BAO_0000218,CHEMBL622932,14793,10116.0,Intermediate,1,,,50597,N,1,,
7614,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622736,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7615,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,BAO_0000218,CHEMBL622737,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7616,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622738,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7617,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,BAO_0000218,CHEMBL622739,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7618,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622740,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7619,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,BAO_0000218,CHEMBL622741,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7620,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,BAO_0000218,CHEMBL622742,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7621,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,BAO_0000218,CHEMBL622743,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7622,,AUC in mice,,BAO_0000218,CHEMBL622744,11637,10090.0,Intermediate,1,,,50594,N,1,1969.0,
7623,,Area under curve was measured from the graph obtained from concentration Vs time,,BAO_0000019,CHEMBL624134,11149,,Autocuration,1,,,22224,U,0,,
7624,,Area under curve value of compound per hour after oral administration,,BAO_0000019,CHEMBL624135,10016,,Autocuration,1,,,22224,U,0,,
7625,,Area under curve was determined after oral administration in rats,,BAO_0000218,CHEMBL624136,17796,10116.0,Intermediate,1,,,50597,N,1,,
7626,,Area under curve was determined after oral administration in rats; No data,,BAO_0000218,CHEMBL624137,17796,10116.0,Intermediate,1,,,50597,N,1,,
7627,,Area under curve was determined after oral administration in rats;No data,,BAO_0000218,CHEMBL624320,17796,10116.0,Intermediate,1,,,50597,N,1,,
7628,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,BAO_0000218,CHEMBL624321,12923,9615.0,Intermediate,1,,,50588,N,1,,
7629,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,BAO_0000218,CHEMBL624322,15372,10116.0,Intermediate,1,,,50597,N,1,,
7630,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,BAO_0000218,CHEMBL624323,15372,10116.0,Intermediate,1,,,50597,N,1,,
7631,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,BAO_0000218,CHEMBL624324,15372,10116.0,Intermediate,1,,,50597,N,1,,
7632,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,BAO_0000218,CHEMBL624325,15372,10116.0,Intermediate,1,,,50597,N,1,,
7633,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,BAO_0000218,CHEMBL624326,15372,10116.0,Intermediate,1,,,50597,N,1,,
7634,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,BAO_0000218,CHEMBL624327,15372,10116.0,Intermediate,1,,,50597,N,1,,
7635,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,BAO_0000218,CHEMBL624328,15372,10116.0,Intermediate,1,,,50597,N,1,,
7636,,Area under curve was determined in Dogs after peroral administration,,BAO_0000218,CHEMBL627848,14169,9615.0,Intermediate,1,,,50588,N,1,,
7637,,Area under curve was determined in Rats after peroral administration,,BAO_0000218,CHEMBL627849,14169,10116.0,Intermediate,1,,,50597,N,1,,
7638,,Area under curve was determined in carotid blood of rat when administered intradermally,,BAO_0000218,CHEMBL627850,14258,10116.0,Intermediate,1,,,50597,N,1,,
7639,,Area under curve was determined in portal blood of rat when administered intradermally,,BAO_0000218,CHEMBL627851,14258,10116.0,Intermediate,1,,,50597,N,1,,
7640,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL627852,15011,10090.0,Intermediate,1,,,50594,N,1,,
7641,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL627853,15011,10090.0,Intermediate,1,,,50594,N,1,,
7642,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,BAO_0000218,CHEMBL627854,15011,10090.0,Intermediate,1,,,50594,N,1,,
7643,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL627855,15011,10090.0,Intermediate,1,,,50594,N,1,,
7644,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,BAO_0000218,CHEMBL627856,15011,10090.0,Intermediate,1,,,50594,N,1,,
7645,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL875339,15011,10090.0,Intermediate,1,,,50594,N,1,,
7646,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,BAO_0000218,CHEMBL627857,15011,10090.0,Intermediate,1,,,50594,N,1,,
7647,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,BAO_0000218,CHEMBL627858,11195,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7648,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627859,10130,10116.0,Intermediate,1,,,50597,N,1,178.0,
7649,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627860,10130,10116.0,Intermediate,1,,,50597,N,1,955.0,
7650,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627019,10130,10116.0,Intermediate,1,,,50597,N,1,948.0,
7651,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627020,10130,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7652,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627021,10130,10116.0,Intermediate,1,,,50597,N,1,2048.0,
7653,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627022,10130,10116.0,Intermediate,1,,,50597,N,1,2385.0,
7654,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627023,10130,10116.0,Intermediate,1,,,50597,N,1,,
7655,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627024,10130,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7656,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627025,10130,10116.0,Intermediate,1,,,50597,N,1,2046.0,
7657,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627026,10130,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7658,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627027,10130,10116.0,Intermediate,1,,,50597,N,1,178.0,
7659,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627028,10130,10116.0,Intermediate,1,,,50597,N,1,955.0,
7660,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627029,10130,10116.0,Intermediate,1,,,50597,N,1,948.0,
7661,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627030,10130,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7662,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627031,10130,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7663,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627032,10130,10116.0,Intermediate,1,,,50597,N,1,2048.0,
7664,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627033,10130,10116.0,Intermediate,1,,,50597,N,1,2385.0,
7665,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627034,10130,10116.0,Intermediate,1,,,50597,N,1,,
7666,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627035,10130,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7667,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627036,10130,10116.0,Intermediate,1,,,50597,N,1,2046.0,
7668,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,BAO_0000218,CHEMBL875340,10130,10116.0,Intermediate,1,,,50597,N,1,178.0,
7669,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627037,10130,10116.0,Intermediate,1,,,50597,N,1,948.0,
7670,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627038,10130,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7671,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627039,10130,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7672,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,BAO_0000218,CHEMBL627040,10130,10116.0,Intermediate,1,,,50597,N,1,2385.0,
7673,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,BAO_0000218,CHEMBL624663,10130,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7674,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,BAO_0000218,CHEMBL625963,10130,10116.0,Intermediate,1,,,50597,N,1,2046.0,
7675,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,BAO_0000218,CHEMBL876799,10130,10116.0,Intermediate,1,,,50597,N,1,955.0,
7676,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,BAO_0000218,CHEMBL626133,10130,10116.0,Intermediate,1,,,50597,N,1,2048.0,
7677,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,BAO_0000218,CHEMBL626134,10130,10116.0,Intermediate,1,,,50597,N,1,,
7678,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,BAO_0000218,CHEMBL626135,6295,10116.0,Intermediate,1,,,50597,N,1,,
7679,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,BAO_0000218,CHEMBL626136,6296,10116.0,Intermediate,1,,,50597,N,1,,
7680,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,BAO_0000218,CHEMBL626137,6296,10116.0,Intermediate,1,,,50597,N,1,,
7681,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,BAO_0000218,CHEMBL626138,6295,10116.0,Intermediate,1,,,50597,N,1,,
7682,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,BAO_0000218,CHEMBL626139,6296,10116.0,Intermediate,1,,,50597,N,1,,
7683,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,CHEMBL626140,17260,10116.0,Intermediate,1,,,50597,N,1,,
7684,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,CHEMBL626141,17260,10116.0,Intermediate,1,,,50597,N,1,,
7685,,C24h in rat p.o. at 20 mg/kg concentration,,BAO_0000218,CHEMBL626142,17686,10116.0,Intermediate,1,,,50597,N,1,,
7686,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,CHEMBL627930,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
7687,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,CHEMBL627931,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
7688,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,CHEMBL627932,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
7689,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,BAO_0000218,CHEMBL627933,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7690,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,BAO_0000218,CHEMBL627934,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7691,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,BAO_0000218,CHEMBL627935,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
7692,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,BAO_0000218,CHEMBL627936,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7693,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL627937,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7694,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,CHEMBL627938,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7695,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,CHEMBL627939,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7696,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,CHEMBL627940,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7697,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,CHEMBL627941,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7698,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,CHEMBL876800,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7699,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL627942,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7700,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,BAO_0000218,CHEMBL627943,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7701,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,BAO_0000218,CHEMBL627944,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7702,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,CHEMBL627945,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7703,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,CHEMBL628584,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7704,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,BAO_0000218,CHEMBL628585,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7705,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,BAO_0000218,CHEMBL628586,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7706,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,BAO_0000218,CHEMBL628587,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7707,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,BAO_0000218,CHEMBL628588,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7708,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,BAO_0000218,CHEMBL628589,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7709,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,CHEMBL625304,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7710,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,CHEMBL625305,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7711,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,BAO_0000218,CHEMBL625306,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7712,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,BAO_0000218,CHEMBL625307,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7713,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,CHEMBL625308,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7714,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,CHEMBL627740,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7715,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,BAO_0000218,CHEMBL627741,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7716,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,CHEMBL627742,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7717,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL627743,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7718,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL627744,9866,10116.0,Intermediate,1,,,50597,N,1,178.0,
7719,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL627745,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7720,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,CHEMBL627746,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7721,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,BAO_0000218,CHEMBL627747,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7722,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,CHEMBL876810,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7723,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,CHEMBL627748,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7724,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,CHEMBL627749,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7725,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,CHEMBL627750,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7726,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL618728,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7727,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,BAO_0000218,CHEMBL618729,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7728,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,BAO_0000218,CHEMBL618730,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7729,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,BAO_0000218,CHEMBL618731,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7730,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,BAO_0000218,CHEMBL618732,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7731,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,BAO_0000218,CHEMBL618733,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7732,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,BAO_0000218,CHEMBL618734,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7733,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,CHEMBL618735,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7734,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,CHEMBL876602,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7735,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,CHEMBL618736,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7736,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,BAO_0000218,CHEMBL618737,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7737,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,CHEMBL618738,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7738,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,CHEMBL618739,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7739,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,CHEMBL618740,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7740,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,CHEMBL618741,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7741,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL618742,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7742,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL618743,9866,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
7743,,Half-life from rat plasma at a single oral dose of 25 mg/kg,,BAO_0000218,CHEMBL618744,17752,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7744,,Half-life in male rat,,BAO_0000218,CHEMBL618745,5610,10116.0,Intermediate,1,,,50597,N,1,,
7745,,Half-life in rat after peroral administration at 10 mg/kg concentration,,BAO_0000218,CHEMBL620479,5939,10116.0,Intermediate,1,,,50597,N,1,,
7746,,Half-life in rat after peroral administration at 5 mg/kg concentration,,BAO_0000218,CHEMBL620480,5939,10116.0,Intermediate,1,,,50597,N,1,,
7747,,Half-life in rat at a dose of 3 mg/kg,,BAO_0000218,CHEMBL620481,17771,10116.0,Intermediate,1,,,50597,N,1,,
7748,,Half-life was evaluated in rats,,BAO_0000218,CHEMBL620482,1974,10116.0,Intermediate,1,,,50597,N,1,,
7749,,Half-life was measured in rat,,BAO_0000218,CHEMBL876603,4239,10116.0,Intermediate,1,,,50597,N,1,,
7750,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,BAO_0000218,CHEMBL620483,6681,10116.0,Intermediate,1,,,50597,N,1,,
7751,,Half-life period in rats after intravenous administration at 5 mg/kg,,BAO_0000218,CHEMBL620484,17752,10116.0,Intermediate,1,,,50597,N,1,,
7752,,Half-life period in rat at 10 mg/kg,,BAO_0000218,CHEMBL620485,6046,10116.0,Intermediate,1,,,50597,N,1,,
7753,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,CHEMBL620486,6685,10116.0,Intermediate,1,,,50597,N,1,,
7754,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,BAO_0000218,CHEMBL620487,6685,10116.0,Intermediate,1,,,50597,N,1,,
7755,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,CHEMBL620488,6685,10116.0,Intermediate,1,,,50597,N,1,,
7756,,Half-life time in rat the dose of 2 mg/kg,,BAO_0000218,CHEMBL620489,4727,10116.0,Intermediate,1,,,50597,N,1,,
7757,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,BAO_0000218,CHEMBL620490,1088,10116.0,Intermediate,1,,,50597,N,1,,
7758,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,BAO_0000218,CHEMBL620491,5610,10116.0,Intermediate,1,,,50597,N,1,,
7759,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,BAO_0000218,CHEMBL876604,3032,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7760,,Oral half life was determined,,BAO_0000218,CHEMBL620492,5199,10116.0,Intermediate,1,,,50597,N,1,,
7761,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,CHEMBL620493,14941,10116.0,Intermediate,1,,,50597,N,1,,
7762,,Pharmacokinetic property (t1/2) in rat,,BAO_0000218,CHEMBL620494,4408,10116.0,Intermediate,1,,,50597,N,1,,
7763,,Plasma elimination half-life was determined,,BAO_0000218,CHEMBL620495,2552,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7764,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,BAO_0000218,CHEMBL620496,5199,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7765,,Plasma half life was observed after intravenous administration in rat,,BAO_0000218,CHEMBL620497,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7766,,Plasma half-life was determined,,BAO_0000218,CHEMBL620498,1465,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7767,,Plasma half-life following oral administration in Fisher rats,,BAO_0000218,CHEMBL620499,1446,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7768,,Plasma half-life in rat,,BAO_0000218,CHEMBL620500,6824,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7769,,Plasmatic Half-life after intravenous administration to rat,,BAO_0000218,CHEMBL873809,17533,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7770,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,BAO_0000218,CHEMBL620501,5979,10116.0,Intermediate,1,,,50597,N,1,,
7771,,Terminal half life after intravenous administration (1 mg/kg) in rat,,BAO_0000218,CHEMBL620502,4689,10116.0,Intermediate,1,,,50597,N,1,,
7772,,Terminal half life in Rat at a oral dose of 5 mg/kg,,BAO_0000218,CHEMBL620503,4689,10116.0,Intermediate,1,,,50597,N,1,,
7773,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,BAO_0000218,CHEMBL620504,2463,10116.0,Intermediate,1,,,50597,N,1,,
7774,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,BAO_0000218,CHEMBL876605,4883,10116.0,Intermediate,1,,,50597,N,1,,
7775,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,BAO_0000218,CHEMBL620505,4883,10116.0,Intermediate,1,,,50597,N,1,,
7776,,plasma half life was observed after intravenous administration in rat,,BAO_0000218,CHEMBL873811,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7777,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL624016,3598,10116.0,Expert,1,,,50597,N,1,,
7778,,Half life of compound determined in rat,,BAO_0000218,CHEMBL624017,4576,10116.0,Intermediate,1,,,50597,N,1,,
7779,,Mean residence time determined in rat,,BAO_0000218,CHEMBL624018,4576,10116.0,Intermediate,1,,,50597,N,1,,
7780,,Plasma half life determined in rat,,BAO_0000218,CHEMBL624019,4576,10116.0,Intermediate,1,,,50597,N,1,,
7781,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,BAO_0000218,CHEMBL624020,4910,10116.0,Intermediate,1,,,50597,N,1,955.0,
7782,,Compound was evaluated for pharmacokinetic parameter maximum time period,,BAO_0000218,CHEMBL624201,4891,10116.0,Intermediate,1,,,50597,N,1,,
7783,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,BAO_0000218,CHEMBL872528,429,10116.0,Intermediate,1,,,50597,N,1,,
7784,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624202,5974,10116.0,Intermediate,1,,,50597,N,1,,
7785,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624203,5974,10116.0,Intermediate,1,,,50597,N,1,,
7786,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624350,5974,10116.0,Intermediate,1,,,50597,N,1,,
7787,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL621320,5974,10116.0,Intermediate,1,,,50597,N,1,,
7788,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,BAO_0000218,CHEMBL621321,17582,10116.0,Intermediate,1,,,50597,N,1,,
7789,,Maximum time (Tmax) required to reach Cmax in rats,,BAO_0000218,CHEMBL621322,4026,10116.0,Intermediate,1,,,50597,N,1,,
7790,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL621323,4890,10116.0,Intermediate,1,,,50597,N,1,,
7791,,Maximum time of clearance of compound in rats after peroral administration,,BAO_0000218,CHEMBL621324,6571,10116.0,Intermediate,1,,,50597,N,1,,
7792,,Maximum time at the dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL621325,4727,10116.0,Intermediate,1,,,50597,N,1,,
7793,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,BAO_0000218,CHEMBL875837,17651,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7794,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,BAO_0000218,CHEMBL621326,17651,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7795,,Tmax in Guinea pig (PO dose),,BAO_0000218,CHEMBL621327,14465,10116.0,Intermediate,1,,,50597,N,1,,
7796,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,CHEMBL621328,14941,10116.0,Intermediate,1,,,50597,N,1,,
7797,,Pharmacokinetic parameter (Tmax) in rat,,BAO_0000218,CHEMBL621329,5960,10116.0,Intermediate,1,,,50597,N,1,,
7798,,Pharmacokinetic parameter (Tmax) was estimated,,BAO_0000218,CHEMBL621330,5022,10116.0,Intermediate,1,,,50597,N,1,,
7799,,Pharmacokinetic property (Tmax) in rat,,BAO_0000218,CHEMBL621331,4408,10116.0,Intermediate,1,,,50597,N,1,,
7800,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,BAO_0000218,CHEMBL621332,5983,10116.0,Intermediate,1,,,50597,N,1,,
7801,,T max in Rat at a oral dose of 5 mg/kg,,BAO_0000218,CHEMBL621333,4689,10116.0,Intermediate,1,,,50597,N,1,,
7802,,T max was determined at 10 mg/kg po dose in rats,,BAO_0000218,CHEMBL621334,2792,10116.0,Intermediate,1,,,50597,N,1,,
7803,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,BAO_0000218,CHEMBL621335,15011,10090.0,Intermediate,1,,,50594,N,1,,
7804,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,BAO_0000218,CHEMBL621336,14180,9615.0,Intermediate,1,,,50588,N,1,,
7805,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,BAO_0000218,CHEMBL621337,14180,10116.0,Intermediate,1,,,50597,N,1,,
7806,,Area under curve was measured after i.v. administration into Beagle dog.,,BAO_0000218,CHEMBL621338,14599,9615.0,Intermediate,1,,,50588,N,1,,
7807,,Area under curve was measured after iv administration into Beagle dog,,BAO_0000218,CHEMBL875838,14599,9615.0,Intermediate,1,,,50588,N,1,,
7808,,Area under curve was measured after po administration into Beagle dog,,BAO_0000218,CHEMBL621339,14599,9615.0,Intermediate,1,,,50588,N,1,,
7809,,Area under curve was measured after po administration into Beagle dog.,,BAO_0000218,CHEMBL621340,14599,9615.0,Intermediate,1,,,50588,N,1,,
7810,,Area under curve was measured at peroral dose of 3 mg/kg,,BAO_0000218,CHEMBL621341,15675,,Autocuration,1,,,22224,U,0,,
7811,,Area under curve was measured by using concentration Vs time,,BAO_0000019,CHEMBL621342,12706,,Autocuration,1,,,22224,U,0,,
7812,,Area under curve was measured by using concentration Vs time; not tested,,BAO_0000019,CHEMBL621343,12706,,Autocuration,1,,,22224,U,0,,
7813,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,BAO_0000218,CHEMBL621344,9750,10090.0,Intermediate,1,,,50594,N,1,,
7814,,Area under curve(AUC) was measured in mice after oral administration.,,BAO_0000218,CHEMBL621345,9750,10090.0,Intermediate,1,,,50594,N,1,,
7815,,Area under curve(AUC) value of the compound,,BAO_0000019,CHEMBL621346,14691,,Autocuration,1,,,22224,U,0,,
7816,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,BAO_0000218,CHEMBL621347,14691,,Autocuration,1,,,22224,U,0,,
7817,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,BAO_0000218,CHEMBL621348,14691,9615.0,Intermediate,1,,,50588,N,1,,
7818,,Area under curve(carotid artery) was determined by the availability in blood,,BAO_0000019,CHEMBL621349,2939,,Autocuration,1,,,22224,U,0,178.0,
7819,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,BAO_0000019,CHEMBL621350,2939,,Autocuration,1,,,22224,U,0,178.0,
7820,,Area under curve(carotid artery) was determined by the availability in blood; No data,,BAO_0000019,CHEMBL875839,2939,,Autocuration,1,,,22224,U,0,178.0,
7821,,Area under curve(portal vein) was determined by the availability in blood,,BAO_0000019,CHEMBL620211,2939,,Autocuration,1,,,22224,U,0,178.0,
7822,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,BAO_0000019,CHEMBL620212,2939,,Autocuration,1,,,22224,U,0,178.0,
7823,,Area under curve(portal vein) was determined by the availability in blood; No data,,BAO_0000019,CHEMBL620213,2939,,Autocuration,1,,,22224,U,0,178.0,
7824,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,BAO_0000218,CHEMBL620214,9552,9544.0,Intermediate,1,,,50797,N,1,1969.0,
7825,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,BAO_0000218,CHEMBL620215,9552,9544.0,Intermediate,1,,,50797,N,1,1969.0,
7826,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,BAO_0000218,CHEMBL620216,9552,9544.0,Intermediate,1,,,50797,N,1,1969.0,
7827,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,BAO_0000218,CHEMBL620888,9552,9615.0,Intermediate,1,,,50588,N,1,1969.0,
7828,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,BAO_0000218,CHEMBL620889,9552,9615.0,Intermediate,1,,,50588,N,1,1969.0,
7829,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,BAO_0000019,CHEMBL620890,9552,,Autocuration,1,,,22224,U,0,1969.0,
7830,,Area under plasma time curve determined in male rat,,BAO_0000218,CHEMBL620891,11911,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7831,,Area under the MAP curve measured over 5 min.,,BAO_0000019,CHEMBL620892,16618,,Autocuration,1,,,22224,U,0,,
7832,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,BAO_0000218,CHEMBL621079,14387,10090.0,Intermediate,1,,,50594,N,1,,
7833,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,BAO_0000218,CHEMBL621080,14387,10090.0,Intermediate,1,,,50594,N,1,,
7834,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,BAO_0000218,CHEMBL621081,12836,9615.0,Intermediate,1,,,50588,N,1,,
7835,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,BAO_0000218,CHEMBL621082,12836,10026.0,Intermediate,1,,,100712,N,1,,
7836,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,BAO_0000218,CHEMBL621083,12836,10116.0,Intermediate,1,,,50597,N,1,,
7837,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,BAO_0000218,CHEMBL621084,14339,9615.0,Intermediate,1,,,50588,N,1,,
7838,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,BAO_0000218,CHEMBL621085,14339,9615.0,Intermediate,1,,,50588,N,1,,
7839,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,BAO_0000218,CHEMBL621086,14339,9615.0,Intermediate,1,,,50588,N,1,,
7840,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,BAO_0000218,CHEMBL621087,10524,9615.0,Intermediate,1,,,50588,N,1,,
7841,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,BAO_0000218,CHEMBL622607,9994,9615.0,Intermediate,1,,,50588,N,1,,
7842,,Serum AUC in marmosets (IV dose),,BAO_0000218,CHEMBL622608,11325,9615.0,Intermediate,1,,,50588,N,1,,
7843,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,BAO_0000019,CHEMBL624481,12536,,Autocuration,1,,,22224,U,0,,
7844,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,BAO_0000019,CHEMBL624482,12536,,Autocuration,1,,,22224,U,0,,
7845,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,BAO_0000019,CHEMBL624483,12536,,Autocuration,1,,,22224,U,0,,
7846,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,BAO_0000019,CHEMBL624484,12536,,Autocuration,1,,,22224,U,0,,
7847,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,BAO_0000019,CHEMBL624485,12536,,Autocuration,1,,,22224,U,0,,
7848,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,BAO_0000218,CHEMBL624486,15556,10116.0,Intermediate,1,,,50597,N,1,,
7849,,Area under the curve for the compound was calculated.,,BAO_0000019,CHEMBL624487,2809,,Autocuration,1,,,22224,U,0,,
7850,,Area under the curve in concentration/ time,,BAO_0000019,CHEMBL624488,9511,,Autocuration,1,,,22224,U,0,,
7851,,Area under the curve administered intraintestinal in rats.,,BAO_0000218,CHEMBL624489,12818,10116.0,Intermediate,1,,,50597,N,1,,
7852,,Area under the curve administered intravenously in rats.,,BAO_0000218,CHEMBL625184,12818,10116.0,Intermediate,1,,,50597,N,1,,
7853,,Area under the curve during intravenous administration,,BAO_0000019,CHEMBL625185,15118,,Autocuration,1,,,22224,U,0,,
7854,,Area under the curve during intravenous administration; Not determined,,BAO_0000019,CHEMBL875954,15118,,Autocuration,1,,,22224,U,0,,
7855,,Area under the curve during systemic administration,,BAO_0000019,CHEMBL625186,15118,,Autocuration,1,,,22224,U,0,,
7856,,Area under the curve during systemic administration; Not determined,,BAO_0000019,CHEMBL625187,15118,,Autocuration,1,,,22224,U,0,,
7857,,Area under the curve was calculated for the compound.,,BAO_0000019,CHEMBL625188,2632,,Autocuration,1,,,22224,U,0,,
7858,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,BAO_0000218,CHEMBL625189,14346,9615.0,Intermediate,1,,,50588,N,1,,
7859,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,BAO_0000218,CHEMBL625190,14346,9615.0,Intermediate,1,,,50588,N,1,,
7860,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL621733,14346,10116.0,Intermediate,1,,,50597,N,1,,
7861,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL621734,14346,10116.0,Intermediate,1,,,50597,N,1,,
7862,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,BAO_0000218,CHEMBL621735,11149,10116.0,Intermediate,1,,,50597,N,1,,
7863,,Clearance of the drug was measured in the plasma of rat; No data,,BAO_0000218,CHEMBL621736,17796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7864,,The pharmacokinetic parameter plasma clearance in vivo in rats,,BAO_0000218,CHEMBL621737,5247,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7865,,Plasma clearance at the dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL621738,4727,10116.0,Intermediate,1,,,50597,N,1,,
7866,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,CHEMBL622806,5654,10116.0,Intermediate,1,,,50597,N,1,,
7867,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,CHEMBL623519,5654,10116.0,Intermediate,1,,,50597,N,1,,
7868,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,CHEMBL623520,17260,10116.0,Intermediate,1,,,50597,N,1,,
7869,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,CHEMBL623521,17065,10116.0,Intermediate,1,,,50597,N,1,,
7870,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,CHEMBL623522,17671,10116.0,Intermediate,1,,,50597,N,1,,
7871,,Clearance rate in rat,,BAO_0000218,CHEMBL623523,6672,10116.0,Intermediate,1,,,50597,N,1,,
7872,,Clearance rate in rat,,BAO_0000218,CHEMBL623690,6673,10116.0,Intermediate,1,,,50597,N,1,,
7873,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL623691,5978,10116.0,Intermediate,1,,,50597,N,1,,
7874,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL623692,5978,10116.0,Intermediate,1,,,50597,N,1,,
7875,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL623693,5978,10116.0,Intermediate,1,,,50597,N,1,,
7876,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL623694,5978,10116.0,Intermediate,1,,,50597,N,1,,
7877,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,BAO_0000218,CHEMBL623695,4413,10116.0,Intermediate,1,,,50597,N,1,,
7878,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,CHEMBL623696,2661,10116.0,Intermediate,1,,,50597,N,1,,
7879,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,CHEMBL623697,2661,10116.0,Intermediate,1,,,50597,N,1,,
7880,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,BAO_0000218,CHEMBL623698,5005,9544.0,Intermediate,1,,,22224,U,0,1969.0,
7881,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,BAO_0000218,CHEMBL623699,5005,10116.0,Intermediate,1,,,22224,U,0,1969.0,
7882,,Mean (%CV) PK parameters for CL(mL/min/kg).,,BAO_0000218,CHEMBL623700,15765,10116.0,Intermediate,1,,,50597,N,1,,
7883,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,BAO_0000218,CHEMBL623701,3747,10116.0,Intermediate,1,,,50597,N,1,,
7884,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,BAO_0000218,CHEMBL623702,16366,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7885,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,BAO_0000218,CHEMBL623703,4199,10116.0,Intermediate,1,,,50597,N,1,,
7886,,Plasma clearance in rat was determined,,BAO_0000218,CHEMBL623704,17267,10116.0,Intermediate,1,,,50597,N,1,,
7887,,Plasma clearance in rat after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL623705,6535,10116.0,Intermediate,1,,,50597,N,1,,
7888,,Plasma clearance in rat after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL623706,6535,10116.0,Intermediate,1,,,50597,N,1,,
7889,,Plasma clearance was determined,,BAO_0000218,CHEMBL623707,5041,10116.0,Intermediate,1,,,50597,N,1,,
7890,,Plasma clearance in rat,,BAO_0000218,CHEMBL623708,5960,10116.0,Intermediate,1,,,50597,N,1,,
7891,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,BAO_0000218,CHEMBL623709,5937,10116.0,Intermediate,1,,,50597,N,1,,
7892,,Plasma clearance in rat by iv administration,,BAO_0000218,CHEMBL623710,5871,10116.0,Intermediate,1,,,50597,N,1,,
7893,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,BAO_0000218,CHEMBL623711,5874,10116.0,Intermediate,1,,,50597,N,1,,
7894,,Plasma clearance in rat p.o.,,BAO_0000218,CHEMBL623712,6504,10116.0,Intermediate,1,,,50597,N,1,,
7895,,Plasma clearance in rats,,BAO_0000218,CHEMBL623713,6803,10116.0,Intermediate,1,,,50597,N,1,,
7896,,Plasma clearance was determined; ND denotes no data,,BAO_0000218,CHEMBL623714,5041,10116.0,Intermediate,1,,,50597,N,1,,
7897,,Plasma clearance was determined; ND denotes not determined,,BAO_0000218,CHEMBL623715,5041,10116.0,Intermediate,1,,,50597,N,1,,
7898,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,BAO_0000218,CHEMBL623716,1916,10116.0,Intermediate,1,,,50597,N,1,,
7899,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,BAO_0000218,CHEMBL622980,5199,10116.0,Intermediate,1,,,50597,N,1,,
7900,,Plasma administration to rats,,BAO_0000218,CHEMBL622981,16367,10116.0,Intermediate,1,,,50597,N,1,,
7901,,Plasma clearance of the compound in female Sprague-Dawley rats,,BAO_0000218,CHEMBL622982,6362,10116.0,Intermediate,1,,,50597,N,1,,
7902,,Plasma clearance was observed after intravenous administration in rat,,BAO_0000218,CHEMBL622983,15662,10116.0,Intermediate,1,,,50597,N,1,,
7903,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,BAO_0000218,CHEMBL622984,6215,10116.0,Intermediate,1,,,50597,N,1,,
7904,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL622985,1466,10116.0,Intermediate,1,,,50597,N,1,,
7905,,plasma clearance was observed after intravenous administration in rat,,BAO_0000218,CHEMBL623631,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7906,,In vivo CL/F determined,,BAO_0000218,CHEMBL623632,4723,10116.0,Intermediate,1,,,50597,N,1,,
7907,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL623633,2792,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7908,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL623634,2792,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7909,,Compound was tested for the lower blood clearance in rat,,BAO_0000218,CHEMBL623635,5213,10116.0,Intermediate,1,,,50597,N,1,,
7910,,Evaluated for the low clearance in rat (in vivo),,BAO_0000218,CHEMBL621195,4687,10116.0,Intermediate,1,,,50597,N,1,,
7911,,Pharmacokinetic property (CLb)of the compound was determined in rat,,BAO_0000218,CHEMBL621196,3371,10116.0,Intermediate,1,,,50597,N,1,,
7912,,Rapid clearance after intravenous administration in rat was determined,,BAO_0000218,CHEMBL875287,4690,10116.0,Intermediate,1,,,50597,N,1,,
7913,,Clearance measured in rat,,BAO_0000218,CHEMBL621197,5702,10116.0,Intermediate,1,,,50597,N,1,,
7914,,Compound was evaluated for plasma clearance in rat,,BAO_0000218,CHEMBL621198,740,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7915,,Low plasma clearance was calculated in rat,,BAO_0000218,CHEMBL621199,4853,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7916,,Pharmacokinetic property (Clp) in rat,,BAO_0000218,CHEMBL621200,5789,10116.0,Intermediate,1,,,50597,N,1,,
7917,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,BAO_0000218,CHEMBL621201,4527,10116.0,Intermediate,1,,,50597,N,1,,
7918,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,BAO_0000218,CHEMBL621202,4527,10116.0,Intermediate,1,,,50597,N,1,,
7919,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,BAO_0000218,CHEMBL621203,6518,10116.0,Intermediate,1,,,50597,N,1,,
7920,,Plasma clearance after IV dosing at 1 mg/kg in rat,,BAO_0000218,CHEMBL621204,6518,10116.0,Intermediate,1,,,50597,N,1,,
7921,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,BAO_0000218,CHEMBL621205,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7922,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL621206,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7923,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,BAO_0000218,CHEMBL621207,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7924,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,BAO_0000218,CHEMBL621208,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7925,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,CHEMBL621209,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7926,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,CHEMBL876484,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7927,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,CHEMBL621210,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7928,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL621211,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7929,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,BAO_0000218,CHEMBL621212,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7930,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,BAO_0000218,CHEMBL621213,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7931,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,BAO_0000218,CHEMBL621214,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7932,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,BAO_0000218,CHEMBL621215,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7933,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,BAO_0000218,CHEMBL621216,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7934,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,CHEMBL621217,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7935,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,CHEMBL621218,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7936,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,CHEMBL621219,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7937,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,BAO_0000218,CHEMBL621220,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7938,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,CHEMBL621221,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7939,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,CHEMBL621222,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7940,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,CHEMBL621223,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7941,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,BAO_0000218,CHEMBL876485,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7942,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,CHEMBL621224,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7943,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL621225,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7944,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL621226,9866,10116.0,Intermediate,1,,,50597,N,1,948.0,
7945,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL621227,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7946,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,CHEMBL621228,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7947,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,BAO_0000218,CHEMBL621229,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7948,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,CHEMBL621230,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7949,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,BAO_0000218,CHEMBL621231,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7950,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,CHEMBL621232,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7951,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,CHEMBL621233,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7952,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL621234,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7953,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,BAO_0000218,CHEMBL621235,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7954,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,CHEMBL621236,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7955,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL621237,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7956,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL876486,9866,10116.0,Intermediate,1,,,50597,N,1,2113.0,
7957,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,BAO_0000218,CHEMBL622436,9866,10116.0,Intermediate,1,,,50597,N,1,160.0,
7958,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,CHEMBL622437,9866,10116.0,Intermediate,1,,,50597,N,1,160.0,
7959,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,CHEMBL622438,9866,10116.0,Intermediate,1,,,50597,N,1,160.0,
7960,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,BAO_0000218,CHEMBL622439,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7961,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,CHEMBL622440,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7962,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL622441,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7963,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,BAO_0000218,CHEMBL622442,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7964,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL622443,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7965,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,BAO_0000218,CHEMBL622444,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7966,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,CHEMBL622445,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7967,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,BAO_0000218,CHEMBL622446,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7968,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,BAO_0000218,CHEMBL622447,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7969,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL622448,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7970,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,BAO_0000218,CHEMBL622449,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7971,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,CHEMBL622450,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7972,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,BAO_0000218,CHEMBL622451,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7973,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,BAO_0000218,CHEMBL622452,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7974,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,BAO_0000218,CHEMBL622453,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7975,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,BAO_0000218,CHEMBL622454,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7976,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,BAO_0000218,CHEMBL622455,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7977,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,BAO_0000218,CHEMBL876024,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
7978,,T max was determined at 3 mg/kg po dose in rats,,BAO_0000218,CHEMBL622456,2792,10116.0,Intermediate,1,,,50597,N,1,,
7979,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622457,15078,10116.0,Intermediate,1,,,50597,N,1,,
7980,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622458,15078,10116.0,Intermediate,1,,,50597,N,1,,
7981,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,BAO_0000218,CHEMBL622459,15022,10116.0,Intermediate,1,,,50597,N,1,,
7982,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,BAO_0000218,CHEMBL873343,15022,10116.0,Intermediate,1,,,50597,N,1,,
7983,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,BAO_0000218,CHEMBL622460,15022,10116.0,Intermediate,1,,,50597,N,1,,
7984,,Time for maximum plasma concentration determined in rat,,BAO_0000218,CHEMBL622461,4576,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7985,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,BAO_0000218,CHEMBL622462,6681,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7986,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,BAO_0000218,CHEMBL622463,16365,10116.0,Intermediate,1,,,50597,N,1,,
7987,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,BAO_0000218,CHEMBL622464,16365,10116.0,Intermediate,1,,,50597,N,1,,
7988,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,BAO_0000218,CHEMBL622465,16365,10116.0,Intermediate,1,,,50597,N,1,,
7989,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,BAO_0000218,CHEMBL622466,16365,10116.0,Intermediate,1,,,50597,N,1,,
7990,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,BAO_0000218,CHEMBL622467,16365,10116.0,Intermediate,1,,,50597,N,1,,
7991,,Time of maximum plasma concentration in rat,,BAO_0000218,CHEMBL622468,6824,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7992,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,CHEMBL876025,6685,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7993,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,BAO_0000218,CHEMBL622469,6685,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7994,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,BAO_0000218,CHEMBL622470,6685,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7995,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,BAO_0000218,CHEMBL622471,15662,10116.0,Intermediate,1,,,50597,N,1,,
7996,,Time required to reach maximum concentration in rat plasma,,BAO_0000218,CHEMBL622472,1742,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7997,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,BAO_0000218,CHEMBL622473,2774,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7998,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,BAO_0000218,CHEMBL624282,5199,10116.0,Intermediate,1,,,50597,N,1,1969.0,
7999,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,CHEMBL624283,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8000,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,CHEMBL624284,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8001,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,BAO_0000218,CHEMBL624285,1916,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8002,,Time to reach Cmax after oral administration to rats,,BAO_0000218,CHEMBL624286,16367,10116.0,Intermediate,1,,,50597,N,1,,
8003,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,BAO_0000218,CHEMBL624287,16366,10116.0,Intermediate,1,,,50597,N,1,,
8004,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,BAO_0000218,CHEMBL624288,216,10116.0,Intermediate,1,,,50597,N,1,,
8005,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,BAO_0000218,CHEMBL624289,6410,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8006,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL873344,6410,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8007,,Tmax after peroral administration (10 mg/kg) was determined in rat,,BAO_0000218,CHEMBL619623,6215,10116.0,Intermediate,1,,,50597,N,1,,
8008,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL621399,3598,10116.0,Expert,1,,,50597,N,1,,
8009,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,CHEMBL621400,4527,10116.0,Intermediate,1,,,50597,N,1,,
8010,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,CHEMBL621401,17670,10116.0,Intermediate,1,,,50597,N,1,,
8011,,Tmax was determined,,BAO_0000218,CHEMBL621402,1465,10116.0,Intermediate,1,,,50597,N,1,,
8012,,Tmax was determined,,BAO_0000218,CHEMBL621403,2552,10116.0,Intermediate,1,,,50597,N,1,,
8013,,Tmax after oral administration in rat,,BAO_0000218,CHEMBL621121,5656,10116.0,Intermediate,1,,,50597,N,1,,
8014,,Tmax after peroral administration in rats at 2.4 uM/kg,,BAO_0000218,CHEMBL872525,17764,10116.0,Intermediate,1,,,50597,N,1,,
8015,,Tmax in male rat,,BAO_0000218,CHEMBL621122,5610,10116.0,Intermediate,1,,,50597,N,1,,
8016,,Tmax in rat at 10 mg/kg,,BAO_0000218,CHEMBL621123,6046,10116.0,Intermediate,1,,,50597,N,1,,
8017,,Tmax in rat by po administration at a dose of 40 mg/kg,,BAO_0000218,CHEMBL621124,5874,10116.0,Intermediate,1,,,50597,N,1,,
8018,,Tmax in rats,,BAO_0000218,CHEMBL621125,17596,10116.0,Intermediate,1,,,50597,N,1,,
8019,,Tmax was measured in rats after peroral administration at 5 mg/kg,,BAO_0000218,CHEMBL621126,17804,10116.0,Intermediate,1,,,50597,N,1,,
8020,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,BAO_0000218,CHEMBL621127,1908,10116.0,Intermediate,1,,,50597,N,1,,
8021,,Tmax value after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,CHEMBL621128,2959,10116.0,Intermediate,1,,,50597,N,1,,
8022,,Tmax value at a dose of 10 mg/kg in male SD rats,,BAO_0000218,CHEMBL618263,6757,10116.0,Intermediate,1,,,50597,N,1,,
8023,,Tmax value at a dose of 100 mg/kg in male SD rats,,BAO_0000218,CHEMBL618264,6757,10116.0,Intermediate,1,,,50597,N,1,,
8024,,Tmax value at a dose of 50 mg/kg in male SD rats,,BAO_0000218,CHEMBL618265,6757,10116.0,Intermediate,1,,,50597,N,1,,
8025,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,CHEMBL618266,4186,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8026,,time required to reach maximum concentration (Cmax) after oral administration in rat,,BAO_0000218,CHEMBL618267,15662,10116.0,Intermediate,1,,,50597,N,1,,
8027,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,BAO_0000218,CHEMBL618450,429,10116.0,Intermediate,1,,,50597,N,1,1088.0,
8028,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,BAO_0000218,CHEMBL618451,429,10116.0,Intermediate,1,,,50597,N,1,1088.0,
8029,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,BAO_0000218,CHEMBL618452,5546,10116.0,Intermediate,1,,,50597,N,1,,
8030,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,BAO_0000218,CHEMBL618453,3173,10116.0,Intermediate,1,,,50597,N,1,1088.0,
8031,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,BAO_0000218,CHEMBL618454,3173,10116.0,Intermediate,1,,,50597,N,1,1088.0,
8032,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,BAO_0000218,CHEMBL618455,3173,10116.0,Intermediate,1,,,50597,N,1,1088.0,
8033,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,BAO_0000218,CHEMBL618456,4257,10116.0,Intermediate,1,,,50597,N,1,,
8034,,Compound distribution in rat tissues was determined,,BAO_0000218,CHEMBL618457,6011,10116.0,Intermediate,1,,,50597,N,1,,
8035,,Volume of distribution was evaluated in rat,,BAO_0000218,CHEMBL618458,5472,10116.0,Intermediate,1,,,50597,N,1,,
8036,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL618459,14346,10116.0,Intermediate,1,,,50597,N,1,,
8037,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL876733,14346,10116.0,Intermediate,1,,,50597,N,1,,
8038,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,BAO_0000218,CHEMBL618460,14346,9615.0,Intermediate,1,,,50588,N,1,,
8039,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL618461,14346,10116.0,Intermediate,1,,,50597,N,1,,
8040,,Area under the curve was determined after oral administration (300 uM/Kg),,BAO_0000019,CHEMBL618462,15469,,Autocuration,1,,,22224,U,0,,
8041,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL618463,14346,10116.0,Intermediate,1,,,50597,N,1,,
8042,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,BAO_0000218,CHEMBL618464,14346,10116.0,Intermediate,1,,,50597,N,1,,
8043,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL618465,14346,10116.0,Intermediate,1,,,50597,N,1,,
8044,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,BAO_0000218,CHEMBL618466,14346,10116.0,Intermediate,1,,,50597,N,1,,
8045,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,BAO_0000218,CHEMBL618467,14346,10116.0,Intermediate,1,,,50597,N,1,,
8046,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,BAO_0000218,CHEMBL618468,15372,10116.0,Intermediate,1,,,50597,N,1,,
8047,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,BAO_0000218,CHEMBL618469,12935,9615.0,Intermediate,1,,,50588,N,1,1969.0,
8048,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,BAO_0000218,CHEMBL618470,12935,9615.0,Intermediate,1,,,50588,N,1,1969.0,
8049,,Plasma drug AUC in rat (PO dose),,BAO_0000218,CHEMBL618471,14813,,Autocuration,1,,,22224,U,0,,
8050,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,BAO_0000218,CHEMBL618472,15792,10090.0,Intermediate,1,,,50594,N,1,,
8051,,Area under was determined at a dose of 30 mg/kg,,BAO_0000218,CHEMBL618473,3579,,Autocuration,1,,,22224,U,0,,
8052,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,BAO_0000218,CHEMBL621699,12487,9669.0,Intermediate,1,,,50506,N,1,,
8053,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,BAO_0000218,CHEMBL621700,12487,10116.0,Intermediate,1,,,50597,N,1,,
8054,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,BAO_0000218,CHEMBL621701,12487,10116.0,Intermediate,1,,,50597,N,1,,
8055,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,BAO_0000218,CHEMBL621702,12487,9669.0,Intermediate,1,,,50506,N,1,,
8056,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,BAO_0000218,CHEMBL621703,12487,9615.0,Intermediate,1,,,50588,N,1,,
8057,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,BAO_0000218,CHEMBL621704,12487,9615.0,Intermediate,1,,,50588,N,1,,
8058,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,BAO_0000218,CHEMBL624259,12902,10116.0,Intermediate,1,,,50597,N,1,,
8059,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,BAO_0000218,CHEMBL624260,12902,10116.0,Intermediate,1,,,50597,N,1,,
8060,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,BAO_0000218,CHEMBL624430,12902,10116.0,Intermediate,1,,,50597,N,1,,
8061,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,BAO_0000218,CHEMBL624431,12902,10116.0,Intermediate,1,,,50597,N,1,,
8062,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,BAO_0000218,CHEMBL624432,12902,10116.0,Intermediate,1,,,50597,N,1,,
8063,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,BAO_0000218,CHEMBL624433,12902,10116.0,Intermediate,1,,,50597,N,1,,
8064,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,BAO_0000218,CHEMBL624434,12902,10116.0,Intermediate,1,,,50597,N,1,,
8065,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,BAO_0000218,CHEMBL624435,12902,10116.0,Intermediate,1,,,50597,N,1,,
8066,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,BAO_0000218,CHEMBL618570,12745,10090.0,Intermediate,1,,,50594,N,1,,
8067,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,CHEMBL618571,12745,10090.0,Intermediate,1,,,50594,N,1,,
8068,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,BAO_0000218,CHEMBL618572,12745,10090.0,Intermediate,1,,,50594,N,1,,
8069,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,CHEMBL618573,12745,10090.0,Intermediate,1,,,50594,N,1,,
8070,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,BAO_0000218,CHEMBL619267,12745,10090.0,Intermediate,1,,,50594,N,1,,
8071,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,CHEMBL619431,12745,10090.0,Intermediate,1,,,50594,N,1,,
8072,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,BAO_0000218,CHEMBL619432,12745,10090.0,Intermediate,1,,,50594,N,1,,
8073,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,BAO_0000218,CHEMBL619433,12745,10090.0,Intermediate,1,,,50594,N,1,,
8074,,AUC in mice after oral dose (50 mg/kg),,BAO_0000218,CHEMBL619434,13298,,Autocuration,1,,,22224,U,0,1969.0,
8075,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,BAO_0000218,CHEMBL619435,12226,10090.0,Intermediate,1,,,50594,N,1,1977.0,
8076,,AUC (0-4 hr) ug/ml/h,,BAO_0000019,CHEMBL619436,12634,,Autocuration,1,,,22224,U,0,1969.0,
8077,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,BAO_0000218,CHEMBL619437,14810,10116.0,Intermediate,1,,,50597,N,1,,
8078,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,BAO_0000218,CHEMBL619438,13889,,Autocuration,1,,,22224,U,0,,
8079,,Compound was evaluated for Area under curve in mice,,BAO_0000218,CHEMBL619439,10018,10090.0,Intermediate,1,,,50594,N,1,,
8080,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,BAO_0000218,CHEMBL619440,8758,10116.0,Intermediate,1,,,50597,N,1,,
8081,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,BAO_0000218,CHEMBL619441,8758,,Autocuration,1,,,22224,U,0,,
8082,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,BAO_0000218,CHEMBL619442,8758,10116.0,Intermediate,1,,,50597,N,1,,
8083,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,BAO_0000019,CHEMBL875156,2249,,Autocuration,1,,,22224,U,0,,
8084,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,BAO_0000019,CHEMBL619443,2249,,Autocuration,1,,,22224,U,0,,
8085,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,BAO_0000019,CHEMBL619444,2249,,Autocuration,1,,,22224,U,0,,
8086,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,BAO_0000019,CHEMBL623464,2249,,Autocuration,1,,,22224,U,0,,
8087,,Compound was evaluated for area under curve when administered through oral route in mouse,,BAO_0000218,CHEMBL623465,15115,10090.0,Intermediate,1,,,50594,N,1,,
8088,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,BAO_0000218,CHEMBL623466,6518,10116.0,Intermediate,1,,,50597,N,1,,
8089,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,BAO_0000218,CHEMBL623467,6518,10116.0,Intermediate,1,,,50597,N,1,,
8090,,Plasma clearance in rat,,BAO_0000218,CHEMBL623468,6249,10116.0,Intermediate,1,,,50597,N,1,,
8091,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,BAO_0000218,CHEMBL622660,2463,10116.0,Intermediate,1,,,50597,N,1,,
8092,,Plasma clearance rate in Sprague-Dawley rats,,BAO_0000218,CHEMBL622661,4969,10116.0,Intermediate,1,,,50597,N,1,,
8093,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL622662,17720,10116.0,Intermediate,1,,,50597,N,1,,
8094,,Pharmacokinetic property (total body clearance) in rat,,BAO_0000218,CHEMBL622663,3457,10116.0,Intermediate,1,,,50597,N,1,,
8095,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,BAO_0000218,CHEMBL622664,5983,10116.0,Intermediate,1,,,50597,N,1,,
8096,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,BAO_0000218,CHEMBL622665,6295,10116.0,Intermediate,1,,,50597,N,1,,
8097,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,BAO_0000218,CHEMBL622666,6296,10116.0,Intermediate,1,,,50597,N,1,,
8098,,Cl in rat i.v. at 2 mg/kg concentration,,BAO_0000218,CHEMBL621615,17686,10116.0,Intermediate,1,,,50597,N,1,,
8099,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,CHEMBL621616,17764,10116.0,Intermediate,1,,,50597,N,1,,
8100,,Clearance was determined,,BAO_0000218,CHEMBL621617,5503,10116.0,Intermediate,1,,,50597,N,1,,
8101,,Clearance by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,CHEMBL621618,4368,10116.0,Intermediate,1,,,50597,N,1,,
8102,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,BAO_0000218,CHEMBL621619,6005,10116.0,Intermediate,1,,,50597,N,1,,
8103,,Clearance rate after i.v. administration in rats,,BAO_0000218,CHEMBL621620,5031,10116.0,Intermediate,1,,,50597,N,1,,
8104,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL621786,4890,10116.0,Intermediate,1,,,50597,N,1,,
8105,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,BAO_0000218,CHEMBL621787,5182,10116.0,Intermediate,1,,,50597,N,1,,
8106,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,BAO_0000218,CHEMBL621788,5979,10116.0,Intermediate,1,,,50597,N,1,,
8107,,Clearance (Cl) after oral administration in rat,,BAO_0000218,CHEMBL621789,5656,10116.0,Intermediate,1,,,50597,N,1,,
8108,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,BAO_0000218,CHEMBL621790,17804,10116.0,Intermediate,1,,,50597,N,1,,
8109,,Compound was tested for plasma clearance in rat,,BAO_0000218,CHEMBL621791,4839,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8110,,In vitro microsome metabolism clearance in rat was determined,,BAO_0000218,CHEMBL621792,5041,10116.0,Intermediate,1,,Microsomes,50597,N,1,,
8111,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,BAO_0000218,CHEMBL621793,5041,10116.0,Intermediate,1,,Microsomes,50597,N,1,,
8112,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL621794,5974,10116.0,Intermediate,1,,,50597,N,1,,
8113,,In vivo plasma clearance was determined,,BAO_0000218,CHEMBL621795,5496,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8114,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,BAO_0000218,CHEMBL621796,5739,10116.0,Intermediate,1,,,50597,N,1,,
8115,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,BAO_0000218,CHEMBL621797,5676,10116.0,Intermediate,1,401.0,,50597,N,1,2107.0,
8116,,Pharmacokinetic property (Plasma clearance) was measured in rat,,BAO_0000218,CHEMBL621798,4239,10116.0,Intermediate,1,,,50597,N,1,,
8117,,Pharmacokinetic property (clearance) in rat i.v.,,BAO_0000218,CHEMBL621799,5676,10116.0,Intermediate,1,,,50597,N,1,,
8118,,"Plasma Clearance was evaluated in rats, iv",,BAO_0000218,CHEMBL621800,1918,10116.0,Intermediate,1,,,50597,N,1,,
8119,,Plasma clearance (in vivo) in rats was determined,,BAO_0000218,CHEMBL621801,17800,10116.0,Intermediate,1,,,50597,N,1,,
8120,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,BAO_0000218,CHEMBL621802,6056,10116.0,Intermediate,1,,,50597,N,1,,
8121,,Plasma clearance was determined,,BAO_0000218,CHEMBL618596,5496,10116.0,Intermediate,1,,,50597,N,1,,
8122,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,BAO_0000218,CHEMBL618597,5939,10116.0,Intermediate,1,,,50597,N,1,,
8123,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,BAO_0000218,CHEMBL618598,5939,10116.0,Intermediate,1,,,50597,N,1,,
8124,,Plasma clearance in rats,,BAO_0000218,CHEMBL618599,17752,10116.0,Intermediate,1,,,50597,N,1,,
8125,,Plasma clearance rate determined in rat,,BAO_0000218,CHEMBL618600,4576,10116.0,Intermediate,1,,,50597,N,1,,
8126,,Plasma clearance was determined in rat,,BAO_0000218,CHEMBL618601,6011,10116.0,Intermediate,1,,,50597,N,1,,
8127,,Plasma clearance was determined,,BAO_0000218,CHEMBL618602,5510,10116.0,Intermediate,1,,,50597,N,1,,
8128,,Plasma clearance value in rat,,BAO_0000218,CHEMBL618603,5948,10116.0,Intermediate,1,,,50597,N,1,,
8129,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,BAO_0000218,CHEMBL618604,6125,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8130,,Clearance in rat,,BAO_0000218,CHEMBL618605,4839,10116.0,Intermediate,1,,,50597,N,1,,
8131,,Total body clearance in rat i.v. at 2 mg/kg concentration,,BAO_0000218,CHEMBL618606,17686,10116.0,Intermediate,1,,,50597,N,1,,
8132,,Clearance of compound in rats after intravenous administration,,BAO_0000218,CHEMBL618607,6571,10116.0,Intermediate,1,,,50597,N,1,,
8133,,Clearance after iv administration to rats,,BAO_0000218,CHEMBL618608,3364,10116.0,Intermediate,1,,,50597,N,1,,
8134,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,BAO_0000218,CHEMBL618609,13569,10116.0,Intermediate,1,,,50597,N,1,,
8135,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,BAO_0000218,CHEMBL618610,13569,10116.0,Intermediate,1,,,50597,N,1,,
8136,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,BAO_0000218,CHEMBL618611,13569,10116.0,Intermediate,1,,,50597,N,1,,
8137,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,BAO_0000218,CHEMBL618612,13569,10116.0,Intermediate,1,,,50597,N,1,,
8138,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,BAO_0000218,CHEMBL618613,13569,10116.0,Intermediate,1,,,50597,N,1,,
8139,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,BAO_0000218,CHEMBL621076,13569,10116.0,Intermediate,1,,,50597,N,1,,
8140,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,BAO_0000218,CHEMBL621077,13569,10116.0,Intermediate,1,,,50597,N,1,,
8141,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,CHEMBL621078,17670,10116.0,Intermediate,1,,,50597,N,1,,
8142,,Clearance in rat,,BAO_0000218,CHEMBL621251,5970,10116.0,Intermediate,1,,,50597,N,1,,
8143,,Clearance in rat after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL621252,6495,10116.0,Intermediate,1,,,50597,N,1,,
8144,,Clearance in rat.,,BAO_0000218,CHEMBL621253,4590,10116.0,Intermediate,1,,,50597,N,1,,
8145,,Clearance rate following an oral dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL621254,6193,10116.0,Intermediate,1,,,50597,N,1,,
8146,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,BAO_0000218,CHEMBL621255,2832,10116.0,Intermediate,1,,,50597,N,1,,
8147,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,BAO_0000218,CHEMBL621256,1052,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8148,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,CHEMBL621257,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8149,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,BAO_0000218,CHEMBL621258,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8150,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,CHEMBL621259,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8151,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,BAO_0000218,CHEMBL621260,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8152,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,CHEMBL876494,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8153,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,BAO_0000218,CHEMBL621261,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8154,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,CHEMBL621262,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8155,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,BAO_0000218,CHEMBL621263,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8156,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL621264,9866,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8157,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL621265,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8158,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,BAO_0000218,CHEMBL621266,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8159,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,BAO_0000218,CHEMBL621267,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8160,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL621268,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8161,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,BAO_0000218,CHEMBL621269,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8162,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,BAO_0000218,CHEMBL621270,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8163,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,BAO_0000218,CHEMBL621271,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8164,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,BAO_0000218,CHEMBL621272,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8165,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,BAO_0000218,CHEMBL621273,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8166,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,BAO_0000218,CHEMBL621274,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8167,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,BAO_0000218,CHEMBL876495,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8168,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,BAO_0000218,CHEMBL621275,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8169,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL621276,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8170,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL621277,9866,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8171,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,CHEMBL621278,9866,10116.0,Intermediate,1,,,50597,N,1,160.0,
8172,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,CHEMBL621279,9866,10116.0,Intermediate,1,,,50597,N,1,160.0,
8173,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,BAO_0000218,CHEMBL621280,9866,10116.0,Intermediate,1,,,50597,N,1,160.0,
8174,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,BAO_0000218,CHEMBL621281,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8175,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,BAO_0000218,CHEMBL621282,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8176,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,BAO_0000218,CHEMBL621283,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8177,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,BAO_0000218,CHEMBL621284,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8178,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,BAO_0000218,CHEMBL621285,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8179,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,CHEMBL621286,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8180,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,BAO_0000218,CHEMBL623220,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8181,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,BAO_0000218,CHEMBL623221,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8182,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,BAO_0000218,CHEMBL876029,9866,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8183,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,BAO_0000218,CHEMBL623222,9866,10116.0,Intermediate,1,,,50597,N,1,945.0,
8184,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,BAO_0000218,CHEMBL623223,9866,10116.0,Intermediate,1,,,50597,N,1,945.0,
8185,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,BAO_0000218,CHEMBL621445,9866,10116.0,Intermediate,1,,,50597,N,1,945.0,
8186,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621446,13950,10116.0,Intermediate,1,,,50597,N,1,178.0,
8187,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621447,13950,10116.0,Intermediate,1,,,50597,N,1,178.0,
8188,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619681,13950,10116.0,Intermediate,1,,,50597,N,1,178.0,
8189,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619682,13950,10116.0,Intermediate,1,,,50597,N,1,178.0,
8190,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619683,13950,10116.0,Intermediate,1,,,50597,N,1,178.0,
8191,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619684,13950,10116.0,Intermediate,1,,,50597,N,1,955.0,
8192,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619685,13950,10116.0,Intermediate,1,,,50597,N,1,955.0,
8193,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619686,13950,10116.0,Intermediate,1,,,50597,N,1,955.0,
8194,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619687,13950,10116.0,Intermediate,1,,,50597,N,1,955.0,
8195,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619688,13950,10116.0,Intermediate,1,,,50597,N,1,955.0,
8196,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619689,13950,10116.0,Intermediate,1,,,50597,N,1,948.0,
8197,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619690,13950,10116.0,Intermediate,1,,,50597,N,1,948.0,
8198,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619691,13950,10116.0,Intermediate,1,,,50597,N,1,948.0,
8199,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,CHEMBL619692,6062,10116.0,Intermediate,1,,,50597,N,1,,
8200,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL619693,3598,10116.0,Expert,1,,,50597,N,1,,
8201,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,BAO_0000218,CHEMBL619694,1908,10116.0,Intermediate,1,,,50597,N,1,,
8202,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,BAO_0000218,CHEMBL619695,17596,10116.0,Intermediate,1,,,50597,N,1,,
8203,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,BAO_0000218,CHEMBL619696,4891,10116.0,Intermediate,1,,,50597,N,1,,
8204,,Compound was evaluated for volume of distribution in rat,,BAO_0000218,CHEMBL619697,740,10116.0,Intermediate,1,,,50597,N,1,,
8205,,Steady state volume distribution was determined; steady state(ss),,BAO_0000218,CHEMBL619698,16366,10116.0,Intermediate,1,,,50597,N,1,,
8206,,Steady state volume of distribution after iv administration to rats,,BAO_0000218,CHEMBL619699,3364,10116.0,Intermediate,1,,,50597,N,1,,
8207,,Steady state volume of distribution dosing at 3 mg/kg iv,,BAO_0000218,CHEMBL619700,2552,10116.0,Intermediate,1,,,50597,N,1,,
8208,,The compound was evaluated for volume of distribution in rat,,BAO_0000218,CHEMBL619701,406,10116.0,Intermediate,1,,,50597,N,1,,
8209,,The compound was tested for volume of distribution in rat,,BAO_0000218,CHEMBL619702,12500,10116.0,Intermediate,1,,,50597,N,1,,
8210,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,BAO_0000218,CHEMBL620335,12500,10116.0,Intermediate,1,,,50597,N,1,,
8211,,Volume distribution (VD) after oral administration in rat,,BAO_0000218,CHEMBL620336,5656,10116.0,Intermediate,1,,,50597,N,1,,
8212,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,CHEMBL620337,17671,10116.0,Intermediate,1,,,50597,N,1,,
8213,,Volume distribution in rat,,BAO_0000218,CHEMBL620520,1094,10116.0,Intermediate,1,,,50597,N,1,,
8214,,Volume distribution in rat,,BAO_0000218,CHEMBL620521,5833,10116.0,Intermediate,1,,,50597,N,1,,
8215,,Volume distribution in rat after peroral administration at 10 mg/kg,,BAO_0000218,CHEMBL875825,5939,10116.0,Intermediate,1,,,50597,N,1,,
8216,,Volume distribution in rat after peroral administration at 5 mg/kg,,BAO_0000218,CHEMBL620522,5939,10116.0,Intermediate,1,,,50597,N,1,,
8217,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,BAO_0000218,CHEMBL620523,6005,10116.0,Intermediate,1,,,50597,N,1,,
8218,,Volume of distribution in rat.,,BAO_0000218,CHEMBL620524,1696,10116.0,Intermediate,1,,,50597,N,1,,
8219,,Volume of distribution in rat,,BAO_0000218,CHEMBL620525,6672,10116.0,Intermediate,1,,,50597,N,1,,
8220,,Volume of distribution in rat,,BAO_0000218,CHEMBL620526,6673,10116.0,Intermediate,1,,,50597,N,1,,
8221,,Volume of distribution in rat by iv administration,,BAO_0000218,CHEMBL620527,5871,10116.0,Intermediate,1,,,50597,N,1,,
8222,,Volume of distribution in rats,,BAO_0000218,CHEMBL620528,6803,10116.0,Intermediate,1,,,50597,N,1,,
8223,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,BAO_0000218,CHEMBL620529,5199,10116.0,Intermediate,1,,,50597,N,1,,
8224,,Volume distribution at the dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL620530,4727,10116.0,Intermediate,1,,,50597,N,1,,
8225,,Steady state volume of distribution was determined,,BAO_0000218,CHEMBL620531,16367,10116.0,Intermediate,1,,,50597,N,1,,
8226,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,BAO_0000218,CHEMBL620532,5005,9544.0,Intermediate,1,,,22224,U,0,,
8227,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,BAO_0000218,CHEMBL620533,5005,10116.0,Intermediate,1,,,22224,U,0,,
8228,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,BAO_0000218,CHEMBL620534,5005,10116.0,Intermediate,1,,,22224,U,0,,
8229,,Mean (%CV) PK parameters for Vdss(mL/kg).,,BAO_0000218,CHEMBL620535,15765,10116.0,Intermediate,1,,,50597,N,1,,
8230,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL875826,2792,10116.0,Intermediate,1,,,50597,N,1,,
8231,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL620536,2792,10116.0,Intermediate,1,,,50597,N,1,,
8232,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,BAO_0000218,CHEMBL620537,5334,10116.0,Intermediate,1,,,50597,N,1,,
8233,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,BAO_0000218,CHEMBL618526,5334,10116.0,Intermediate,1,,,50597,N,1,,
8234,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,BAO_0000218,CHEMBL618527,5739,10116.0,Intermediate,1,,,50597,N,1,,
8235,,Pharmacokinetic property (Vdss) in rat,,BAO_0000218,CHEMBL618528,5789,10116.0,Intermediate,1,,,50597,N,1,,
8236,,Pharmacokinetic property (vdss) was measured in rat,,BAO_0000218,CHEMBL618529,4239,10116.0,Intermediate,1,,,50597,N,1,,
8237,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,BAO_0000218,CHEMBL618530,4709,10116.0,Intermediate,1,,,50597,N,1,,
8238,,Volume of distribution in rat,,BAO_0000218,CHEMBL618531,6642,10116.0,Intermediate,1,,,50597,N,1,,
8239,,The pharmacokinetic parameter volume of distribution in vivo in rats,,BAO_0000218,CHEMBL618532,5247,10116.0,Intermediate,1,,,50597,N,1,,
8240,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL618533,17720,10116.0,Intermediate,1,,,50597,N,1,,
8241,,Vdss in rat i.v. at 2 mg/kg concentration,,BAO_0000218,CHEMBL618534,17686,10116.0,Intermediate,1,,,50597,N,1,,
8242,,Volume distribution after intravenous administration (1 mg/kg) in rat,,BAO_0000218,CHEMBL618535,4689,10116.0,Intermediate,1,,,50597,N,1,,
8243,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,CHEMBL618536,5654,10116.0,Intermediate,1,,,50597,N,1,,
8244,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,CHEMBL618537,5654,10116.0,Intermediate,1,,,50597,N,1,,
8245,,Volume distribution at a dose of 10 uM/kg in rat was determined,,BAO_0000218,CHEMBL618538,4527,10116.0,Intermediate,1,,,50597,N,1,,
8246,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,CHEMBL618539,4521,10116.0,Intermediate,1,,,50597,N,1,,
8247,,Volume distribution was calculated in rat,,BAO_0000218,CHEMBL618540,6057,10116.0,Intermediate,1,,,50597,N,1,,
8248,,Volume distribution was determined,,BAO_0000218,CHEMBL618541,5510,10116.0,Intermediate,1,,,50597,N,1,,
8249,,Volume of distribution after intravenous administration was evaluated in rat,,BAO_0000218,CHEMBL618542,2938,10116.0,Intermediate,1,,,50597,N,1,,
8250,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,CHEMBL622544,6679,10116.0,Intermediate,1,,,50597,N,1,,
8251,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,BAO_0000218,CHEMBL622545,6685,10116.0,Intermediate,1,,,50597,N,1,,
8252,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,BAO_0000218,CHEMBL622546,6685,10116.0,Intermediate,1,,,50597,N,1,,
8253,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,CHEMBL622547,6685,10116.0,Intermediate,1,,,50597,N,1,,
8254,,Volume of distribution in steady state was determined in rat,,BAO_0000218,CHEMBL622548,5145,10116.0,Intermediate,1,,,50597,N,1,,
8255,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,BAO_0000218,CHEMBL622549,6467,10116.0,Intermediate,1,,,50597,N,1,,
8256,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,BAO_0000218,CHEMBL622550,6467,10116.0,Intermediate,1,,,50597,N,1,,
8257,,Compound was evaluated for area under curve when administered through oral route to mouse,,BAO_0000218,CHEMBL622551,15115,10090.0,Intermediate,1,,,50594,N,1,,
8258,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,BAO_0000218,CHEMBL622552,8758,10116.0,Intermediate,1,,,50597,N,1,,
8259,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,BAO_0000218,CHEMBL622553,8758,10116.0,Intermediate,1,,,50597,N,1,,
8260,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,BAO_0000218,CHEMBL622554,8267,,Autocuration,1,,,22224,U,0,,
8261,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,BAO_0000218,CHEMBL622555,8267,9615.0,Intermediate,1,,,50588,N,1,,
8262,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,BAO_0000218,CHEMBL622556,14239,10090.0,Intermediate,1,,,50594,N,1,,
8263,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,BAO_0000218,CHEMBL622557,14239,10090.0,Intermediate,1,,,50594,N,1,,
8264,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,BAO_0000218,CHEMBL622558,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
8265,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,BAO_0000218,CHEMBL622559,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
8266,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,BAO_0000218,CHEMBL622560,10754,9615.0,Intermediate,1,,,50588,N,1,,
8267,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,BAO_0000218,CHEMBL622561,14681,10116.0,Intermediate,1,,,50597,N,1,,
8268,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,BAO_0000218,CHEMBL622562,14681,10116.0,Intermediate,1,,,50597,N,1,,
8269,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,BAO_0000218,CHEMBL622563,14681,10116.0,Intermediate,1,,,50597,N,1,,
8270,,Concentration of compound in Central nervous system,,BAO_0000019,CHEMBL622564,13118,,Autocuration,1,,,22224,U,0,,
8271,,Concentration of compound in Central nervous system; Not detectable,,BAO_0000019,CHEMBL622565,13118,,Autocuration,1,,,22224,U,0,,
8272,,"Concentration of diester in the blood, following oral administration in mice",,BAO_0000218,CHEMBL622566,13318,10090.0,Intermediate,1,,,50594,N,1,,
8273,,"Concentration of monoester in the blood, following oral administration in mice",,BAO_0000218,CHEMBL624515,13318,10090.0,Intermediate,1,,,50594,N,1,,
8274,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,BAO_0000218,CHEMBL624516,13318,10090.0,Intermediate,1,,,50594,N,1,,
8275,,Evaluated for Pharmacokinetic property: Area under the curve,,BAO_0000019,CHEMBL624517,15692,,Autocuration,1,,,22224,U,0,,
8276,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,BAO_0000218,CHEMBL624518,14839,10090.0,Intermediate,1,,,50594,N,1,,
8277,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,BAO_0000218,CHEMBL624519,14839,9541.0,Intermediate,1,,,100710,N,1,,
8278,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL624520,14839,9541.0,Intermediate,1,,,100710,N,1,,
8279,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL624521,14839,9541.0,Intermediate,1,,,100710,N,1,,
8280,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL624522,14839,9541.0,Intermediate,1,,,100710,N,1,,
8281,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL624523,14839,9541.0,Intermediate,1,,,100710,N,1,,
8282,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,CHEMBL624409,14839,9541.0,Intermediate,1,,,100710,N,1,,
8283,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,BAO_0000218,CHEMBL624410,14839,9541.0,Intermediate,1,,,100710,N,1,,
8284,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,CHEMBL624411,14839,9541.0,Intermediate,1,,,100710,N,1,,
8285,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,BAO_0000218,CHEMBL623531,14839,9541.0,Intermediate,1,,,100710,N,1,,
8286,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,CHEMBL623532,14839,9541.0,Intermediate,1,,,100710,N,1,,
8287,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,BAO_0000218,CHEMBL623533,14839,9541.0,Intermediate,1,,,100710,N,1,,
8288,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,BAO_0000218,CHEMBL623534,14839,9541.0,Intermediate,1,,,100710,N,1,,
8289,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL623535,14839,10090.0,Intermediate,1,,,50594,N,1,,
8290,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL623536,14839,10090.0,Intermediate,1,,,50594,N,1,,
8291,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL623537,14839,10090.0,Intermediate,1,,,50594,N,1,,
8292,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL623538,14839,10090.0,Intermediate,1,,,50594,N,1,,
8293,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL623539,14839,10090.0,Intermediate,1,,,50594,N,1,,
8294,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,BAO_0000218,CHEMBL623540,14839,10090.0,Intermediate,1,,,50594,N,1,,
8295,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,BAO_0000218,CHEMBL623541,14839,10090.0,Intermediate,1,,,50594,N,1,,
8296,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,BAO_0000218,CHEMBL623542,14839,10090.0,Intermediate,1,,,50594,N,1,,
8297,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,BAO_0000218,CHEMBL623543,14839,10090.0,Intermediate,1,,,50594,N,1,,
8298,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,BAO_0000218,CHEMBL623544,14839,10090.0,Intermediate,1,,,50594,N,1,,
8299,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,BAO_0000218,CHEMBL623545,14839,10090.0,Intermediate,1,,,50594,N,1,,
8300,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,BAO_0000218,CHEMBL623546,14839,10090.0,Intermediate,1,,,50594,N,1,,
8301,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL623547,5408,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8302,,High i.v. clearance in Dawley rats,,BAO_0000218,CHEMBL623548,6827,10116.0,Intermediate,1,,,50597,N,1,,
8303,,In vitro clearance in rat liver microsomes,,BAO_0000218,CHEMBL623549,17538,10116.0,Intermediate,1,,Microsomes,50597,N,1,2107.0,
8304,,Intrinsic clearance in rat liver microsomes was determined,,BAO_0000218,CHEMBL623550,6331,10116.0,Intermediate,1,,Microsomes,50597,N,1,2107.0,
8305,,Intrinsic clearance in rat hepatocytes was determined,,BAO_0000218,CHEMBL875276,5948,10116.0,Intermediate,1,401.0,,50597,N,1,2107.0,
8306,,Plasma Clearance was determined,,BAO_0000218,CHEMBL621872,4026,10116.0,Intermediate,1,,,50597,N,1,,
8307,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,BAO_0000218,CHEMBL621873,6647,10116.0,Intermediate,1,,,50597,N,1,,
8308,,Plasma clearance in rat.,,BAO_0000218,CHEMBL621874,1696,10116.0,Intermediate,1,,,50597,N,1,,
8309,,Plasma clearance in rats,,BAO_0000218,CHEMBL621875,6597,10116.0,Intermediate,1,,,50597,N,1,,
8310,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,BAO_0000218,CHEMBL621876,347,10116.0,Intermediate,1,,,50597,N,1,,
8311,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,CHEMBL621877,16423,10116.0,Intermediate,1,,,50597,N,1,,
8312,,Plasma clearance was measured in rat,,BAO_0000218,CHEMBL621878,2879,10116.0,Intermediate,1,,,50597,N,1,,
8313,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,BAO_0000218,CHEMBL621879,4883,10116.0,Intermediate,1,,,50597,N,1,,
8314,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,BAO_0000218,CHEMBL621880,5328,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8315,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,BAO_0000218,CHEMBL621881,5160,10116.0,Intermediate,1,,,50597,N,1,,
8316,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,CHEMBL621882,17582,10116.0,Intermediate,1,,,50597,N,1,,
8317,,Total clearance at 1 mg/kg was determined in rat,,BAO_0000218,CHEMBL875283,17651,10116.0,Intermediate,1,,,50597,N,1,,
8318,,Total clearance at 10 mg/kg was determined in rat,,BAO_0000218,CHEMBL621883,17651,10116.0,Intermediate,1,,,50597,N,1,,
8319,,Clearance in rat,,BAO_0000218,CHEMBL621884,6596,10116.0,Intermediate,1,,,50597,N,1,,
8320,,Plasma clearance rate determined in rats,,BAO_0000218,CHEMBL621885,4796,10116.0,Intermediate,1,,,50597,N,1,,
8321,,Clearance of compound in rat was evaluated,,BAO_0000218,CHEMBL621886,6850,10116.0,Intermediate,1,,,50597,N,1,,
8322,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,BAO_0000218,CHEMBL621887,5932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8323,,Pharmacokinetic property (blood clearance) in rat,,BAO_0000218,CHEMBL621888,3371,10116.0,Intermediate,1,,,50597,N,1,,
8324,,Plasma clearance in rat,,BAO_0000218,CHEMBL621889,2083,10116.0,Intermediate,1,,,50597,N,1,,
8325,,Plasma clearance in rats,,BAO_0000218,CHEMBL621890,4942,10116.0,Intermediate,1,,,50597,N,1,,
8326,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,BAO_0000218,CHEMBL621891,6838,10116.0,Intermediate,1,,Microsomes,50597,N,1,2107.0,
8327,,Clearance in Dawley rat,,BAO_0000218,CHEMBL621892,5353,10116.0,Intermediate,1,,,50597,N,1,,
8328,,Clearance rat,,BAO_0000218,CHEMBL621893,6641,10116.0,Intermediate,1,,,50597,N,1,,
8329,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,BAO_0000218,CHEMBL621894,6641,10116.0,Intermediate,1,,,50597,N,1,,
8330,,Clearance rat; Not determined,,BAO_0000218,CHEMBL621895,6641,10116.0,Intermediate,1,,,50597,N,1,,
8331,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,BAO_0000218,CHEMBL875284,6444,10116.0,Intermediate,1,,,50597,N,1,,
8332,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,BAO_0000218,CHEMBL618699,6444,10116.0,Intermediate,1,,,50597,N,1,,
8333,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,BAO_0000218,CHEMBL618700,6444,10116.0,Intermediate,1,,,50597,N,1,,
8334,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,CHEMBL618701,6211,10116.0,Intermediate,1,,,50597,N,1,,
8335,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,BAO_0000218,CHEMBL876600,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8336,,Clearance of compound in rat after 1 mg/kg i.v. administration,,BAO_0000218,CHEMBL618702,6570,10116.0,Intermediate,1,,,50597,N,1,,
8337,,Compound was evaluated for Hepatic clearance in rat,,BAO_0000218,CHEMBL618703,3341,10116.0,Intermediate,1,,,50597,N,1,,
8338,,In vivo clearance after 5 mg/kg dose,,BAO_0000218,CHEMBL618704,4891,10116.0,Intermediate,1,,,50597,N,1,,
8339,,Compound was tested for plasma clearance in rats,,BAO_0000218,CHEMBL618705,1094,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8340,,Hepatic clearance after intravenous administration was evaluated in rat,,BAO_0000218,CHEMBL618706,2938,10116.0,Intermediate,1,,,50597,N,1,,
8341,,Lower clearance in rat (i.v.) at 0.5 mpk,,BAO_0000218,CHEMBL618707,17853,10116.0,Intermediate,1,,,50597,N,1,,
8342,,Pharmacokinetic parameter expressed as plasma clearance in rat,,BAO_0000218,CHEMBL618708,6049,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8343,,Pharmacokinetic property (Clp) in rat,,BAO_0000218,CHEMBL618709,5789,10116.0,Intermediate,1,,,50597,N,1,,
8344,,Plasma clearance in Sprague-Dawley rats,,BAO_0000218,CHEMBL618710,4514,10116.0,Intermediate,1,,,50597,N,1,,
8345,,Plasma clearance (Clp) in rat,,BAO_0000218,CHEMBL618711,6448,10116.0,Intermediate,1,,,50597,N,1,,
8346,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,CHEMBL618712,6062,10116.0,Intermediate,1,,,50597,N,1,,
8347,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,BAO_0000218,CHEMBL618713,5710,10116.0,Intermediate,1,,,50597,N,1,,
8348,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,BAO_0000218,CHEMBL618714,4709,10116.0,Intermediate,1,,,50597,N,1,,
8349,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,CHEMBL618715,4521,10116.0,Intermediate,1,,,50597,N,1,,
8350,,Plasma clearance in rat was determined,,BAO_0000218,CHEMBL618716,1742,10116.0,Intermediate,1,,,50597,N,1,,
8351,,Plasma clearance measured in rat,,BAO_0000218,CHEMBL876601,6057,10116.0,Intermediate,1,,,50597,N,1,,
8352,,Plasma clearance was calculated in rat,,BAO_0000218,CHEMBL618717,6057,10116.0,Intermediate,1,,,50597,N,1,,
8353,,Plasma clearance in rat,,BAO_0000218,CHEMBL618718,5145,10116.0,Intermediate,1,,,50597,N,1,,
8354,,Plasma clearance in rat,,BAO_0000218,CHEMBL618719,5833,10116.0,Intermediate,1,,,50597,N,1,,
8355,,Plasma clearance in rat,,BAO_0000218,CHEMBL618720,6453,10116.0,Intermediate,1,,,50597,N,1,,
8356,,Plasma clearance in rat,,BAO_0000218,CHEMBL618721,6640,10116.0,Intermediate,1,,,50597,N,1,,
8357,,Plasma clearance in rats,,BAO_0000218,CHEMBL621477,6305,10116.0,Intermediate,1,,,50597,N,1,,
8358,,Plasma clearance in rat,,BAO_0000218,CHEMBL621478,6642,10116.0,Intermediate,1,,,50597,N,1,,
8359,,Plasma clearance was evaluated in rat,,BAO_0000218,CHEMBL621479,5472,10116.0,Intermediate,1,,,50597,N,1,,
8360,,Plasma clearance was evaluated in rat; Not tested,,BAO_0000218,CHEMBL621480,5472,10116.0,Intermediate,1,,,50597,N,1,,
8361,,Plasma clearance rate was determined for the compound in rat,,BAO_0000218,CHEMBL621481,5144,10116.0,Intermediate,1,,,50597,N,1,,
8362,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,BAO_0000218,CHEMBL621482,6685,10116.0,Intermediate,1,,,50597,N,1,,
8363,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,BAO_0000218,CHEMBL621483,6685,10116.0,Intermediate,1,,,50597,N,1,,
8364,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,CHEMBL621484,6685,10116.0,Intermediate,1,,,50597,N,1,,
8365,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621485,13950,10116.0,Intermediate,1,,,50597,N,1,948.0,
8366,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621486,13950,10116.0,Intermediate,1,,,50597,N,1,948.0,
8367,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621487,13950,10116.0,Intermediate,1,,,50597,N,1,160.0,
8368,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621488,13950,10116.0,Intermediate,1,,,50597,N,1,160.0,
8369,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621489,13950,10116.0,Intermediate,1,,,50597,N,1,160.0,
8370,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621490,13950,10116.0,Intermediate,1,,,50597,N,1,160.0,
8371,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621491,13950,10116.0,Intermediate,1,,,50597,N,1,160.0,
8372,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621492,13950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8373,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621493,13950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8374,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621494,13950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8375,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621495,13950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8376,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621496,13950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8377,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621497,13950,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8378,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621498,13950,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8379,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL621499,13950,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8380,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL618634,13950,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8381,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL618635,13950,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8382,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL618636,13950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8383,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619737,13950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8384,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL619738,13950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8385,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624329,13950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8386,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624330,13950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8387,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624331,13950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8388,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624332,13950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8389,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624333,13950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8390,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624334,13950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8391,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL624335,13950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8392,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620016,13950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8393,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620169,13950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8394,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620170,13950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8395,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620171,13950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8396,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620172,13950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
8397,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620173,13950,10116.0,Intermediate,1,,,50597,N,1,945.0,
8398,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620174,13950,10116.0,Intermediate,1,,,50597,N,1,945.0,
8399,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620175,13950,10116.0,Intermediate,1,,,50597,N,1,945.0,
8400,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620176,13950,10116.0,Intermediate,1,,,50597,N,1,945.0,
8401,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620177,13950,10116.0,Intermediate,1,,,50597,N,1,945.0,
8402,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620178,13950,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8403,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620179,13950,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8404,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620180,13950,10116.0,Intermediate,1,,,50597,N,1,,
8405,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,BAO_0000218,CHEMBL620181,6570,10116.0,Intermediate,1,,,50597,N,1,,
8406,,Volume of distribution of compound in rats after intravenous administration,,BAO_0000218,CHEMBL620182,6571,10116.0,Intermediate,1,,,50597,N,1,,
8407,,Volume of distribution in rat,,BAO_0000218,CHEMBL620183,6453,10116.0,Intermediate,1,,,50597,N,1,,
8408,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,BAO_0000218,CHEMBL620184,6444,10116.0,Intermediate,1,,,50597,N,1,,
8409,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,BAO_0000218,CHEMBL620185,6444,10116.0,Intermediate,1,,,50597,N,1,,
8410,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,BAO_0000218,CHEMBL620186,6444,10116.0,Intermediate,1,,,50597,N,1,,
8411,,Volume of distribution was determined in Dawley rat,,BAO_0000218,CHEMBL620187,5353,10116.0,Intermediate,1,,,50597,N,1,,
8412,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,BAO_0000218,CHEMBL620188,5334,10116.0,Intermediate,1,,,50597,N,1,,
8413,,Volume of distribution was reported in Sprague-Dawley rat,,BAO_0000218,CHEMBL620189,5334,10116.0,Intermediate,1,,,50597,N,1,,
8414,,Volumes of distribution in rat after peroral administration,,BAO_0000218,CHEMBL620190,6641,10116.0,Intermediate,1,,,50597,N,1,,
8415,,Volumes of distribution in rat after po administration,,BAO_0000218,CHEMBL620191,6641,10116.0,Intermediate,1,,,50597,N,1,,
8416,,Volumes of distribution in rat after po administration; Not determined,,BAO_0000218,CHEMBL620192,6641,10116.0,Intermediate,1,,,50597,N,1,,
8417,,Pharmacokinetic property (Volume) in rat i.v.,,BAO_0000218,CHEMBL620193,5676,10116.0,Intermediate,1,,,50597,N,1,,
8418,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,BAO_0000218,CHEMBL620194,6410,10116.0,Intermediate,1,,,50597,N,1,,
8419,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,BAO_0000218,CHEMBL876730,17670,10116.0,Intermediate,1,,,50597,N,1,,
8420,,Volume distribution in rat after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL620195,6495,10116.0,Intermediate,1,,,50597,N,1,,
8421,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL620196,5408,10116.0,Intermediate,1,,,50597,N,1,,
8422,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,BAO_0000218,CHEMBL620197,4883,10116.0,Intermediate,1,,,50597,N,1,,
8423,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,BAO_0000218,CHEMBL620198,6647,10116.0,Intermediate,1,,,50597,N,1,,
8424,,Volume of distribution in rats,,BAO_0000218,CHEMBL620199,6495,10116.0,Intermediate,1,,,50597,N,1,,
8425,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,CHEMBL620200,2661,10116.0,Intermediate,1,,,50597,N,1,,
8426,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,CHEMBL620201,2661,10116.0,Intermediate,1,,,50597,N,1,,
8427,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL620202,5974,10116.0,Intermediate,1,,,50597,N,1,,
8428,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL620203,5974,10116.0,Intermediate,1,,,50597,N,1,,
8429,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,BAO_0000218,CHEMBL620204,5974,10116.0,Intermediate,1,,,50597,N,1,,
8430,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL620205,5974,10116.0,Intermediate,1,,,50597,N,1,,
8431,,Pharmacokinetic parameter (Vss) in rat,,BAO_0000218,CHEMBL624664,5960,10116.0,Intermediate,1,,,50597,N,1,,
8432,,Pharmacokinetic property (Volume) in rat i.v.,,BAO_0000218,CHEMBL624665,5676,10116.0,Intermediate,1,,,50597,N,1,,
8433,,Pharmacokinetic property (Vss) in rat,,BAO_0000218,CHEMBL624666,5948,10116.0,Intermediate,1,,,50597,N,1,,
8434,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,BAO_0000218,CHEMBL624667,5979,10116.0,Intermediate,1,,,50597,N,1,,
8435,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL624668,5978,10116.0,Intermediate,1,,,50597,N,1,,
8436,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL624669,5978,10116.0,Intermediate,1,,,50597,N,1,,
8437,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL624670,5978,10116.0,Intermediate,1,,,50597,N,1,,
8438,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL624671,5978,10116.0,Intermediate,1,,,50597,N,1,,
8439,,Steady state volume distribution in rat,,BAO_0000218,CHEMBL624672,6448,10116.0,Intermediate,1,,,50597,N,1,,
8440,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,BAO_0000218,CHEMBL624673,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8441,,Steady state volume of distribution determined in rat,,BAO_0000218,CHEMBL624674,4576,10116.0,Intermediate,1,,,50597,N,1,,
8442,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,CHEMBL624675,17582,10116.0,Intermediate,1,,,50597,N,1,,
8443,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL621728,1466,10116.0,Intermediate,1,,,50597,N,1,,
8444,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,BAO_0000218,CHEMBL621729,5182,10116.0,Intermediate,1,,,50597,N,1,,
8445,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,BAO_0000218,CHEMBL621730,5182,10116.0,Intermediate,1,,,50597,N,1,,
8446,,Volume distribution in rat after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL621731,6535,10116.0,Intermediate,1,,,50597,N,1,,
8447,,Volume distribution in rat after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL621732,6535,10116.0,Intermediate,1,,,50597,N,1,,
8448,,Volume in steady state distribution value was determined,,BAO_0000218,CHEMBL621908,5041,10116.0,Intermediate,1,,,50597,N,1,,
8449,,Volume in steady state distribution value was determined; ND denotes no data,,BAO_0000218,CHEMBL875347,5041,10116.0,Intermediate,1,,,50597,N,1,,
8450,,Volume in steady state distribution value was determined; ND denotes not determined,,BAO_0000218,CHEMBL621909,5041,10116.0,Intermediate,1,,,50597,N,1,,
8451,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,CHEMBL621910,17065,10116.0,Intermediate,1,,,50597,N,1,,
8452,,Volume of distribution at steady state was evaluated in rats,,BAO_0000218,CHEMBL621911,6597,10116.0,Intermediate,1,,,50597,N,1,,
8453,,Volume of distribution at steady state was observed after intravenous administration in rat,,BAO_0000218,CHEMBL621912,15662,10116.0,Intermediate,1,,,50597,N,1,,
8454,,Volume of distribution in steady state was determined in rat,,BAO_0000218,CHEMBL621913,6485,10116.0,Intermediate,1,,,50597,N,1,,
8455,,Volume of distribution in steady state was determined in rat,,BAO_0000218,CHEMBL621914,17655,10116.0,Intermediate,1,,,50597,N,1,,
8456,,Volume of distribution after i.v. administration,,BAO_0000218,CHEMBL621915,6616,10116.0,Intermediate,1,,,50597,N,1,,
8457,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,BAO_0000218,CHEMBL621916,1916,10116.0,Intermediate,1,,,50597,N,1,,
8458,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,BAO_0000218,CHEMBL621917,16438,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8459,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,BAO_0000218,CHEMBL621918,16438,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8460,,Biodistribution of compound (oxidized form) in spleen tissue,,BAO_0000218,CHEMBL621919,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8461,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,BAO_0000218,CHEMBL621920,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8462,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,BAO_0000218,CHEMBL621921,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8463,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL622401,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8464,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,BAO_0000218,CHEMBL875348,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8465,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,BAO_0000218,CHEMBL622402,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8466,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,BAO_0000218,CHEMBL622403,16438,10090.0,Intermediate,1,,,50594,N,1,178.0,
8467,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL622404,16438,10090.0,Intermediate,1,,,50594,N,1,178.0,
8468,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,BAO_0000218,CHEMBL622405,16438,10090.0,Intermediate,1,,,50594,N,1,955.0,
8469,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL622406,16438,10090.0,Intermediate,1,,,50594,N,1,955.0,
8470,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL622407,16438,10090.0,Intermediate,1,,,50594,N,1,955.0,
8471,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,BAO_0000218,CHEMBL622408,16438,10090.0,Intermediate,1,,,50594,N,1,948.0,
8472,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL622409,16438,10090.0,Intermediate,1,,,50594,N,1,948.0,
8473,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL622410,16438,10090.0,Intermediate,1,,,50594,N,1,948.0,
8474,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,BAO_0000218,CHEMBL622411,16438,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8475,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,BAO_0000218,CHEMBL627864,16438,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8476,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL627865,16438,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8477,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,BAO_0000218,CHEMBL627866,16438,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8478,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL627751,16438,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8479,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,BAO_0000218,CHEMBL627752,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8480,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,BAO_0000218,CHEMBL627753,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8481,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,BAO_0000218,CHEMBL627754,16438,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8482,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,BAO_0000218,CHEMBL627755,12467,10090.0,Intermediate,1,,,50594,N,1,,
8483,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627756,17208,10090.0,Intermediate,1,,,50594,N,1,955.0,
8484,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627757,17208,10090.0,Intermediate,1,,,50594,N,1,955.0,
8485,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627758,17208,10090.0,Intermediate,1,,,50594,N,1,955.0,
8486,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627759,17208,10090.0,Intermediate,1,,,50594,N,1,955.0,
8487,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627760,17208,10090.0,Intermediate,1,,,50594,N,1,955.0,
8488,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627761,17208,10090.0,Intermediate,1,,,50594,N,1,955.0,
8489,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL876811,17208,10090.0,Intermediate,1,,,50594,N,1,948.0,
8490,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627762,17208,10090.0,Intermediate,1,,,50594,N,1,948.0,
8491,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627763,17208,10090.0,Intermediate,1,,,50594,N,1,948.0,
8492,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627764,17208,10090.0,Intermediate,1,,,50594,N,1,948.0,
8493,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627765,17208,10090.0,Intermediate,1,,,50594,N,1,948.0,
8494,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627766,17208,10090.0,Intermediate,1,,,50594,N,1,948.0,
8495,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627767,17208,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8496,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627768,17208,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8497,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL628422,17208,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8498,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL628423,17208,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8499,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,BAO_0000218,CHEMBL628424,5089,10116.0,Intermediate,1,,,50597,N,1,,
8500,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,BAO_0000218,CHEMBL628425,5089,10116.0,Intermediate,1,,,50597,N,1,,
8501,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,BAO_0000218,CHEMBL628426,4257,10116.0,Intermediate,1,,,50597,N,1,,
8502,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,CHEMBL628427,6679,10116.0,Intermediate,1,,,50597,N,1,,
8503,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,BAO_0000218,CHEMBL626938,5546,10116.0,Intermediate,1,,,50597,N,1,,
8504,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,BAO_0000218,CHEMBL626939,6141,10116.0,Intermediate,1,,,50597,N,1,,
8505,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,BAO_0000218,CHEMBL626940,5334,10116.0,Intermediate,1,,,50597,N,1,,
8506,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,BAO_0000218,CHEMBL626941,5334,10116.0,Intermediate,1,,,50597,N,1,,
8507,,Plasma clearance was reported in Sprague-Dawley rat,,BAO_0000218,CHEMBL626942,5334,10116.0,Intermediate,1,,,50597,N,1,,
8508,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,BAO_0000218,CHEMBL876812,4689,10116.0,Intermediate,1,,,50597,N,1,,
8509,,Plasma clearance of compound in rats was evaluated,,BAO_0000218,CHEMBL626943,6848,10116.0,Intermediate,1,,,50597,N,1,,
8510,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,BAO_0000218,CHEMBL626944,6848,10116.0,Intermediate,1,,,50597,N,1,,
8511,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,BAO_0000218,CHEMBL626945,6467,10116.0,Intermediate,1,,,50597,N,1,,
8512,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,BAO_0000218,CHEMBL626946,6467,10116.0,Intermediate,1,,,50597,N,1,,
8513,,Plasma clearance rate in Sprague-Dawley rats,,BAO_0000218,CHEMBL626856,4956,10116.0,Intermediate,1,,,50597,N,1,,
8514,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,BAO_0000218,CHEMBL626857,5529,10116.0,Intermediate,1,,,50597,N,1,,
8515,,The compound was evaluated for plasma clearance in rat,,BAO_0000218,CHEMBL626858,406,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8516,,Total plasma clearance in rat,,BAO_0000218,CHEMBL627018,17655,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8517,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,BAO_0000218,CHEMBL625331,3293,10116.0,Intermediate,1,,,50597,N,1,178.0,
8518,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,BAO_0000218,CHEMBL625332,4075,10116.0,Intermediate,1,,,50597,N,1,178.0,
8519,,C max was determined at 10 mg/kg po dose in rats,,BAO_0000218,CHEMBL877590,2792,10116.0,Intermediate,1,,,50597,N,1,,
8520,,C max was determined at 3 mg/kg po dose in rats,,BAO_0000218,CHEMBL625333,2792,10116.0,Intermediate,1,,,50597,N,1,,
8521,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,BAO_0000218,CHEMBL625334,17594,10116.0,Intermediate,1,,,50597,N,1,,
8522,,Cmax after single intravenous bolus of 1 mg/kg in rats,,BAO_0000218,CHEMBL625335,17594,10116.0,Intermediate,1,,,50597,N,1,,
8523,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,BAO_0000218,CHEMBL625336,4762,10116.0,Intermediate,1,,,50597,N,1,,
8524,,Cmax 24 hr after 10 mg/kg oral administration in rats,,BAO_0000218,CHEMBL625337,17509,10116.0,Intermediate,1,,,50597,N,1,,
8525,,Cmax 24 hr after 2 mg/kg oral administration in rats,,BAO_0000218,CHEMBL625338,17509,10116.0,Intermediate,1,,,50597,N,1,,
8526,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL625339,1466,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8527,,Cmax in rat after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL625340,6535,10116.0,Intermediate,1,,,50597,N,1,,
8528,,Cmax in rat after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL625341,6535,10116.0,Intermediate,1,,,50597,N,1,,
8529,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,BAO_0000218,CHEMBL622687,3169,10116.0,Intermediate,1,,,50597,N,1,,
8530,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,BAO_0000218,CHEMBL622688,6515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8531,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,BAO_0000218,CHEMBL622689,11149,10116.0,Intermediate,1,,,50597,N,1,178.0,
8532,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,BAO_0000218,CHEMBL620295,11149,10116.0,Intermediate,1,,,50597,N,1,178.0,
8533,,Cmax after 10 mg/kg oral administration in rat,,BAO_0000218,CHEMBL620296,17858,10116.0,Intermediate,1,,,50597,N,1,,
8534,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,BAO_0000218,CHEMBL620297,6518,10116.0,Intermediate,1,,,50597,N,1,,
8535,,Cmax after IV dosing at 1 mg/kg in rat; no data,,BAO_0000218,CHEMBL620298,6518,10116.0,Intermediate,1,,,50597,N,1,,
8536,,Cmax after oral administration at 20 mpk in rats,,BAO_0000218,CHEMBL620299,4426,10116.0,Intermediate,1,,,50597,N,1,,
8537,,Cmax after oral administration at 20 mpk in rats; Not performed.,,BAO_0000218,CHEMBL620300,4426,10116.0,Intermediate,1,,,50597,N,1,,
8538,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,BAO_0000218,CHEMBL620301,4426,10116.0,Intermediate,1,,,50597,N,1,,
8539,,Cmax after oral administration in rat,,BAO_0000218,CHEMBL620302,5656,10116.0,Intermediate,1,,,50597,N,1,,
8540,,Cmax after oral administration at a dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL620303,6518,10116.0,Intermediate,1,,,50597,N,1,,
8541,,Cmax after oral administration at a dose of 4 mg/kg in rat,,BAO_0000218,CHEMBL620304,6518,10116.0,Intermediate,1,,,50597,N,1,,
8542,,Cmax in rats after 20 mg/kg oral dose,,BAO_0000218,CHEMBL620305,6113,10116.0,Intermediate,1,,,50597,N,1,,
8543,,Cmax after peroral administration in rats at 2.4 uM/kg,,BAO_0000218,CHEMBL620306,17764,10116.0,Intermediate,1,,,50597,N,1,,
8544,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL620307,4756,10116.0,Intermediate,1,,,50597,N,1,,
8545,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL620308,4756,10116.0,Intermediate,1,,,50597,N,1,,
8546,,Cmax by administering at 20 mg/kg p.o. in rats,,BAO_0000218,CHEMBL620309,6402,10116.0,Intermediate,1,,,50597,N,1,,
8547,,Cmax in male rat,,BAO_0000218,CHEMBL620310,5610,10116.0,Intermediate,1,,,50597,N,1,,
8548,,Cmax in rat,,BAO_0000218,CHEMBL620311,5207,10116.0,Intermediate,1,,,50597,N,1,,
8549,,Cmax in rat,,BAO_0000218,CHEMBL620312,6011,10116.0,Intermediate,1,,,50597,N,1,,
8550,,Cmax in rat,,BAO_0000218,CHEMBL620313,6504,10116.0,Intermediate,1,,,50597,N,1,,
8551,,Cmax in rat at 10 mg/kg,,BAO_0000218,CHEMBL620314,6046,10116.0,Intermediate,1,,,50597,N,1,,
8552,,Cmax in rat at the dose of 1 mg/kg i.v.,,BAO_0000218,CHEMBL620315,6504,10116.0,Intermediate,1,,,50597,N,1,,
8553,,Cmax in rat by po administration at a dose of 40 mg/kg,,BAO_0000218,CHEMBL620316,5874,10116.0,Intermediate,1,,,50597,N,1,,
8554,,Cmax in rat p.o. at 20 mg/kg concentration,,BAO_0000218,CHEMBL620317,17686,10116.0,Intermediate,1,,,50597,N,1,,
8555,,Cmax in rats,,BAO_0000218,CHEMBL620318,5836,10116.0,Intermediate,1,,,50597,N,1,,
8556,,Cmax in rats,,BAO_0000218,CHEMBL620319,17596,10116.0,Intermediate,1,,,50597,N,1,,
8557,,Cmax was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,CHEMBL620320,16423,10116.0,Intermediate,1,,,50597,N,1,,
8558,,Cmax was measured in rats after peroral administration at 3 mg/kg,,BAO_0000218,CHEMBL620321,17804,10116.0,Intermediate,1,,,50597,N,1,,
8559,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,BAO_0000218,CHEMBL620322,1908,10116.0,Intermediate,1,,,50597,N,1,,
8560,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620323,13950,10116.0,Intermediate,1,,,50597,N,1,,
8561,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620324,13950,10116.0,Intermediate,1,,,50597,N,1,1870.0,
8562,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620325,13950,10116.0,Intermediate,1,,,50597,N,1,1870.0,
8563,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620326,13950,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
8564,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620327,13950,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
8565,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620328,13950,10116.0,Intermediate,1,,,50597,N,1,,
8566,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620329,13950,10116.0,Intermediate,1,,,50597,N,1,,
8567,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620330,13950,10116.0,Intermediate,1,,,50597,N,1,1891.0,
8568,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL875286,13950,10116.0,Intermediate,1,,,50597,N,1,1891.0,
8569,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620331,13950,10116.0,Intermediate,1,,,50597,N,1,,
8570,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620332,13950,10116.0,Intermediate,1,,,50597,N,1,,
8571,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620333,13950,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8572,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,BAO_0000218,CHEMBL620334,13950,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8573,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL621015,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8574,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL621016,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8575,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL621191,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8576,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL621192,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8577,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL621193,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8578,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL621194,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8579,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL624204,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8580,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL624205,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8581,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL624206,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8582,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL624207,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8583,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL624208,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8584,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL624209,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8585,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL624210,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8586,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL624211,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8587,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL624212,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8588,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL624213,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8589,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL876611,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8590,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL624214,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8591,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL624215,16434,10116.0,Intermediate,1,,,50597,N,1,178.0,
8592,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL624216,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8593,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL624217,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8594,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL624218,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8595,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL624219,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8596,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL624220,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8597,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL624221,16435,10116.0,Intermediate,1,,,50597,N,1,178.0,
8598,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL624222,16434,10116.0,Intermediate,1,,,50597,N,1,,
8599,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL624223,16434,10116.0,Intermediate,1,,,50597,N,1,,
8600,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL624224,16434,10116.0,Intermediate,1,,,50597,N,1,,
8601,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL624225,16434,10116.0,Intermediate,1,,,50597,N,1,,
8602,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,BAO_0000218,CHEMBL622420,17764,10116.0,Intermediate,1,,,50597,N,1,,
8603,,Volume of steady state distribution after i.v. administration in rats,,BAO_0000218,CHEMBL622421,5031,10116.0,Intermediate,1,,,50597,N,1,,
8604,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,BAO_0000218,CHEMBL622422,6215,10116.0,Intermediate,1,,,50597,N,1,,
8605,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,CHEMBL622423,17671,10116.0,Intermediate,1,,,50597,N,1,,
8606,,Vss was determined,,BAO_0000218,CHEMBL622424,17752,10116.0,Intermediate,1,,,50597,N,1,,
8607,,Vss in rat,,BAO_0000218,CHEMBL622425,6596,10116.0,Intermediate,1,,,50597,N,1,,
8608,,Vss was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,CHEMBL876612,16423,10116.0,Intermediate,1,,,50597,N,1,,
8609,,volume of distribution at steady state was observed after intravenous administration in rat,,BAO_0000218,CHEMBL622426,15662,10116.0,Intermediate,1,,,50597,N,1,,
8610,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,CHEMBL622427,6062,10116.0,Intermediate,1,,,50597,N,1,,
8611,,Pharmacokinetic (PK) parameter Vz in rat,,BAO_0000218,CHEMBL622428,5874,10116.0,Intermediate,1,,,50597,N,1,,
8612,,Volume distribution in rats,,BAO_0000218,CHEMBL622429,4942,10116.0,Intermediate,1,,,50597,N,1,,
8613,,Volume of distribution in rat; No data,,BAO_0000218,CHEMBL622430,17796,10116.0,Intermediate,1,,,50597,N,1,,
8614,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL622431,4890,10116.0,Intermediate,1,,,50597,N,1,,
8615,,% absorption predicted from in vitro rat ileum transport studies,,BAO_0000218,CHEMBL622432,15765,10116.0,Intermediate,1,,,50597,N,1,2116.0,
8616,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,BAO_0000218,CHEMBL622433,13569,10116.0,Intermediate,1,,,50597,N,1,,
8617,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,BAO_0000218,CHEMBL622434,13569,10116.0,Intermediate,1,,,50597,N,1,,
8618,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,BAO_0000218,CHEMBL622435,13569,10116.0,Intermediate,1,,,50597,N,1,,
8619,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,BAO_0000218,CHEMBL618748,13569,10116.0,Intermediate,1,,,50597,N,1,,
8620,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,BAO_0000218,CHEMBL618749,13569,10116.0,Intermediate,1,,,50597,N,1,,
8621,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,BAO_0000218,CHEMBL618750,13569,10116.0,Intermediate,1,,,50597,N,1,,
8622,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,BAO_0000218,CHEMBL618751,13569,10116.0,Intermediate,1,,,50597,N,1,,
8623,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,BAO_0000218,CHEMBL618752,13569,10116.0,Intermediate,1,,,50597,N,1,,
8624,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618753,4576,10116.0,Intermediate,1,,,50597,N,1,,
8625,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,BAO_0000218,CHEMBL618754,750,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8626,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618755,750,10116.0,Intermediate,1,,,50597,N,1,,
8627,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618756,4590,10116.0,Intermediate,1,,,50597,N,1,,
8628,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618757,1716,10116.0,Intermediate,1,,,50597,N,1,,
8629,,Bioavailability in rat,,BAO_0000218,CHEMBL618758,1974,10116.0,Intermediate,1,,,50597,N,1,,
8630,,Oral bioavailability in rat (dose 30 mg/kg),,BAO_0000218,CHEMBL621088,4502,10116.0,Intermediate,1,,,50597,N,1,,
8631,,Pharmacokinetic property (cLogP) in rat,,BAO_0000218,CHEMBL621089,3371,10116.0,Intermediate,1,,,50597,N,1,,
8632,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,BAO_0000218,CHEMBL621090,9099,10116.0,Intermediate,1,,,50597,N,1,178.0,
8633,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,BAO_0000218,CHEMBL621091,9099,10116.0,Intermediate,1,,,50597,N,1,178.0,
8634,,Clearance in rat.,,BAO_0000218,CHEMBL876731,4590,10116.0,Intermediate,1,,,50597,N,1,,
8635,,Compound was evaluated for its clearance when administered intravenously in rat,,BAO_0000218,CHEMBL621092,3184,10116.0,Intermediate,1,,,50597,N,1,,
8636,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL621093,16456,10116.0,Intermediate,1,,,50597,N,1,,
8637,,Blood: Brain distribution ratio is determined in rat,,BAO_0000218,CHEMBL621094,4199,10116.0,Intermediate,1,,,50597,N,1,,
8638,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,BAO_0000218,CHEMBL621095,4199,10116.0,Intermediate,1,,,50597,N,1,,
8639,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,BAO_0000218,CHEMBL621096,4199,10116.0,Intermediate,1,,,50597,N,1,,
8640,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL621097,8677,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8641,,Percent dose excreted in 0-48 hours administered ip to male rat,,BAO_0000218,CHEMBL621098,7449,10116.0,Intermediate,1,,,50597,N,1,,
8642,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621099,11977,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8643,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621100,11977,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8644,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL621101,11977,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8645,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621102,11977,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8646,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL876732,11977,10116.0,Intermediate,1,,,50597,N,1,2037.0,
8647,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621103,11977,10116.0,Intermediate,1,,,50597,N,1,,
8648,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621104,11977,10116.0,Intermediate,1,,,50597,N,1,,
8649,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL621105,11977,10116.0,Intermediate,1,,,50597,N,1,,
8650,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621106,11977,10116.0,Intermediate,1,,,50597,N,1,,
8651,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621107,11977,10116.0,Intermediate,1,,,50597,N,1,,
8652,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621108,11977,10116.0,Intermediate,1,,,50597,N,1,,
8653,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621109,11977,10116.0,Intermediate,1,,,50597,N,1,,
8654,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL621110,17208,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8655,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL621111,17208,10090.0,Intermediate,1,,,50594,N,1,2113.0,
8656,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL622541,17208,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8657,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL622542,17208,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8658,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL622543,17208,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8659,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624412,17208,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8660,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624413,17208,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8661,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624414,17208,10090.0,Intermediate,1,,,50594,N,1,2107.0,
8662,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624415,17208,10090.0,Intermediate,1,,,50594,N,1,2048.0,
8663,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624416,17208,10090.0,Intermediate,1,,,50594,N,1,2048.0,
8664,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624417,17208,10090.0,Intermediate,1,,,50594,N,1,2048.0,
8665,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624418,17208,10090.0,Intermediate,1,,,50594,N,1,2048.0,
8666,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624419,17208,10090.0,Intermediate,1,,,50594,N,1,2048.0,
8667,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624420,17208,10090.0,Intermediate,1,,,50594,N,1,2048.0,
8668,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624421,17208,10090.0,Intermediate,1,,,50594,N,1,2385.0,
8669,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624422,17208,10090.0,Intermediate,1,,,50594,N,1,2385.0,
8670,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL624423,17208,10090.0,Intermediate,1,,,50594,N,1,2385.0,
8671,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL625123,17208,10090.0,Intermediate,1,,,50594,N,1,2385.0,
8672,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL625124,17208,10090.0,Intermediate,1,,,50594,N,1,2385.0,
8673,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL625125,17208,10090.0,Intermediate,1,,,50594,N,1,2385.0,
8674,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL625126,17208,10090.0,Intermediate,1,,,50594,N,1,14.0,
8675,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626947,17208,10090.0,Intermediate,1,,,50594,N,1,14.0,
8676,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626948,17208,10090.0,Intermediate,1,,,50594,N,1,14.0,
8677,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626949,17208,10090.0,Intermediate,1,,,50594,N,1,14.0,
8678,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626950,17208,10090.0,Intermediate,1,,,50594,N,1,14.0,
8679,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626951,17208,10090.0,Intermediate,1,,,50594,N,1,14.0,
8680,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626952,17208,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8681,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626953,17208,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8682,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626954,17208,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8683,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626955,17208,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8684,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626956,17208,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8685,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626957,17208,10090.0,Intermediate,1,,,50594,N,1,2106.0,
8686,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626958,17208,10090.0,Intermediate,1,,,50594,N,1,178.0,
8687,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626959,17208,10090.0,Intermediate,1,,,50594,N,1,178.0,
8688,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626960,17208,10090.0,Intermediate,1,,,50594,N,1,178.0,
8689,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL626961,17208,10090.0,Intermediate,1,,,50594,N,1,178.0,
8690,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627589,17208,10090.0,Intermediate,1,,,50594,N,1,178.0,
8691,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,BAO_0000218,CHEMBL627590,17208,10090.0,Intermediate,1,,,50594,N,1,178.0,
8692,,Time taken for EC90 was determined when tested in mouse,,BAO_0000218,CHEMBL627591,3132,10090.0,Intermediate,1,,,50594,N,1,,
8693,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,BAO_0000218,CHEMBL627592,3132,10090.0,Intermediate,1,,,50594,N,1,,
8694,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,BAO_0000218,CHEMBL627593,16597,10090.0,Intermediate,1,,,50594,N,1,,
8695,,Half life in mice,,BAO_0000218,CHEMBL627594,5727,10090.0,Intermediate,1,,,50594,N,1,,
8696,,Half life period in mouse after 10 mg/Kg dose,,BAO_0000218,CHEMBL876813,5302,10090.0,Intermediate,1,,,50594,N,1,,
8697,,Half life period in mouse after 10 mg/kg dose,,BAO_0000218,CHEMBL627595,5302,10090.0,Intermediate,1,,,50594,N,1,,
8698,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,BAO_0000218,CHEMBL627596,6348,10090.0,Intermediate,1,,,50594,N,1,,
8699,,Cmax value at 5 mg/kg po was determined in rat,,BAO_0000218,CHEMBL627597,5964,10116.0,Intermediate,1,,,50597,N,1,,
8700,,Cmax value evaluated in rat,,BAO_0000218,CHEMBL627598,6078,10116.0,Intermediate,1,,,50597,N,1,,
8701,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,BAO_0000218,CHEMBL627599,5206,10116.0,Intermediate,1,,,50597,N,1,955.0,
8702,,Cmax value after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,CHEMBL627600,2959,10116.0,Intermediate,1,,,50597,N,1,,
8703,,Cmax value at 1 mg/kg po in rat,,BAO_0000218,CHEMBL627601,5964,10116.0,Intermediate,1,,,50597,N,1,,
8704,,Cmax value at 5 mg/kg po in rat,,BAO_0000218,CHEMBL627776,5964,10116.0,Intermediate,1,,,50597,N,1,,
8705,,Cmax value at a dose of 10 mg/kg in male SD rats,,BAO_0000218,CHEMBL627777,6757,10116.0,Intermediate,1,,,50597,N,1,,
8706,,Cmax value at a dose of 100 mg/kg in male SD rats,,BAO_0000218,CHEMBL627778,6757,10116.0,Intermediate,1,,,50597,N,1,,
8707,,Cmax value at a dose of 50 mg/kg in male SD rats,,BAO_0000218,CHEMBL627779,6757,10116.0,Intermediate,1,,,50597,N,1,,
8708,,Cmax value in rats at 10 mg/kg,,BAO_0000218,CHEMBL876814,17617,10116.0,Intermediate,1,,,50597,N,1,,
8709,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,BAO_0000218,CHEMBL627780,1445,10116.0,Intermediate,1,,,50597,N,1,,
8710,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,BAO_0000218,CHEMBL627781,6082,10116.0,Intermediate,1,,,50597,N,1,,
8711,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,BAO_0000218,CHEMBL627782,1446,10116.0,Intermediate,1,,,50597,N,1,,
8712,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,BAO_0000218,CHEMBL627783,5407,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8713,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,BAO_0000218,CHEMBL627784,2690,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8714,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,CHEMBL627785,2661,10116.0,Intermediate,1,,,50597,N,1,,
8715,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,CHEMBL627786,2661,10116.0,Intermediate,1,,,50597,N,1,,
8716,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,BAO_0000218,CHEMBL627787,4891,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8717,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,BAO_0000218,CHEMBL627788,2807,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8718,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,BAO_0000218,CHEMBL626579,2807,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8719,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,BAO_0000218,CHEMBL626580,2807,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8720,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,BAO_0000218,CHEMBL876815,3634,10116.0,Intermediate,1,,,50597,N,1,,
8721,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,BAO_0000218,CHEMBL626581,1881,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8722,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,BAO_0000218,CHEMBL626582,1881,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8723,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,BAO_0000218,CHEMBL626583,429,10116.0,Intermediate,1,,,50597,N,1,,
8724,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL626205,5974,10116.0,Intermediate,1,,,50597,N,1,,
8725,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL626206,5974,10116.0,Intermediate,1,,,50597,N,1,,
8726,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL626207,5974,10116.0,Intermediate,1,,,50597,N,1,,
8727,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL623882,5974,10116.0,Intermediate,1,,,50597,N,1,,
8728,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,BAO_0000218,CHEMBL623883,17582,10116.0,Intermediate,1,,,50597,N,1,,
8729,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,BAO_0000218,CHEMBL623884,17582,10116.0,Intermediate,1,,,50597,N,1,,
8730,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,BAO_0000218,CHEMBL623885,3032,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8731,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,BAO_0000218,CHEMBL623886,6295,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8732,,Maximal concentration in rat was determined,,BAO_0000218,CHEMBL623887,6619,10116.0,Intermediate,1,,,50597,N,1,,
8733,,Maximal concentration after i.v. administration,,BAO_0000218,CHEMBL623888,6616,10116.0,Intermediate,1,,,50597,N,1,,
8734,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,BAO_0000218,CHEMBL623889,3249,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8735,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,BAO_0000218,CHEMBL623890,17791,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8736,,Cmax in rat plasma after oral dose (50 mg/Kg),,BAO_0000218,CHEMBL623891,17791,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8737,,Maximal plasma concentration was determined.,,BAO_0000218,CHEMBL623892,1360,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8738,,Maximal plasma drug concentration was determined,,BAO_0000218,CHEMBL623893,2552,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8739,,Maximal concentration in rats after peroral administration,,BAO_0000218,CHEMBL877616,6571,10116.0,Intermediate,1,,,50597,N,1,,
8740,,Maximum concentration in rat after 2 mg/kg peroral administration,,BAO_0000218,CHEMBL623894,6570,10116.0,Intermediate,1,,,50597,N,1,,
8741,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,BAO_0000218,CHEMBL623895,6567,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8742,,Maximum concentration of compound in rat was evaluated.,,BAO_0000218,CHEMBL623896,3031,10116.0,Intermediate,1,,,50597,N,1,,
8743,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL623897,3436,10116.0,Intermediate,1,,,50597,N,1,,
8744,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL623898,3436,10116.0,Intermediate,1,,,50597,N,1,,
8745,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,BAO_0000218,CHEMBL623899,2083,10116.0,Intermediate,1,,,50597,N,1,,
8746,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL623900,3436,10116.0,Intermediate,1,,,50597,N,1,,
8747,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,CHEMBL623901,4527,10116.0,Intermediate,1,,,50597,N,1,,
8748,,Maximum concentration was evaluated in rats,,BAO_0000218,CHEMBL623902,1974,10116.0,Intermediate,1,,,50597,N,1,,
8749,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,BAO_0000218,CHEMBL623903,3307,10116.0,Intermediate,1,,,50597,N,1,1359.0,
8750,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,BAO_0000218,CHEMBL623904,3307,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8751,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,BAO_0000218,CHEMBL877617,1916,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8752,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,BAO_0000218,CHEMBL623905,1500,10116.0,Intermediate,1,,,50597,N,1,,
8753,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,BAO_0000218,CHEMBL623906,1500,10116.0,Intermediate,1,,,50597,N,1,,
8754,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,CHEMBL623907,4186,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8755,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL623908,16434,10116.0,Intermediate,1,,,50597,N,1,,
8756,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL623909,16434,10116.0,Intermediate,1,,,50597,N,1,,
8757,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL623910,16434,10116.0,Intermediate,1,,,50597,N,1,,
8758,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL623911,16434,10116.0,Intermediate,1,,,50597,N,1,,
8759,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL623912,16435,10116.0,Intermediate,1,,,50597,N,1,,
8760,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL624616,16435,10116.0,Intermediate,1,,,50597,N,1,,
8761,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL624617,16435,10116.0,Intermediate,1,,,50597,N,1,,
8762,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL624618,16435,10116.0,Intermediate,1,,,50597,N,1,,
8763,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL624619,16435,10116.0,Intermediate,1,,,50597,N,1,,
8764,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL624794,16435,10116.0,Intermediate,1,,,50597,N,1,,
8765,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL624795,16435,10116.0,Intermediate,1,,,50597,N,1,,
8766,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL623921,16435,10116.0,Intermediate,1,,,50597,N,1,,
8767,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL623922,16434,10116.0,Intermediate,1,,,50597,N,1,,
8768,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL623923,16434,10116.0,Intermediate,1,,,50597,N,1,,
8769,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL623924,16434,10116.0,Intermediate,1,,,50597,N,1,,
8770,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL623925,16435,10116.0,Intermediate,1,,,50597,N,1,,
8771,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL623926,16435,10116.0,Intermediate,1,,,50597,N,1,,
8772,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL623927,16435,10116.0,Intermediate,1,,,50597,N,1,,
8773,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL623928,16435,10116.0,Intermediate,1,,,50597,N,1,,
8774,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL623929,16435,10116.0,Intermediate,1,,,50597,N,1,,
8775,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL623930,16435,10116.0,Intermediate,1,,,50597,N,1,,
8776,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL623931,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8777,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL622165,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8778,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL621249,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8779,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL621250,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8780,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL621448,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8781,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL621449,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8782,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL621450,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8783,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL621451,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8784,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL621452,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8785,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL621453,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8786,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL621454,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8787,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL621455,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8788,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL621456,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8789,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL625145,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8790,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL875847,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8791,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL625146,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8792,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL625147,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8793,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL625148,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8794,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL625149,16434,10116.0,Intermediate,1,,,50597,N,1,955.0,
8795,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL625150,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8796,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL625151,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8797,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL625152,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8798,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL625153,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8799,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL625154,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8800,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL625155,16435,10116.0,Intermediate,1,,,50597,N,1,955.0,
8801,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL625156,11977,10116.0,Intermediate,1,,,50597,N,1,,
8802,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624354,11977,10116.0,Intermediate,1,,,50597,N,1,,
8803,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624355,11977,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
8804,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624356,11977,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
8805,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624357,11977,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
8806,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624358,11977,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
8807,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624359,11977,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8808,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624360,11977,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8809,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL624361,11977,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8810,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624362,11977,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8811,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624363,11977,10116.0,Intermediate,1,,,50597,N,1,2435.0,
8812,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624364,11977,10116.0,Intermediate,1,,,50597,N,1,178.0,
8813,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624365,11977,10116.0,Intermediate,1,,,50597,N,1,178.0,
8814,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624366,11977,10116.0,Intermediate,1,,,50597,N,1,178.0,
8815,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624367,11977,10116.0,Intermediate,1,,,50597,N,1,178.0,
8816,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624368,11977,10116.0,Intermediate,1,,,50597,N,1,955.0,
8817,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL624369,11977,10116.0,Intermediate,1,,,50597,N,1,955.0,
8818,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL624370,11977,10116.0,Intermediate,1,,,50597,N,1,955.0,
8819,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625069,11977,10116.0,Intermediate,1,,,50597,N,1,955.0,
8820,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625070,11977,10116.0,Intermediate,1,,,50597,N,1,955.0,
8821,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626051,11977,10116.0,Intermediate,1,,,50597,N,1,948.0,
8822,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626052,11977,10116.0,Intermediate,1,,,50597,N,1,948.0,
8823,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL626053,11977,10116.0,Intermediate,1,,,50597,N,1,948.0,
8824,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626054,11977,10116.0,Intermediate,1,,,50597,N,1,948.0,
8825,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626055,11977,10116.0,Intermediate,1,,,50597,N,1,948.0,
8826,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626056,11977,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8827,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626057,11977,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8828,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625193,11977,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8829,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625194,11977,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8830,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625195,11977,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8831,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625196,11977,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8832,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL625197,11977,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8833,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625198,11977,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8834,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL627929,11977,10116.0,Intermediate,1,,,50597,N,1,2107.0,
8835,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL627074,11977,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8836,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL627075,11977,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8837,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL627076,11977,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8838,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL627077,11977,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8839,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL627078,11977,10116.0,Intermediate,1,,,50597,N,1,2048.0,
8840,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL627079,11977,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8841,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,BAO_0000218,CHEMBL873824,4573,10090.0,Intermediate,1,,,50594,N,1,,
8842,,Half life in mouse plasma was determined at dose 25 mg/kg,,BAO_0000218,CHEMBL627080,3132,10090.0,Intermediate,1,,,50594,N,1,1969.0,
8843,,Half life was determined,,BAO_0000218,CHEMBL627081,17718,10090.0,Intermediate,1,,,50594,N,1,,
8844,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,BAO_0000218,CHEMBL627082,17728,10090.0,Intermediate,1,,,50594,N,1,,
8845,,Half-life in male mice after 1 mg/kg intravenous dose,,BAO_0000218,CHEMBL627083,5961,10090.0,Intermediate,1,,,50594,N,1,,
8847,,Half life in mice plasma,,BAO_0000218,CHEMBL627085,17731,10090.0,Intermediate,1,,,50594,N,1,1969.0,
8848,,Half life in mouse,,BAO_0000218,CHEMBL627086,17592,10090.0,Intermediate,1,,,50594,N,1,,
8849,,Half life in mouse plasma at dose 25 mg/kg,,BAO_0000218,CHEMBL627087,3132,10090.0,Intermediate,1,,,50594,N,1,1969.0,
8850,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,BAO_0000218,CHEMBL627088,17729,10090.0,Intermediate,1,,,50594,N,1,,
8851,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,BAO_0000218,CHEMBL627089,17729,10090.0,Intermediate,1,,,50594,N,1,,
8852,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,BAO_0000218,CHEMBL627090,17729,10090.0,Intermediate,1,,,50594,N,1,,
8853,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,BAO_0000218,CHEMBL627091,3277,10090.0,Intermediate,1,,,50594,N,1,,
8854,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,BAO_0000218,CHEMBL627092,3760,10090.0,Intermediate,1,,,50594,N,1,,
8855,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,BAO_0000218,CHEMBL876785,3760,10090.0,Intermediate,1,,,50594,N,1,,
8856,,Half-life by iv administration in mouse,,BAO_0000218,CHEMBL627093,2862,10090.0,Intermediate,1,,,50594,N,1,,
8857,,Half-life by oral administration in mouse,,BAO_0000218,CHEMBL627094,2862,10090.0,Intermediate,1,,,50594,N,1,,
8858,,Half-life in mice,,BAO_0000218,CHEMBL627095,5980,10090.0,Intermediate,1,,,50594,N,1,,
8859,,Half-life using mouse brain homogenate,,BAO_0000218,CHEMBL627096,6159,10090.0,Intermediate,1,,,50594,N,1,955.0,
8860,,Half-life was measured in mice,,BAO_0000218,CHEMBL627097,6254,10090.0,Intermediate,1,,,50594,N,1,,
8861,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,BAO_0000218,CHEMBL627098,6062,10090.0,Intermediate,1,,,50594,N,1,,
8862,,Half-life period was determined in mouse blood,,BAO_0000218,CHEMBL627099,1574,10090.0,Intermediate,1,,,50594,N,1,178.0,
8863,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,BAO_0000218,CHEMBL627100,56,10090.0,Intermediate,1,,,50594,N,1,955.0,
8864,,Plasma half life in mouse,,BAO_0000218,CHEMBL627101,993,10090.0,Intermediate,1,,,50594,N,1,1969.0,
8865,,Stability of the peptide in the presence of mouse serum,,BAO_0000218,CHEMBL627102,6652,10090.0,Intermediate,1,,,50594,N,1,,
8866,,Terminal half life of compound was determined in mouse,,BAO_0000218,CHEMBL627103,17852,10090.0,Intermediate,1,,,50594,N,1,,
8867,,Terminal half life was evaluated in mice after intravenous administration,,BAO_0000218,CHEMBL627104,2675,10090.0,Intermediate,1,,,50594,N,1,,
8868,,Terminal half life was evaluated in mice after oral administration,,BAO_0000218,CHEMBL627105,2675,10090.0,Intermediate,1,,,50594,N,1,,
8869,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,BAO_0000218,CHEMBL876786,499,10090.0,Intermediate,1,,,50594,N,1,,
8870,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,BAO_0000218,CHEMBL873825,499,10090.0,Intermediate,1,,,50594,N,1,,
8871,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,BAO_0000218,CHEMBL627106,499,10090.0,Intermediate,1,,,50594,N,1,,
8872,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,BAO_0000218,CHEMBL626336,14239,10090.0,Intermediate,1,,,50594,N,1,,
8873,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,BAO_0000218,CHEMBL877462,5506,10090.0,Intermediate,1,,,50594,N,1,,
8874,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,BAO_0000218,CHEMBL626337,5506,10090.0,Intermediate,1,,,50594,N,1,,
8875,,Half life after intraperitoneal administration of 100 mg/kg in mice,,BAO_0000218,CHEMBL626338,17734,10090.0,Intermediate,1,,,50594,N,1,,
8876,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,BAO_0000218,CHEMBL626339,17728,10090.0,Intermediate,1,,,50594,N,1,,
8877,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,BAO_0000218,CHEMBL626340,17728,10090.0,Intermediate,1,,,50594,N,1,,
8878,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,BAO_0000218,CHEMBL625377,17728,10090.0,Intermediate,1,,,50594,N,1,,
8879,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,BAO_0000218,CHEMBL625378,17728,10090.0,Intermediate,1,,,50594,N,1,,
8880,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,BAO_0000218,CHEMBL625379,17728,10090.0,Intermediate,1,,,50594,N,1,,
8881,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,BAO_0000251,CHEMBL625380,14294,9823.0,Autocuration,1,,Microsomes,22224,U,0,,
8882,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,BAO_0000251,CHEMBL625381,14294,9823.0,Autocuration,1,,Microsomes,22224,U,0,,
8883,,Stability to porcine renal DHP-I,,BAO_0000019,CHEMBL625382,6056,9823.0,Autocuration,1,,,22224,U,0,,
8884,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,BAO_0000218,CHEMBL873828,1317,9823.0,Autocuration,1,,,22224,U,0,,
8885,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,BAO_0000218,CHEMBL625383,1317,9823.0,Autocuration,1,,,22224,U,0,,
8886,,Half-life of the parent prodrug in porcine esterase solution,,BAO_0000019,CHEMBL625384,5229,9823.0,Autocuration,1,,,22224,U,0,,
8887,,"First order rate constant, k was determined in in pig liver Esterase",,BAO_0000019,CHEMBL625385,4231,9823.0,Autocuration,1,,,22224,U,0,,
8888,,Half life of the in pig liver Esterase,,BAO_0000221,CHEMBL625386,4231,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8889,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,BAO_0000221,CHEMBL623571,5318,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8890,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,BAO_0000221,CHEMBL623572,5318,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8891,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,BAO_0000221,CHEMBL623573,5318,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8892,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,BAO_0000221,CHEMBL623574,3305,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8893,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,BAO_0000221,CHEMBL623575,3305,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8894,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,BAO_0000221,CHEMBL623749,2842,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8895,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,BAO_0000221,CHEMBL623750,2842,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8896,,Half-life in vitro in pig liver,,BAO_0000221,CHEMBL623751,889,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8897,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,BAO_0000221,CHEMBL623752,1904,9823.0,Autocuration,1,,,22224,U,0,2107.0,
8898,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,BAO_0000218,CHEMBL623753,4186,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8899,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,BAO_0000218,CHEMBL623754,2774,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8900,,Maximum concentration in rat plasma was determined,,BAO_0000218,CHEMBL623755,1742,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8901,,Maximum concentration in rats,,BAO_0000218,CHEMBL623756,3169,10116.0,Intermediate,1,,,50597,N,1,,
8902,,Maximum concentration in rats at 1-2 hours,,BAO_0000218,CHEMBL623757,3169,10116.0,Intermediate,1,,,50597,N,1,,
8903,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,BAO_0000218,CHEMBL623758,2081,10116.0,Intermediate,1,,,50597,N,1,,
8904,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,BAO_0000218,CHEMBL623759,3307,10116.0,Intermediate,1,,,50597,N,1,955.0,
8905,,Maximum concentration at the dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL623760,4727,10116.0,Intermediate,1,,,50597,N,1,,
8906,,Maximum concentration was evaluated in rats,,BAO_0000218,CHEMBL623761,6597,10116.0,Intermediate,1,,,50597,N,1,,
8907,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,BAO_0000218,CHEMBL623762,16365,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8908,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,BAO_0000218,CHEMBL877594,16365,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8909,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,BAO_0000218,CHEMBL623763,16365,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8910,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,BAO_0000218,CHEMBL623764,16365,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8911,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,BAO_0000218,CHEMBL623765,16365,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8912,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,BAO_0000218,CHEMBL623766,2591,10116.0,Intermediate,1,,,50597,N,1,178.0,
8913,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,BAO_0000218,CHEMBL623767,2591,10116.0,Intermediate,1,,,50597,N,1,178.0,
8914,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,BAO_0000218,CHEMBL623768,2591,10116.0,Intermediate,1,,,50597,N,1,178.0,
8915,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623769,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8916,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623770,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8917,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623771,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8918,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623772,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8919,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623773,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8920,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623774,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8921,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,BAO_0000218,CHEMBL623775,5978,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8922,,Cmax in rat (PO dose),,BAO_0000218,CHEMBL623776,14465,10116.0,Intermediate,1,,,50597,N,1,,
8923,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL622191,4723,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8924,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL622192,4723,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8925,,Maximum plasma concentration determined in rat,,BAO_0000218,CHEMBL622193,4576,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8926,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,CHEMBL622194,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8927,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,BAO_0000218,CHEMBL622195,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8928,,Maximum plasma concentration in rat,,BAO_0000218,CHEMBL622196,6824,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8929,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,CHEMBL622197,17065,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8930,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,BAO_0000218,CHEMBL622198,2932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8931,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,BAO_0000218,CHEMBL622199,2932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8932,,Maximum plasma concentration of compound was measured in rat,,BAO_0000218,CHEMBL622200,2879,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8933,,Maximum plasma concentration after 20 mg/kg oral administration in rat,,BAO_0000218,CHEMBL622201,2864,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8934,,Maximum plasma concentration after oral administration to rats,,BAO_0000218,CHEMBL623990,16367,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8935,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,CHEMBL623991,17717,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8936,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,BAO_0000218,CHEMBL623992,17717,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8937,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,CHEMBL623993,17717,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8938,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,BAO_0000218,CHEMBL623994,17717,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8939,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL623995,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8940,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL623996,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8941,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL623997,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8942,,Maximum plasma concentration dosed orally in rats,,BAO_0000218,CHEMBL623998,4516,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8943,,Maximum plasma concentration dosed orally in rats after 6 hours,,BAO_0000218,CHEMBL623999,4516,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8944,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,BAO_0000218,CHEMBL624000,4516,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8945,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,BAO_0000218,CHEMBL624001,5199,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8946,,Maximum plasma concentration in rat after po administration,,BAO_0000218,CHEMBL624002,17538,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8947,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,BAO_0000218,CHEMBL624003,6685,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8948,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,BAO_0000218,CHEMBL624004,6685,10116.0,Intermediate,1,,,50597,N,1,1969.0,
8949,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL624005,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8950,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL624006,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8951,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL624007,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8952,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL624008,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8953,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL624009,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8954,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL874387,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8955,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL624010,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8956,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL624011,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8957,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL624012,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8958,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL624013,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8959,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL624736,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8960,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL624737,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8961,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL624738,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8962,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL624739,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8963,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL624740,16434,10116.0,Intermediate,1,,,50597,N,1,948.0,
8964,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL624896,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8965,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL624897,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8966,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL624108,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8967,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL624109,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8968,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL624110,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8969,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL624111,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8970,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL624112,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8971,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL624113,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8972,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL619709,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8973,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL619710,16435,10116.0,Intermediate,1,,,50597,N,1,948.0,
8974,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL619711,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8975,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL619712,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8976,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL619713,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8977,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL619714,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8978,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL619715,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8979,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL619716,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8980,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL619717,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8981,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL619718,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8982,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL619719,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8983,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL875329,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8984,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL619720,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8985,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL619721,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8986,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL619722,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8987,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL619723,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8988,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL619724,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8989,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL619725,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8990,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL619726,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8991,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL619727,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8992,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL619728,16434,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8993,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL619729,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
8994,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL619730,11977,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8995,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL619731,11977,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8996,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL619732,11977,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8997,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL619733,11977,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8998,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL619734,11977,10116.0,Intermediate,1,,,50597,N,1,2385.0,
8999,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL619735,11977,10116.0,Intermediate,1,,,50597,N,1,14.0,
9000,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL875330,11977,10116.0,Intermediate,1,,,50597,N,1,14.0,
9001,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL628465,11977,10116.0,Intermediate,1,,,50597,N,1,14.0,
9002,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL628466,11977,10116.0,Intermediate,1,,,50597,N,1,14.0,
9003,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL628467,11977,10116.0,Intermediate,1,,,50597,N,1,14.0,
9004,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL628468,11977,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9005,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL628469,11977,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9006,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL628470,11977,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9007,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL628471,11977,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9008,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL628472,11977,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9009,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625191,11977,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9010,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL625192,11977,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9011,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,BAO_0000218,CHEMBL875337,11977,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9012,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626341,11977,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9013,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL626342,11977,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9014,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,BAO_0000218,CHEMBL621943,11977,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9015,,Half life in rats,,BAO_0000218,CHEMBL621944,3748,10116.0,Intermediate,1,,,50597,N,1,,
9016,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,BAO_0000218,CHEMBL621945,15765,10116.0,Intermediate,1,,,50597,N,1,,
9017,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,BAO_0000218,CHEMBL621946,4871,10116.0,Intermediate,1,,,50597,N,1,,
9018,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,BAO_0000218,CHEMBL621947,4871,10116.0,Intermediate,1,,,50597,N,1,,
9019,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,BAO_0000218,CHEMBL621948,4872,10116.0,Intermediate,1,,,50597,N,1,,
9020,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,BAO_0000218,CHEMBL621949,4872,10116.0,Intermediate,1,,,50597,N,1,,
9021,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,BAO_0000218,CHEMBL621950,5413,10116.0,Intermediate,1,,,50597,N,1,,
9022,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,BAO_0000218,CHEMBL621951,5413,10116.0,Intermediate,1,,,50597,N,1,,
9023,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,BAO_0000218,CHEMBL621952,15272,10116.0,Intermediate,1,,,50597,N,1,178.0,
9024,,Stability (%) in rat liver microsomes,,BAO_0000218,CHEMBL621953,4689,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9025,,Area under curve was calculated after intravenous administration,,BAO_0000218,CHEMBL621954,6057,10116.0,Intermediate,1,,,50597,N,1,,
9026,,Area under the curve was calculated after iv administration in rat,,BAO_0000218,CHEMBL621955,6057,10116.0,Intermediate,1,,,50597,N,1,,
9027,,Area under the curve was calculated in rat after peroral administration,,BAO_0000218,CHEMBL621956,6057,10116.0,Intermediate,1,,,50597,N,1,,
9028,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,CHEMBL621957,6211,10116.0,Intermediate,1,,,50597,N,1,,
9029,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,BAO_0000218,CHEMBL621958,5710,10116.0,Intermediate,1,,,50597,N,1,,
9030,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,BAO_0000218,CHEMBL621959,5710,10116.0,Intermediate,1,,,50597,N,1,,
9031,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,BAO_0000218,CHEMBL621960,17853,10116.0,Intermediate,1,,,50597,N,1,,
9032,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,BAO_0000218,CHEMBL621961,17853,10116.0,Intermediate,1,,,50597,N,1,,
9033,,p value of the compound,,BAO_0000218,CHEMBL621962,15765,10116.0,Intermediate,1,,,50597,N,1,,
9034,,p value of the compound,,BAO_0000218,CHEMBL876787,15765,10116.0,Intermediate,1,,,50597,N,1,,
9035,,p value of the compound,,BAO_0000218,CHEMBL621963,15765,10116.0,Intermediate,1,,,50597,N,1,,
9036,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL622637,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9037,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL622638,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9038,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL626561,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9039,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,BAO_0000019,CHEMBL626562,7991,9986.0,Autocuration,1,,,22224,U,0,,
9040,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,BAO_0000218,CHEMBL626563,429,9986.0,Autocuration,1,,,22224,U,0,,
9041,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,BAO_0000218,CHEMBL626564,429,9986.0,Autocuration,1,,,22224,U,0,,
9042,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,BAO_0000218,CHEMBL626565,6253,9986.0,Autocuration,1,,,22224,U,0,,
9043,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,BAO_0000218,CHEMBL626566,6253,9986.0,Autocuration,1,,,22224,U,0,,
9044,,Clearance rate in rabbits,,BAO_0000218,CHEMBL626567,3615,9986.0,Autocuration,1,,,22224,U,0,,
9045,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,BAO_0000218,CHEMBL626568,4059,9986.0,Autocuration,1,,,22224,U,0,,
9046,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,BAO_0000218,CHEMBL626569,5124,9986.0,Autocuration,1,,,22224,U,0,,
9047,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,BAO_0000218,CHEMBL626570,5124,9986.0,Autocuration,1,,,22224,U,0,,
9048,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,BAO_0000218,CHEMBL626571,5124,9986.0,Autocuration,1,,,22224,U,0,,
9049,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,BAO_0000218,CHEMBL626572,429,9986.0,Autocuration,1,,,22224,U,0,,
9050,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,BAO_0000218,CHEMBL626573,4059,9986.0,Autocuration,1,,,22224,U,0,1969.0,
9051,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,BAO_0000251,CHEMBL626574,9659,9986.0,Autocuration,1,,Microsomes,22224,U,0,2107.0,
9052,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,BAO_0000251,CHEMBL626575,9659,9986.0,Autocuration,1,,Microsomes,22224,U,0,2107.0,
9053,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,BAO_0000218,CHEMBL626576,3639,9986.0,Autocuration,1,,,22224,U,0,,
9054,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,BAO_0000218,CHEMBL626577,3639,9986.0,Autocuration,1,,,22224,U,0,,
9055,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,BAO_0000218,CHEMBL626578,3639,9986.0,Autocuration,1,,,22224,U,0,,
9056,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,BAO_0000218,CHEMBL625263,5124,9986.0,Autocuration,1,,,22224,U,0,,
9057,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,BAO_0000218,CHEMBL625264,5124,9986.0,Autocuration,1,,,22224,U,0,,
9058,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,BAO_0000218,CHEMBL625265,5124,9986.0,Autocuration,1,,,22224,U,0,,
9059,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,BAO_0000251,CHEMBL625266,14294,9986.0,Autocuration,1,,Microsomes,22224,U,0,,
9060,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,BAO_0000251,CHEMBL876796,14294,9986.0,Autocuration,1,,Microsomes,22224,U,0,,
9061,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,BAO_0000218,CHEMBL625267,429,9986.0,Autocuration,1,,,22224,U,0,,
9062,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,BAO_0000218,CHEMBL625268,5124,9986.0,Autocuration,1,,,22224,U,0,1969.0,
9063,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,BAO_0000218,CHEMBL625269,5124,9986.0,Autocuration,1,,,22224,U,0,1969.0,
9064,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,BAO_0000218,CHEMBL624689,5124,9986.0,Autocuration,1,,,22224,U,0,1969.0,
9065,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,BAO_0000218,CHEMBL624690,429,9986.0,Autocuration,1,,,22224,U,0,,
9066,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,BAO_0000218,CHEMBL624691,429,9986.0,Autocuration,1,,,22224,U,0,1088.0,
9067,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,BAO_0000218,CHEMBL624692,429,9986.0,Autocuration,1,,,22224,U,0,1088.0,
9068,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,BAO_0000218,CHEMBL624693,4059,9986.0,Autocuration,1,,,22224,U,0,,
9069,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,BAO_0000218,CHEMBL624694,4137,9986.0,Autocuration,1,,,22224,U,0,,
9070,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,BAO_0000221,CHEMBL877596,11672,9986.0,Autocuration,1,,,22224,U,0,,
9071,,Time within which only 10% of the drug was degraded,,BAO_0000019,CHEMBL624695,12886,9986.0,Autocuration,1,,,22224,U,0,,
9072,,Half life period in rabbit liver homogenate,,BAO_0000221,CHEMBL624696,3853,9986.0,Autocuration,1,,,22224,U,0,2107.0,
9073,,Half life value in rabbits,,BAO_0000019,CHEMBL624697,3615,9986.0,Autocuration,1,,,22224,U,0,,
9074,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,BAO_0000218,CHEMBL624698,6253,9986.0,Autocuration,1,,,22224,U,0,178.0,
9075,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,BAO_0000218,CHEMBL624699,6253,9986.0,Autocuration,1,,,22224,U,0,178.0,
9076,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,BAO_0000218,CHEMBL624700,6077,9986.0,Autocuration,1,,,22224,U,0,,
9077,,AUC 0-8 hr value in rats at 10 mg/kg,,BAO_0000218,CHEMBL622903,17617,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9078,,AUC after administration at 2000 mg/kg/day in rats,,BAO_0000218,CHEMBL622904,17594,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9079,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,BAO_0000218,CHEMBL622905,6149,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9080,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,BAO_0000218,CHEMBL622906,17260,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9081,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,CHEMBL622907,17260,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9082,,AUC in rat after oral administration at 10.5 mg/kg dose,,BAO_0000218,CHEMBL622908,6644,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9083,,AUC in rat after oral administration at 11.2 mg/kg dose,,BAO_0000218,CHEMBL622909,6644,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9084,,AUC in rat after oral administration at 9.7 mg/kg dose,,BAO_0000218,CHEMBL622910,6644,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9085,,AUC in rat brain after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL622911,6495,10116.0,Intermediate,1,,,50597,N,1,955.0,
9086,,AUC in rat p.o.,,BAO_0000218,CHEMBL622912,6504,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9087,,AUC in rat p.o. at 20 mg/kg concentration,,BAO_0000218,CHEMBL622913,17686,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9088,,AUC in rat plasma after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL622914,6495,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9089,,AUC in rats,,BAO_0000218,CHEMBL622915,216,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9090,,AUC value after IV dose at a dose of 5 mg/kg in rats.,,BAO_0000218,CHEMBL622916,1908,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9091,,AUC value after oral dose at a dose of 10 mg/kg in rats.,,BAO_0000218,CHEMBL622917,1908,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9092,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,BAO_0000218,CHEMBL622918,6685,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9093,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,BAO_0000218,CHEMBL622919,216,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9094,,Maximum plasma concentration was evaluated in rat,,BAO_0000218,CHEMBL622920,6049,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9095,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,BAO_0000218,CHEMBL622921,2463,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9096,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,BAO_0000218,CHEMBL622922,6679,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9097,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,BAO_0000218,CHEMBL622923,6681,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9098,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL877604,4890,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9099,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,BAO_0000218,CHEMBL622924,6410,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9100,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL622925,6410,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9101,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,BAO_0000218,CHEMBL622926,16366,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9102,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,BAO_0000218,CHEMBL623625,6227,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9103,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL623626,3598,10116.0,Expert,1,,,50597,N,1,1969.0,
9104,,Maximum plasma drug concentration was determined,,BAO_0000218,CHEMBL623627,1465,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9105,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,CHEMBL623628,4368,10116.0,Intermediate,1,,,50597,N,1,,
9106,,Mean peak plasma concentration was observed after intravenous administration in rat,,BAO_0000218,CHEMBL623629,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9107,,Mean peak plasma concentration was observed after oral administration in rat,,BAO_0000218,CHEMBL623630,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9108,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,BAO_0000218,CHEMBL623804,5355,10116.0,Intermediate,1,,,50597,N,1,,
9109,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL623805,5355,10116.0,Intermediate,1,,,50597,N,1,,
9110,,Peak oral plasma concentration was determined in rats by oral administration,,BAO_0000218,CHEMBL623806,1567,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9111,,Peak plasma concentration (Cmax) was determined,,BAO_0000218,CHEMBL623807,4026,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9112,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL623808,6193,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9113,,Peak plasma concentration (Cmax) in rats,,BAO_0000218,CHEMBL623809,4026,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9114,,Peak plasma concentration at 1 mg/kg peroral administration,,BAO_0000218,CHEMBL623810,6485,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9115,,Peak plasma concentration in rat,,BAO_0000218,CHEMBL623811,17655,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9116,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,CHEMBL623812,14941,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9117,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,BAO_0000218,CHEMBL877605,5394,10116.0,Intermediate,1,,,50597,N,1,,
9118,,Pharmacokinetic property (Cmax) in rat,,BAO_0000218,CHEMBL623813,4408,10116.0,Intermediate,1,,,50597,N,1,,
9119,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,BAO_0000218,CHEMBL623814,5983,10116.0,Intermediate,1,,,50597,N,1,,
9120,,Cmax in rat after 3mg/kg oral dose,,BAO_0000218,CHEMBL623815,4878,10116.0,Intermediate,1,,,50597,N,1,,
9121,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,BAO_0000218,CHEMBL623816,5862,10116.0,Intermediate,1,,,50597,N,1,,
9122,,Cmax in rats after 20 mg/kg oral dose,,BAO_0000218,CHEMBL623145,4517,10116.0,Intermediate,1,,,50597,N,1,,
9123,,Cmax in rat plasma after 30mg/kg oral dose,,BAO_0000218,CHEMBL623146,5932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9124,,Plasma concentration after oral administration of 100 mg/kg to rats,,BAO_0000218,CHEMBL623147,5436,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9125,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,CHEMBL623042,4910,10116.0,Intermediate,1,,,50597,N,1,955.0,
9126,,Tested for the Cmax in rat at 10 mg/kg per orally,,BAO_0000218,CHEMBL623043,4950,10116.0,Intermediate,1,,,50597,N,1,,
9127,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL623044,15078,10116.0,Intermediate,1,,,50597,N,1,,
9128,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL623045,15078,10116.0,Intermediate,1,,,50597,N,1,,
9129,,Bioavailability as oral Cmax in rats at 30 mins,,BAO_0000218,CHEMBL623046,3360,10116.0,Intermediate,1,,,50597,N,1,,
9130,,Bioavailability as oral Cmax in rats at 6hr,,BAO_0000218,CHEMBL623226,3360,10116.0,Intermediate,1,,,50597,N,1,,
9131,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,BAO_0000218,CHEMBL623227,15022,10116.0,Intermediate,1,,,50597,N,1,,
9132,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,BAO_0000218,CHEMBL623228,15022,10116.0,Intermediate,1,,,50597,N,1,,
9133,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,BAO_0000218,CHEMBL623229,15022,10116.0,Intermediate,1,,,50597,N,1,,
9134,,The maximum plasma levels for the compounds were determined by LC-MS.,,BAO_0000218,CHEMBL623230,5160,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9135,,mean peak plasma concentration was observed after intravenous administration in rat,,BAO_0000218,CHEMBL623231,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9136,,mean peak plasma concentration was observed after oral administration in rat,,BAO_0000218,CHEMBL623232,15662,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9137,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,BAO_0000218,CHEMBL623233,4709,10116.0,Intermediate,1,,,50597,N,1,,
9138,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,BAO_0000218,CHEMBL623234,3535,10116.0,Intermediate,1,,,50597,N,1,,
9139,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,BAO_0000218,CHEMBL623235,3535,10116.0,Intermediate,1,,,50597,N,1,,
9140,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,BAO_0000218,CHEMBL623236,3535,10116.0,Intermediate,1,,,50597,N,1,,
9141,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,BAO_0000218,CHEMBL623237,3535,10116.0,Intermediate,1,,,50597,N,1,,
9142,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,BAO_0000218,CHEMBL623238,3535,10116.0,Intermediate,1,,,50597,N,1,,
9143,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,BAO_0000218,CHEMBL623239,3535,10116.0,Intermediate,1,,,50597,N,1,,
9144,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,BAO_0000218,CHEMBL623240,5005,10116.0,Intermediate,1,,,22224,U,0,1969.0,
9145,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,BAO_0000218,CHEMBL623241,6326,10116.0,Intermediate,1,,,50597,N,1,1898.0,
9146,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,BAO_0000218,CHEMBL623242,6326,10116.0,Intermediate,1,,,50597,N,1,1898.0,
9147,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,BAO_0000218,CHEMBL874394,6326,10116.0,Intermediate,1,,,50597,N,1,,
9148,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,BAO_0000218,CHEMBL623243,6326,10116.0,Intermediate,1,,,50597,N,1,,
9149,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL623244,17411,10116.0,Intermediate,1,,,50597,N,1,,
9150,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL623245,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9151,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL623246,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9152,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL623247,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9153,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL623248,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9154,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL623249,16435,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9155,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL625072,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9156,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL625073,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9157,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL625074,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9158,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL625075,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9159,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL625076,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9160,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL625077,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9161,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL625078,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9162,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL874395,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9163,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL625079,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9164,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL625080,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9165,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL625081,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9166,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL625082,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9167,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL625083,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9168,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL625084,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9169,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL625085,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9170,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL625086,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9171,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL625087,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9172,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL625088,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9173,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL622205,16434,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9174,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL622206,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9175,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL622207,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9176,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL622366,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9177,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL622367,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9178,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL875331,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9179,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL622368,16435,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9180,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL622369,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9181,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL622370,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9182,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL622371,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9183,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL622372,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9184,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL622373,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9185,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL622374,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9186,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL622375,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9187,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL622376,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9188,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL622377,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9189,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL622378,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9190,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL622379,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9191,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL622380,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9192,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL622381,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9193,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL622382,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9194,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL622383,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9195,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL875332,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9196,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL622384,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9197,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL622385,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9198,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,BAO_0000218,CHEMBL622386,6175,10116.0,Intermediate,1,,,50597,N,1,945.0,
9199,,The compound was tested for the plasma binding in rat,,BAO_0000218,CHEMBL622387,10839,10116.0,Intermediate,1,,,50597,N,1,,
9200,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,BAO_0000218,CHEMBL622388,16459,10116.0,Intermediate,1,,,50597,N,1,,
9201,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,BAO_0000218,CHEMBL622389,16459,10116.0,Intermediate,1,,,50597,N,1,,
9202,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,BAO_0000218,CHEMBL622390,16459,10116.0,Intermediate,1,,,50597,N,1,,
9203,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,BAO_0000218,CHEMBL622391,16459,10116.0,Intermediate,1,,,50597,N,1,,
9204,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,BAO_0000218,CHEMBL622392,16459,10116.0,Intermediate,1,,,50597,N,1,,
9205,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,BAO_0000218,CHEMBL622393,16459,10116.0,Intermediate,1,,,50597,N,1,,
9206,,Plasma level at 2 hr after administration of the compound,,BAO_0000218,CHEMBL622394,3278,10116.0,Intermediate,1,,,50597,N,1,,
9207,,plasma level at 2 hr after administration of the compound,,BAO_0000218,CHEMBL622395,3278,10116.0,Intermediate,1,,,50597,N,1,,
9208,,Stability in rat serum measured as % recovery at 1 min,,BAO_0000218,CHEMBL622396,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9209,,Stability in rat serum measured as % recovery at 10 min,,BAO_0000218,CHEMBL624894,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9210,,Stability in rat serum measured as % recovery at 10 mins,,BAO_0000218,CHEMBL624895,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9211,,Stability in rat serum measured as % recovery at 2 hr,,BAO_0000218,CHEMBL624058,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9212,,Stability in rat serum measured as % recovery at 3 min,,BAO_0000218,CHEMBL624059,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9213,,Stability in rat serum measured as % recovery at 3 mins,,BAO_0000218,CHEMBL624060,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9214,,Stability in rat serum measured as % recovery at 5 min,,BAO_0000218,CHEMBL624061,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9215,,Stability in rat serum measured as % recovery at 5 mins,,BAO_0000218,CHEMBL624062,4684,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9216,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL624063,16456,10116.0,Intermediate,1,,,50597,N,1,,
9217,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL624064,16456,10116.0,Intermediate,1,,,50597,N,1,,
9218,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,BAO_0000218,CHEMBL624065,723,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9219,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,BAO_0000218,CHEMBL624066,723,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9220,,Half life tested in mature male rat at a dose of 30 mg/kg,,BAO_0000218,CHEMBL877490,5160,10116.0,Intermediate,1,,,50597,N,1,,
9221,,Half life after intravenous administration of 1 mg/kg in rat,,BAO_0000218,CHEMBL874442,4709,10116.0,Intermediate,1,,,50597,N,1,,
9222,,Half life period after administration (30 mg/kg) in rat,,BAO_0000218,CHEMBL626890,5633,10116.0,Intermediate,1,,,50597,N,1,,
9223,,Half life period in rat after 5 mg/Kg dose,,BAO_0000218,CHEMBL626891,5302,10116.0,Intermediate,1,,,50597,N,1,,
9224,,Half life period in rat after 5 mg/kg dose,,BAO_0000218,CHEMBL626892,5302,10116.0,Intermediate,1,,,50597,N,1,,
9225,,Half life period was determined,,BAO_0000218,CHEMBL626893,17791,10116.0,Intermediate,1,,,50597,N,1,,
9226,,Half life period was evaluated in rat,,BAO_0000218,CHEMBL626894,17791,10116.0,Intermediate,1,,,50597,N,1,,
9227,,Half life period was evaluated in rat; 0.5-1.0,,BAO_0000218,CHEMBL626895,17791,10116.0,Intermediate,1,,,50597,N,1,,
9228,,Half life period was evaluated in rat; 5.9-7.5,,BAO_0000218,CHEMBL626896,17791,10116.0,Intermediate,1,,,50597,N,1,,
9229,,Half-life in rat plasma,,BAO_0000218,CHEMBL626897,14512,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9230,,Half-life time in rat was determined,,BAO_0000218,CHEMBL626898,6230,10116.0,Intermediate,1,,,50597,N,1,,
9231,,Terminal half-life after iv administration to rats,,BAO_0000218,CHEMBL626899,3364,10116.0,Intermediate,1,,,50597,N,1,,
9232,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,BAO_0000218,CHEMBL626900,6874,10116.0,Intermediate,1,,,50597,N,1,,
9233,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,BAO_0000218,CHEMBL626901,857,10116.0,Intermediate,1,,,50597,N,1,,
9234,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,BAO_0000218,CHEMBL626902,858,10116.0,Intermediate,1,,,50597,N,1,,
9235,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,BAO_0000218,CHEMBL626903,858,10116.0,Intermediate,1,,,50597,N,1,,
9236,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,BAO_0000218,CHEMBL874443,5355,10116.0,Intermediate,1,,,50597,N,1,,
9237,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL626904,5355,10116.0,Intermediate,1,,,50597,N,1,,
9238,,Half life in rats,,BAO_0000218,CHEMBL626905,6305,10116.0,Intermediate,1,,,50597,N,1,,
9239,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,BAO_0000218,CHEMBL873830,13501,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9240,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,BAO_0000218,CHEMBL626906,17594,10116.0,Intermediate,1,,,50597,N,1,,
9241,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,CHEMBL631076,4186,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9242,,Biological half-life was measured in plasma of rats,,BAO_0000218,CHEMBL631077,2932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9243,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,CHEMBL631078,17065,10116.0,Intermediate,1,,,50597,N,1,,
9244,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,BAO_0000218,CHEMBL631079,15765,10116.0,Intermediate,1,,,50597,N,1,,
9245,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,BAO_0000218,CHEMBL631080,2713,10116.0,Intermediate,1,,,50597,N,1,,
9246,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,CHEMBL631081,2661,10116.0,Intermediate,1,,,50597,N,1,,
9247,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,CHEMBL631239,2661,10116.0,Intermediate,1,,,50597,N,1,,
9248,,Compound was evaluated for plasma half life in rat,,BAO_0000218,CHEMBL631240,740,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9249,,AUC value at a dose of 5 mg/kg (p.o.) in rats,,BAO_0000218,CHEMBL631241,6597,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9250,,AUC value after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,CHEMBL631242,2959,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9251,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,BAO_0000218,CHEMBL631243,17594,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9252,,AUC0-96 after administration at 50 mg/kg,,BAO_0000218,CHEMBL874444,17596,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9253,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,BAO_0000218,CHEMBL631244,17594,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9254,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,BAO_0000218,CHEMBL631245,3293,10116.0,Intermediate,1,,,50597,N,1,,
9255,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,BAO_0000218,CHEMBL627162,6757,10116.0,Intermediate,1,,,50597,N,1,,
9256,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,BAO_0000218,CHEMBL627163,6757,10116.0,Intermediate,1,,,50597,N,1,,
9257,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,BAO_0000218,CHEMBL627164,6757,10116.0,Intermediate,1,,,50597,N,1,,
9258,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,BAO_0000218,CHEMBL627165,5979,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9259,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,BAO_0000218,CHEMBL627166,5979,10116.0,Intermediate,1,,,50597,N,1,,
9260,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,BAO_0000218,CHEMBL627167,5979,10116.0,Intermediate,1,,,50597,N,1,,
9261,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,BAO_0000218,CHEMBL627822,4026,10116.0,Intermediate,1,,,50597,N,1,,
9262,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL627823,5355,10116.0,Intermediate,1,,,50597,N,1,,
9263,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,BAO_0000218,CHEMBL627824,5355,10116.0,Intermediate,1,,,50597,N,1,,
9264,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,BAO_0000218,CHEMBL627825,5355,10116.0,Intermediate,1,,,50597,N,1,,
9265,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,BAO_0000218,CHEMBL627826,5633,10116.0,Intermediate,1,,,50597,N,1,,
9266,,Area under curve (Pharmacokinetic property) was determined,,BAO_0000218,CHEMBL627827,1716,10116.0,Intermediate,1,,,50597,N,1,,
9267,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,BAO_0000218,CHEMBL627828,1716,10116.0,Intermediate,1,,,50597,N,1,,
9268,,Area under curve after intravenous administration (1 mg/kg) in rat,,BAO_0000218,CHEMBL627829,4689,10116.0,Intermediate,1,,,50597,N,1,,
9269,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,BAO_0000218,CHEMBL627830,4527,10116.0,Intermediate,1,,,50597,N,1,,
9270,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,CHEMBL627831,4527,10116.0,Intermediate,1,,,50597,N,1,,
9271,,Area under curve in male SD rats was observed after oral administration in rat,,BAO_0000218,CHEMBL627832,15662,10116.0,Intermediate,1,,,50597,N,1,,
9272,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,BAO_0000218,CHEMBL627833,4413,10116.0,Intermediate,1,,,50597,N,1,,
9273,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL627834,3598,10116.0,Expert,1,,,50597,N,1,,
9274,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL628004,3598,10116.0,Expert,1,,,50597,N,1,,
9275,,Area under curve at 5 mg/kg po was determined in rat,,BAO_0000218,CHEMBL628005,5964,10116.0,Intermediate,1,,,50597,N,1,,
9276,,Area under curve in Rat at a oral dose of 5 mg/kg,,BAO_0000218,CHEMBL628006,4689,10116.0,Intermediate,1,,,50597,N,1,,
9277,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,BAO_0000218,CHEMBL628007,4186,10116.0,Intermediate,1,,,50597,N,1,,
9278,,Area under curve was determined,,BAO_0000218,CHEMBL625676,5510,10116.0,Intermediate,1,,,50597,N,1,,
9279,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,BAO_0000218,CHEMBL631309,17858,10116.0,Intermediate,1,,,50597,N,1,,
9280,,Area under curve after intravenous administration at 3 mg/kg,,BAO_0000218,CHEMBL631310,17804,10116.0,Intermediate,1,,,50597,N,1,,
9281,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,BAO_0000218,CHEMBL631311,6106,10116.0,Intermediate,1,,,50597,N,1,,
9282,,Area under curve at 4 hr in rat,,BAO_0000218,CHEMBL631312,5964,10116.0,Intermediate,1,,,50597,N,1,,
9283,,Area under curve at a dose of 30 mg/kg,,BAO_0000218,CHEMBL631313,4026,10116.0,Intermediate,1,,,50597,N,1,,
9284,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL631314,4756,10116.0,Intermediate,1,,,50597,N,1,,
9285,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL631315,4756,10116.0,Intermediate,1,,,50597,N,1,,
9286,,Area under curve for a 2-mpk po dose in SD rats,,BAO_0000218,CHEMBL631316,5862,10116.0,Intermediate,1,,,50597,N,1,,
9287,,Area under curve in SD rats,,BAO_0000218,CHEMBL631317,5862,10116.0,Intermediate,1,,,50597,N,1,,
9288,,Area under curve in rat after oral administration at 13 mg/kg dose,,BAO_0000218,CHEMBL874471,6644,10116.0,Intermediate,1,,,50597,N,1,,
9289,,Area under curve in rat by po administration at 0-24 hr,,BAO_0000218,CHEMBL631318,5871,10116.0,Intermediate,1,,,50597,N,1,,
9290,,Area under curve in rat plasma,,BAO_0000218,CHEMBL631319,5919,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9291,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,BAO_0000218,CHEMBL631320,5939,10116.0,Intermediate,1,,,50597,N,1,,
9292,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,BAO_0000218,CHEMBL631321,5939,10116.0,Intermediate,1,,,50597,N,1,,
9293,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,BAO_0000218,CHEMBL631322,10,10116.0,Intermediate,1,,,50597,N,1,,
9294,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,BAO_0000218,CHEMBL631323,11149,10116.0,Intermediate,1,,,50597,N,1,,
9295,,Area under curve value in rat at a dose of 5 mg/kg,,BAO_0000218,CHEMBL631324,5302,10116.0,Intermediate,1,,,50597,N,1,,
9296,,Area under curve was determined after oral administration in rats,,BAO_0000218,CHEMBL631325,17796,10116.0,Intermediate,1,,,50597,N,1,,
9297,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL631326,4890,10116.0,Intermediate,1,,,50597,N,1,,
9298,,Area under curve was determined after peroral administration in rat,,BAO_0000218,CHEMBL631327,6011,10116.0,Intermediate,1,,,50597,N,1,,
9299,,Area under curve was determined at a dose 30 mpk administered orally.,,BAO_0000218,CHEMBL631328,5375,10116.0,Intermediate,1,,,50597,N,1,,
9300,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,CHEMBL631329,17764,10116.0,Intermediate,1,,,50597,N,1,,
9301,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,CHEMBL627217,4368,10116.0,Intermediate,1,,,50597,N,1,,
9302,,Area under curve was determined in male rat,,BAO_0000218,CHEMBL626352,5610,10116.0,Intermediate,1,,,50597,N,1,,
9303,,Area under curve was determined in rat after PO administration,,BAO_0000218,CHEMBL626353,5833,10116.0,Intermediate,1,,,50597,N,1,,
9304,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,BAO_0000218,CHEMBL626354,4257,10116.0,Intermediate,1,,,50597,N,1,,
9305,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,BAO_0000218,CHEMBL626355,5937,10116.0,Intermediate,1,,,50597,N,1,,
9306,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,BAO_0000218,CHEMBL626356,5932,10116.0,Intermediate,1,,,50597,N,1,,
9307,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,BAO_0000218,CHEMBL626357,5932,10116.0,Intermediate,1,,,50597,N,1,,
9308,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL626358,17411,10116.0,Intermediate,1,,,50597,N,1,,
9309,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL626359,17411,10116.0,Intermediate,1,,,50597,N,1,,
9310,,Peak plasma concentration in rat at a dose of 3 mg/kg,,BAO_0000218,CHEMBL626360,17771,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9311,,Plasma concentration at 2 hr in rats was evaluated.,,BAO_0000218,CHEMBL626361,1628,10116.0,Intermediate,1,,,50597,N,1,,
9312,,Plasma concentration at 2 hr in rats was evaluated; Not available,,BAO_0000218,CHEMBL626362,1628,10116.0,Intermediate,1,,,50597,N,1,,
9313,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL626363,17411,10116.0,Intermediate,1,,,50597,N,1,,
9314,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL626970,4910,10116.0,Intermediate,1,,,50597,N,1,,
9315,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL626971,4910,10116.0,Intermediate,1,,,50597,N,1,,
9316,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL626972,4910,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9317,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL626973,4910,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9318,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL626974,4910,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9319,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL874592,4910,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9320,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,BAO_0000218,CHEMBL626975,5510,10116.0,Intermediate,1,,,50597,N,1,,
9321,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,BAO_0000218,CHEMBL626976,5510,10116.0,Intermediate,1,,,50597,N,1,,
9322,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,BAO_0000218,CHEMBL626977,5510,10116.0,Intermediate,1,,,50597,N,1,,
9323,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,BAO_0000218,CHEMBL626978,5510,10116.0,Intermediate,1,,,50597,N,1,,
9324,,PK study was carried to determine the relative absorption ranking in rat.,,BAO_0000218,CHEMBL626979,16427,10116.0,Intermediate,1,,,50597,N,1,,
9325,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,BAO_0000218,CHEMBL626980,4689,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9326,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,BAO_0000218,CHEMBL626981,11450,10116.0,Intermediate,1,,,50597,N,1,178.0,
9327,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,BAO_0000218,CHEMBL626982,11450,10116.0,Intermediate,1,,,50597,N,1,178.0,
9328,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,BAO_0000218,CHEMBL626983,11450,10116.0,Intermediate,1,,,50597,N,1,178.0,
9329,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,BAO_0000218,CHEMBL622522,11450,10116.0,Intermediate,1,,,50597,N,1,178.0,
9330,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,BAO_0000218,CHEMBL622523,11450,10116.0,Intermediate,1,,,50597,N,1,178.0,
9331,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,BAO_0000218,CHEMBL622524,11450,10116.0,Intermediate,1,,,50597,N,1,178.0,
9332,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,BAO_0000218,CHEMBL622525,11450,10116.0,Intermediate,1,,,50597,N,1,955.0,
9333,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,BAO_0000218,CHEMBL622526,11450,10116.0,Intermediate,1,,,50597,N,1,955.0,
9334,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,BAO_0000218,CHEMBL619849,11450,10116.0,Intermediate,1,,,50597,N,1,955.0,
9335,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,BAO_0000218,CHEMBL619850,11450,10116.0,Intermediate,1,,,50597,N,1,955.0,
9336,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,BAO_0000218,CHEMBL623864,11450,10116.0,Intermediate,1,,,50597,N,1,955.0,
9337,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,BAO_0000218,CHEMBL623865,11450,10116.0,Intermediate,1,,,50597,N,1,955.0,
9338,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,BAO_0000218,CHEMBL623866,11450,10116.0,Intermediate,1,,,50597,N,1,948.0,
9339,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,BAO_0000218,CHEMBL623867,11450,10116.0,Intermediate,1,,,50597,N,1,948.0,
9340,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,BAO_0000218,CHEMBL877615,11450,10116.0,Intermediate,1,,,50597,N,1,948.0,
9341,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,BAO_0000218,CHEMBL623868,11450,10116.0,Intermediate,1,,,50597,N,1,948.0,
9342,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,BAO_0000218,CHEMBL623869,11450,10116.0,Intermediate,1,,,50597,N,1,948.0,
9343,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,BAO_0000218,CHEMBL623870,11450,10116.0,Intermediate,1,,,50597,N,1,948.0,
9344,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL623871,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9345,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL623872,16434,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9346,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL622129,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9347,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL622130,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9348,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL622131,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9349,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL622132,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9350,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL622133,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9351,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL622134,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9352,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL622135,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9353,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL622136,16435,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9354,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL622137,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9355,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL622138,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9356,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL623017,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9357,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL623018,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9358,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL623019,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9359,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL623020,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9360,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL623021,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9361,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL623022,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9362,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL623023,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9363,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL623024,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9364,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL623025,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9365,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL620545,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9366,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL620546,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9367,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL620547,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9368,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL620548,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9369,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL620549,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9370,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL620550,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9371,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL620551,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9372,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL620552,16434,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9373,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL620553,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9374,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL620554,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9375,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL875845,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9376,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL620555,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9377,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL620556,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9378,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL620557,16435,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9379,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL620558,16434,10116.0,Intermediate,1,,,50597,N,1,,
9380,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL620559,16434,10116.0,Intermediate,1,,,50597,N,1,,
9381,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL622939,16434,10116.0,Intermediate,1,,,50597,N,1,,
9382,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL622940,16434,10116.0,Intermediate,1,,,50597,N,1,,
9383,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL622941,16434,10116.0,Intermediate,1,,,50597,N,1,,
9384,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL622942,16434,10116.0,Intermediate,1,,,50597,N,1,,
9385,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL622943,16434,10116.0,Intermediate,1,,,50597,N,1,,
9386,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL622944,16434,10116.0,Intermediate,1,,,50597,N,1,,
9387,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL622945,16435,10116.0,Intermediate,1,,,50597,N,1,,
9388,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL622946,16435,10116.0,Intermediate,1,,,50597,N,1,,
9389,,Compound was evaluated for terminal half life in rat,,BAO_0000218,CHEMBL622947,3341,10116.0,Intermediate,1,,,50597,N,1,,
9390,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,BAO_0000218,CHEMBL622948,3634,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9391,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,BAO_0000218,CHEMBL622949,3634,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9392,,Compound was tested for its half life in rat,,BAO_0000218,CHEMBL622950,4839,10116.0,Intermediate,1,,,50597,N,1,,
9393,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,BAO_0000218,CHEMBL622951,5005,9544.0,Intermediate,1,,,22224,U,0,1969.0,
9394,,Compound was tested for its plasma half life in Sprague Dawley rats,,BAO_0000366,CHEMBL622952,5005,10116.0,Intermediate,1,,,22224,U,0,1969.0,
9395,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,BAO_0000366,CHEMBL622953,5005,10116.0,Intermediate,1,,,22224,U,0,1969.0,
9396,,Compound was tested for plasma half-life period in rat,,BAO_0000218,CHEMBL873818,1094,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9397,,Elimination half life after i.v. administration of compound in rats,,BAO_0000218,CHEMBL622954,5031,10116.0,Intermediate,1,,,50597,N,1,,
9398,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,BAO_0000218,CHEMBL622955,6518,10116.0,Intermediate,1,,,50597,N,1,,
9399,,Elimination half-life after IV dosing at 1 mg/kg in rat,,BAO_0000218,CHEMBL875229,6518,10116.0,Intermediate,1,,,50597,N,1,,
9400,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL622956,6518,10116.0,Intermediate,1,,,50597,N,1,,
9401,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,BAO_0000218,CHEMBL622957,6518,10116.0,Intermediate,1,,,50597,N,1,,
9402,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,BAO_0000218,CHEMBL622958,5408,10116.0,Intermediate,1,,,50597,N,1,955.0,
9403,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,CHEMBL622959,5408,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9404,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,BAO_0000218,CHEMBL622960,5408,10116.0,Intermediate,1,,,50597,N,1,955.0,
9405,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,CHEMBL622961,5408,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9406,,Evaluated for the half life in rat (in vivo),,BAO_0000218,CHEMBL622962,4687,10116.0,Intermediate,1,,,50597,N,1,,
9407,,Hafl life in rat,,BAO_0000218,CHEMBL622963,6640,10116.0,Intermediate,1,,,50597,N,1,,
9408,,Hafl life rat,,BAO_0000218,CHEMBL622964,6640,10116.0,Intermediate,1,,,50597,N,1,,
9409,,Hafl life rat,,BAO_0000218,CHEMBL622965,6641,10116.0,Intermediate,1,,,50597,N,1,,
9410,,Hafl life rat; Not determined,,BAO_0000218,CHEMBL622966,6640,10116.0,Intermediate,1,,,50597,N,1,,
9411,,Hafl life rat; Not determined,,BAO_0000218,CHEMBL622967,6641,10116.0,Intermediate,1,,,50597,N,1,,
9412,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL622968,17411,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9413,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL622969,17411,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9414,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL875327,17411,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9415,,Half life in rat after 1 mg/kg i.v. administration,,BAO_0000218,CHEMBL628638,6570,10116.0,Intermediate,1,,,50597,N,1,,
9416,,Half life in rat after 2 mg/kg peroral administration,,BAO_0000218,CHEMBL628639,6570,10116.0,Intermediate,1,,,50597,N,1,,
9417,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL625840,17411,10116.0,Intermediate,1,,,50597,N,1,,
9418,,Half life of 10 mg/kg oral dose determined in rats,,BAO_0000218,CHEMBL625841,4722,10116.0,Intermediate,1,,,50597,N,1,,
9419,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL625842,5978,10116.0,Intermediate,1,,,50597,N,1,,
9420,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL625843,5978,10116.0,Intermediate,1,,,50597,N,1,,
9421,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL625844,5978,10116.0,Intermediate,1,,,50597,N,1,,
9422,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL873822,5978,10116.0,Intermediate,1,,,50597,N,1,,
9423,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL625845,5978,10116.0,Intermediate,1,,,50597,N,1,,
9424,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL627059,5978,10116.0,Intermediate,1,,,50597,N,1,,
9425,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL627060,5978,10116.0,Intermediate,1,,,50597,N,1,,
9426,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL627061,5978,10116.0,Intermediate,1,,,50597,N,1,,
9427,,Half life of compound at 5 mg/kg after po administration was determined in rat,,BAO_0000218,CHEMBL627709,4762,10116.0,Intermediate,1,,,50597,N,1,,
9428,,Half life of compound determined after intravenous administration to rat,,BAO_0000218,CHEMBL627710,5327,10116.0,Intermediate,1,,,50597,N,1,,
9429,,Half life of compound was determined in rat,,BAO_0000218,CHEMBL627711,4847,10116.0,Intermediate,1,,,50597,N,1,,
9430,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL627712,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9431,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL627713,4723,10116.0,Intermediate,1,,,50597,N,1,,
9432,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL627714,4723,10116.0,Intermediate,1,,,50597,N,1,,
9433,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,BAO_0000218,CHEMBL627889,4256,9541.0,Intermediate,1,,,22224,U,0,,
9434,,Half life determined in rat by intravenous administration,,BAO_0000218,CHEMBL627890,4256,10116.0,Intermediate,1,,,22224,U,0,,
9435,,Half life determined in rats after iv administration,,BAO_0000218,CHEMBL627891,4722,10116.0,Intermediate,1,,,50597,N,1,,
9436,,Half life in rat plasma after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL627892,6535,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9437,,Half life in rat plasma after administration of 2 mg/kg iv,,BAO_0000218,CHEMBL627893,6535,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9438,,Half life in rat plasma was determined,,BAO_0000218,CHEMBL627894,1435,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9439,,Half life in rat plasma was determined; NA means not applicable,,BAO_0000218,CHEMBL627895,1435,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9440,,Half life in rat was tested,,BAO_0000218,CHEMBL627896,5206,10116.0,Intermediate,1,,,50597,N,1,,
9441,,Half life measured in rat plasma,,BAO_0000218,CHEMBL627897,6080,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9442,,Half life recorded in rats,,BAO_0000218,CHEMBL627898,4449,10116.0,Intermediate,1,,,50597,N,1,,
9443,,Half life was calculated,,BAO_0000218,CHEMBL627899,6057,10116.0,Intermediate,1,,,50597,N,1,,
9444,,Half life was calculated in rat,,BAO_0000218,CHEMBL873823,6057,10116.0,Intermediate,1,,,50597,N,1,,
9445,,Half life was determined,,BAO_0000218,CHEMBL627900,3747,10116.0,Intermediate,1,,,50597,N,1,,
9446,,Half life after 10 mg/kg oral administration in rat,,BAO_0000218,CHEMBL627901,17858,10116.0,Intermediate,1,,,50597,N,1,,
9447,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,BAO_0000218,CHEMBL627902,16365,10116.0,Intermediate,1,,,50597,N,1,,
9448,,Half life after administering orally a dose of 30 mg/kg,,BAO_0000218,CHEMBL627903,16365,10116.0,Intermediate,1,,,50597,N,1,,
9449,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,BAO_0000218,CHEMBL627904,5031,10116.0,Intermediate,1,,,50597,N,1,,
9450,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,BAO_0000218,CHEMBL627905,4722,10116.0,Intermediate,1,,,50597,N,1,,
9451,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,BAO_0000218,CHEMBL627906,6078,10116.0,Intermediate,1,,,50597,N,1,,
9452,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,BAO_0000218,CHEMBL627907,6078,10116.0,Intermediate,1,,,50597,N,1,,
9453,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL876783,6078,10116.0,Intermediate,1,,,50597,N,1,,
9454,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,BAO_0000218,CHEMBL627908,6078,10116.0,Intermediate,1,,,50597,N,1,,
9455,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,BAO_0000218,CHEMBL627909,17065,10116.0,Intermediate,1,,,50597,N,1,,
9456,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,BAO_0000218,CHEMBL627910,1353,10116.0,Intermediate,1,,,50597,N,1,,
9457,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,BAO_0000218,CHEMBL627911,1353,10116.0,Intermediate,1,,,50597,N,1,,
9458,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,BAO_0000218,CHEMBL627912,1353,10116.0,Intermediate,1,,,50597,N,1,,
9459,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,BAO_0000218,CHEMBL627913,1353,10116.0,Intermediate,1,,,50597,N,1,,
9460,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,BAO_0000218,CHEMBL627914,1353,10116.0,Intermediate,1,,,50597,N,1,,
9461,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,CHEMBL627915,16423,10116.0,Intermediate,1,,,50597,N,1,,
9462,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,CHEMBL627916,16423,10116.0,Intermediate,1,,,50597,N,1,,
9463,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,CHEMBL627917,6062,10116.0,Intermediate,1,,,50597,N,1,,
9464,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,BAO_0000218,CHEMBL627918,6056,10116.0,Intermediate,1,,,50597,N,1,,
9465,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,BAO_0000218,CHEMBL627919,5182,10116.0,Intermediate,1,,,50597,N,1,,
9466,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,BAO_0000218,CHEMBL627920,6410,10116.0,Intermediate,1,,,50597,N,1,,
9467,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL627921,6410,10116.0,Intermediate,1,,,50597,N,1,,
9468,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL627922,4723,10116.0,Intermediate,1,,,50597,N,1,,
9469,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL876784,4723,10116.0,Intermediate,1,,,50597,N,1,,
9470,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL627923,4723,10116.0,Intermediate,1,,,50597,N,1,,
9471,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL626208,4723,10116.0,Intermediate,1,,,50597,N,1,,
9472,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL626209,4723,10116.0,Intermediate,1,,,50597,N,1,,
9473,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL626210,4723,10116.0,Intermediate,1,,,50597,N,1,,
9474,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,BAO_0000218,CHEMBL627994,2463,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9475,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,BAO_0000218,CHEMBL627995,4709,10116.0,Intermediate,1,,,50597,N,1,,
9476,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,BAO_0000218,CHEMBL627996,4075,10116.0,Intermediate,1,,,50597,N,1,,
9477,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,BAO_0000218,CHEMBL627997,5394,10116.0,Intermediate,1,,,50597,N,1,,
9478,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,BAO_0000218,CHEMBL627998,2661,10116.0,Intermediate,1,,,50597,N,1,,
9479,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,BAO_0000218,CHEMBL628640,2661,10116.0,Intermediate,1,,,50597,N,1,,
9480,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,CHEMBL628641,2661,10116.0,Intermediate,1,,,50597,N,1,,
9481,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,CHEMBL628642,2661,10116.0,Intermediate,1,,,50597,N,1,,
9482,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,BAO_0000218,CHEMBL628643,17791,10116.0,Intermediate,1,,,50597,N,1,,
9483,,Compound was tested for area under curve in rat,,BAO_0000218,CHEMBL628644,2591,10116.0,Intermediate,1,,,50597,N,1,,
9484,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,BAO_0000218,CHEMBL628645,6567,10116.0,Intermediate,1,,,50597,N,1,,
9485,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,CHEMBL628646,6211,10116.0,Intermediate,1,,,50597,N,1,,
9486,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,BAO_0000218,CHEMBL628647,5529,10116.0,Intermediate,1,,,50597,N,1,,
9487,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,BAO_0000218,CHEMBL628648,5408,10116.0,Intermediate,1,,,50597,N,1,,
9488,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,CHEMBL625358,5408,10116.0,Intermediate,1,,,50597,N,1,,
9489,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,BAO_0000218,CHEMBL625359,5408,10116.0,Intermediate,1,,,50597,N,1,,
9490,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,BAO_0000218,CHEMBL625360,5408,10116.0,Intermediate,1,,,50597,N,1,,
9491,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,BAO_0000218,CHEMBL625361,429,10116.0,Intermediate,1,,,50597,N,1,,
9492,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,BAO_0000218,CHEMBL625362,429,10116.0,Intermediate,1,,,50597,N,1,,
9493,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,BAO_0000218,CHEMBL625363,429,10116.0,Intermediate,1,,,50597,N,1,,
9494,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,BAO_0000218,CHEMBL625364,4796,10116.0,Intermediate,1,,,50597,N,1,,
9495,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL625365,5974,10116.0,Intermediate,1,,,50597,N,1,,
9496,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL625366,5974,10116.0,Intermediate,1,,,50597,N,1,,
9497,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL625367,5974,10116.0,Intermediate,1,,,50597,N,1,,
9498,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,BAO_0000218,CHEMBL625368,11450,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9499,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,BAO_0000218,CHEMBL625369,11450,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9500,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,BAO_0000218,CHEMBL625370,11450,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9501,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,BAO_0000218,CHEMBL625371,11450,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9502,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,BAO_0000218,CHEMBL625372,11450,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9503,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,BAO_0000218,CHEMBL625373,11450,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9504,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,BAO_0000218,CHEMBL625374,11450,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9505,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,BAO_0000218,CHEMBL877593,11450,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9506,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,BAO_0000218,CHEMBL625375,11450,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9507,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,BAO_0000218,CHEMBL625376,11450,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9508,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,BAO_0000218,CHEMBL621973,11450,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9509,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,BAO_0000218,CHEMBL621974,11450,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9510,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,BAO_0000218,CHEMBL621975,11450,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9511,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,BAO_0000218,CHEMBL622166,11450,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9512,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,BAO_0000218,CHEMBL622167,11450,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9513,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,BAO_0000218,CHEMBL622168,11450,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9514,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,BAO_0000218,CHEMBL622169,11450,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9515,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,BAO_0000218,CHEMBL622170,11450,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9516,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,BAO_0000218,CHEMBL622171,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9517,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,BAO_0000218,CHEMBL622172,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9518,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,BAO_0000218,CHEMBL622173,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9519,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,BAO_0000218,CHEMBL622174,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9520,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,BAO_0000218,CHEMBL622175,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9521,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,BAO_0000218,CHEMBL622176,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9522,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,BAO_0000218,CHEMBL622177,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9523,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,BAO_0000218,CHEMBL622178,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9524,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,BAO_0000218,CHEMBL622179,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9525,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,BAO_0000218,CHEMBL622180,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9526,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL622181,16435,10116.0,Intermediate,1,,,50597,N,1,,
9527,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL622182,16435,10116.0,Intermediate,1,,,50597,N,1,,
9528,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL622183,16435,10116.0,Intermediate,1,,,50597,N,1,,
9529,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL622184,16435,10116.0,Intermediate,1,,,50597,N,1,,
9530,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL622185,16435,10116.0,Intermediate,1,,,50597,N,1,,
9531,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL622186,16435,10116.0,Intermediate,1,,,50597,N,1,,
9532,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL622187,16434,10116.0,Intermediate,1,,,50597,N,1,,
9533,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL625002,16434,10116.0,Intermediate,1,,,50597,N,1,,
9534,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL622090,16434,10116.0,Intermediate,1,,,50597,N,1,,
9535,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL622091,16435,10116.0,Intermediate,1,,,50597,N,1,,
9536,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL622092,16435,10116.0,Intermediate,1,,,50597,N,1,,
9537,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL622093,16435,10116.0,Intermediate,1,,,50597,N,1,,
9538,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL622094,16435,10116.0,Intermediate,1,,,50597,N,1,,
9539,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL622095,16435,10116.0,Intermediate,1,,,50597,N,1,,
9540,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL622264,16435,10116.0,Intermediate,1,,,50597,N,1,,
9541,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL622265,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9542,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL622266,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9543,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL622267,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9544,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL622268,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9545,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL622269,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9546,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL625071,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9547,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL621621,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9548,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL621622,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9549,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL621623,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9550,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL621624,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9551,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL621625,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9552,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL621626,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9553,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL621627,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9554,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL621628,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9555,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL875328,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9556,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL621629,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9557,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL621630,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9558,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL621631,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9559,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL621632,16434,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9560,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL621633,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9561,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL621634,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9562,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL621635,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9563,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL621636,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9564,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL621637,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9565,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL621638,16435,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9566,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL618883,16434,10116.0,Intermediate,1,,,50597,N,1,,
9567,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,BAO_0000218,CHEMBL618884,16434,10116.0,Intermediate,1,,,50597,N,1,,
9568,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL628627,16434,10116.0,Intermediate,1,,,50597,N,1,,
9569,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL628628,16434,10116.0,Intermediate,1,,,50597,N,1,,
9570,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,BAO_0000218,CHEMBL628629,16434,10116.0,Intermediate,1,,,50597,N,1,,
9571,,Half life after administering orally a dose of 3 mg/kg,,BAO_0000218,CHEMBL628630,16365,10116.0,Intermediate,1,,,50597,N,1,,
9572,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,BAO_0000218,CHEMBL628631,16365,10116.0,Intermediate,1,,,50597,N,1,,
9573,,Half life after administering intravenously a dose of 1 mg/kg,,BAO_0000218,CHEMBL628632,16365,10116.0,Intermediate,1,,,50597,N,1,,
9574,,Half life after oral dosing in rats,,BAO_0000218,CHEMBL628633,526,10116.0,Intermediate,1,,,50597,N,1,,
9575,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,BAO_0000218,CHEMBL628634,16365,10116.0,Intermediate,1,,,50597,N,1,,
9576,,Half life by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,CHEMBL627789,4368,10116.0,Intermediate,1,,,50597,N,1,,
9577,,Half life in rat,,BAO_0000218,CHEMBL627790,3371,10116.0,Intermediate,1,,,50597,N,1,,
9578,,Half life in rat,,BAO_0000218,CHEMBL627791,6448,10116.0,Intermediate,1,,,50597,N,1,,
9579,,Half life in rat,,BAO_0000218,CHEMBL627792,6453,10116.0,Intermediate,1,,,50597,N,1,,
9580,,Half life in rat after intravenous administration of the compound,,BAO_0000218,CHEMBL627793,4353,10116.0,Intermediate,1,,,50597,N,1,,
9581,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,BAO_0000218,CHEMBL627794,4353,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9582,,Half life in rat after po administration of the compound,,BAO_0000218,CHEMBL627795,4353,10116.0,Intermediate,1,,,50597,N,1,,
9583,,Half life in rat after po administration of the compound; ND means Not determined,,BAO_0000218,CHEMBL627796,4353,10116.0,Intermediate,1,,,50597,N,1,,
9584,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,BAO_0000218,CHEMBL875335,4353,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9585,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,BAO_0000218,CHEMBL627797,4353,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9586,,Half life in rat i.v.,,BAO_0000218,CHEMBL627798,5789,10116.0,Intermediate,1,,,50597,N,1,,
9587,,Half life in rat i.v. at 2 mg/kg concentration,,BAO_0000218,CHEMBL627799,17686,10116.0,Intermediate,1,,,50597,N,1,,
9588,,Half life in rats,,BAO_0000218,CHEMBL627800,6495,10116.0,Intermediate,1,,,50597,N,1,,
9589,,Half life in rats after intravenous administration,,BAO_0000218,CHEMBL627801,484,10116.0,Intermediate,1,,,50597,N,1,,
9590,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,BAO_0000218,CHEMBL627802,6467,10116.0,Intermediate,1,,,50597,N,1,,
9591,,Half life in rat,,BAO_0000218,CHEMBL627803,6642,10116.0,Expert,1,,,50597,N,1,,
9592,,Half life was evaluated after intravenous administration to rats,,BAO_0000218,CHEMBL873820,16367,10116.0,Intermediate,1,,,50597,N,1,,
9593,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,BAO_0000218,CHEMBL627804,1369,10116.0,Intermediate,1,,,50597,N,1,,
9594,,Half life was evaluated in rat,,BAO_0000218,CHEMBL627805,5472,10116.0,Intermediate,1,,,50597,N,1,,
9595,,Half life was evaluated in rat,,BAO_0000218,CHEMBL627806,6049,10116.0,Intermediate,1,,,50597,N,1,,
9596,,Half life was evaluated in rat; Not tested,,BAO_0000218,CHEMBL627107,5472,10116.0,Intermediate,1,,,50597,N,1,,
9597,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,BAO_0000218,CHEMBL627108,16366,10116.0,Intermediate,1,,,50597,N,1,,
9598,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,BAO_0000218,CHEMBL627109,11149,10116.0,Intermediate,1,,,50597,N,1,,
9599,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,BAO_0000218,CHEMBL627110,11149,10116.0,Intermediate,1,,,50597,N,1,178.0,
9600,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,BAO_0000218,CHEMBL627111,2891,9443.0,Intermediate,1,,,22224,U,0,,
9601,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,BAO_0000218,CHEMBL627112,2891,9443.0,Intermediate,1,,,22224,U,0,,
9602,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,BAO_0000218,CHEMBL627113,2891,10116.0,Intermediate,1,,,22224,U,0,,
9603,,Half life was measured in rat at dose of 30 mg/kg by po administration,,BAO_0000218,CHEMBL627114,2891,10116.0,Intermediate,1,,,22224,U,0,,
9604,,Half life (t1/2) was determined,,BAO_0000218,CHEMBL627115,4026,10116.0,Intermediate,1,,,50597,N,1,,
9605,,Half life period at a dose of 10 uM/kg in rat was determined,,BAO_0000218,CHEMBL627116,4527,10116.0,Intermediate,1,,,50597,N,1,,
9606,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,BAO_0000218,CHEMBL627117,4527,10116.0,Intermediate,1,,,50597,N,1,,
9607,,Half life period was determined,,BAO_0000218,CHEMBL627118,5503,10116.0,Intermediate,1,,,50597,N,1,,
9608,,Half life period after intravenous administration at 20 mpk in rats,,BAO_0000218,CHEMBL627119,4426,10116.0,Intermediate,1,,,50597,N,1,,
9609,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,BAO_0000218,CHEMBL627120,4426,10116.0,Intermediate,1,,,50597,N,1,,
9610,,Half life period after intravenous administration in rat,,BAO_0000218,CHEMBL626922,6109,10116.0,Intermediate,1,,,50597,N,1,,
9611,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,CHEMBL626923,5654,10116.0,Intermediate,1,,,50597,N,1,,
9612,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,CHEMBL626924,5654,10116.0,Intermediate,1,,,50597,N,1,,
9613,,Half life period in 80% rat plasma at 37 degree Centigrade,,BAO_0000218,CHEMBL626925,4755,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9614,,Half life period in SD rats,,BAO_0000218,CHEMBL626926,5862,10116.0,Intermediate,1,,,50597,N,1,,
9615,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,BAO_0000218,CHEMBL626927,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9616,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,BAO_0000218,CHEMBL626928,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9617,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,CHEMBL626929,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9618,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,CHEMBL626930,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9619,,Half life period in rat,,BAO_0000218,CHEMBL626931,5960,10116.0,Intermediate,1,,,50597,N,1,,
9620,,Half life period in rat,,BAO_0000218,CHEMBL626932,6103,10116.0,Intermediate,1,,,50597,N,1,,
9621,,Half life period in rat,,BAO_0000218,CHEMBL626933,6317,10116.0,Intermediate,1,,,50597,N,1,,
9622,,Half life period in rat after oral administration at 10.5 mg/kg dose,,BAO_0000218,CHEMBL873826,6644,10116.0,Intermediate,1,,,50597,N,1,,
9623,,Half life period in rat after oral administration at 11.2 mg/kg dose,,BAO_0000218,CHEMBL626934,6644,10116.0,Intermediate,1,,,50597,N,1,,
9624,,Half life period in rat after oral administration at 13 mg/kg dose,,BAO_0000218,CHEMBL626935,6644,10116.0,Intermediate,1,,,50597,N,1,,
9625,,Half life period in rat after oral administration at 9.7 mg/kg dose,,BAO_0000218,CHEMBL626936,6644,10116.0,Intermediate,1,,,50597,N,1,,
9626,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL626937,5974,10116.0,Intermediate,1,,,50597,N,1,,
9627,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,BAO_0000218,CHEMBL625906,6295,10116.0,Intermediate,1,,,50597,N,1,,
9628,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,BAO_0000218,CHEMBL625907,6296,10116.0,Intermediate,1,,,50597,N,1,,
9629,,PK study was carried to determine AUC (area under curve) value in rat,,BAO_0000218,CHEMBL625908,16427,10116.0,Intermediate,1,,,50597,N,1,,
9630,,Pharmacokinetic parameter AUC after intravenous administration to rats,,BAO_0000218,CHEMBL625909,16367,10116.0,Intermediate,1,,,50597,N,1,,
9631,,Pharmacokinetic parameter AUC after oral administration to rats,,BAO_0000218,CHEMBL625910,16367,10116.0,Intermediate,1,,,50597,N,1,,
9632,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,BAO_0000218,CHEMBL625911,16365,10116.0,Intermediate,1,,,50597,N,1,,
9633,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,BAO_0000218,CHEMBL625912,16365,10116.0,Intermediate,1,,,50597,N,1,,
9634,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,BAO_0000218,CHEMBL626538,16365,10116.0,Intermediate,1,,,50597,N,1,,
9635,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,BAO_0000218,CHEMBL876794,16365,10116.0,Intermediate,1,,,50597,N,1,,
9636,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,BAO_0000218,CHEMBL626539,16365,10116.0,Intermediate,1,,,50597,N,1,,
9637,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,BAO_0000218,CHEMBL626540,16365,10116.0,Intermediate,1,,,50597,N,1,,
9638,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,BAO_0000218,CHEMBL626541,5394,10116.0,Intermediate,1,,,50597,N,1,,
9639,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,BAO_0000218,CHEMBL626542,5394,10116.0,Intermediate,1,,,50597,N,1,,
9640,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,BAO_0000218,CHEMBL626543,2792,10116.0,Intermediate,1,,,50597,N,1,,
9641,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL626544,2792,10116.0,Intermediate,1,,,50597,N,1,,
9642,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,BAO_0000218,CHEMBL626545,2792,10116.0,Intermediate,1,,,50597,N,1,,
9643,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL626546,2792,10116.0,Intermediate,1,,,50597,N,1,,
9644,,Pharmacokinetic parameter area under curve was reported,,BAO_0000218,CHEMBL626547,5334,10116.0,Intermediate,1,,,50597,N,1,,
9645,,Pharmacokinetic property (AUC) in rat,,BAO_0000218,CHEMBL626548,4408,10116.0,Intermediate,1,,,50597,N,1,,
9646,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,BAO_0000218,CHEMBL626549,5983,10116.0,Intermediate,1,,,50597,N,1,,
9647,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,BAO_0000218,CHEMBL626550,4397,10116.0,Intermediate,1,,,50597,N,1,,
9648,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,BAO_0000218,CHEMBL626551,4397,10116.0,Intermediate,1,,,50597,N,1,,
9649,,Pharmacokinetic property was determined,,BAO_0000218,CHEMBL623777,5491,10116.0,Intermediate,1,,,50597,N,1,,
9650,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,BAO_0000218,CHEMBL623778,5491,10116.0,Intermediate,1,,,50597,N,1,,
9651,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,BAO_0000218,CHEMBL623779,5491,10116.0,Intermediate,1,,,50597,N,1,,
9652,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,CHEMBL623780,4199,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9653,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,CHEMBL622015,4199,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9654,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,CHEMBL622016,4199,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9655,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,BAO_0000218,CHEMBL622017,5173,10116.0,Intermediate,1,,,50597,N,1,,
9656,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,BAO_0000218,CHEMBL622018,5173,10116.0,Intermediate,1,,,50597,N,1,,
9657,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,BAO_0000218,CHEMBL622019,5173,10116.0,Intermediate,1,,,50597,N,1,,
9658,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,BAO_0000218,CHEMBL622020,5173,10116.0,Intermediate,1,,,50597,N,1,,
9659,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,BAO_0000218,CHEMBL622021,16366,10116.0,Intermediate,1,,,50597,N,1,,
9660,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,BAO_0000218,CHEMBL622022,16366,10116.0,Intermediate,1,,,50597,N,1,,
9661,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,BAO_0000218,CHEMBL622023,5327,10116.0,Intermediate,1,,,50597,N,1,,
9662,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,BAO_0000218,CHEMBL622024,6681,10116.0,Intermediate,1,,,50597,N,1,,
9663,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,BAO_0000218,CHEMBL622693,12873,10116.0,Intermediate,1,,,50597,N,1,,
9664,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,BAO_0000218,CHEMBL622694,12873,10116.0,Intermediate,1,,,50597,N,1,,
9665,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622695,6685,10116.0,Intermediate,1,,,50597,N,1,,
9666,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,BAO_0000218,CHEMBL622696,6685,10116.0,Intermediate,1,,,50597,N,1,,
9667,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,BAO_0000218,CHEMBL622697,6685,10116.0,Intermediate,1,,,50597,N,1,,
9668,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,BAO_0000218,CHEMBL622874,6619,10116.0,Intermediate,1,,,50597,N,1,,
9669,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,BAO_0000218,CHEMBL622875,6619,10116.0,Intermediate,1,,,50597,N,1,,
9670,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,BAO_0000218,CHEMBL622876,10363,10116.0,Intermediate,1,,,50597,N,1,,
9671,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,BAO_0000218,CHEMBL622877,4796,10116.0,Intermediate,1,,,50597,N,1,,
9672,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,CHEMBL622878,4910,10116.0,Intermediate,1,,,50597,N,1,,
9673,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,CHEMBL622879,4910,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9674,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,BAO_0000218,CHEMBL877602,4839,10116.0,Intermediate,1,,,50597,N,1,,
9675,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622880,15078,10116.0,Intermediate,1,,,50597,N,1,,
9676,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622881,15078,10116.0,Intermediate,1,,,50597,N,1,,
9677,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622882,15078,10116.0,Intermediate,1,,,50597,N,1,,
9678,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL622883,15078,10116.0,Intermediate,1,,,50597,N,1,,
9679,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,BAO_0000218,CHEMBL622884,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9680,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,BAO_0000218,CHEMBL622885,11450,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9681,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,BAO_0000218,CHEMBL622886,8151,10116.0,Intermediate,1,,,50597,N,1,,
9682,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000218,CHEMBL622887,8151,10116.0,Intermediate,1,,,50597,N,1,,
9683,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,BAO_0000218,CHEMBL622888,8151,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9684,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622889,8677,10116.0,Intermediate,1,,,50597,N,1,178.0,
9685,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622890,8677,10116.0,Intermediate,1,,,50597,N,1,178.0,
9686,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622891,8677,10116.0,Intermediate,1,,,50597,N,1,178.0,
9687,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL877603,8677,10116.0,Intermediate,1,,,50597,N,1,178.0,
9688,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622892,8677,10116.0,Intermediate,1,,,50597,N,1,955.0,
9689,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622893,8677,10116.0,Intermediate,1,,,50597,N,1,955.0,
9690,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622894,8677,10116.0,Intermediate,1,,,50597,N,1,955.0,
9691,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622895,8677,10116.0,Intermediate,1,,,50597,N,1,955.0,
9692,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,BAO_0000218,CHEMBL622896,8677,10116.0,Intermediate,1,,,50597,N,1,955.0,
9693,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622897,8677,10116.0,Intermediate,1,,,50597,N,1,948.0,
9694,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622898,8677,10116.0,Intermediate,1,,,50597,N,1,948.0,
9695,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622899,8677,10116.0,Intermediate,1,,,50597,N,1,948.0,
9696,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622900,8677,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9697,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624114,8677,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9698,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624115,8677,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9699,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624116,8677,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9700,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624117,8677,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9701,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624118,8677,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9702,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624119,8677,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9703,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624120,8677,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9704,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624121,8677,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9705,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624122,8677,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9706,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624123,8677,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9707,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624124,8677,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9708,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624125,8677,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9709,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624126,8677,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9710,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624127,8677,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9711,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624128,8677,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9712,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL624129,8677,10116.0,Intermediate,1,,,50597,N,1,14.0,
9713,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL624130,8677,10116.0,Intermediate,1,,,50597,N,1,14.0,
9714,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622340,8677,10116.0,Intermediate,1,,,50597,N,1,14.0,
9715,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622341,8677,10116.0,Intermediate,1,,,50597,N,1,14.0,
9716,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622342,8677,10116.0,Intermediate,1,,,50597,N,1,160.0,
9717,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622343,8677,10116.0,Intermediate,1,,,50597,N,1,160.0,
9718,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622344,8677,10116.0,Intermediate,1,,,50597,N,1,160.0,
9719,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622345,8677,10116.0,Intermediate,1,,,50597,N,1,160.0,
9720,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622346,8677,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9721,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622347,8677,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9722,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622348,8677,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9723,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622349,8677,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9724,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,BAO_0000218,CHEMBL622350,16434,10116.0,Intermediate,1,,,50597,N,1,,
9725,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,BAO_0000218,CHEMBL622351,16434,10116.0,Intermediate,1,,,50597,N,1,,
9726,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,BAO_0000218,CHEMBL622352,16434,10116.0,Intermediate,1,,,50597,N,1,,
9727,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,BAO_0000218,CHEMBL622353,16435,10116.0,Intermediate,1,,,50597,N,1,,
9728,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,BAO_0000218,CHEMBL622354,16435,10116.0,Intermediate,1,,,50597,N,1,,
9729,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,BAO_0000218,CHEMBL622355,16435,10116.0,Intermediate,1,,,50597,N,1,,
9730,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,BAO_0000218,CHEMBL622356,16435,10116.0,Intermediate,1,,,50597,N,1,,
9731,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,BAO_0000218,CHEMBL622357,16435,10116.0,Intermediate,1,,,50597,N,1,,
9732,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,BAO_0000218,CHEMBL622358,16435,10116.0,Intermediate,1,,,50597,N,1,,
9733,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,BAO_0000218,CHEMBL622359,16435,10116.0,Intermediate,1,,,50597,N,1,,
9734,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,BAO_0000218,CHEMBL874393,16435,10116.0,Intermediate,1,,,50597,N,1,,
9735,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL622872,16434,10116.0,Intermediate,1,,,50597,N,1,,
9736,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL622873,16434,10116.0,Intermediate,1,,,50597,N,1,,
9737,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL623047,16434,10116.0,Intermediate,1,,,50597,N,1,,
9738,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL623048,16435,10116.0,Intermediate,1,,,50597,N,1,,
9739,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL623049,16435,10116.0,Intermediate,1,,,50597,N,1,,
9740,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL623050,16435,10116.0,Intermediate,1,,,50597,N,1,,
9741,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL623051,16435,10116.0,Intermediate,1,,,50597,N,1,,
9742,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL623052,16435,10116.0,Intermediate,1,,,50597,N,1,,
9743,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL626343,16435,10116.0,Intermediate,1,,,50597,N,1,,
9744,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,BAO_0000218,CHEMBL626344,16434,10116.0,Intermediate,1,,,50597,N,1,,
9745,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,BAO_0000218,CHEMBL626345,16434,10116.0,Intermediate,1,,,50597,N,1,,
9746,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,BAO_0000218,CHEMBL626346,16434,10116.0,Intermediate,1,,,50597,N,1,,
9747,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,BAO_0000218,CHEMBL626347,16434,10116.0,Intermediate,1,,,50597,N,1,,
9748,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,BAO_0000218,CHEMBL626348,16434,10116.0,Intermediate,1,,,50597,N,1,,
9749,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,BAO_0000218,CHEMBL626349,16434,10116.0,Intermediate,1,,,50597,N,1,,
9750,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,BAO_0000218,CHEMBL626350,16435,10116.0,Intermediate,1,,,50597,N,1,,
9751,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,BAO_0000218,CHEMBL626351,16435,10116.0,Intermediate,1,,,50597,N,1,,
9752,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,BAO_0000218,CHEMBL627650,16435,10116.0,Intermediate,1,,,50597,N,1,,
9753,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,BAO_0000218,CHEMBL627651,16435,10116.0,Intermediate,1,,,50597,N,1,,
9754,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,BAO_0000218,CHEMBL627652,16435,10116.0,Intermediate,1,,,50597,N,1,,
9755,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,BAO_0000218,CHEMBL627653,16435,10116.0,Intermediate,1,,,50597,N,1,,
9756,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,BAO_0000218,CHEMBL627654,13091,10116.0,Intermediate,1,,,50597,N,1,,
9757,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,BAO_0000218,CHEMBL627835,13091,10116.0,Intermediate,1,,,50597,N,1,,
9758,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,BAO_0000218,CHEMBL627836,13091,10116.0,Intermediate,1,,,50597,N,1,,
9759,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,BAO_0000218,CHEMBL627837,13091,10116.0,Intermediate,1,,,50597,N,1,,
9760,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,BAO_0000218,CHEMBL627838,13091,10116.0,Intermediate,1,,,50597,N,1,,
9761,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,BAO_0000218,CHEMBL875338,13091,10116.0,Intermediate,1,,,50597,N,1,,
9762,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,BAO_0000218,CHEMBL627839,13091,10116.0,Intermediate,1,,,50597,N,1,,
9763,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,BAO_0000218,CHEMBL627840,13091,10116.0,Intermediate,1,,,50597,N,1,,
9764,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,BAO_0000218,CHEMBL627841,13091,10116.0,Intermediate,1,,,50597,N,1,,
9765,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,BAO_0000218,CHEMBL627842,13091,10116.0,Intermediate,1,,,50597,N,1,,
9766,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,BAO_0000218,CHEMBL627843,13091,10116.0,Intermediate,1,,,50597,N,1,,
9767,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,BAO_0000218,CHEMBL627844,13091,10116.0,Intermediate,1,,,50597,N,1,,
9768,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,BAO_0000218,CHEMBL627845,13091,10116.0,Intermediate,1,,,50597,N,1,,
9769,,Half life period in rat by iv administration at a dose of 3 mg/kg,,BAO_0000218,CHEMBL627846,5874,10116.0,Intermediate,1,,,50597,N,1,,
9770,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,BAO_0000218,CHEMBL627847,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9771,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,BAO_0000218,CHEMBL873821,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9772,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,CHEMBL626079,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9773,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,BAO_0000218,CHEMBL626080,1515,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9774,,Half life period was evaluated in rat plasma,,BAO_0000218,CHEMBL626081,5491,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9775,,Half life period was evaluated in rat plasma; Not tested,,BAO_0000218,CHEMBL875344,5491,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9776,,Half life period was evaluated in rats,,BAO_0000218,CHEMBL626082,1918,10116.0,Intermediate,1,,,50597,N,1,,
9777,,"Half life period was evaluated in rats, iv",,BAO_0000218,CHEMBL626250,1918,10116.0,Intermediate,1,,,50597,N,1,,
9778,,Half life period after intravenous administration at 5 mg/kg in rat,,BAO_0000218,CHEMBL626251,6113,10116.0,Intermediate,1,,,50597,N,1,,
9779,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,BAO_0000218,CHEMBL626252,5546,10116.0,Intermediate,1,,,50597,N,1,,
9780,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,BAO_0000218,CHEMBL626253,5553,10116.0,Intermediate,1,,,50597,N,1,,
9781,,Half life stability of compound was evaluated in rat plasma,,BAO_0000218,CHEMBL626254,4188,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9782,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,BAO_0000218,CHEMBL626255,6215,10116.0,Intermediate,1,,,50597,N,1,,
9783,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,BAO_0000218,CHEMBL626256,6141,10116.0,Intermediate,1,,,50597,N,1,,
9784,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,BAO_0000218,CHEMBL626257,5182,10116.0,Intermediate,1,,,50597,N,1,,
9785,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,BAO_0000218,CHEMBL626258,5182,10116.0,Intermediate,1,,,50597,N,1,,
9786,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,BAO_0000218,CHEMBL626259,5710,10116.0,Intermediate,1,,,50597,N,1,,
9787,,Half in rat i.v.,,BAO_0000218,CHEMBL626260,5789,10116.0,Intermediate,1,,,50597,N,1,,
9788,,Half period in rat after intravenous administration,,BAO_0000218,CHEMBL875345,6011,10116.0,Intermediate,1,,,50597,N,1,,
9789,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,BAO_0000218,CHEMBL626261,17594,10116.0,Intermediate,1,,,50597,N,1,,
9790,,Half-life measured in in vitro Cathepsin B assay in rat liver,,BAO_0000218,CHEMBL626262,12357,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9791,,Half-life of compound was determined in rats,,BAO_0000218,CHEMBL626263,5210,10116.0,Intermediate,1,,,50597,N,1,,
9792,,Half-life at 10 mg/kg in rat upon intravenous administration,,BAO_0000218,CHEMBL625270,17596,10116.0,Intermediate,1,,,50597,N,1,,
9793,,Half-life determined in rat,,BAO_0000218,CHEMBL625271,6672,10116.0,Intermediate,1,,,50597,N,1,,
9794,,Half-life determined in rat,,BAO_0000218,CHEMBL625272,6673,10116.0,Intermediate,1,,,50597,N,1,,
9795,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,CHEMBL625273,4910,10116.0,Intermediate,1,,,50597,N,1,955.0,
9796,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,BAO_0000218,CHEMBL625274,3741,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9797,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,CHEMBL625275,17671,10116.0,Intermediate,1,,,50597,N,1,,
9798,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,BAO_0000218,CHEMBL625276,4910,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9799,,Half-life in rat plasma,,BAO_0000218,CHEMBL625277,17537,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9800,,Half-life in rat plasma was determined,,BAO_0000218,CHEMBL625278,4965,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9801,,Half-life in rat plasma; Not tested,,BAO_0000218,CHEMBL625279,17537,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9802,,Half-life in rat serum,,BAO_0000218,CHEMBL625280,6124,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9803,,Half-life in rat serum; na is not available,,BAO_0000218,CHEMBL876797,6124,10116.0,Intermediate,1,,,50597,N,1,1977.0,
9804,,Half-life was calculated in rat,,BAO_0000218,CHEMBL625281,6078,10116.0,Intermediate,1,,,50597,N,1,,
9805,,Half-life was calculated in rat plasma,,BAO_0000218,CHEMBL873827,17668,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9806,,Half-life was determined,,BAO_0000218,CHEMBL625282,3185,10116.0,Intermediate,1,,,50597,N,1,,
9807,,Half-life was determined,,BAO_0000218,CHEMBL625283,4883,10116.0,Intermediate,1,,,50597,N,1,,
9808,,Half-life after administration of 20 mg/Kg oral dose in rat,,BAO_0000218,CHEMBL625284,2959,10116.0,Intermediate,1,,,50597,N,1,,
9809,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,BAO_0000218,CHEMBL625285,4029,10116.0,Intermediate,1,,,50597,N,1,,
9810,,Half-life after intravenous administration in female rat,,BAO_0000218,CHEMBL625286,4029,10116.0,Intermediate,1,,,50597,N,1,,
9811,,Half-life after intravenous administration in male rat,,BAO_0000218,CHEMBL625287,4029,10116.0,Intermediate,1,,,50597,N,1,,
9812,,Half-life after intravenous dose in rat,,BAO_0000218,CHEMBL625288,6180,10116.0,Intermediate,1,,,50597,N,1,,
9813,,Half-life in a rat liver homogenate preparation,,BAO_0000218,CHEMBL625289,1557,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9814,,Half-life in plasma of rat,,BAO_0000218,CHEMBL625290,12500,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9815,,Half-life in plasma of rat at dose of 3-10 mgkg,,BAO_0000218,CHEMBL876798,12500,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9816,,Half-life in rat,,BAO_0000218,CHEMBL625291,5064,10116.0,Intermediate,1,,,50597,N,1,,
9817,,Half-life in rat,,BAO_0000218,CHEMBL625292,5145,10116.0,Intermediate,1,,,50597,N,1,,
9818,,Half-life in rat,,BAO_0000218,CHEMBL625293,5147,10116.0,Intermediate,1,,,50597,N,1,,
9819,,Half-life in rat,,BAO_0000218,CHEMBL622832,5833,10116.0,Intermediate,1,,,50597,N,1,,
9820,,Half-life in rat,,BAO_0000218,CHEMBL622833,6596,10116.0,Intermediate,1,,,50597,N,1,,
9821,,Half-life in rat,,BAO_0000218,CHEMBL622834,17655,10116.0,Intermediate,1,,,50597,N,1,,
9822,,Half-life in rat after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL622835,6495,10116.0,Intermediate,1,,,50597,N,1,,
9823,,Half-life in rat after po administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL622836,17538,10116.0,Intermediate,1,,,50597,N,1,,
9824,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,BAO_0000218,CHEMBL622837,17538,10116.0,Intermediate,1,,,50597,N,1,,
9825,,Half-life in rat at 3 mg/kg dose administered intravenously,,BAO_0000218,CHEMBL622838,10,10116.0,Intermediate,1,,,50597,N,1,,
9826,,Half-life in rat brain homogenate,,BAO_0000218,CHEMBL622839,17669,10116.0,Intermediate,1,,,50597,N,1,955.0,
9827,,Half-life in rat plasma,,BAO_0000218,CHEMBL622840,17065,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9828,,Half-life in rats,,BAO_0000218,CHEMBL622841,4333,10116.0,Intermediate,1,,,50597,N,1,,
9829,,Half-life in Dawley rats,,BAO_0000218,CHEMBL622842,6827,10116.0,Intermediate,1,,,50597,N,1,,
9830,,Half-life in vitro in rat plasma,,BAO_0000218,CHEMBL622843,889,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9831,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,BAO_0000218,CHEMBL622844,889,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9832,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,BAO_0000218,CHEMBL622845,3747,10116.0,Intermediate,1,,,50597,N,1,,
9833,,The area under the curve of compound was measured at the dose of 100 umol/kg,,BAO_0000218,CHEMBL622846,15022,10116.0,Intermediate,1,,,50597,N,1,,
9834,,The area under the curve of compound was measured at the dose of 300 umol/kg,,BAO_0000218,CHEMBL622847,15022,10116.0,Intermediate,1,,,50597,N,1,,
9835,,The area under the curve of compound was measured at the dose of 30 umol/kg,,BAO_0000218,CHEMBL622848,15022,10116.0,Intermediate,1,,,50597,N,1,,
9836,,Bioavailability as oral AUC in rats,,BAO_0000218,CHEMBL622849,3360,10116.0,Intermediate,1,,,50597,N,1,,
9837,,The plasma concentration versus time curve (AUC) was determined,,BAO_0000218,CHEMBL622850,5334,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9838,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL876807,17411,10116.0,Intermediate,1,,,50597,N,1,,
9839,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL622851,17411,10116.0,Intermediate,1,,,50597,N,1,,
9840,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL622852,17411,10116.0,Intermediate,1,,,50597,N,1,,
9841,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,BAO_0000218,CHEMBL622853,6570,10116.0,Intermediate,1,,,50597,N,1,,
9842,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,BAO_0000218,CHEMBL622854,6570,10116.0,Intermediate,1,,,50597,N,1,,
9843,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,BAO_0000218,CHEMBL622855,17411,10116.0,Intermediate,1,,,50597,N,1,,
9844,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,CHEMBL622856,14941,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9845,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,CHEMBL622857,14941,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9846,,AUC in rat after po administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL622858,17538,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9847,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,BAO_0000218,CHEMBL622859,17752,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9848,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,BAO_0000218,CHEMBL622860,17509,10116.0,Intermediate,1,,,50597,N,1,,
9849,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,BAO_0000218,CHEMBL622861,17509,10116.0,Intermediate,1,,,50597,N,1,,
9850,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,BAO_0000218,CHEMBL622862,17509,10116.0,Intermediate,1,,,50597,N,1,,
9851,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,BAO_0000218,CHEMBL622863,17509,10116.0,Intermediate,1,,,50597,N,1,,
9852,,Area under curve value 6 hr after po administration in rat,,BAO_0000218,CHEMBL623817,17509,10116.0,Intermediate,1,,,50597,N,1,,
9853,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,CHEMBL623818,17717,10116.0,Intermediate,1,,,50597,N,1,,
9854,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,BAO_0000218,CHEMBL623819,17717,10116.0,Intermediate,1,,,50597,N,1,,
9855,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,CHEMBL623820,17717,10116.0,Intermediate,1,,,50597,N,1,,
9856,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,BAO_0000218,CHEMBL623821,17717,10116.0,Intermediate,1,,,50597,N,1,,
9857,,AUC normalized for dose (AUCN) in rat,,BAO_0000218,CHEMBL623822,6642,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9858,,Area under curve in rat after p.o. administration,,BAO_0000218,CHEMBL623823,6640,10116.0,Intermediate,1,,,50597,N,1,,
9859,,Area under curve in rat after p.o. administration,,BAO_0000218,CHEMBL623824,6641,10116.0,Intermediate,1,,,50597,N,1,,
9860,,Area under curve in rat after p.o. administration; Not determined,,BAO_0000218,CHEMBL623825,6641,10116.0,Intermediate,1,,,50597,N,1,,
9861,,Area under curve in rat after peroral administration,,BAO_0000218,CHEMBL622070,6641,10116.0,Intermediate,1,,,50597,N,1,,
9862,,Area under curve (carotid artery) value of the compound,,BAO_0000218,CHEMBL622071,3603,10116.0,Intermediate,1,,,50597,N,1,,
9863,,Bioavailability expressed as the area under curve of rat carotid artery,,BAO_0000218,CHEMBL622072,3550,10116.0,Intermediate,1,,,50597,N,1,,
9864,,Area under curve in male SD rats was observed after intravenous administration in rat,,BAO_0000218,CHEMBL622073,15662,10116.0,Intermediate,1,,,50597,N,1,,
9865,,Area under curve of the compound was determined,,BAO_0000218,CHEMBL622074,17720,10116.0,Intermediate,1,,,50597,N,1,,
9866,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,BAO_0000218,CHEMBL622075,5407,10116.0,Intermediate,1,,,50597,N,1,,
9867,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,BAO_0000218,CHEMBL622076,17752,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9868,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,BAO_0000218,CHEMBL622077,17752,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9869,,Area under curve (portal vein) value of the compound,,BAO_0000218,CHEMBL622078,3603,10116.0,Intermediate,1,,,50597,N,1,,
9870,,Bioavailability expressed as the area under curve of rat portal vein,,BAO_0000218,CHEMBL622079,3550,10116.0,Intermediate,1,,,50597,N,1,,
9871,,Area Under plasma concentration time curve in rat upon peroral administration,,BAO_0000218,CHEMBL622080,17655,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9872,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,BAO_0000218,CHEMBL877612,17582,10116.0,Intermediate,1,,,50597,N,1,,
9873,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,BAO_0000218,CHEMBL622081,17582,10116.0,Intermediate,1,,,50597,N,1,,
9874,,Compound was evaluated for oral bioavailability in rats,,BAO_0000218,CHEMBL622082,17791,10116.0,Intermediate,1,,,50597,N,1,,
9875,,Compound was evaluated for oral bioavailability in rats after iv administration,,BAO_0000218,CHEMBL622083,17791,10116.0,Intermediate,1,,,50597,N,1,,
9876,,Compound was evaluated for oral bioavailability in rats; 30-80,,BAO_0000218,CHEMBL622084,17791,10116.0,Intermediate,1,,,50597,N,1,,
9877,,Compound was evaluated for oral bioavailability in rats; 50-60,,BAO_0000218,CHEMBL622085,17791,10116.0,Intermediate,1,,,50597,N,1,,
9878,,Compound was evaluated for oral bioavailability in rats; no data,,BAO_0000218,CHEMBL622086,17791,10116.0,Intermediate,1,,,50597,N,1,,
9879,,Compound was evaluated for oral bioavailability in rats; peptide,,BAO_0000218,CHEMBL622087,17791,10116.0,Intermediate,1,,,50597,N,1,,
9880,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,BAO_0000218,CHEMBL622088,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
9881,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,BAO_0000218,CHEMBL622089,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
9882,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,BAO_0000218,CHEMBL623685,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
9883,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,BAO_0000218,CHEMBL623686,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
9884,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL623687,8677,10116.0,Intermediate,1,,,50597,N,1,945.0,
9885,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL623688,8677,10116.0,Intermediate,1,,,50597,N,1,945.0,
9886,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL623689,8677,10116.0,Intermediate,1,,,50597,N,1,945.0,
9887,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622485,8677,10116.0,Intermediate,1,,,50597,N,1,945.0,
9888,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622486,8677,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9889,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL877613,8677,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9890,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622487,8677,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9891,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622488,8677,10116.0,Intermediate,1,,,50597,N,1,2046.0,
9892,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,BAO_0000218,CHEMBL622489,8677,10116.0,Intermediate,1,,,50597,N,1,948.0,
9893,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,BAO_0000218,CHEMBL622490,6899,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9894,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,BAO_0000218,CHEMBL622491,6899,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9895,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,BAO_0000218,CHEMBL622492,6899,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9896,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,BAO_0000218,CHEMBL622493,6899,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9897,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,BAO_0000218,CHEMBL622494,6899,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9898,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,BAO_0000218,CHEMBL622495,8677,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9899,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,BAO_0000218,CHEMBL622496,6899,10116.0,Intermediate,1,,,50597,N,1,,
9900,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,BAO_0000218,CHEMBL622497,6899,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9901,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,BAO_0000218,CHEMBL622498,2189,10116.0,Intermediate,1,,,50597,N,1,,
9902,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,BAO_0000218,CHEMBL624918,2189,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9903,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,BAO_0000218,CHEMBL624919,2189,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9904,,Biodistribution of compound in rat blood after 5 min of administration,,BAO_0000218,CHEMBL624920,10839,10116.0,Intermediate,1,,,50597,N,1,178.0,
9905,,Biodistribution of compound in rat blood after 5 min of administration.,,BAO_0000218,CHEMBL624921,10839,10116.0,Intermediate,1,,,50597,N,1,178.0,
9906,,Biodistribution of compound in rat brain after 5 min of administration,,BAO_0000218,CHEMBL624922,10839,10116.0,Intermediate,1,,,50597,N,1,955.0,
9907,,Biodistribution of compound in rat heart after 5 min of administration,,BAO_0000218,CHEMBL624923,10839,10116.0,Intermediate,1,,,50597,N,1,948.0,
9908,,Biodistribution of compound in rat heart after 5 min of administration.,,BAO_0000218,CHEMBL624924,10839,10116.0,Intermediate,1,,,50597,N,1,948.0,
9909,,Biodistribution of compound in rat kidney after 5 min of administration,,BAO_0000218,CHEMBL624925,10839,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9910,,Biodistribution of compound in rat kidney after 5 min of administration.,,BAO_0000218,CHEMBL624926,10839,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9911,,Biodistribution of compound in rat liver after 5 min of administration,,BAO_0000218,CHEMBL624927,10839,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9912,,Biodistribution of compound in rat liver after 5 min of administration.,,BAO_0000218,CHEMBL874402,10839,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9913,,Biodistribution of compound in rat lung after 5 min of administration,,BAO_0000218,CHEMBL624928,10839,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9914,,Biodistribution of compound in rat lung after 5 min of administration.,,BAO_0000218,CHEMBL624929,10839,10116.0,Intermediate,1,,,50597,N,1,2048.0,
9915,,Biodistribution of compound in rat muscle after 5 min of administration,,BAO_0000218,CHEMBL624930,10839,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9916,,Biodistribution of compound in rat muscle after 5 min of administration.,,BAO_0000218,CHEMBL624931,10839,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9917,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624932,4043,10116.0,Intermediate,1,,,50597,N,1,948.0,
9918,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624933,4043,10116.0,Intermediate,1,,,50597,N,1,948.0,
9919,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624934,4043,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9920,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624935,4043,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9921,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624936,4043,10116.0,Intermediate,1,,,50597,N,1,,
9922,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624937,4043,10116.0,Intermediate,1,,,50597,N,1,,
9923,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624938,4043,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9924,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624939,4043,10116.0,Intermediate,1,,,50597,N,1,2106.0,
9925,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL624940,4043,10116.0,Intermediate,1,,,50597,N,1,,
9926,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,BAO_0000218,CHEMBL874403,4043,10116.0,Intermediate,1,,,50597,N,1,,
9927,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,BAO_0000218,CHEMBL624941,1446,10116.0,Intermediate,1,,,50597,N,1,,
9928,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,BAO_0000218,CHEMBL624942,9971,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9929,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,BAO_0000218,CHEMBL624943,9971,10116.0,Intermediate,1,,,50597,N,1,1088.0,
9930,,% Bioavailability after 1 day of the drug administration in rats,,BAO_0000218,CHEMBL624944,5765,10116.0,Intermediate,1,,,50597,N,1,,
9931,,% Bioavailability after 4 day of the drug administration in rats,,BAO_0000218,CHEMBL624945,5765,10116.0,Intermediate,1,,,50597,N,1,,
9932,,Absolute bioavailability was evaluated in rat,,BAO_0000218,CHEMBL624946,4257,10116.0,Intermediate,1,,,50597,N,1,,
9933,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,BAO_0000218,CHEMBL624947,13091,10116.0,Intermediate,1,,,50597,N,1,,
9934,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,BAO_0000218,CHEMBL624948,13091,10116.0,Intermediate,1,,,50597,N,1,,
9935,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,BAO_0000218,CHEMBL624949,13091,10116.0,Intermediate,1,,,50597,N,1,,
9936,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,BAO_0000218,CHEMBL622025,13091,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9937,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,BAO_0000218,CHEMBL622026,13091,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9938,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,BAO_0000218,CHEMBL622027,13091,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9939,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,BAO_0000218,CHEMBL622028,13091,10116.0,Intermediate,1,,,50597,N,1,2113.0,
9940,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,BAO_0000218,CHEMBL622029,13091,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9941,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,BAO_0000218,CHEMBL622208,13091,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9942,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,BAO_0000218,CHEMBL622209,13091,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9943,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,BAO_0000218,CHEMBL622210,13091,10116.0,Intermediate,1,,,50597,N,1,2107.0,
9944,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,BAO_0000218,CHEMBL622211,13091,10116.0,Intermediate,1,,,50597,N,1,,
9945,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,BAO_0000218,CHEMBL622212,13091,10116.0,Intermediate,1,,,50597,N,1,,
9946,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,BAO_0000218,CHEMBL622213,13091,10116.0,Intermediate,1,,,50597,N,1,,
9947,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,BAO_0000218,CHEMBL874404,13091,10116.0,Intermediate,1,,,50597,N,1,,
9948,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,BAO_0000218,CHEMBL620452,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9949,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,BAO_0000218,CHEMBL620453,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9950,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,BAO_0000218,CHEMBL620454,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9951,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,BAO_0000218,CHEMBL624067,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9952,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,BAO_0000218,CHEMBL624068,13091,10116.0,Intermediate,1,,,50597,N,1,,
9953,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,BAO_0000218,CHEMBL624069,13091,10116.0,Intermediate,1,,,50597,N,1,992.0,
9954,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,BAO_0000218,CHEMBL624070,13091,10116.0,Intermediate,1,,,50597,N,1,992.0,
9955,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,BAO_0000218,CHEMBL624071,13091,10116.0,Intermediate,1,,,50597,N,1,992.0,
9956,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,BAO_0000218,CHEMBL624072,13091,10116.0,Intermediate,1,,,50597,N,1,995.0,
9957,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,BAO_0000218,CHEMBL624073,13091,10116.0,Intermediate,1,,,50597,N,1,995.0,
9958,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,BAO_0000218,CHEMBL624788,13091,10116.0,Intermediate,1,,,50597,N,1,995.0,
9959,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,BAO_0000218,CHEMBL624789,13091,10116.0,Intermediate,1,,,50597,N,1,995.0,
9960,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,BAO_0000218,CHEMBL624790,13091,10116.0,Intermediate,1,,,50597,N,1,,
9961,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,BAO_0000218,CHEMBL624791,13091,10116.0,Intermediate,1,,,50597,N,1,,
9962,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,BAO_0000218,CHEMBL624792,13091,10116.0,Intermediate,1,,,50597,N,1,,
9963,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,BAO_0000218,CHEMBL624793,13091,10116.0,Intermediate,1,,,50597,N,1,,
9964,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,BAO_0000218,CHEMBL877491,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9965,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,BAO_0000218,CHEMBL624957,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9966,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,BAO_0000218,CHEMBL624958,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9967,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,BAO_0000218,CHEMBL624959,13091,10116.0,Intermediate,1,,,50597,N,1,2385.0,
9968,,Dissociation constant was determined,,BAO_0000218,CHEMBL624960,11977,10116.0,Intermediate,1,,,50597,N,1,,
9969,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,BAO_0000218,CHEMBL624961,14941,10116.0,Intermediate,1,,,50597,N,1,,
9970,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL624962,15078,10116.0,Intermediate,1,,,50597,N,1,,
9971,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL624963,15078,10116.0,Intermediate,1,,,50597,N,1,,
9972,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,BAO_0000218,CHEMBL624964,4755,10116.0,Intermediate,1,,,50597,N,1,,
9973,,LogP value was evaluated in the in situ rat gut perfusion assay,,BAO_0000218,CHEMBL624965,589,10116.0,Intermediate,1,,,50597,N,1,,
9974,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,CHEMBL624966,17582,10116.0,Intermediate,1,,,50597,N,1,,
9975,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,BAO_0000218,CHEMBL624967,5031,10116.0,Intermediate,1,,,50597,N,1,,
9976,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,BAO_0000218,CHEMBL624968,17764,10116.0,Intermediate,1,,,50597,N,1,,
9977,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL624969,17720,10116.0,Intermediate,1,,,50597,N,1,,
9978,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,BAO_0000218,CHEMBL624970,2862,10116.0,Expert,1,,,50597,N,1,,
9979,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,BAO_0000218,CHEMBL624971,16423,10116.0,Intermediate,1,,,50597,N,1,,
9980,,Half-life was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,CHEMBL624972,16423,10116.0,Intermediate,1,,,50597,N,1,,
9981,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,BAO_0000218,CHEMBL624973,6005,10116.0,Intermediate,1,,,50597,N,1,,
9982,,Half-life was evaluated in plasma of rat,,BAO_0000218,CHEMBL624974,2938,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9983,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,BAO_0000218,CHEMBL624975,6410,10116.0,Intermediate,1,,,50597,N,1,,
9984,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL877492,6410,10116.0,Intermediate,1,,,50597,N,1,,
9985,,Half-life was measured in rat after an iv dose of 1 mg/kg,,BAO_0000218,CHEMBL624976,6062,10116.0,Intermediate,1,,,50597,N,1,,
9986,,Half-life period of compound in rats after peroral administration,,BAO_0000218,CHEMBL624977,6571,10116.0,Intermediate,1,,,50597,N,1,,
9987,,Half-life period of compound was measured in rat plasma.,,BAO_0000218,CHEMBL626848,3136,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9988,,Half-life period of compound was measured in rat plasma; ND is not determined,,BAO_0000218,CHEMBL626849,3136,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9989,,Half-life period of compound was measured in rat plasma; not determined,,BAO_0000218,CHEMBL626850,3136,10116.0,Intermediate,1,,,50597,N,1,1969.0,
9990,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,CHEMBL626851,4521,10116.0,Intermediate,1,,,50597,N,1,,
9991,,Half-life period in rat by iv administration,,BAO_0000218,CHEMBL626852,5871,10116.0,Intermediate,1,,,50597,N,1,,
9992,,Half-life period in rats following intravenous administration at 2 mg/kg,,BAO_0000218,CHEMBL626853,6077,10116.0,Intermediate,1,,,50597,N,1,,
9993,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,CHEMBL626854,6679,10116.0,Intermediate,1,,,50597,N,1,,
9994,,Half-life period was determined for the compound in rat,,BAO_0000218,CHEMBL627486,5144,10116.0,Intermediate,1,,,50597,N,1,,
9995,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,BAO_0000218,CHEMBL627487,4498,10116.0,Intermediate,1,,,50597,N,1,,
9996,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,BAO_0000218,CHEMBL627488,4498,10116.0,Intermediate,1,,,50597,N,1,,
9997,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,BAO_0000218,CHEMBL627489,1908,10116.0,Intermediate,1,,,50597,N,1,,
9998,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,BAO_0000218,CHEMBL627490,6211,10116.0,Intermediate,1,,,50597,N,1,,
9999,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,BAO_0000218,CHEMBL873829,5529,10116.0,Intermediate,1,,,50597,N,1,,
10000,,Half-life was determined in rat at a dose of 1 mpk i.v.,,BAO_0000218,CHEMBL627655,6444,10116.0,Intermediate,1,,,50597,N,1,,
10001,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,BAO_0000218,CHEMBL625994,6444,10116.0,Intermediate,1,,,50597,N,1,,
10002,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,BAO_0000218,CHEMBL625995,6444,10116.0,Intermediate,1,,,50597,N,1,,
10003,,Half-life in rat,,BAO_0000218,CHEMBL625996,5207,10116.0,Intermediate,1,,,50597,N,1,,
10004,,In vitro half life in rat plasma,,BAO_0000218,CHEMBL625850,530,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10005,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,BAO_0000218,CHEMBL625851,1116,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10006,,In vitro half life in rat,,BAO_0000218,CHEMBL625852,3219,10116.0,Intermediate,1,,,50597,N,1,,
10007,,In vivo half life period after intravenous administration in rat,,BAO_0000218,CHEMBL625853,6109,10116.0,Intermediate,1,,,50597,N,1,,
10008,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,BAO_0000218,CHEMBL625854,17582,10116.0,Intermediate,1,,,50597,N,1,,
10009,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,BAO_0000218,CHEMBL874450,17582,10116.0,Intermediate,1,,,50597,N,1,,
10010,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL625855,5974,10116.0,Intermediate,1,,,50597,N,1,,
10011,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL625856,5974,10116.0,Intermediate,1,,,50597,N,1,,
10012,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL625857,5974,10116.0,Intermediate,1,,,50597,N,1,,
10013,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL873831,5974,10116.0,Intermediate,1,,,50597,N,1,,
10014,,Longer half-life in rat (i.v.) at 0.5 mpk,,BAO_0000218,CHEMBL625858,17853,10116.0,Intermediate,1,,,50597,N,1,,
10015,,Longer half-life in rat (p.o.) at 2.0 mpk,,BAO_0000218,CHEMBL625859,17853,10116.0,Intermediate,1,,,50597,N,1,,
10016,,Pharmacokinetic property (half life) in rat,,BAO_0000218,CHEMBL625860,3457,10116.0,Intermediate,1,,,50597,N,1,,
10017,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,BAO_0000218,CHEMBL625861,2792,10116.0,Intermediate,1,,,50597,N,1,,
10018,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL625862,2792,10116.0,Intermediate,1,,,50597,N,1,,
10019,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,BAO_0000218,CHEMBL625863,2792,10116.0,Intermediate,1,,,50597,N,1,,
10020,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,BAO_0000218,CHEMBL625864,2792,10116.0,Intermediate,1,,,50597,N,1,,
10021,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,BAO_0000218,CHEMBL625865,5739,10116.0,Intermediate,1,,,50597,N,1,,
10022,,Pharmacokinetic half time was determined intravenously in rats.,,BAO_0000218,CHEMBL625866,15765,10116.0,Intermediate,1,,,50597,N,1,,
10023,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,BAO_0000218,CHEMBL625867,6567,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10024,,Plasma half life of hydrolysis of the compound,,BAO_0000218,CHEMBL625868,2448,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10025,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,BAO_0000218,CHEMBL625869,5423,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10026,,Plasma half life period was calculated in rat,,BAO_0000218,CHEMBL874451,4853,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10027,,Plasma half-life in Sprague-Dawley rats,,BAO_0000218,CHEMBL625870,4514,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10028,,Plasma half-life in Sprague-Dawley rats; Not determined,,BAO_0000218,CHEMBL625871,4514,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10029,,Plasma half-life in rats,,BAO_0000218,CHEMBL625872,1500,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10030,,Plasma half-life in rats; <MQL,,BAO_0000218,CHEMBL625873,1500,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10031,,Plasma half-life period (0-8 h) was determined,,BAO_0000218,CHEMBL625874,5334,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10032,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL625875,5334,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10033,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,BAO_0000218,CHEMBL625876,5334,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10034,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,BAO_0000218,CHEMBL631258,5334,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10035,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,BAO_0000218,CHEMBL631259,4956,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10036,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,BAO_0000218,CHEMBL631260,4956,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10037,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,BAO_0000218,CHEMBL631261,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
10038,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,BAO_0000218,CHEMBL631262,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
10039,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,BAO_0000218,CHEMBL631263,7768,10116.0,Intermediate,1,,,50597,N,1,178.0,
10040,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,BAO_0000218,CHEMBL631264,7768,10116.0,Intermediate,1,,,50597,N,1,,
10041,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,BAO_0000218,CHEMBL631265,7768,10116.0,Intermediate,1,,,50597,N,1,,
10042,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,BAO_0000218,CHEMBL631266,7768,10116.0,Intermediate,1,,,50597,N,1,,
10043,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,BAO_0000218,CHEMBL631267,7768,10116.0,Intermediate,1,,,50597,N,1,,
10044,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,BAO_0000218,CHEMBL631268,7768,10116.0,Intermediate,1,,,50597,N,1,,
10045,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,BAO_0000218,CHEMBL631269,7768,10116.0,Intermediate,1,,,50597,N,1,,
10046,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,BAO_0000218,CHEMBL631270,7768,10116.0,Intermediate,1,,,50597,N,1,,
10047,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,BAO_0000218,CHEMBL631271,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10048,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,BAO_0000218,CHEMBL631272,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10049,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,BAO_0000218,CHEMBL631273,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10050,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,BAO_0000218,CHEMBL631274,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10051,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,BAO_0000218,CHEMBL631275,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10052,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,BAO_0000218,CHEMBL626984,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10053,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,BAO_0000218,CHEMBL626985,7768,10116.0,Intermediate,1,,,50597,N,1,948.0,
10054,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,BAO_0000218,CHEMBL626986,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10055,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,BAO_0000218,CHEMBL626987,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10056,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,BAO_0000218,CHEMBL626988,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10057,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,BAO_0000218,CHEMBL626989,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10058,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,BAO_0000218,CHEMBL626990,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10059,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,BAO_0000218,CHEMBL626991,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10060,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,BAO_0000218,CHEMBL626992,7768,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10061,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,BAO_0000218,CHEMBL626993,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10062,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,BAO_0000218,CHEMBL874593,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10063,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,BAO_0000218,CHEMBL626994,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10064,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,BAO_0000218,CHEMBL626995,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10065,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,BAO_0000218,CHEMBL626190,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10066,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,BAO_0000218,CHEMBL626191,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10067,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,BAO_0000218,CHEMBL626364,7768,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10068,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,BAO_0000218,CHEMBL626365,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10069,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,BAO_0000218,CHEMBL626366,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10070,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,BAO_0000218,CHEMBL626367,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10071,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,BAO_0000218,CHEMBL626368,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10072,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,BAO_0000218,CHEMBL626369,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10073,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,BAO_0000218,CHEMBL626370,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10074,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,BAO_0000218,CHEMBL626371,4498,10116.0,Intermediate,1,,,50597,N,1,,
10075,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,BAO_0000218,CHEMBL626372,4498,10116.0,Intermediate,1,,,50597,N,1,,
10076,,Bioavailability after a dose of 10 mg/kg p.o.,,BAO_0000218,CHEMBL626373,3603,10116.0,Intermediate,1,,,50597,N,1,,
10077,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,BAO_0000218,CHEMBL626374,6215,10116.0,Intermediate,1,,,50597,N,1,,
10078,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,BAO_0000218,CHEMBL626375,5710,10116.0,Intermediate,1,,,50597,N,1,,
10079,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,BAO_0000218,CHEMBL626376,5710,10116.0,Intermediate,1,,,50597,N,1,,
10080,,Bioavailability in rat po was determined,,BAO_0000218,CHEMBL626377,5676,10116.0,Intermediate,1,,,50597,N,1,,
10081,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,BAO_0000218,CHEMBL626378,17667,10116.0,Intermediate,1,,,50597,N,1,,
10082,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,BAO_0000218,CHEMBL626379,17667,10116.0,Intermediate,1,,,50597,N,1,,
10083,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,CHEMBL626380,6848,10116.0,Intermediate,1,,,50597,N,1,,
10084,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,CHEMBL626381,6848,10116.0,Intermediate,1,,,50597,N,1,,
10085,,Bioavailability in rat,,BAO_0000218,CHEMBL626382,17267,10116.0,Intermediate,1,,,50597,N,1,,
10086,,Bioavailability in rat (Sprague-Dawley) (female),,BAO_0000218,CHEMBL626383,6362,10116.0,Intermediate,1,,,50597,N,1,,
10087,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,BAO_0000218,CHEMBL874652,17671,10116.0,Intermediate,1,,,50597,N,1,,
10088,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,BAO_0000218,CHEMBL626384,17671,10116.0,Intermediate,1,,,50597,N,1,,
10089,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,BAO_0000218,CHEMBL626385,4333,10116.0,Intermediate,1,,,50597,N,1,,
10090,,Bioavailability in rat at an oral dose of 2 mg/kg,,BAO_0000218,CHEMBL626386,6077,10116.0,Intermediate,1,,,50597,N,1,,
10091,,Bioavailability in rat,,BAO_0000218,CHEMBL626387,3278,10116.0,Intermediate,1,,,50597,N,1,,
10092,,Bioavailability in rat,,BAO_0000218,CHEMBL626388,5964,10116.0,Intermediate,1,,,50597,N,1,,
10093,,Bioavailability in rat,,BAO_0000218,CHEMBL626389,4884,10116.0,Intermediate,1,,,50597,N,1,,
10094,,Bioavailability in rat,,BAO_0000218,CHEMBL626390,4905,10116.0,Intermediate,1,,,50597,N,1,,
10095,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,BAO_0000218,CHEMBL626391,4884,10116.0,Intermediate,1,,,50597,N,1,,
10096,,Bioavailability in rat,,BAO_0000218,CHEMBL626392,6850,10116.0,Intermediate,1,,,50597,N,1,,
10097,,Oral bioavailability in rat,,BAO_0000218,CHEMBL626393,2864,10116.0,Intermediate,1,,,50597,N,1,,
10098,,Bioavailability was determined in rat,,BAO_0000218,CHEMBL623026,5780,10116.0,Intermediate,1,,,50597,N,1,,
10099,,Bioavailability,,BAO_0000218,CHEMBL623027,1465,10116.0,Intermediate,1,,,50597,N,1,,
10100,,Bioavailability,,BAO_0000218,CHEMBL623028,5199,10116.0,Intermediate,1,,,50597,N,1,,
10101,,Bioavailability in rat after 1 day dosing,,BAO_0000218,CHEMBL623029,5765,10116.0,Intermediate,1,,,50597,N,1,,
10102,,Bioavailability in rat after 4 day dosing,,BAO_0000218,CHEMBL623030,5765,10116.0,Intermediate,1,,,50597,N,1,,
10103,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,BAO_0000218,CHEMBL623031,6518,10116.0,Intermediate,1,,,50597,N,1,,
10104,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,BAO_0000218,CHEMBL623032,6518,10116.0,Intermediate,1,,,50597,N,1,,
10105,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL623033,6518,10116.0,Intermediate,1,,,50597,N,1,,
10106,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,BAO_0000218,CHEMBL623034,6518,10116.0,Intermediate,1,,,50597,N,1,,
10107,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,BAO_0000218,CHEMBL623035,2083,10116.0,Intermediate,1,,,50597,N,1,,
10108,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,BAO_0000218,CHEMBL623036,17260,10116.0,Intermediate,1,,,50597,N,1,,
10109,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,CHEMBL623037,4956,10116.0,Intermediate,1,,,50597,N,1,,
10110,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,BAO_0000218,CHEMBL623038,4368,10116.0,Intermediate,1,,,50597,N,1,,
10111,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,BAO_0000218,CHEMBL874385,17752,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10112,,Bioavailability in rat (Fisher) (fasted),,BAO_0000218,CHEMBL623039,1446,10116.0,Intermediate,1,,,50597,N,1,,
10113,,Bioavailability in monkey after po administration of 10 mg/kg dose,,BAO_0000218,CHEMBL623040,2891,9443.0,Intermediate,1,,,22224,U,0,,
10114,,Oral bioavailability in monkey (dose 10 mg/kg),,BAO_0000218,CHEMBL623041,2891,9443.0,Intermediate,1,,,22224,U,0,,
10115,,Bioavailability in rat,,BAO_0000218,CHEMBL623741,6672,10116.0,Intermediate,1,,,50597,N,1,,
10116,,Bioavailability in rat,,BAO_0000218,CHEMBL623742,6673,10116.0,Intermediate,1,,,50597,N,1,,
10117,,Bioavailability in rat,,BAO_0000218,CHEMBL623743,17655,10116.0,Intermediate,1,,,50597,N,1,,
10118,,Bioavailability in rat,,BAO_0000218,CHEMBL623744,17796,10116.0,Intermediate,1,,,50597,N,1,,
10119,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,BAO_0000218,CHEMBL623745,17853,10116.0,Intermediate,1,,,50597,N,1,,
10120,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,BAO_0000218,CHEMBL623746,4521,10116.0,Intermediate,1,,,50597,N,1,,
10121,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,BAO_0000218,CHEMBL623747,4940,10116.0,Intermediate,1,,,50597,N,1,,
10122,,Bioavailability in rat after po administration of 30 mg/kg dose,,BAO_0000218,CHEMBL623748,2891,10116.0,Intermediate,1,,,22224,U,0,,
10123,,Bioavailability in rat after po administration of 30 mg/kg dose,,BAO_0000218,CHEMBL623916,2891,10116.0,Intermediate,1,,,22224,U,0,,
10124,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,BAO_0000218,CHEMBL623917,4521,10116.0,Intermediate,1,,,50597,N,1,,
10125,,Bioavailability in rat (dose 2 mg/kg i.v.),,BAO_0000218,CHEMBL623918,17686,10116.0,Intermediate,1,,,50597,N,1,,
10126,,Bioavailability in rat,,BAO_0000218,CHEMBL874386,17796,10116.0,Intermediate,1,,,50597,N,1,,
10127,,Bioavailability in rat; Only traces detected in rat plasma,,BAO_0000218,CHEMBL623919,17796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10128,,Bioavailability in rat,,BAO_0000218,CHEMBL623920,5064,10116.0,Intermediate,1,,,50597,N,1,,
10129,,Bioavailability upon oral administration of compound,,BAO_0000218,CHEMBL623148,5147,10116.0,Intermediate,1,,,50597,N,1,,
10130,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,BAO_0000218,CHEMBL623149,1916,10116.0,Intermediate,1,,,50597,N,1,,
10131,,Bioavailability in rat,,BAO_0000218,CHEMBL623150,6049,10116.0,Intermediate,1,,,50597,N,1,,
10132,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,BAO_0000218,CHEMBL623151,1445,10116.0,Intermediate,1,,,50597,N,1,,
10133,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,BAO_0000218,CHEMBL623152,1445,10116.0,Intermediate,1,,,50597,N,1,,
10134,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,BAO_0000218,CHEMBL623153,2862,10116.0,Expert,1,,,50597,N,1,,
10135,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,BAO_0000218,CHEMBL623154,2862,10116.0,Expert,1,,,50597,N,1,,
10136,,In vitro and metabolic stability was determined,,BAO_0000218,CHEMBL623155,4194,10116.0,Intermediate,1,,,50597,N,1,,
10137,,In vitro metabolic stability in rat hepatocytes,,BAO_0000218,CHEMBL623156,4194,10116.0,Intermediate,1,,,50597,N,1,,
10138,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,BAO_0000218,CHEMBL623157,5486,10116.0,Intermediate,1,,,50597,N,1,,
10139,,Metabolic rate for compound was observed in rat hepatocytes,,BAO_0000218,CHEMBL623158,17582,10116.0,Intermediate,1,401.0,,50597,N,1,2107.0,
10140,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,BAO_0000218,CHEMBL623159,5600,10116.0,Intermediate,1,,,50597,N,1,,
10141,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,BAO_0000218,CHEMBL874390,14294,10116.0,Intermediate,1,,,50597,N,1,,
10142,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,BAO_0000218,CHEMBL623160,14294,10116.0,Intermediate,1,,,50597,N,1,,
10143,,Metabolism of compound in rat S9 microsomes; Trace,,BAO_0000218,CHEMBL623161,14294,10116.0,Intermediate,1,,,50597,N,1,,
10144,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,BAO_0000218,CHEMBL623162,17847,10116.0,Intermediate,1,,,50597,N,1,,
10145,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,BAO_0000218,CHEMBL623163,11020,10116.0,Intermediate,1,,,50597,N,1,,
10146,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,BAO_0000218,CHEMBL623164,11020,10116.0,Intermediate,1,,,50597,N,1,,
10147,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,BAO_0000218,CHEMBL623165,11020,10116.0,Intermediate,1,,,50597,N,1,,
10148,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,BAO_0000218,CHEMBL623166,11020,10116.0,Intermediate,1,,,50597,N,1,,
10149,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,BAO_0000218,CHEMBL624983,11020,10116.0,Intermediate,1,,,50597,N,1,,
10150,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,BAO_0000218,CHEMBL624984,11020,10116.0,Intermediate,1,,,50597,N,1,,
10151,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,BAO_0000218,CHEMBL624985,11020,10116.0,Intermediate,1,,,50597,N,1,,
10152,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,BAO_0000218,CHEMBL622970,11020,10116.0,Intermediate,1,,,50597,N,1,,
10153,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,BAO_0000218,CHEMBL622971,11020,10116.0,Intermediate,1,,,50597,N,1,,
10154,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,BAO_0000218,CHEMBL622972,11020,10116.0,Intermediate,1,,,50597,N,1,,
10155,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,BAO_0000218,CHEMBL622973,11020,10116.0,Intermediate,1,,,50597,N,1,,
10156,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,BAO_0000218,CHEMBL622974,11020,10116.0,Intermediate,1,,,50597,N,1,,
10157,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,BAO_0000218,CHEMBL622975,11020,10116.0,Intermediate,1,,,50597,N,1,,
10158,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,BAO_0000218,CHEMBL622976,11020,10116.0,Intermediate,1,,,50597,N,1,,
10159,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,BAO_0000218,CHEMBL622977,11020,10116.0,Intermediate,1,,,50597,N,1,,
10160,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,BAO_0000218,CHEMBL624351,11020,10116.0,Intermediate,1,,,50597,N,1,,
10161,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,BAO_0000218,CHEMBL624352,11020,10116.0,Intermediate,1,,,50597,N,1,,
10162,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,BAO_0000218,CHEMBL624353,11020,10116.0,Intermediate,1,,,50597,N,1,,
10163,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,BAO_0000218,CHEMBL622397,11020,10116.0,Intermediate,1,,,50597,N,1,,
10164,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,BAO_0000218,CHEMBL622398,11020,10116.0,Intermediate,1,,,50597,N,1,,
10165,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,BAO_0000218,CHEMBL622399,11020,10116.0,Intermediate,1,,,50597,N,1,,
10166,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,BAO_0000218,CHEMBL622400,11020,10116.0,Intermediate,1,,,50597,N,1,,
10167,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,BAO_0000218,CHEMBL628428,11020,10116.0,Intermediate,1,,,50597,N,1,,
10168,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,BAO_0000218,CHEMBL628590,11020,10116.0,Intermediate,1,,,50597,N,1,,
10169,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,BAO_0000218,CHEMBL628591,11020,10116.0,Intermediate,1,,,50597,N,1,,
10170,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,BAO_0000218,CHEMBL628592,11020,10116.0,Intermediate,1,,,50597,N,1,,
10171,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,BAO_0000218,CHEMBL628593,11020,10116.0,Intermediate,1,,,50597,N,1,,
10172,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,BAO_0000218,CHEMBL875333,11020,10116.0,Intermediate,1,,,50597,N,1,,
10173,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,BAO_0000218,CHEMBL628594,11020,10116.0,Intermediate,1,,,50597,N,1,,
10174,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,BAO_0000218,CHEMBL628595,4969,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10175,,Stability in rat plasma was determined,,BAO_0000218,CHEMBL628596,6737,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10176,,Stability in rat plasma was determined; ND= no data,,BAO_0000218,CHEMBL628597,6737,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10177,,Tested for plasma half life period in rat (0-8 hr),,BAO_0000218,CHEMBL628598,5089,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10178,,Tested for plasma half life period in rat (0-8 hr); Not determined,,BAO_0000218,CHEMBL628599,5089,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10179,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL628600,1466,10116.0,Intermediate,1,,,50597,N,1,,
10180,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL628601,1466,10116.0,Intermediate,1,,,50597,N,1,,
10181,,Tested for the half life in rat,,BAO_0000218,CHEMBL628602,4950,10116.0,Intermediate,1,,,50597,N,1,,
10182,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,BAO_0000218,CHEMBL628603,2412,10116.0,Intermediate,1,,,50597,N,1,,
10183,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,BAO_0000218,CHEMBL628604,2412,10116.0,Intermediate,1,,,50597,N,1,,
10184,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,BAO_0000218,CHEMBL628605,2412,10116.0,Intermediate,1,,,50597,N,1,,
10185,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,BAO_0000218,CHEMBL628606,2412,10116.0,Intermediate,1,,,50597,N,1,,
10186,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,BAO_0000218,CHEMBL628607,2412,10116.0,Intermediate,1,,,50597,N,1,,
10187,,The biological half life the compound was measured at the dose of 100 umol/kg,,BAO_0000218,CHEMBL628608,15022,10116.0,Intermediate,1,,,50597,N,1,,
10188,,The biological half life the compound was measured at the dose of 30 umol/kg,,BAO_0000218,CHEMBL628609,15022,10116.0,Intermediate,1,,,50597,N,1,,
10189,,The compound was evaluated for plasma half life period in rat,,BAO_0000218,CHEMBL628610,406,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10190,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL873819,15078,10116.0,Intermediate,1,,,50597,N,1,,
10191,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL628611,15078,10116.0,Intermediate,1,,,50597,N,1,,
10192,,The pharmacokinetic parameter half-life period in vivo in rats,,BAO_0000218,CHEMBL628612,5247,10116.0,Intermediate,1,,,50597,N,1,,
10193,,"The pharmacokinetic property, Half-life was determined",,BAO_0000218,CHEMBL628613,5041,10116.0,Intermediate,1,,,50597,N,1,,
10194,,"The pharmacokinetic property, Half-life in rat in vivo",,BAO_0000218,CHEMBL628614,5041,10116.0,Intermediate,1,,,50597,N,1,,
10195,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,BAO_0000218,CHEMBL628615,5041,10116.0,Intermediate,1,,,50597,N,1,,
10196,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,BAO_0000218,CHEMBL628616,5041,10116.0,Intermediate,1,,,50597,N,1,,
10197,,The plasma half life period in rats,,BAO_0000218,CHEMBL627924,3918,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10198,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,BAO_0000218,CHEMBL627925,2906,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10199,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,BAO_0000218,CHEMBL627926,6467,10116.0,Intermediate,1,,,50597,N,1,,
10200,,t1/2 (apparent elimination)of the compound was determined,,BAO_0000218,CHEMBL627927,5510,10116.0,Intermediate,1,,,50597,N,1,,
10201,,t1/2 value in rat,,BAO_0000218,CHEMBL627928,3788,10116.0,Intermediate,1,,,50597,N,1,,
10202,,Half life in rat,,BAO_0000218,CHEMBL627539,17796,10116.0,Intermediate,1,,,50597,N,1,,
10203,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,BAO_0000218,CHEMBL876790,12873,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10204,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,BAO_0000218,CHEMBL858186,5983,10116.0,Intermediate,1,,,50597,N,1,,
10205,,Half-life period in fasted rats,,BAO_0000218,CHEMBL627540,15765,10116.0,Intermediate,1,,,50597,N,1,,
10206,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,CHEMBL627541,2661,10116.0,Intermediate,1,,,50597,N,1,,
10207,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,CHEMBL627715,2661,10116.0,Intermediate,1,,,50597,N,1,,
10208,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,BAO_0000218,CHEMBL627716,429,10116.0,Intermediate,1,,,50597,N,1,,
10209,,Maximum time required to achieve Cmax was determined in rat,,BAO_0000218,CHEMBL627717,17655,10116.0,Intermediate,1,,,50597,N,1,,
10210,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,CHEMBL627718,17717,10116.0,Intermediate,1,,,50597,N,1,,
10211,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,BAO_0000218,CHEMBL627719,17717,10116.0,Intermediate,1,,,50597,N,1,,
10212,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,BAO_0000218,CHEMBL627720,17717,10116.0,Intermediate,1,,,50597,N,1,,
10213,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,BAO_0000218,CHEMBL627721,6570,10116.0,Intermediate,1,,,50597,N,1,,
10214,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,BAO_0000218,CHEMBL627722,6570,10116.0,Intermediate,1,,,50597,N,1,,
10215,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL627723,5978,10116.0,Intermediate,1,,,50597,N,1,,
10216,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL626058,5978,10116.0,Intermediate,1,,,50597,N,1,,
10217,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL626059,5978,10116.0,Intermediate,1,,,50597,N,1,,
10218,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL626060,5978,10116.0,Intermediate,1,,,50597,N,1,,
10219,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL626061,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10220,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL876791,4723,10116.0,Intermediate,1,,,50597,N,1,,
10221,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,BAO_0000218,CHEMBL626062,4723,10116.0,Intermediate,1,,,50597,N,1,,
10222,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL626063,4756,10116.0,Intermediate,1,,,50597,N,1,,
10223,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL626064,4756,10116.0,Intermediate,1,,,50597,N,1,,
10224,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL626065,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10225,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,BAO_0000218,CHEMBL626066,17720,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10226,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL626067,1466,10116.0,Intermediate,1,,,50597,N,1,,
10227,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,BAO_0000218,CHEMBL626068,7449,10116.0,Intermediate,1,,,50597,N,1,,
10228,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,BAO_0000218,CHEMBL626069,7449,10116.0,Intermediate,1,,,50597,N,1,,
10229,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,BAO_0000218,CHEMBL626070,7449,10116.0,Intermediate,1,,,50597,N,1,,
10230,,Percent total excretion of N-methoxyacetaminophen glucuronide,,BAO_0000218,CHEMBL626071,7449,10116.0,Intermediate,1,,,50597,N,1,,
10231,,Percent total excretion of N-methoxyacetaminophen sulfate,,BAO_0000218,CHEMBL626072,7449,10116.0,Intermediate,1,,,50597,N,1,,
10232,,Percent total excretion of acetaminophen,,BAO_0000218,CHEMBL626073,7449,10116.0,Intermediate,1,,,50597,N,1,,
10233,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,BAO_0000218,CHEMBL626741,7768,10116.0,Intermediate,1,,,50597,N,1,2046.0,
10234,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,BAO_0000218,CHEMBL626742,17655,10116.0,Intermediate,1,,,50597,N,1,,
10235,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,BAO_0000218,CHEMBL626743,17735,10116.0,Intermediate,1,,,50597,N,1,,
10236,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,BAO_0000218,CHEMBL876792,5960,10116.0,Intermediate,1,,,50597,N,1,,
10237,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,BAO_0000218,CHEMBL626744,17735,10116.0,Intermediate,1,,,50597,N,1,,
10238,,Compound was tested for antidiuretic activity in rats,,BAO_0000218,CHEMBL626745,7116,10116.0,Intermediate,1,,,50597,N,1,,
10239,,AUC in rat after 3mg/kg oral dose,,BAO_0000218,CHEMBL626746,4878,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10240,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,BAO_0000218,CHEMBL626747,5939,10116.0,Intermediate,1,,,50597,N,1,,
10241,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,BAO_0000218,CHEMBL626748,5939,10116.0,Intermediate,1,,,50597,N,1,,
10242,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,BAO_0000218,CHEMBL626749,16367,10116.0,Intermediate,1,,,50597,N,1,,
10243,,Oral Bioavailability was determined,,BAO_0000218,CHEMBL626750,16366,10116.0,Intermediate,1,,,50597,N,1,,
10244,,Oral bioavailability in rat,,BAO_0000218,CHEMBL626751,4426,10116.0,Intermediate,1,,,50597,N,1,,
10245,,Oral bioavailability in rat; Not performed.,,BAO_0000218,CHEMBL626913,4426,10116.0,Intermediate,1,,,50597,N,1,,
10246,,Bioavailability,,BAO_0000218,CHEMBL626914,5041,10116.0,Intermediate,1,,,50597,N,1,,
10247,,Bioavailability was determined; ND denotes no data,,BAO_0000218,CHEMBL626915,5041,10116.0,Intermediate,1,,,50597,N,1,,
10248,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,BAO_0000218,CHEMBL626916,1500,10116.0,Intermediate,1,,,50597,N,1,,
10249,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,BAO_0000218,CHEMBL626917,1500,10116.0,Intermediate,1,,,50597,N,1,,
10250,,Binding towards rat plasma protein at 10 uM,,BAO_0000218,CHEMBL626918,17409,10116.0,Intermediate,1,,,50597,N,1,,
10251,,Binding towards rat plasma protein at 100 uM,,BAO_0000218,CHEMBL626919,17409,10116.0,Intermediate,1,,,50597,N,1,,
10252,,Bioavailability in rat (dose 20 mg/kg p.o.),,BAO_0000218,CHEMBL626920,2959,10116.0,Intermediate,1,,,50597,N,1,,
10253,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,BAO_0000218,CHEMBL621976,13501,10116.0,Intermediate,1,,,50597,N,1,,
10254,,Bioavailability in rat after 5 mg/kg oral gavage,,BAO_0000218,CHEMBL877599,6567,10116.0,Intermediate,1,,,50597,N,1,,
10255,,Bioavailability in rat,,BAO_0000218,CHEMBL621977,6571,10116.0,Intermediate,1,,,50597,N,1,,
10256,,Bioavailability in rat (dose 1 mg/kg i.v.),,BAO_0000218,CHEMBL621978,6715,10116.0,Intermediate,1,,,50597,N,1,,
10257,,Bioavailability in rat (dose 3 mg/kg p.o.),,BAO_0000218,CHEMBL621979,6715,10116.0,Intermediate,1,,,50597,N,1,,
10258,,Oral bioavailability in rat,,BAO_0000218,CHEMBL621980,2932,10116.0,Intermediate,1,,,50597,N,1,,
10259,,Bioavailability of the compound in rats after administration of 30 mg/kg,,BAO_0000218,CHEMBL621981,4171,10116.0,Intermediate,1,,,50597,N,1,,
10260,,Bioavailability after administration of 10 mg/kg in rats,,BAO_0000218,CHEMBL621982,17509,10116.0,Intermediate,1,,,50597,N,1,,
10261,,Bioavailability after administration of 2 mg/kg in rats,,BAO_0000218,CHEMBL882953,17509,10116.0,Intermediate,1,,,50597,N,1,,
10262,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,BAO_0000218,CHEMBL621983,4527,10116.0,Intermediate,1,,,50597,N,1,,
10263,,Bioavailability in dogs was determined; high,,BAO_0000218,CHEMBL621984,4026,10116.0,Intermediate,1,,,50597,N,1,,
10264,,Bioavailability in monkey after intravenous administration at 1 mpk,,BAO_0000218,CHEMBL621985,6659,10116.0,Intermediate,1,,,50597,N,1,,
10265,,Bioavailability in monkey after peroral administration at 10 mpk,,BAO_0000218,CHEMBL621986,6659,10116.0,Intermediate,1,,,50597,N,1,,
10266,,Bioavailability in rat after intravenous administration at 1 mpk,,BAO_0000218,CHEMBL621987,6659,10116.0,Intermediate,1,,,50597,N,1,,
10267,,Bioavailability in rat after intravenous administration at 2 mpk,,BAO_0000218,CHEMBL877600,6659,10116.0,Intermediate,1,,,50597,N,1,,
10268,,Bioavailability in rat after peroral administration at 30 mpk,,BAO_0000218,CHEMBL621988,6659,10116.0,Intermediate,1,,,50597,N,1,,
10269,,Bioavailability in rat after peroral administration at at 100 mpk,,BAO_0000218,CHEMBL621989,6659,10116.0,Intermediate,1,,,50597,N,1,,
10270,,Bioavailability in rats was evaluated,,BAO_0000218,CHEMBL621990,6597,10116.0,Intermediate,1,,,50597,N,1,,
10271,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,BAO_0000218,CHEMBL621991,1202,10116.0,Intermediate,1,,,50597,N,1,,
10272,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,BAO_0000218,CHEMBL621992,1202,10116.0,Intermediate,1,,,50597,N,1,,
10273,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,BAO_0000218,CHEMBL621993,1202,10116.0,Intermediate,1,,,50597,N,1,,
10274,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,BAO_0000218,CHEMBL621994,1202,10116.0,Intermediate,1,,,50597,N,1,,
10275,,Bioavailability in rat,,BAO_0000218,CHEMBL621995,5207,10116.0,Intermediate,1,,,50597,N,1,,
10276,,Bioavailability in rat,,BAO_0000218,CHEMBL621996,5970,10116.0,Intermediate,1,,,50597,N,1,,
10277,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,CHEMBL621997,17538,10116.0,Intermediate,1,,,50597,N,1,,
10278,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,BAO_0000218,CHEMBL621998,17538,10116.0,Intermediate,1,,,50597,N,1,,
10279,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,BAO_0000218,CHEMBL621999,1466,10116.0,Intermediate,1,,,50597,N,1,,
10280,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622000,2879,10116.0,Intermediate,1,,,50597,N,1,,
10281,,Bioavailability was measured in rat after oral administration; 2-4,,BAO_0000218,CHEMBL622001,2879,10116.0,Intermediate,1,,,50597,N,1,,
10282,,Bioavailability was measured in rat after oral administration; 3-7,,BAO_0000218,CHEMBL622002,2879,10116.0,Intermediate,1,,,50597,N,1,,
10283,,Bioavailability in rat (intraduodenal administration),,BAO_0000218,CHEMBL622003,3777,10116.0,Intermediate,1,,,50597,N,1,,
10284,,Bioavailability in rat (intraduodenal administration),,BAO_0000218,CHEMBL877601,3777,10116.0,Intermediate,1,,,50597,N,1,,
10285,,Oral bioavailability in rat,,BAO_0000218,CHEMBL624871,3777,10116.0,Intermediate,1,,,50597,N,1,,
10286,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622004,3777,10116.0,Intermediate,1,,,50597,N,1,,
10287,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,BAO_0000218,CHEMBL882954,5423,10116.0,Intermediate,1,,,50597,N,1,,
10288,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,BAO_0000218,CHEMBL622005,16365,10116.0,Intermediate,1,,,50597,N,1,,
10289,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,BAO_0000218,CHEMBL622006,16365,10116.0,Intermediate,1,,,50597,N,1,,
10290,,Bioavailability was measured in rat,,BAO_0000218,CHEMBL622007,4239,10116.0,Intermediate,1,,,50597,N,1,,
10291,,Bioavailability was reported,,BAO_0000218,CHEMBL622008,5438,10116.0,Intermediate,1,,,50597,N,1,,
10292,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,CHEMBL622009,5334,10116.0,Intermediate,1,,,50597,N,1,,
10293,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,CHEMBL622010,5334,10116.0,Intermediate,1,,,50597,N,1,,
10294,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,BAO_0000218,CHEMBL622011,4199,10116.0,Intermediate,1,,,50597,N,1,,
10295,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,BAO_0000218,CHEMBL622012,4199,10116.0,Intermediate,1,,,50597,N,1,,
10296,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,BAO_0000218,CHEMBL622013,4199,10116.0,Intermediate,1,,,50597,N,1,,
10297,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,BAO_0000218,CHEMBL622014,4890,10116.0,Intermediate,1,,,50597,N,1,,
10298,,Bioavailability was determined at 3 mg/kg po dose in rats,,BAO_0000218,CHEMBL624749,2792,10116.0,Intermediate,1,,,50597,N,1,,
10299,,Oral bioavailability in rat (dose 2 mg/kg),,BAO_0000218,CHEMBL624750,5529,10116.0,Intermediate,1,,,50597,N,1,,
10300,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,BAO_0000218,CHEMBL624751,6685,10116.0,Intermediate,1,,,50597,N,1,,
10301,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,BAO_0000218,CHEMBL624752,6685,10116.0,Intermediate,1,,,50597,N,1,,
10302,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,BAO_0000218,CHEMBL624753,6685,10116.0,Intermediate,1,,,50597,N,1,,
10303,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,BAO_0000218,CHEMBL624754,6005,10116.0,Intermediate,1,,,50597,N,1,,
10304,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,BAO_0000218,CHEMBL624755,6410,10116.0,Intermediate,1,,,50597,N,1,,
10305,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL624756,6410,10116.0,Intermediate,1,,,50597,N,1,,
10306,,Bioavailability in rat,,BAO_0000218,CHEMBL624757,6103,10116.0,Intermediate,1,,,50597,N,1,,
10307,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,BAO_0000218,CHEMBL624758,6410,10116.0,Intermediate,1,,,50597,N,1,,
10308,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL622270,6410,10116.0,Intermediate,1,,,50597,N,1,,
10309,,Bioavailability in rat (Sprague-Dawley),,BAO_0000218,CHEMBL622271,5353,10116.0,Intermediate,1,,,50597,N,1,,
10310,,Bioavailability in rat at the dose of 2 mg/kg,,BAO_0000218,CHEMBL622272,4727,10116.0,Intermediate,1,,,50597,N,1,,
10311,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622273,17804,10116.0,Intermediate,1,,,50597,N,1,,
10312,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,BAO_0000218,CHEMBL622274,5809,10116.0,Intermediate,1,,,50597,N,1,,
10313,,Bioavailability value of compound in rats was determined after peroral administration,,BAO_0000218,CHEMBL622275,17804,10116.0,Intermediate,1,,,50597,N,1,,
10314,,Oral bioavailability in rat (dose 20 mg/kg),,BAO_0000218,CHEMBL622276,3634,10116.0,Intermediate,1,,,50597,N,1,,
10315,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622277,3341,10116.0,Intermediate,1,,,50597,N,1,,
10316,,Oral bioavailability in rat (dose 5 mg/kg),,BAO_0000218,CHEMBL622278,2690,10116.0,Intermediate,1,,,50597,N,1,,
10317,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622279,3184,10116.0,Intermediate,1,,,50597,N,1,,
10318,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622280,740,10116.0,Intermediate,1,,,50597,N,1,,
10319,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,BAO_0000218,CHEMBL624083,1806,10116.0,Intermediate,1,,,50597,N,1,,
10320,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,BAO_0000218,CHEMBL624084,4891,10116.0,Intermediate,1,,,50597,N,1,,
10321,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,BAO_0000218,CHEMBL624085,3634,10116.0,Intermediate,1,,,50597,N,1,,
10322,,Compound was tested for bioavailability in rats,,BAO_0000218,CHEMBL624086,64,10116.0,Intermediate,1,,,50597,N,1,,
10323,,Bioavailability in rat,,BAO_0000218,CHEMBL624087,4839,10116.0,Intermediate,1,,,50597,N,1,,
10324,,Oral bioavailability in rat,,BAO_0000218,CHEMBL624088,1094,10116.0,Intermediate,1,,,50597,N,1,,
10325,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,BAO_0000218,CHEMBL624089,5005,9544.0,Intermediate,1,,,22224,U,0,,
10326,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,BAO_0000218,CHEMBL624090,5005,10116.0,Intermediate,1,,,22224,U,0,,
10327,,Evaluated for the bioavailability in rat (in vivo),,BAO_0000218,CHEMBL624091,4687,10116.0,Intermediate,1,,,50597,N,1,,
10328,,F value of compound in rats was determined after peroral administration,,BAO_0000218,CHEMBL624092,17804,10116.0,Intermediate,1,,,50597,N,1,,
10329,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624093,5974,10116.0,Intermediate,1,,,50597,N,1,,
10330,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624094,5974,10116.0,Intermediate,1,,,50597,N,1,,
10331,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624095,5974,10116.0,Intermediate,1,,,50597,N,1,,
10332,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,BAO_0000218,CHEMBL624096,5974,10116.0,Intermediate,1,,,50597,N,1,,
10333,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,BAO_0000218,CHEMBL624097,1088,10116.0,Intermediate,1,,,50597,N,1,,
10334,,Maximum fall in carotid flow in rat,,BAO_0000218,CHEMBL624098,1742,10116.0,Intermediate,1,,,50597,N,1,,
10335,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,BAO_0000218,CHEMBL874392,4689,10116.0,Intermediate,1,,,50597,N,1,,
10336,,Oral bioavailability in rat (dose 5 mg/kg),,BAO_0000218,CHEMBL624099,2463,10116.0,Intermediate,1,,,50597,N,1,,
10337,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,BAO_0000218,CHEMBL624100,5654,10116.0,Intermediate,1,,,50597,N,1,,
10338,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,BAO_0000218,CHEMBL624101,5654,10116.0,Intermediate,1,,,50597,N,1,,
10339,,Oral bioavailability in rat (male Wistar),,BAO_0000218,CHEMBL624102,6874,10116.0,Intermediate,1,,,50597,N,1,,
10340,,Oral bioavailability after administration (30 mg/kg) in rat; good,,BAO_0000218,CHEMBL624103,5633,10116.0,Intermediate,1,,,50597,N,1,,
10341,,Oral bioavailability at the dose of 2 mg/kg in rat,,BAO_0000218,CHEMBL624104,5496,10116.0,Intermediate,1,,,50597,N,1,,
10342,,Oral bioavailability determined in rats,,BAO_0000218,CHEMBL624105,2358,10116.0,Intermediate,1,,,50597,N,1,,
10343,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,BAO_0000218,CHEMBL624106,16456,10116.0,Intermediate,1,,,50597,N,1,,
10344,,Oral bioavailability in rat (dose single 10 mg/kg),,BAO_0000218,CHEMBL624107,5302,10116.0,Intermediate,1,,,50597,N,1,,
10345,,Oral bioavailability in rat (dose single 10 mg/kg),,BAO_0000218,CHEMBL623943,5302,10116.0,Intermediate,1,,,50597,N,1,,
10346,,Oral bioavailability in rat (dose 5 mg/kg,,BAO_0000218,CHEMBL623944,5302,10116.0,Intermediate,1,,,50597,N,1,,
10347,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,BAO_0000218,CHEMBL623945,11020,10116.0,Intermediate,1,,,50597,N,1,,
10348,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,BAO_0000218,CHEMBL623946,11020,10116.0,Intermediate,1,,,50597,N,1,,
10349,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,BAO_0000218,CHEMBL623947,11020,10116.0,Intermediate,1,,,50597,N,1,,
10350,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,BAO_0000218,CHEMBL623948,11020,10116.0,Intermediate,1,,,50597,N,1,,
10351,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,BAO_0000218,CHEMBL623949,11020,10116.0,Intermediate,1,,,50597,N,1,,
10352,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,BAO_0000218,CHEMBL623950,11020,10116.0,Intermediate,1,,,50597,N,1,,
10353,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,BAO_0000218,CHEMBL874398,11020,10116.0,Intermediate,1,,,50597,N,1,,
10354,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,BAO_0000218,CHEMBL623951,11020,10116.0,Intermediate,1,,,50597,N,1,,
10355,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,BAO_0000218,CHEMBL623952,11020,10116.0,Intermediate,1,,,50597,N,1,,
10356,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,BAO_0000218,CHEMBL623953,11020,10116.0,Intermediate,1,,,50597,N,1,,
10357,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,BAO_0000218,CHEMBL623954,11020,10116.0,Intermediate,1,,,50597,N,1,,
10358,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,BAO_0000218,CHEMBL623955,11020,10116.0,Intermediate,1,,,50597,N,1,,
10359,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,BAO_0000218,CHEMBL623956,11020,10116.0,Intermediate,1,,,50597,N,1,,
10360,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,BAO_0000218,CHEMBL627807,11020,10116.0,Intermediate,1,,,50597,N,1,,
10361,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,BAO_0000218,CHEMBL627808,11020,10116.0,Intermediate,1,,,50597,N,1,,
10362,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,BAO_0000218,CHEMBL627809,11020,10116.0,Intermediate,1,,,50597,N,1,,
10363,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,BAO_0000218,CHEMBL627810,11020,10116.0,Intermediate,1,,,50597,N,1,,
10364,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,BAO_0000218,CHEMBL627811,11020,10116.0,Intermediate,1,,,50597,N,1,,
10365,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,BAO_0000218,CHEMBL627812,11020,10116.0,Intermediate,1,,,50597,N,1,,
10366,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,BAO_0000218,CHEMBL627813,11020,10116.0,Intermediate,1,,,50597,N,1,,
10367,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,BAO_0000218,CHEMBL627814,11020,10116.0,Intermediate,1,,,50597,N,1,,
10368,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,BAO_0000218,CHEMBL875336,11020,10116.0,Intermediate,1,,,50597,N,1,,
10369,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,BAO_0000218,CHEMBL627815,11020,10116.0,Intermediate,1,,,50597,N,1,,
10370,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,BAO_0000218,CHEMBL627816,11020,10116.0,Intermediate,1,,,50597,N,1,,
10371,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,BAO_0000218,CHEMBL627817,11020,10116.0,Intermediate,1,,,50597,N,1,,
10372,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,BAO_0000218,CHEMBL627818,11020,10116.0,Intermediate,1,,,50597,N,1,,
10373,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,BAO_0000218,CHEMBL627819,11020,10116.0,Intermediate,1,,,50597,N,1,,
10374,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,BAO_0000218,CHEMBL627820,11020,10116.0,Intermediate,1,,,50597,N,1,,
10375,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,BAO_0000218,CHEMBL627821,11020,10116.0,Intermediate,1,,,50597,N,1,,
10376,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,BAO_0000218,CHEMBL628464,11020,10116.0,Intermediate,1,,,50597,N,1,,
10377,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,BAO_0000218,CHEMBL626239,11020,10116.0,Intermediate,1,,,50597,N,1,,
10378,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,BAO_0000218,CHEMBL626240,11020,10116.0,Intermediate,1,,,50597,N,1,,
10379,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,BAO_0000218,CHEMBL626241,11020,10116.0,Intermediate,1,,,50597,N,1,,
10380,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,BAO_0000218,CHEMBL626242,11020,10116.0,Intermediate,1,,,50597,N,1,,
10381,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,BAO_0000218,CHEMBL626243,11020,10116.0,Intermediate,1,,,50597,N,1,,
10382,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,BAO_0000218,CHEMBL626244,11020,10116.0,Intermediate,1,,,50597,N,1,,
10383,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,BAO_0000218,CHEMBL626907,11020,10116.0,Intermediate,1,,,50597,N,1,,
10384,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,BAO_0000218,CHEMBL626908,11020,10116.0,Intermediate,1,,,50597,N,1,,
10385,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,BAO_0000218,CHEMBL626909,11020,10116.0,Intermediate,1,,,50597,N,1,,
10386,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,BAO_0000218,CHEMBL626910,11020,10116.0,Intermediate,1,,,50597,N,1,,
10387,,Percent total excretion of acetaminophen cysteine conjugate,,BAO_0000218,CHEMBL875342,7449,10116.0,Intermediate,1,,,50597,N,1,,
10388,,Percent total excretion of acetaminophen glucuronide,,BAO_0000218,CHEMBL626911,7449,10116.0,Intermediate,1,,,50597,N,1,,
10389,,Percent total excretion of acetaminophen sulfate,,BAO_0000218,CHEMBL626912,7449,10116.0,Intermediate,1,,,50597,N,1,,
10390,,Percent total excretion of acetaminophen-mercapturic acid,,BAO_0000218,CHEMBL627065,7449,10116.0,Intermediate,1,,,50597,N,1,,
10391,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,BAO_0000218,CHEMBL627066,3172,10116.0,Intermediate,1,,,50597,N,1,1088.0,
10392,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL627067,16456,10116.0,Intermediate,1,,,50597,N,1,,
10393,,Biodistribution of compound in rat muscle after 5 min of administration,,BAO_0000218,CHEMBL627068,10839,8656.0,Autocuration,1,,,22224,U,0,2385.0,
10394,,Biodistribution of compound in rat muscle after 5 min of administration.,,BAO_0000218,CHEMBL627069,10839,8656.0,Autocuration,1,,,22224,U,0,2385.0,
10395,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL627070,5334,9940.0,Autocuration,1,,,22224,U,0,,
10396,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL627071,5334,9940.0,Autocuration,1,,,22224,U,0,,
10397,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL627072,5334,9940.0,Autocuration,1,,,22224,U,0,,
10398,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL627073,5334,9940.0,Autocuration,1,,,22224,U,0,,
10399,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL625387,5334,9940.0,Autocuration,1,,,22224,U,0,,
10400,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL625388,5334,9940.0,Autocuration,1,,,22224,U,0,,
10401,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL625389,5334,9940.0,Autocuration,1,,,22224,U,0,1969.0,
10402,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,BAO_0000218,CHEMBL875343,5334,9940.0,Autocuration,1,,,22224,U,0,1969.0,
10403,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,BAO_0000218,CHEMBL876795,1735,8570.0,Intermediate,1,,,50497,N,1,,
10404,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,BAO_0000218,CHEMBL626552,1469,8570.0,Intermediate,1,,,50497,N,1,,
10405,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,BAO_0000218,CHEMBL626553,1336,8570.0,Intermediate,1,,,50497,N,1,,
10406,,The human biological plasma half life of the compound,,BAO_0000366,CHEMBL626554,12403,9606.0,Autocuration,1,,,22224,U,0,1969.0,
10407,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,BAO_0000218,CHEMBL626555,8151,10116.0,Intermediate,1,,,50597,N,1,1088.0,
10408,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,BAO_0000218,CHEMBL626556,8004,10116.0,Intermediate,1,,,50597,N,1,,
10409,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,BAO_0000218,CHEMBL626557,8004,10116.0,Intermediate,1,,,50597,N,1,,
10410,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,BAO_0000218,CHEMBL626558,8004,10116.0,Intermediate,1,,,50597,N,1,,
10411,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,BAO_0000218,CHEMBL626559,8004,10116.0,Intermediate,1,,,50597,N,1,,
10412,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,BAO_0000218,CHEMBL626560,8004,10116.0,Intermediate,1,,,50597,N,1,,
10413,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,BAO_0000218,CHEMBL876803,8004,10116.0,Intermediate,1,,,50597,N,1,,
10414,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,BAO_0000218,CHEMBL627964,8004,10116.0,Intermediate,1,,,50597,N,1,,
10415,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,BAO_0000218,CHEMBL627965,8004,10116.0,Intermediate,1,,,50597,N,1,,
10416,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,BAO_0000218,CHEMBL627966,8004,10116.0,Intermediate,1,,,50597,N,1,,
10417,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,BAO_0000218,CHEMBL627967,8004,10116.0,Intermediate,1,,,50597,N,1,,
10418,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,BAO_0000218,CHEMBL627968,8004,10116.0,Intermediate,1,,,50597,N,1,,
10419,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,BAO_0000218,CHEMBL627969,8004,10116.0,Intermediate,1,,,50597,N,1,,
10420,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,BAO_0000218,CHEMBL627970,8004,10116.0,Intermediate,1,,,50597,N,1,,
10421,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,BAO_0000218,CHEMBL627971,8004,10116.0,Intermediate,1,,,50597,N,1,178.0,
10422,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,BAO_0000218,CHEMBL627972,8004,10116.0,Intermediate,1,,,50597,N,1,178.0,
10423,,Dissociation constant against binding to human cyclophilin A,,BAO_0000357,CHEMBL856029,15917,9606.0,Expert,1,,,180,D,9,,
10424,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,BAO_0000019,CHEMBL627973,12396,9913.0,Expert,1,,,11591,H,8,,
10425,,-Log C was determined by performing the electroshock minimum test,,BAO_0000019,CHEMBL627974,7065,,Autocuration,1,,,22224,U,0,,
10426,,-Log C was determined by performing the foot shock test,,BAO_0000019,CHEMBL627975,7065,,Autocuration,1,,,22224,U,0,,
10427,,-Log C was determined by performing the incl screen test,,BAO_0000019,CHEMBL627976,7065,,Autocuration,1,,,22224,U,0,,
10428,,-Log C was determined by performing the maximum electroshock test,,BAO_0000019,CHEMBL627977,7065,,Autocuration,1,,,22224,U,0,,
10429,,-Log C was determined by performing the pentylenetetrazole test,,BAO_0000019,CHEMBL627978,7065,,Autocuration,1,,,22224,U,0,,
10430,,Tested for experimental arotinoid inhibitory dose,,BAO_0000019,CHEMBL627979,12415,,Autocuration,1,,,22224,U,0,,
10431,,Negative log transformed activity,,BAO_0000019,CHEMBL876804,10256,,Autocuration,1,,,22224,U,0,,
10432,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,BAO_0000019,CHEMBL627980,7991,,Autocuration,1,,,22224,U,0,,
10433,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,BAO_0000218,CHEMBL627981,14342,10141.0,Intermediate,1,,,50512,N,1,,
10434,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,BAO_0000218,CHEMBL627982,14342,10141.0,Intermediate,1,,,50512,N,1,,
10435,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,BAO_0000218,CHEMBL627983,14342,10141.0,Intermediate,1,,,50512,N,1,,
10436,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,BAO_0000218,CHEMBL627984,14342,10141.0,Intermediate,1,,,50512,N,1,2116.0,
10437,,Solubility in water was determined; values expressed as -log,,BAO_0000100,CHEMBL627985,6047,,Autocuration,1,,,22229,U,0,,
10438,,Ratio of Kcat to that of Km was determined,,BAO_0000019,CHEMBL627986,17269,,Autocuration,1,,,22224,U,0,,
10439,,Observed first order rate constant,,BAO_0000019,CHEMBL627987,10026,,Autocuration,1,,,22224,U,0,,
10440,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,BAO_0000019,CHEMBL627988,14583,,Autocuration,1,,,22224,U,0,,
10441,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,BAO_0000218,CHEMBL627989,2661,10116.0,Intermediate,1,,,50597,N,1,,
10442,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,BAO_0000218,CHEMBL627990,2661,10116.0,Intermediate,1,,,50597,N,1,,
10443,,Oral Bioavailability after administration of 10 mg/kg in male rat,,BAO_0000218,CHEMBL876805,4029,10116.0,Intermediate,1,,,50597,N,1,,
10444,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,BAO_0000218,CHEMBL627991,17735,10116.0,Intermediate,1,,,50597,N,1,,
10445,,Oral bioavailability in rat,,BAO_0000218,CHEMBL627992,4576,10116.0,Intermediate,1,,,50597,N,1,,
10446,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,BAO_0000218,CHEMBL627993,17582,10116.0,Intermediate,1,,,50597,N,1,,
10447,,Oral bioavailability at 1 mg/kg was determined in rat,,BAO_0000218,CHEMBL622817,17651,10116.0,Intermediate,1,,,50597,N,1,,
10448,,Oral bioavailability at 10 mg/kg was determined in rat,,BAO_0000218,CHEMBL622818,17651,10116.0,Intermediate,1,,,50597,N,1,,
10449,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,BAO_0000218,CHEMBL622819,17670,10116.0,Intermediate,1,,,50597,N,1,,
10450,,Oral bioavailability in rat,,BAO_0000218,CHEMBL872267,5045,10116.0,Intermediate,1,,,50597,N,1,,
10451,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622820,1696,10116.0,Intermediate,1,,,50597,N,1,,
10452,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,BAO_0000218,CHEMBL622821,17764,10116.0,Intermediate,1,,,50597,N,1,,
10453,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622822,6448,10116.0,Intermediate,1,,,50597,N,1,,
10454,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622823,6596,10116.0,Intermediate,1,,,50597,N,1,,
10455,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622824,17547,10116.0,Intermediate,1,,,50597,N,1,,
10456,,Oral bioavailability in rat at a dose of 3 mg/kg,,BAO_0000218,CHEMBL622825,17771,10116.0,Intermediate,1,,,50597,N,1,,
10457,,Oral bioavailability in rat after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL622901,6495,10116.0,Intermediate,1,,,50597,N,1,,
10458,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622902,4558,10116.0,Intermediate,1,,,50597,N,1,,
10459,,Oral bioavailability in rat,,BAO_0000218,CHEMBL621844,17596,10116.0,Intermediate,1,,,50597,N,1,,
10460,,Oral bioavailability in Dawley rats,,BAO_0000218,CHEMBL621845,6827,10116.0,Intermediate,1,,,50597,N,1,,
10461,,Oral bioavailability,,BAO_0000218,CHEMBL621846,4026,10116.0,Intermediate,1,,,50597,N,1,,
10462,,Oral bioavailability in rat (dose 30 mg/kg),,BAO_0000218,CHEMBL621847,10,10116.0,Intermediate,1,,,50597,N,1,,
10463,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,CHEMBL877609,17717,10116.0,Intermediate,1,,,50597,N,1,,
10464,,Bioavailability in rat (dose 3 mg/kg i.v.),,BAO_0000218,CHEMBL621848,17717,10116.0,Intermediate,1,,,50597,N,1,,
10465,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,CHEMBL621849,17717,10116.0,Intermediate,1,,,50597,N,1,,
10466,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,BAO_0000218,CHEMBL622030,17717,10116.0,Intermediate,1,,,50597,N,1,,
10467,,Percent oral bioavailability determined in rats,,BAO_0000218,CHEMBL622031,4796,10116.0,Intermediate,1,,,50597,N,1,,
10468,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,BAO_0000218,CHEMBL622032,4883,10116.0,Intermediate,1,,,50597,N,1,,
10469,,The compound was evaluated for bioavailability in rats; 32-51,,BAO_0000218,CHEMBL622033,2137,10116.0,Intermediate,1,,,50597,N,1,,
10470,,Bioavailability in rat (dose 20 mg/kg p.o.),,BAO_0000218,CHEMBL622034,2959,10116.0,Intermediate,1,,,50597,N,1,,
10471,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622035,1361,10116.0,Intermediate,1,,,50597,N,1,,
10472,,Bioavailability percent in rat at the dose of 2 mg/kg,,BAO_0000218,CHEMBL882966,4727,10116.0,Intermediate,1,,,50597,N,1,,
10473,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,BAO_0000218,CHEMBL622036,16423,10116.0,Intermediate,1,,,50597,N,1,,
10474,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622037,5206,10116.0,Intermediate,1,,,50597,N,1,,
10475,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622038,6448,10116.0,Intermediate,1,,,50597,N,1,,
10476,,Bioavailability in rats,,BAO_0000218,CHEMBL622039,17723,10116.0,Intermediate,1,,,50597,N,1,,
10477,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622040,17738,10116.0,Intermediate,1,,,50597,N,1,178.0,
10478,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622041,17738,10116.0,Intermediate,1,,,50597,N,1,178.0,
10479,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622042,17738,10116.0,Intermediate,1,,,50597,N,1,178.0,
10480,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622043,17738,10116.0,Intermediate,1,,,50597,N,1,178.0,
10481,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622044,17738,10116.0,Intermediate,1,,,50597,N,1,178.0,
10482,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622045,17738,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
10483,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622046,17738,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
10484,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622047,17738,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
10485,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL877610,17738,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
10486,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622048,17738,10116.0,Intermediate,1,,,50597,N,1,955.0,
10487,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622049,17738,10116.0,Intermediate,1,,,50597,N,1,955.0,
10488,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622050,17738,10116.0,Intermediate,1,,,50597,N,1,955.0,
10489,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622051,17738,10116.0,Intermediate,1,,,50597,N,1,955.0,
10490,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622052,17738,10116.0,Intermediate,1,,,50597,N,1,,
10491,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622053,17738,10116.0,Intermediate,1,,,50597,N,1,,
10492,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622054,17738,10116.0,Intermediate,1,,,50597,N,1,,
10493,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622055,17738,10116.0,Intermediate,1,,,50597,N,1,,
10494,,Oral bioavailability in rats was determined; High,,BAO_0000218,CHEMBL622056,5237,10116.0,Intermediate,1,,,50597,N,1,,
10495,,Oral bioavailability in the rat was determined,,BAO_0000218,CHEMBL622057,5503,10116.0,Intermediate,1,,,50597,N,1,,
10496,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,BAO_0000218,CHEMBL628008,15765,10116.0,Intermediate,1,,,50597,N,1,,
10497,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,BAO_0000218,CHEMBL622058,15660,10116.0,Intermediate,1,,,50597,N,1,,
10498,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL622059,5978,10116.0,Intermediate,1,,,50597,N,1,,
10499,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL622060,5978,10116.0,Intermediate,1,,,50597,N,1,,
10500,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL622061,5978,10116.0,Intermediate,1,,,50597,N,1,,
10501,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,BAO_0000218,CHEMBL622062,5978,10116.0,Intermediate,1,,,50597,N,1,,
10502,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,BAO_0000218,CHEMBL622063,5656,10116.0,Intermediate,1,,,50597,N,1,,
10503,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL877611,3598,10116.0,Expert,1,,,50597,N,1,,
10504,,Oral bioavailability of compound in Sprague Dawley rats,,BAO_0000218,CHEMBL622064,4216,10116.0,Intermediate,1,,,50597,N,1,,
10505,,Oral bioavailability of compound in rat,,BAO_0000218,CHEMBL622065,17839,10116.0,Intermediate,1,,,50597,N,1,,
10506,,Oral bioavailability in rat (dose 2 mg/kg),,BAO_0000218,CHEMBL622066,6570,10116.0,Intermediate,1,,,50597,N,1,,
10507,,Oral bioavailability of compound in rat was determined,,BAO_0000218,CHEMBL622067,5334,10116.0,Intermediate,1,,,50597,N,1,,
10508,,Oral bioavailability of compound in rats,,BAO_0000218,CHEMBL622068,6886,10116.0,Intermediate,1,,,50597,N,1,,
10509,,Oral bioavailability of compound was determined in rats,,BAO_0000218,CHEMBL622069,5210,10116.0,Intermediate,1,,,50597,N,1,,
10510,,Oral bioavailability at a dose of 30 mg/kg in rats,,BAO_0000218,CHEMBL624796,4170,10116.0,Intermediate,1,,,50597,N,1,,
10511,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,CHEMBL624797,6028,10116.0,Intermediate,1,,,50597,N,1,,
10512,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,CHEMBL623053,6028,10116.0,Intermediate,1,,,50597,N,1,,
10513,,Oral bioavailability evaluated in rat,,BAO_0000218,CHEMBL623054,6078,10116.0,Intermediate,1,,,50597,N,1,,
10514,,Oral bioavailability in fasted rat,,BAO_0000218,CHEMBL623055,6168,10116.0,Intermediate,1,,,50597,N,1,,
10515,,Oral bioavailability in fed rat,,BAO_0000218,CHEMBL623056,6168,10116.0,Intermediate,1,,,50597,N,1,,
10516,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,BAO_0000218,CHEMBL623057,5160,10116.0,Intermediate,1,,,50597,N,1,,
10517,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623058,6057,10116.0,Intermediate,1,,,50597,N,1,,
10518,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,BAO_0000218,CHEMBL623059,6535,10116.0,Intermediate,1,,,50597,N,1,,
10519,,Oral bioavailability in rat after administration of 10 mg/kg po,,BAO_0000218,CHEMBL623060,6535,10116.0,Intermediate,1,,,50597,N,1,,
10520,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623061,4194,10116.0,Intermediate,1,,,50597,N,1,,
10521,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623062,6230,10116.0,Intermediate,1,,,50597,N,1,,
10522,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623063,6619,10116.0,Intermediate,1,,,50597,N,1,,
10523,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623064,17607,10116.0,Intermediate,1,,,50597,N,1,,
10524,,Oral bioavailability in ratrs,,BAO_0000218,CHEMBL623065,4942,10116.0,Intermediate,1,,,50597,N,1,,
10525,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623066,4942,10116.0,Intermediate,1,,,50597,N,1,,
10526,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623067,6646,10116.0,Intermediate,1,,,50597,N,1,,
10527,,Oral bioavailability in rats was determined; High,,BAO_0000218,CHEMBL623068,5237,10116.0,Intermediate,1,,,50597,N,1,,
10528,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623069,6646,10116.0,Intermediate,1,,,50597,N,1,,
10529,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623070,4449,10116.0,Intermediate,1,,,50597,N,1,,
10530,,Oral bioavailability was calculated in rat,,BAO_0000218,CHEMBL623071,6057,10116.0,Intermediate,1,,,50597,N,1,,
10531,,Oral bioavailability,,BAO_0000218,CHEMBL623072,2552,10116.0,Intermediate,1,,,50597,N,1,,
10532,,Oral bioavailability,,BAO_0000218,CHEMBL623073,5496,10116.0,Intermediate,1,,,50597,N,1,,
10533,,Oral bioavailability,,BAO_0000218,CHEMBL623074,6484,10116.0,Intermediate,1,,,50597,N,1,,
10534,,Oral bioavailability,,BAO_0000218,CHEMBL623075,6485,10116.0,Intermediate,1,,,50597,N,1,,
10535,,Oral bioavailability after i.v. administration,,BAO_0000218,CHEMBL623076,6616,10116.0,Intermediate,1,,,50597,N,1,,
10536,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,CHEMBL623077,4969,10116.0,Intermediate,1,,,50597,N,1,,
10537,,Oral bioavailability in rat (Sprague-Dawley),,BAO_0000218,CHEMBL623078,5862,10116.0,Intermediate,1,,,50597,N,1,,
10538,,Oral bioavailability in Sprague-Dawley rats,,BAO_0000218,CHEMBL623079,4514,10116.0,Intermediate,1,,,50597,N,1,,
10539,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,CHEMBL623080,4514,10116.0,Intermediate,1,,,50597,N,1,,
10540,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,CHEMBL623081,4514,10116.0,Intermediate,1,,,50597,N,1,,
10541,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,BAO_0000218,CHEMBL623082,5546,10116.0,Intermediate,1,,,50597,N,1,,
10542,,Oral bioavailability in fasted rat,,BAO_0000218,CHEMBL874400,6168,10116.0,Intermediate,1,,,50597,N,1,,
10543,,Oral bioavailability in fed rat,,BAO_0000218,CHEMBL623083,6168,10116.0,Intermediate,1,,,50597,N,1,,
10544,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623084,3624,10116.0,Intermediate,1,,,50597,N,1,,
10545,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623085,5213,10116.0,Intermediate,1,,,50597,N,1,,
10546,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623086,5496,10116.0,Intermediate,1,,,50597,N,1,,
10547,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623087,5553,10116.0,Intermediate,1,,,50597,N,1,,
10548,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623088,5833,10116.0,Intermediate,1,,,50597,N,1,,
10549,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623089,5836,10116.0,Intermediate,1,,,50597,N,1,,
10550,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623090,5865,10116.0,Intermediate,1,,,50597,N,1,,
10551,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623091,5960,10116.0,Intermediate,1,,,50597,N,1,,
10552,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623092,6249,10116.0,Intermediate,1,,,50597,N,1,,
10553,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623093,6448,10116.0,Intermediate,1,,,50597,N,1,,
10554,,Oral bioavailability in rat,,BAO_0000218,CHEMBL874401,6453,10116.0,Intermediate,1,,,50597,N,1,,
10555,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623094,6640,10116.0,Intermediate,1,,,50597,N,1,,
10556,,Oral bioavailability in rat,,BAO_0000218,CHEMBL623095,17607,10116.0,Intermediate,1,,,50597,N,1,,
10557,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,BAO_0000218,CHEMBL623096,5939,10116.0,Intermediate,1,,,50597,N,1,,
10558,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,BAO_0000218,CHEMBL624913,5939,10116.0,Intermediate,1,,,50597,N,1,,
10559,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,BAO_0000218,CHEMBL624914,6281,10116.0,Intermediate,1,,,50597,N,1,,
10560,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,BAO_0000218,CHEMBL624915,5874,10116.0,Intermediate,1,,,50597,N,1,,
10561,,Oral bioavailability in rat; Not measured,,BAO_0000218,CHEMBL624916,5213,10116.0,Intermediate,1,,,50597,N,1,,
10562,,Oral bioavailability in rat,,BAO_0000218,CHEMBL624917,4964,10116.0,Intermediate,1,,,50597,N,1,,
10563,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,BAO_0000218,CHEMBL625157,11020,10116.0,Intermediate,1,,,50597,N,1,,
10564,,In vitro metabolic potential in rat liver microsomes,,BAO_0000218,CHEMBL625158,6251,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10565,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,BAO_0000218,CHEMBL625159,1568,10116.0,Intermediate,1,,,50597,N,1,,
10566,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,BAO_0000218,CHEMBL625160,3032,10116.0,Intermediate,1,,,50597,N,1,,
10567,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,BAO_0000218,CHEMBL625161,3748,10116.0,Intermediate,1,,,50597,N,1,,
10568,,Oral bioavailability in rat,,BAO_0000218,CHEMBL625162,401,10116.0,Intermediate,1,,,50597,N,1,,
10569,,Oral bioavailability in rat,,BAO_0000218,CHEMBL625163,6512,10116.0,Intermediate,1,,,50597,N,1,,
10570,,Oral bioavailability in rats at 10 mg/kg,,BAO_0000218,CHEMBL625164,17617,10116.0,Intermediate,1,,,50597,N,1,,
10571,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,BAO_0000218,CHEMBL625165,6679,10116.0,Intermediate,1,,,50597,N,1,,
10572,,Oral bioavailability in rat,,BAO_0000218,CHEMBL625166,6742,10116.0,Intermediate,1,,,50597,N,1,,
10573,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,BAO_0000218,CHEMBL625167,589,10116.0,Intermediate,1,,,50597,N,1,,
10574,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,BAO_0000218,CHEMBL625168,589,10116.0,Intermediate,1,,,50597,N,1,,
10575,,Plasma clearance of the compound,,BAO_0000218,CHEMBL625169,3185,10116.0,Intermediate,1,,,50597,N,1,,
10576,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,BAO_0000218,CHEMBL626264,17596,10116.0,Intermediate,1,,,50597,N,1,,
10577,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,BAO_0000218,CHEMBL626265,2713,10116.0,Intermediate,1,,,50597,N,1,,
10578,,The compound was tested for plasma clearance in rat,,BAO_0000218,CHEMBL626266,12500,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10579,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,BAO_0000218,CHEMBL626267,12500,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10580,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,BAO_0000218,CHEMBL626268,2713,10116.0,Intermediate,1,,,50597,N,1,,
10581,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,BAO_0000218,CHEMBL626269,1446,10116.0,Intermediate,1,,,50597,N,1,,
10582,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,BAO_0000218,CHEMBL626270,6227,10116.0,Intermediate,1,,,50597,N,1,,
10583,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,BAO_0000218,CHEMBL626271,4709,10116.0,Intermediate,1,,,50597,N,1,,
10584,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,BAO_0000218,CHEMBL626272,5510,10116.0,Intermediate,1,,,50597,N,1,,
10585,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,BAO_0000218,CHEMBL626273,5510,10116.0,Intermediate,1,,,50597,N,1,,
10586,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,BAO_0000218,CHEMBL875346,5510,10116.0,Intermediate,1,,,50597,N,1,,
10587,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,BAO_0000218,CHEMBL626274,5510,10116.0,Intermediate,1,,,50597,N,1,,
10588,,Compound was tested for protein binding in rat plasma,,BAO_0000218,CHEMBL626275,4514,10116.0,Intermediate,1,,,50597,N,1,,
10589,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,BAO_0000218,CHEMBL624646,2713,10116.0,Intermediate,1,,,50597,N,1,,
10590,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,BAO_0000218,CHEMBL624647,2713,10116.0,Intermediate,1,,,50597,N,1,,
10591,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,BAO_0000218,CHEMBL624648,5340,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10592,,Area under curve ratio was determined (po/iv) in rat,,BAO_0000218,CHEMBL624649,12058,10116.0,Intermediate,1,,,50597,N,1,,
10593,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,BAO_0000218,CHEMBL624650,11195,10116.0,Intermediate,1,,,50597,N,1,,
10594,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,BAO_0000218,CHEMBL624651,11195,10116.0,Intermediate,1,,,50597,N,1,,
10595,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,BAO_0000218,CHEMBL624652,11195,10116.0,Intermediate,1,,,50597,N,1,,
10596,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,BAO_0000218,CHEMBL624653,6495,10116.0,Intermediate,1,,,50597,N,1,,
10597,,Ratio of AUCbrain to AUCplasma,,BAO_0000218,CHEMBL624654,6078,10116.0,Intermediate,1,,,50597,N,1,,
10598,,Ratio of brain to plasma,,BAO_0000218,CHEMBL624655,5656,10116.0,Intermediate,1,,,50597,N,1,,
10599,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,BAO_0000218,CHEMBL624656,4910,10116.0,Intermediate,1,,,50597,N,1,,
10600,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,BAO_0000218,CHEMBL624657,4910,10116.0,Intermediate,1,,,50597,N,1,,
10601,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,BAO_0000218,CHEMBL624658,4910,10116.0,Intermediate,1,,,50597,N,1,,
10602,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,BAO_0000218,CHEMBL624659,10130,10116.0,Intermediate,1,,,50597,N,1,,
10603,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,BAO_0000218,CHEMBL624660,10130,10116.0,Intermediate,1,,,50597,N,1,,
10604,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,BAO_0000218,CHEMBL624661,10130,10116.0,Intermediate,1,,,50597,N,1,,
10605,,Steady state brain :blood ratio was determined,,BAO_0000218,CHEMBL624662,5213,10116.0,Intermediate,1,,,50597,N,1,,
10606,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL625199,4910,10116.0,Intermediate,1,,,50597,N,1,,
10607,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,BAO_0000218,CHEMBL625200,4910,10116.0,Intermediate,1,,,50597,N,1,,
10608,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,BAO_0000218,CHEMBL625201,4910,10116.0,Intermediate,1,,,50597,N,1,,
10609,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,BAO_0000218,CHEMBL625202,4910,10116.0,Intermediate,1,,,50597,N,1,,
10610,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,BAO_0000218,CHEMBL625203,2083,10116.0,Intermediate,1,,,50597,N,1,,
10611,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,BAO_0000218,CHEMBL625204,2082,10116.0,Intermediate,1,,,50597,N,1,,
10612,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,BAO_0000218,CHEMBL625205,2082,10116.0,Intermediate,1,,,50597,N,1,,
10613,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,BAO_0000218,CHEMBL625206,6351,10116.0,Intermediate,1,,,50597,N,1,,
10614,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,BAO_0000019,CHEMBL625207,14583,,Autocuration,1,,,22224,U,0,,
10615,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,BAO_0000019,CHEMBL625208,14583,,Autocuration,1,,,22224,U,0,,
10616,,In vivo absorption in Caco-2 cell line monolayers was determined,,BAO_0000218,CHEMBL625209,4608,9606.0,Intermediate,1,495.0,,50587,N,1,,
10617,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625210,13668,,Autocuration,1,,,22229,U,0,,
10618,,Area under curve was determine after peroral administration at 10 mpk in Rat,,BAO_0000218,CHEMBL625211,5669,10116.0,Intermediate,1,,,50597,N,1,,
10619,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,BAO_0000218,CHEMBL625212,5669,9544.0,Intermediate,1,,,50797,N,1,,
10620,,Area under curve was determine after peroral administration at 160 mpk in Rat,,BAO_0000218,CHEMBL625213,5669,10116.0,Intermediate,1,,,50597,N,1,,
10621,,Area under curve was determine after peroral administration at 20 mpk in Rat,,BAO_0000218,CHEMBL625214,5669,10116.0,Intermediate,1,,,50597,N,1,,
10622,,Area under curve was determine after peroral administration at 50 mpk in Rat,,BAO_0000218,CHEMBL874542,5669,10116.0,Intermediate,1,,,50597,N,1,,
10623,,Calculated partition coefficient (clogP) (AlogP),,BAO_0000100,CHEMBL625215,6472,,Autocuration,1,,,22229,U,0,,
10624,,Activated partial thromboplastin time measured,,BAO_0000019,CHEMBL625216,15106,,Autocuration,1,,,22224,U,0,,
10625,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,BAO_0000100,CHEMBL625217,15207,,Autocuration,1,,,22224,U,0,,
10626,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,BAO_0000100,CHEMBL625218,15207,,Autocuration,1,,,22224,U,0,,
10627,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,BAO_0000218,CHEMBL622864,13941,9615.0,Intermediate,1,,,50588,N,1,1969.0,
10628,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,BAO_0000218,CHEMBL622865,13941,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10629,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,BAO_0000218,CHEMBL622866,13941,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10630,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,BAO_0000218,CHEMBL622867,13941,9615.0,Intermediate,1,,,50588,N,1,1969.0,
10631,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,CHEMBL876808,15240,10141.0,Intermediate,1,,,50512,N,1,1969.0,
10632,,AUC in brain,,BAO_0000019,CHEMBL627725,10655,,Autocuration,1,,,22224,U,0,955.0,
10633,,AUC in serum,,BAO_0000019,CHEMBL627726,10655,,Autocuration,1,,,22224,U,0,1977.0,
10634,,AUC was determined,,BAO_0000019,CHEMBL627727,6504,,Autocuration,1,,,22224,U,0,1969.0,
10635,,AUC of the compound.,,BAO_0000019,CHEMBL627728,10615,,Autocuration,1,,,22224,U,0,1969.0,
10636,,AUC value (0-4 hr),,BAO_0000019,CHEMBL627729,10353,,Autocuration,1,,,22224,U,0,1969.0,
10637,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,BAO_0000019,CHEMBL627730,14907,,Autocuration,1,,,22224,U,0,1969.0,
10638,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,BAO_0000019,CHEMBL627731,14907,,Autocuration,1,,,22224,U,0,1969.0,
10639,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,BAO_0000019,CHEMBL627732,14907,,Autocuration,1,,,22224,U,0,1969.0,
10640,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,BAO_0000019,CHEMBL627733,14907,,Autocuration,1,,,22224,U,0,1969.0,
10641,,AUC(area under curve) was determined after intravenous administration in rats,,BAO_0000218,CHEMBL627734,16359,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10642,,AUC(area under curve) was determined after oral administration in rats,,BAO_0000218,CHEMBL627735,16359,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10643,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,CHEMBL627736,15240,10141.0,Intermediate,1,,,50512,N,1,1969.0,
10644,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,BAO_0000218,CHEMBL876809,15240,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10645,,Area Under Curve after oral dosing of 100 uM/Kg,,BAO_0000019,CHEMBL627737,15469,,Autocuration,1,,,22224,U,0,,
10646,,Area Under Curve after oral dosing of 30 uM/Kg,,BAO_0000019,CHEMBL627738,15469,,Autocuration,1,,,22224,U,0,,
10647,,Area Under Curve was measured by ploting the graph between concentration verses time,,BAO_0000019,CHEMBL627739,13520,,Autocuration,1,,,22224,U,0,,
10648,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,BAO_0000218,CHEMBL626143,17025,9615.0,Intermediate,1,,,50588,N,1,,
10649,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,BAO_0000218,CHEMBL626144,17025,314293.0,Autocuration,1,,,22224,U,0,,
10650,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,BAO_0000218,CHEMBL626145,17025,9986.0,Intermediate,1,,,50592,N,1,,
10651,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,BAO_0000218,CHEMBL626146,17025,10116.0,Intermediate,1,,,50597,N,1,,
10652,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,BAO_0000218,CHEMBL626147,12032,10116.0,Intermediate,1,,,50597,N,1,178.0,
10653,,Area under curve (AUC) was determined,,BAO_0000019,CHEMBL626148,10291,,Autocuration,1,,,22224,U,0,,
10654,,Area under curve (AUC) following ip administration at 1 mg/kg,,BAO_0000218,CHEMBL626149,5767,,Autocuration,1,,,22224,U,0,,
10655,,Area under curve (AUC) was determined; ND is Not determined,,BAO_0000019,CHEMBL626150,1434,,Autocuration,1,,,22224,U,0,,
10656,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,BAO_0000218,CHEMBL626151,14925,9615.0,Intermediate,1,,,50588,N,1,,
10657,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,BAO_0000218,CHEMBL626152,14925,9615.0,Intermediate,1,,,50588,N,1,,
10658,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,BAO_0000218,CHEMBL626153,14925,9615.0,Intermediate,1,,,50588,N,1,,
10659,,Area under curve (AUR) was determined,,BAO_0000019,CHEMBL626154,1434,,Autocuration,1,,,22224,U,0,,
10660,,Area under curve at 1 uM/dg administered intravenously,,BAO_0000019,CHEMBL626155,11883,,Autocuration,1,,,22224,U,0,,
10661,,Area under curve at 10 uM/dg administered perorally,,BAO_0000019,CHEMBL626156,11883,,Autocuration,1,,,22224,U,0,,
10662,,Area under curve at 2 uM/dg administered intravenously,,BAO_0000019,CHEMBL626157,11883,,Autocuration,1,,,22224,U,0,,
10663,,Area under curve at 20 uM/dg administered perorally,,BAO_0000019,CHEMBL626158,11883,,Autocuration,1,,,22224,U,0,,
10664,,Area under curve at a peroral dose of 3 mg/kg in dog,,BAO_0000218,CHEMBL626159,15233,9615.0,Intermediate,1,,,50588,N,1,,
10665,,Area under curve at a peroral dose of 3 mg/kg in rat,,BAO_0000218,CHEMBL626160,15233,10116.0,Intermediate,1,,,50597,N,1,,
10666,,Area under curve at an iv dose of 1 mg/kg in dog,,BAO_0000218,CHEMBL626161,15233,9615.0,Intermediate,1,,,50588,N,1,,
10667,,Area under curve at an iv dose of 1 mg/kg in rat,,BAO_0000218,CHEMBL626162,15233,10116.0,Intermediate,1,,,50597,N,1,,
10668,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,BAO_0000019,CHEMBL626163,12978,,Autocuration,1,,,22224,U,0,,
10669,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,BAO_0000019,CHEMBL626164,12978,,Autocuration,1,,,22224,U,0,,
10670,,Area under curve measured as conc vs time after intravenous administration to mice.,,BAO_0000218,CHEMBL626165,11355,10090.0,Intermediate,1,,,50594,N,1,,
10671,,Area under curve measured as conc vs time after peroral administration to mice.,,BAO_0000218,CHEMBL626166,11355,10090.0,Intermediate,1,,,50594,N,1,,
10672,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,BAO_0000218,CHEMBL626167,12923,9615.0,Intermediate,1,,,50588,N,1,,
10673,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,BAO_0000218,CHEMBL626168,12923,9615.0,Intermediate,1,,,50588,N,1,,
10674,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,BAO_0000218,CHEMBL877463,12923,9615.0,Intermediate,1,,,50588,N,1,,
10675,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,BAO_0000218,CHEMBL626169,12923,9615.0,Intermediate,1,,,50588,N,1,,
10676,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626170,17738,10116.0,Intermediate,1,,,50597,N,1,948.0,
10677,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626171,17738,10116.0,Intermediate,1,,,50597,N,1,948.0,
10678,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626172,17738,10116.0,Intermediate,1,,,50597,N,1,948.0,
10679,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626173,17738,10116.0,Intermediate,1,,,50597,N,1,948.0,
10680,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626174,17738,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10681,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626175,17738,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10682,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626176,17738,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10683,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL626177,17738,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10684,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622499,17738,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10685,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622500,17738,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10686,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622501,17738,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10687,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622502,17738,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10688,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL622503,17738,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10689,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL877614,17738,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10690,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624839,17738,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10691,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624840,17738,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10692,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624841,17738,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10693,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624842,17738,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10694,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624843,17738,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10695,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624844,17738,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10696,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL624845,17738,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10697,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,BAO_0000218,CHEMBL621904,17738,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10698,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,BAO_0000218,CHEMBL621905,11195,10116.0,Intermediate,1,,,50597,N,1,178.0,
10699,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,BAO_0000218,CHEMBL874382,11195,10116.0,Intermediate,1,,,50597,N,1,178.0,
10700,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,BAO_0000218,CHEMBL621906,11195,10116.0,Intermediate,1,,,50597,N,1,178.0,
10701,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,BAO_0000218,CHEMBL621907,11195,10116.0,Intermediate,1,,,50597,N,1,955.0,
10702,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,BAO_0000218,CHEMBL622096,11195,10116.0,Intermediate,1,,,50597,N,1,955.0,
10703,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,BAO_0000218,CHEMBL622097,11195,10116.0,Intermediate,1,,,50597,N,1,955.0,
10704,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,BAO_0000218,CHEMBL622098,11195,10116.0,Intermediate,1,,,50597,N,1,948.0,
10705,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,BAO_0000218,CHEMBL622099,11195,10116.0,Intermediate,1,,,50597,N,1,948.0,
10706,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,BAO_0000218,CHEMBL622100,11195,10116.0,Intermediate,1,,,50597,N,1,948.0,
10707,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,BAO_0000218,CHEMBL622101,11195,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10708,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,BAO_0000218,CHEMBL622102,11195,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10709,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,BAO_0000218,CHEMBL622103,11195,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10710,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,BAO_0000218,CHEMBL622104,11195,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10711,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,BAO_0000218,CHEMBL622105,11195,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10712,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,BAO_0000218,CHEMBL622106,11195,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10713,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,BAO_0000218,CHEMBL622107,11195,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10714,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,BAO_0000218,CHEMBL622108,11195,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10715,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,BAO_0000218,CHEMBL622109,11195,10116.0,Intermediate,1,,,50597,N,1,2048.0,
10716,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,BAO_0000218,CHEMBL622110,11195,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10717,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,BAO_0000218,CHEMBL622111,11195,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10718,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,BAO_0000218,CHEMBL874383,11195,10116.0,Intermediate,1,,,50597,N,1,2385.0,
10719,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,BAO_0000218,CHEMBL622112,11195,10116.0,Intermediate,1,,,50597,N,1,14.0,
10720,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,BAO_0000218,CHEMBL622113,11195,10116.0,Intermediate,1,,,50597,N,1,14.0,
10721,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,BAO_0000218,CHEMBL622114,11195,10116.0,Intermediate,1,,,50597,N,1,14.0,
10722,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,BAO_0000218,CHEMBL622115,11195,10116.0,Intermediate,1,,,50597,N,1,2106.0,
10723,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,BAO_0000218,CHEMBL622116,11195,10116.0,Intermediate,1,,,50597,N,1,2106.0,
10724,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622117,6193,10116.0,Intermediate,1,,,50597,N,1,,
10725,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622118,6803,10116.0,Intermediate,1,,,50597,N,1,,
10726,,Oral bioavailability in rats at 6 mg/kg,,BAO_0000218,CHEMBL622119,6647,10116.0,Intermediate,1,,,50597,N,1,,
10727,,Oral bioavailability in rat (dose 6 mg/kg),,BAO_0000218,CHEMBL622120,6647,10116.0,Intermediate,1,,,50597,N,1,,
10728,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,BAO_0000218,CHEMBL622121,6647,10116.0,Intermediate,1,,,50597,N,1,,
10729,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622122,6640,10116.0,Intermediate,1,,,50597,N,1,,
10730,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622123,6641,10116.0,Intermediate,1,,,50597,N,1,,
10731,,Oral bioavailability in rat,,BAO_0000218,CHEMBL622124,6641,10116.0,Intermediate,1,,,50597,N,1,,
10732,,Bioavailability in rat,,BAO_0000218,CHEMBL622125,6642,10116.0,Intermediate,1,,,50597,N,1,,
10733,,Oral bioavailability,,BAO_0000218,CHEMBL622126,5472,10116.0,Intermediate,1,,,50597,N,1,,
10734,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,CHEMBL620455,6141,10116.0,Intermediate,1,,,50597,N,1,,
10735,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620456,4390,10116.0,Intermediate,1,,,50597,N,1,,
10736,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620457,5472,10116.0,Intermediate,1,,,50597,N,1,,
10737,,Oral bioavailability was evaluated; Not tested,,BAO_0000218,CHEMBL620458,5472,10116.0,Intermediate,1,,,50597,N,1,,
10738,,Oral bioavailability,,BAO_0000218,CHEMBL620459,5438,10116.0,Intermediate,1,,,50597,N,1,,
10739,,Oral bioavailability in rat by oral dosing,,BAO_0000218,CHEMBL620460,4883,10116.0,Intermediate,1,,,50597,N,1,,
10740,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,BAO_0000218,CHEMBL620461,1908,10116.0,Intermediate,1,,,50597,N,1,,
10741,,Oral bioavailability in rat (Sprague-Dawley),,BAO_0000218,CHEMBL620462,4853,10116.0,Intermediate,1,,,50597,N,1,,
10742,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,CHEMBL620463,4853,10116.0,Intermediate,1,,,50597,N,1,,
10743,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,BAO_0000218,CHEMBL620464,4853,10116.0,Intermediate,1,,,50597,N,1,,
10744,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,BAO_0000218,CHEMBL620465,4853,10116.0,Intermediate,1,,,50597,N,1,,
10745,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,BAO_0000218,CHEMBL620466,4853,10116.0,Intermediate,1,,,50597,N,1,,
10746,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,BAO_0000218,CHEMBL620467,4853,10116.0,Intermediate,1,,,50597,N,1,,
10747,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,BAO_0000218,CHEMBL620468,4853,10116.0,Intermediate,1,,,50597,N,1,,
10748,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,BAO_0000218,CHEMBL620469,12873,10116.0,Intermediate,1,,,50597,N,1,,
10749,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,BAO_0000218,CHEMBL620470,12873,10116.0,Intermediate,1,,,50597,N,1,,
10750,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620471,3169,10116.0,Intermediate,1,,,50597,N,1,,
10751,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620472,6305,10116.0,Intermediate,1,,,50597,N,1,,
10752,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,BAO_0000218,CHEMBL620473,4762,10116.0,Intermediate,1,,,50597,N,1,,
10753,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620474,17847,10116.0,Intermediate,1,,,50597,N,1,,
10754,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,BAO_0000218,CHEMBL620475,6211,10116.0,Intermediate,1,,,50597,N,1,,
10755,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620476,6011,10116.0,Intermediate,1,,,50597,N,1,,
10756,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620477,6317,10116.0,Intermediate,1,,,50597,N,1,,
10757,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,BAO_0000218,CHEMBL620478,6644,10116.0,Intermediate,1,,,50597,N,1,,
10758,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,BAO_0000218,CHEMBL618768,6644,10116.0,Intermediate,1,,,50597,N,1,,
10759,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,BAO_0000218,CHEMBL618769,6644,10116.0,Intermediate,1,,,50597,N,1,,
10760,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,BAO_0000218,CHEMBL618770,6644,10116.0,Intermediate,1,,,50597,N,1,,
10761,,Oral bioavailability (dose 20 mg/kg p.o.),,BAO_0000218,CHEMBL618771,6113,10116.0,Intermediate,1,,,50597,N,1,,
10762,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,BAO_0000218,CHEMBL618772,5937,10116.0,Intermediate,1,,,50597,N,1,,
10763,,Oral bioavailability in rat at 10 mg/kg of the compound,,BAO_0000218,CHEMBL618773,5711,10116.0,Intermediate,1,,,50597,N,1,,
10764,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,CHEMBL875842,17717,10116.0,Intermediate,1,,,50597,N,1,,
10765,,Bioavailability in rat (dose 3 mg/kg i.v.),,BAO_0000218,CHEMBL618774,17717,10116.0,Intermediate,1,,,50597,N,1,,
10766,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,BAO_0000218,CHEMBL618775,17717,10116.0,Intermediate,1,,,50597,N,1,,
10767,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,BAO_0000218,CHEMBL618776,17717,10116.0,Intermediate,1,,,50597,N,1,,
10768,,Percent bioavailability (F) in rats after iv administration,,BAO_0000218,CHEMBL618777,4722,10116.0,Intermediate,1,,,50597,N,1,,
10769,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,BAO_0000218,CHEMBL618778,4722,10116.0,Intermediate,1,,,50597,N,1,,
10770,,Bioavailability in rat (dose 5 uM/kg p.o.),,BAO_0000218,CHEMBL618779,4353,10116.0,Intermediate,1,,,50597,N,1,,
10771,,Oral bioavailability,,BAO_0000218,CHEMBL618780,15662,10116.0,Intermediate,1,,,50597,N,1,,
10772,,Bioavailability in rat (dose 2 mg/kg p.o.),,BAO_0000218,CHEMBL618781,4756,10116.0,Intermediate,1,,,50597,N,1,,
10773,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,BAO_0000218,CHEMBL618782,4756,10116.0,Intermediate,1,,,50597,N,1,,
10774,,Oral bioavailability in rat (dose 20 mg/kg),,BAO_0000218,CHEMBL618783,3436,10116.0,Intermediate,1,,,50597,N,1,,
10775,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618784,17800,10116.0,Intermediate,1,,,50597,N,1,,
10776,,Percent oral bioavailability evaluated in rat,,BAO_0000218,CHEMBL618785,15762,10116.0,Intermediate,1,,,50597,N,1,,
10777,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618786,5089,10116.0,Intermediate,1,,,50597,N,1,,
10778,,Percent oral bioavailability in rat; Not determined,,BAO_0000218,CHEMBL618787,5089,10116.0,Intermediate,1,,,50597,N,1,,
10779,,Oral bioavailability in rat,,BAO_0000218,CHEMBL618788,3185,10116.0,Intermediate,1,,,50597,N,1,,
10780,,Bioavailability in rat,,BAO_0000218,CHEMBL618789,5145,10116.0,Intermediate,1,,,50597,N,1,,
10781,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,BAO_0000218,CHEMBL618790,3457,10116.0,Intermediate,1,,,50597,N,1,,
10782,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,BAO_0000218,CHEMBL618791,3457,10116.0,Intermediate,1,,,50597,N,1,,
10783,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,BAO_0000218,CHEMBL875843,5983,10116.0,Intermediate,1,,,50597,N,1,,
10784,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,BAO_0000218,CHEMBL618792,5739,10116.0,Intermediate,1,,,50597,N,1,,
10785,,Cmax at a dose of 30 mg/kg in rat,,BAO_0000218,CHEMBL623395,3579,10116.0,Intermediate,1,,,50597,N,1,,
10786,,Cmax in monkeys at a dose of 1 mg/kg,,BAO_0000218,CHEMBL623396,17788,314293.0,Autocuration,1,,,22224,U,0,,
10787,,Cmax in rat,,BAO_0000218,CHEMBL623397,14956,10116.0,Intermediate,1,,,50597,N,1,,
10788,,Cmax in rats at a dose of 1 mg/kg,,BAO_0000218,CHEMBL623398,17788,10116.0,Intermediate,1,,,50597,N,1,,
10789,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,BAO_0000218,CHEMBL623399,9750,10090.0,Intermediate,1,,,50594,N,1,,
10790,,"Cmax value at a dose of 12.7 uM/kg, po",,BAO_0000218,CHEMBL623400,12767,,Autocuration,1,,,22224,U,0,,
10791,,"Cmax value at a dose of 6.3 uM/kg, iv",,BAO_0000218,CHEMBL623401,12767,,Autocuration,1,,,22224,U,0,,
10792,,"Cmax value at a dose of 7.1 uM/kg, iv",,BAO_0000218,CHEMBL623402,12767,,Autocuration,1,,,22224,U,0,,
10793,,Cmax value of compound was determined after 1 hr,,BAO_0000218,CHEMBL623403,12703,,Autocuration,1,,,22224,U,0,,
10794,,Cmax value of the compound,,BAO_0000218,CHEMBL623404,15778,,Autocuration,1,,,22224,U,0,,
10795,,Cmax value administered intraintestinal in rats.,,BAO_0000218,CHEMBL625997,12818,10116.0,Intermediate,1,,,50597,N,1,,
10796,,Cmax value administered perorally was determined in rat; Not determined,,BAO_0000218,CHEMBL625998,14964,10116.0,Intermediate,1,,,50597,N,1,,
10797,,Cmax value at the dose of 2.3 mg/kg,,BAO_0000218,CHEMBL625999,15808,,Autocuration,1,,,22224,U,0,,
10798,,Cmax value at the dose of 5 mg/kg,,BAO_0000218,CHEMBL626000,15808,,Autocuration,1,,,22224,U,0,,
10799,,Cmax value in the period of 8 hr after dosing. ,,BAO_0000218,CHEMBL626001,15778,,Autocuration,1,,,22224,U,0,,
10800,,Cmax value at a oral dose of 20 mg/kg; Not tested,,BAO_0000218,CHEMBL626002,3715,,Autocuration,1,,,22224,U,0,,
10801,,Cmax value at a oral dose of 20 mg/kg,,BAO_0000218,CHEMBL626003,3715,,Autocuration,1,,,22224,U,0,,
10802,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,BAO_0000218,CHEMBL626004,1446,10116.0,Intermediate,1,,,50597,N,1,,
10803,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,CHEMBL626005,15240,10141.0,Intermediate,1,,,50512,N,1,,
10804,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,BAO_0000218,CHEMBL626006,15240,10116.0,Intermediate,1,,,50597,N,1,,
10805,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,BAO_0000218,CHEMBL626007,14810,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10806,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,BAO_0000218,CHEMBL626008,14239,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10807,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,BAO_0000218,CHEMBL626009,12555,9615.0,Intermediate,1,,,50588,N,1,2107.0,
10808,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,BAO_0000218,CHEMBL626010,10754,9615.0,Intermediate,1,,,50588,N,1,,
10809,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,BAO_0000218,CHEMBL626011,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
10810,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,BAO_0000218,CHEMBL626012,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
10811,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,BAO_0000218,CHEMBL626013,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
10812,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,BAO_0000218,CHEMBL626014,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
10813,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,BAO_0000218,CHEMBL877496,10754,10090.0,Intermediate,1,,,50594,N,1,178.0,
10814,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,BAO_0000218,CHEMBL626015,14600,9615.0,Intermediate,1,,,50588,N,1,,
10815,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,BAO_0000218,CHEMBL626016,14600,9615.0,Intermediate,1,,,50588,N,1,,
10816,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,BAO_0000218,CHEMBL626017,14600,9615.0,Intermediate,1,,,50588,N,1,,
10817,,Bioavailability as maximal plasma concentration in dogs,,BAO_0000218,CHEMBL626018,13543,9615.0,Intermediate,1,,,50588,N,1,1969.0,
10818,,Bioavailability as maximal plasma concentration in dogs,,BAO_0000218,CHEMBL626692,13543,9615.0,Intermediate,1,,,50588,N,1,1969.0,
10819,,Bioavailability as maximal plasma concentration in rats,,BAO_0000218,CHEMBL626693,13543,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10820,,Bioavailability as maximal plasma concentration in rats,,BAO_0000218,CHEMBL626694,13543,10116.0,Autocuration,1,,,22224,U,0,1969.0,
10821,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,CHEMBL626695,14600,9615.0,Intermediate,1,,,50588,N,1,178.0,
10822,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,CHEMBL626696,14600,9615.0,Intermediate,1,,,50588,N,1,178.0,
10823,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,CHEMBL626697,14600,9615.0,Intermediate,1,,,50588,N,1,178.0,
10824,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,BAO_0000218,CHEMBL626859,14600,9615.0,Intermediate,1,,,50588,N,1,178.0,
10825,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,CHEMBL626860,14600,9615.0,Intermediate,1,,,50588,N,1,178.0,
10826,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,BAO_0000218,CHEMBL626861,14600,9615.0,Intermediate,1,,,50588,N,1,178.0,
10827,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,BAO_0000218,CHEMBL626296,14681,10116.0,Intermediate,1,,,50597,N,1,,
10828,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,BAO_0000218,CHEMBL626297,15905,,Autocuration,1,,,22224,U,0,,
10829,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,BAO_0000218,CHEMBL626298,15905,,Autocuration,1,,,22224,U,0,1969.0,
10830,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,BAO_0000218,CHEMBL626299,13304,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10831,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,BAO_0000218,CHEMBL626300,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10832,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,BAO_0000218,CHEMBL626301,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10833,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,BAO_0000218,CHEMBL626962,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10834,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,BAO_0000218,CHEMBL626963,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10835,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,BAO_0000218,CHEMBL626964,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10836,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,BAO_0000218,CHEMBL626965,14839,9541.0,Intermediate,1,,,100710,N,1,1969.0,
10837,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,CHEMBL626966,14839,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10838,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,CHEMBL626967,14839,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10839,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,BAO_0000218,CHEMBL626968,14839,9541.0,Intermediate,1,,,100710,N,1,1969.0,
10840,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,BAO_0000218,CHEMBL626969,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10841,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,BAO_0000218,CHEMBL627126,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10842,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,BAO_0000218,CHEMBL631276,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10843,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,BAO_0000218,CHEMBL631277,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10844,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,BAO_0000218,CHEMBL631278,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10845,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,BAO_0000218,CHEMBL874457,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10846,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,BAO_0000218,CHEMBL631279,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10847,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,BAO_0000218,CHEMBL631280,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10848,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,BAO_0000218,CHEMBL631281,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10849,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,BAO_0000218,CHEMBL631968,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10850,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,BAO_0000218,CHEMBL631969,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10851,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,BAO_0000218,CHEMBL631970,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10852,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,BAO_0000218,CHEMBL631971,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10853,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,BAO_0000218,CHEMBL631972,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10854,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,BAO_0000218,CHEMBL630435,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10855,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,BAO_0000218,CHEMBL630436,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10856,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,BAO_0000218,CHEMBL630437,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10857,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,BAO_0000218,CHEMBL630438,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10858,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,BAO_0000218,CHEMBL630439,8418,10116.0,Intermediate,1,,,50597,N,1,948.0,
10859,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,BAO_0000218,CHEMBL630440,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10860,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,BAO_0000218,CHEMBL630441,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10861,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,BAO_0000218,CHEMBL630442,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10862,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,BAO_0000218,CHEMBL625234,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10863,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,BAO_0000218,CHEMBL625235,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10864,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,BAO_0000218,CHEMBL625236,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10865,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,BAO_0000218,CHEMBL625237,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10866,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,BAO_0000218,CHEMBL626125,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10867,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,BAO_0000218,CHEMBL626126,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10868,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,BAO_0000218,CHEMBL626127,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10869,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,BAO_0000218,CHEMBL626128,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10870,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,BAO_0000218,CHEMBL626129,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10871,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,BAO_0000218,CHEMBL626130,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10872,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,BAO_0000218,CHEMBL626131,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10873,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,BAO_0000218,CHEMBL626132,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10874,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,BAO_0000218,CHEMBL626752,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10875,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,BAO_0000218,CHEMBL626753,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10876,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,BAO_0000218,CHEMBL626754,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10877,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,BAO_0000218,CHEMBL626755,8418,10116.0,Intermediate,1,,,50597,N,1,2113.0,
10878,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,BAO_0000218,CHEMBL626756,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10879,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,BAO_0000218,CHEMBL626757,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10880,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,BAO_0000218,CHEMBL626758,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10881,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,BAO_0000218,CHEMBL626759,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10882,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,BAO_0000218,CHEMBL626760,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
10883,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL626394,6996,9615.0,Intermediate,1,,,50588,N,1,,
10884,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,BAO_0000218,CHEMBL626395,6996,9615.0,Intermediate,1,,,50588,N,1,,
10885,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL626396,6996,9615.0,Intermediate,1,,,50588,N,1,,
10886,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL626397,6996,9615.0,Intermediate,1,,,50588,N,1,,
10887,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,CHEMBL626398,6996,9615.0,Intermediate,1,,,50588,N,1,,
10888,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL626399,6996,9615.0,Intermediate,1,,,50588,N,1,,
10889,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,BAO_0000218,CHEMBL874653,6996,10116.0,Intermediate,1,,,50597,N,1,,
10890,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL626400,6996,10116.0,Intermediate,1,,,50597,N,1,,
10891,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL626401,6996,10116.0,Intermediate,1,,,50597,N,1,,
10892,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL626402,6996,10116.0,Intermediate,1,,,50597,N,1,,
10893,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL626403,6996,10116.0,Intermediate,1,,,50597,N,1,,
10894,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL626404,6996,10116.0,Intermediate,1,,,50597,N,1,,
10895,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,BAO_0000218,CHEMBL626405,6996,10116.0,Intermediate,1,,,50597,N,1,,
10896,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL625529,6996,10116.0,Intermediate,1,,,50597,N,1,,
10897,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL625530,6996,10116.0,Intermediate,1,,,50597,N,1,,
10898,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL625531,6996,10116.0,Intermediate,1,,,50597,N,1,,
10899,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL625532,6996,10116.0,Intermediate,1,,,50597,N,1,,
10900,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL625533,6996,10116.0,Intermediate,1,,,50597,N,1,,
10901,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,BAO_0000218,CHEMBL875474,6996,10116.0,Intermediate,1,,,50597,N,1,,
10902,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL625534,6996,10116.0,Intermediate,1,,,50597,N,1,,
10903,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL625535,6996,10116.0,Intermediate,1,,,50597,N,1,,
10904,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL625536,6996,10116.0,Intermediate,1,,,50597,N,1,,
10905,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL625537,6996,10116.0,Intermediate,1,,,50597,N,1,,
10906,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL625538,6996,10116.0,Intermediate,1,,,50597,N,1,,
10907,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,BAO_0000218,CHEMBL625539,6996,10116.0,Intermediate,1,,,50597,N,1,,
10908,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL625540,6996,10116.0,Intermediate,1,,,50597,N,1,,
10909,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL625541,6996,10116.0,Intermediate,1,,,50597,N,1,,
10910,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL625542,6996,10116.0,Intermediate,1,,,50597,N,1,,
10911,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL625543,6996,10116.0,Intermediate,1,,,50597,N,1,,
10912,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL625544,6996,10116.0,Intermediate,1,,,50597,N,1,,
10913,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,BAO_0000218,CHEMBL625545,6996,9615.0,Intermediate,1,,,50588,N,1,,
10914,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL625546,6996,9615.0,Intermediate,1,,,50588,N,1,,
10915,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,BAO_0000218,CHEMBL625547,6996,9615.0,Intermediate,1,,,50588,N,1,,
10916,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL625548,6996,9615.0,Intermediate,1,,,50588,N,1,,
10917,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL625549,6996,9615.0,Intermediate,1,,,50588,N,1,,
10918,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL625550,6996,9615.0,Intermediate,1,,,50588,N,1,,
10919,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL625551,6996,9615.0,Intermediate,1,,,50588,N,1,,
10920,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL875475,6996,9615.0,Intermediate,1,,,50588,N,1,,
10921,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL625552,6996,9615.0,Intermediate,1,,,50588,N,1,,
10922,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL625553,6996,9615.0,Intermediate,1,,,50588,N,1,,
10923,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL625554,6996,9615.0,Intermediate,1,,,50588,N,1,,
10924,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,CHEMBL625555,6996,9615.0,Intermediate,1,,,50588,N,1,,
10925,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL625556,6996,9615.0,Intermediate,1,,,50588,N,1,,
10926,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,BAO_0000218,CHEMBL624986,6996,9615.0,Intermediate,1,,,50588,N,1,,
10927,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL624987,6996,9615.0,Intermediate,1,,,50588,N,1,,
10928,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL624988,6996,9615.0,Intermediate,1,,,50588,N,1,,
10929,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,BAO_0000218,CHEMBL624989,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10930,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,BAO_0000218,CHEMBL624990,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10931,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,BAO_0000218,CHEMBL874391,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10932,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,BAO_0000218,CHEMBL624991,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10933,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,BAO_0000218,CHEMBL624992,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10934,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,BAO_0000218,CHEMBL624993,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10935,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,BAO_0000218,CHEMBL624994,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10936,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,BAO_0000218,CHEMBL624995,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10937,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,BAO_0000218,CHEMBL624996,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10938,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,BAO_0000218,CHEMBL624997,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10939,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,BAO_0000218,CHEMBL624998,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10940,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,BAO_0000218,CHEMBL624999,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10941,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,BAO_0000218,CHEMBL882955,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10942,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,BAO_0000218,CHEMBL625000,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10943,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,BAO_0000218,CHEMBL625001,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10944,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,BAO_0000218,CHEMBL625089,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10945,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,BAO_0000218,CHEMBL625090,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10946,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,BAO_0000218,CHEMBL625091,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10947,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,BAO_0000218,CHEMBL625092,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10948,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,BAO_0000218,CHEMBL625093,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10949,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,BAO_0000218,CHEMBL625094,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10950,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,BAO_0000218,CHEMBL625095,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
10951,,Compound was evaluated for its bioavailability in the dogs,,BAO_0000218,CHEMBL625096,2249,9615.0,Intermediate,1,,,50588,N,1,,
10952,,Compound was evaluated for its bioavailability in the rats,,BAO_0000218,CHEMBL625097,2249,10116.0,Intermediate,1,,,50597,N,1,,
10953,,Compound was evaluated for oral bioavailability,,BAO_0000218,CHEMBL882956,17515,,Autocuration,1,,,22224,U,0,,
10954,,Compound was evaluated for percentage of Oral bioavailability in rats,,BAO_0000218,CHEMBL625098,14541,10116.0,Intermediate,1,,,50597,N,1,,
10955,,Bioavailability in guinea pig,,BAO_0000218,CHEMBL625099,12797,10141.0,Autocuration,1,,,22224,U,0,,
10956,,Compound was evaluated for the oral bioavailability in rat,,BAO_0000218,CHEMBL625100,12797,10116.0,Intermediate,1,,,50597,N,1,,
10957,,Compound was evaluated for the oral bioavailability in dog,,BAO_0000218,CHEMBL625101,12797,9615.0,Intermediate,1,,,50588,N,1,,
10958,,Compound was evaluated for the oral bioavailability in rat,,BAO_0000218,CHEMBL874396,12797,10116.0,Intermediate,1,,,50597,N,1,,
10959,,Bioavailability in dog (dosed i.v.),,BAO_0000218,CHEMBL625102,11727,9615.0,Autocuration,1,,,22224,U,0,,
10960,,Compound was tested for in vivo bioavailability in dog,,BAO_0000218,CHEMBL625103,13249,9615.0,Intermediate,1,,,50588,N,1,,
10961,,Compound was tested for in vivo bioavailability in hamsters,,BAO_0000218,CHEMBL625104,13249,10026.0,Intermediate,1,,,100712,N,1,,
10962,,Compound was tested for in vivo bioavailability in monkey,,BAO_0000218,CHEMBL625105,13249,314293.0,Autocuration,1,,,22224,U,0,,
10963,,Compound was tested for in vivo bioavailability in rat,,BAO_0000218,CHEMBL625106,13249,10116.0,Intermediate,1,,,50597,N,1,,
10964,,Oral bioavailability in mouse,,BAO_0000218,CHEMBL625107,9552,10090.0,Autocuration,1,,,22224,U,0,,
10965,,Compound was tested for percent of oral bioavailability in mice; 56-74,,BAO_0000218,CHEMBL625108,9552,10090.0,Intermediate,1,,,50594,N,1,,
10966,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,BAO_0000218,CHEMBL625109,14839,10090.0,Autocuration,1,,,22224,U,0,,
10967,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,BAO_0000218,CHEMBL625110,14839,9541.0,Autocuration,1,,,22224,U,0,,
10968,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,BAO_0000218,CHEMBL625111,14839,9541.0,Autocuration,1,,,22224,U,0,,
10969,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,BAO_0000218,CHEMBL625112,14839,10090.0,Intermediate,1,,,50594,N,1,,
10970,,Oral bioavailability in nude mice,,BAO_0000218,CHEMBL875334,14839,10090.0,Intermediate,1,,,50594,N,1,,
10971,,Bioavailability in monkey (i.d. dosing),,BAO_0000218,CHEMBL628617,11219,9443.0,Autocuration,1,,,22224,U,0,,
10972,,Bioavailability in rat,,BAO_0000218,CHEMBL628618,9552,10116.0,Autocuration,1,,,22224,U,0,,
10973,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,BAO_0000218,CHEMBL628619,11732,,Autocuration,1,,,22224,U,0,,
10974,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,BAO_0000218,CHEMBL628620,11732,,Autocuration,1,,,22224,U,0,,
10975,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,BAO_0000218,CHEMBL628621,14839,9541.0,Intermediate,1,,,100710,N,1,,
10976,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,BAO_0000218,CHEMBL628622,14839,9541.0,Intermediate,1,,,100710,N,1,,
10977,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,BAO_0000218,CHEMBL628623,14839,9541.0,Intermediate,1,,,100710,N,1,,
10978,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,BAO_0000218,CHEMBL628624,14839,9541.0,Intermediate,1,,,100710,N,1,1969.0,
10979,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,CHEMBL628625,14839,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10980,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,BAO_0000218,CHEMBL628626,14839,9541.0,Intermediate,1,,,100710,N,1,1969.0,
10981,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,CHEMBL627041,14839,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10982,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,CHEMBL627042,14839,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10983,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,BAO_0000218,CHEMBL627043,14839,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10984,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,BAO_0000218,CHEMBL627044,13932,,Autocuration,1,,,22224,U,0,1969.0,
10985,,Cmax in mouse plasma,,BAO_0000218,CHEMBL627045,11637,10090.0,Intermediate,1,,,50594,N,1,1969.0,
10986,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,BAO_0000218,CHEMBL627046,11637,,Autocuration,1,,,22224,U,0,1969.0,
10987,,Maximal plasma concentration in rat,,BAO_0000218,CHEMBL627047,13960,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10988,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,BAO_0000218,CHEMBL627048,15905,10116.0,Intermediate,1,,,50597,N,1,1969.0,
10989,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,BAO_0000218,CHEMBL627049,14062,10116.0,Intermediate,1,,,50597,N,1,,
10990,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,BAO_0000218,CHEMBL627050,14062,10116.0,Intermediate,1,,,50597,N,1,,
10991,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,BAO_0000218,CHEMBL627051,14062,10116.0,Intermediate,1,,,50597,N,1,,
10992,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,BAO_0000218,CHEMBL627052,14062,10116.0,Intermediate,1,,,50597,N,1,,
10993,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,BAO_0000218,CHEMBL627053,14062,10116.0,Intermediate,1,,,50597,N,1,,
10994,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,BAO_0000218,CHEMBL627054,14062,10116.0,Intermediate,1,,,50597,N,1,,
10995,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL627055,15011,10090.0,Intermediate,1,,,50594,N,1,,
10996,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL627056,15011,10090.0,Intermediate,1,,,50594,N,1,,
10997,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,BAO_0000218,CHEMBL627057,15011,10090.0,Intermediate,1,,,50594,N,1,,
10998,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL627058,15011,10090.0,Intermediate,1,,,50594,N,1,,
10999,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,BAO_0000218,CHEMBL626211,15011,10090.0,Intermediate,1,,,50594,N,1,,
11000,,Maximum Concentration of the compound.,,BAO_0000218,CHEMBL626212,10291,,Autocuration,1,,,22224,U,0,,
11001,,Maximum Concentration was measured after iv administration into Beagle dog,,BAO_0000218,CHEMBL626213,14599,9615.0,Intermediate,1,,,50588,N,1,,
11002,,Maximum Concentration was measured after iv administration into Beagle dog.,,BAO_0000218,CHEMBL626214,14599,9615.0,Intermediate,1,,,50588,N,1,,
11003,,Maximum Concentration was measured after po administration into Beagle dog,,BAO_0000218,CHEMBL626215,14599,9615.0,Intermediate,1,,,50588,N,1,,
11004,,Maximum Concentration was measured after po administration into Beagle dog.,,BAO_0000218,CHEMBL626216,14599,9615.0,Intermediate,1,,,50588,N,1,,
11005,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,BAO_0000218,CHEMBL626217,12767,,Autocuration,1,,,22224,U,0,178.0,
11006,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,BAO_0000218,CHEMBL626218,12767,,Autocuration,1,,,22224,U,0,178.0,
11007,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,BAO_0000218,CHEMBL626219,12767,,Autocuration,1,,,22224,U,0,178.0,
11008,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,BAO_0000218,CHEMBL626220,12767,,Autocuration,1,,,22224,U,0,178.0,
11009,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,BAO_0000218,CHEMBL626221,12767,,Autocuration,1,,,22224,U,0,178.0,
11010,,Maximum blood level reached at dose of 10.6 uM/kg orally,,BAO_0000218,CHEMBL626222,12767,,Autocuration,1,,,22224,U,0,178.0,
11011,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,BAO_0000218,CHEMBL626223,14706,10141.0,Intermediate,1,,,50512,N,1,,
11012,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,BAO_0000218,CHEMBL626224,14706,10141.0,Intermediate,1,,,50512,N,1,,
11013,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,CHEMBL626225,14793,10116.0,Intermediate,1,,,50597,N,1,955.0,
11014,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,BAO_0000218,CHEMBL626226,14793,10116.0,Intermediate,1,,,50597,N,1,955.0,
11015,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,BAO_0000218,CHEMBL626227,14793,10116.0,Intermediate,1,,,50597,N,1,955.0,
11016,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,BAO_0000218,CHEMBL626228,14793,10116.0,Intermediate,1,,,50597,N,1,955.0,
11017,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,CHEMBL626229,14793,10116.0,Intermediate,1,,,50597,N,1,,
11018,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,BAO_0000218,CHEMBL626921,14793,10116.0,Intermediate,1,,,50597,N,1,,
11019,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,BAO_0000218,CHEMBL876793,14793,10116.0,Intermediate,1,,,50597,N,1,,
11020,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,BAO_0000218,CHEMBL625309,14793,10116.0,Intermediate,1,,,50597,N,1,,
11021,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,BAO_0000218,CHEMBL625310,10524,1423.0,Intermediate,1,,,50278,N,1,,
11022,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,BAO_0000218,CHEMBL625311,11871,314293.0,Autocuration,1,,,22224,U,0,,
11023,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,BAO_0000218,CHEMBL625312,11871,10116.0,Intermediate,1,,,50597,N,1,,
11024,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,BAO_0000218,CHEMBL625313,3437,,Autocuration,1,,,22224,U,0,,
11025,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,BAO_0000218,CHEMBL625314,12038,10090.0,Intermediate,1,,,50594,N,1,,
11026,,Maximum concentration in male rats after iv administration of 20 mg/kg,,BAO_0000218,CHEMBL625315,12038,10116.0,Intermediate,1,,,50597,N,1,,
11027,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,BAO_0000218,CHEMBL625316,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11028,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,BAO_0000218,CHEMBL625317,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11029,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,BAO_0000218,CHEMBL625318,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11030,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,BAO_0000218,CHEMBL625319,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11031,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,BAO_0000218,CHEMBL625320,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11032,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,BAO_0000218,CHEMBL625321,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11033,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,BAO_0000218,CHEMBL625322,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11034,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,BAO_0000218,CHEMBL876801,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11035,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,BAO_0000218,CHEMBL625323,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11036,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,BAO_0000218,CHEMBL625324,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11037,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,BAO_0000218,CHEMBL625325,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11038,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,BAO_0000218,CHEMBL625326,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11039,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,BAO_0000218,CHEMBL625327,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11040,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,BAO_0000218,CHEMBL625328,8418,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11041,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,BAO_0000218,CHEMBL625329,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11042,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,BAO_0000218,CHEMBL625330,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11043,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,BAO_0000218,CHEMBL627774,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11044,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,BAO_0000218,CHEMBL627775,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11045,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,BAO_0000218,CHEMBL627949,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11046,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,BAO_0000218,CHEMBL627950,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11047,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,BAO_0000218,CHEMBL627951,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11048,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,BAO_0000218,CHEMBL627952,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11049,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,BAO_0000218,CHEMBL627953,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11050,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,BAO_0000218,CHEMBL627954,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11051,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,BAO_0000218,CHEMBL627955,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11052,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,BAO_0000218,CHEMBL627956,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11053,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,BAO_0000218,CHEMBL876802,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11054,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,BAO_0000218,CHEMBL627957,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11055,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,BAO_0000218,CHEMBL627958,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11056,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,BAO_0000218,CHEMBL627959,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11057,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,BAO_0000218,CHEMBL627960,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11058,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,BAO_0000218,CHEMBL627961,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11059,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,BAO_0000218,CHEMBL627962,8418,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11060,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL627963,9796,10116.0,Intermediate,1,,,50597,N,1,,
11061,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624759,9796,10116.0,Intermediate,1,,,50597,N,1,,
11062,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624760,9796,10116.0,Intermediate,1,,,50597,N,1,,
11063,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624761,9796,10116.0,Intermediate,1,,,50597,N,1,,
11064,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL877607,9796,10116.0,Intermediate,1,,,50597,N,1,,
11065,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624762,9796,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11066,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624763,9796,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11067,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624764,9796,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11068,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624765,9796,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11069,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL624766,9796,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11070,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL624767,6996,9615.0,Intermediate,1,,,50588,N,1,,
11071,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,BAO_0000218,CHEMBL624768,6996,9615.0,Intermediate,1,,,50588,N,1,,
11072,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL624769,6996,9615.0,Intermediate,1,,,50588,N,1,,
11073,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL624770,6996,9615.0,Intermediate,1,,,50588,N,1,,
11074,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,CHEMBL624771,6996,9615.0,Intermediate,1,,,50588,N,1,,
11075,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL624772,6996,9615.0,Intermediate,1,,,50588,N,1,,
11076,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,BAO_0000218,CHEMBL624773,6996,10116.0,Intermediate,1,,,50597,N,1,,
11077,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL624774,6996,10116.0,Intermediate,1,,,50597,N,1,,
11078,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL624775,6996,10116.0,Intermediate,1,,,50597,N,1,,
11079,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL624776,6996,10116.0,Intermediate,1,,,50597,N,1,,
11080,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL624777,6996,10116.0,Intermediate,1,,,50597,N,1,,
11081,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL624778,6996,10116.0,Intermediate,1,,,50597,N,1,,
11082,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,BAO_0000218,CHEMBL624779,6996,10116.0,Intermediate,1,,,50597,N,1,,
11083,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL624780,6996,10116.0,Intermediate,1,,,50597,N,1,,
11084,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL624781,6996,10116.0,Intermediate,1,,,50597,N,1,,
11085,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL877608,6996,10116.0,Intermediate,1,,,50597,N,1,,
11086,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL624782,6996,10116.0,Intermediate,1,,,50597,N,1,,
11087,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL624783,6996,10116.0,Intermediate,1,,,50597,N,1,,
11088,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,BAO_0000218,CHEMBL624784,6996,10116.0,Intermediate,1,,,50597,N,1,,
11089,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL624785,6996,10116.0,Intermediate,1,,,50597,N,1,,
11090,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL624786,6996,10116.0,Intermediate,1,,,50597,N,1,,
11091,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL624787,6996,10116.0,Intermediate,1,,,50597,N,1,,
11092,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL628676,6996,10116.0,Intermediate,1,,,50597,N,1,,
11093,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,BAO_0000218,CHEMBL621842,6996,10116.0,Intermediate,1,,,50597,N,1,,
11094,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL621843,6996,10116.0,Intermediate,1,,,50597,N,1,,
11095,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL623873,6996,10116.0,Intermediate,1,,,50597,N,1,,
11096,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL623874,6996,10116.0,Intermediate,1,,,50597,N,1,,
11097,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL623875,6996,10116.0,Intermediate,1,,,50597,N,1,,
11098,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL623876,6996,10116.0,Intermediate,1,,,50597,N,1,,
11099,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,BAO_0000218,CHEMBL623877,6996,9615.0,Intermediate,1,,,50588,N,1,,
11100,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL623878,6996,9615.0,Intermediate,1,,,50588,N,1,,
11101,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,BAO_0000218,CHEMBL623879,6996,9615.0,Intermediate,1,,,50588,N,1,,
11102,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL623880,6996,9615.0,Intermediate,1,,,50588,N,1,,
11103,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL623881,6996,9615.0,Intermediate,1,,,50588,N,1,,
11104,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL623957,6996,9615.0,Intermediate,1,,,50588,N,1,,
11105,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL623958,6996,9615.0,Intermediate,1,,,50588,N,1,,
11106,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL623959,6996,9615.0,Intermediate,1,,,50588,N,1,,
11107,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL623960,6996,9615.0,Intermediate,1,,,50588,N,1,,
11108,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL623961,6996,9615.0,Intermediate,1,,,50588,N,1,,
11109,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL623962,6996,9615.0,Intermediate,1,,,50588,N,1,,
11110,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,CHEMBL624676,6996,9615.0,Intermediate,1,,,50588,N,1,,
11111,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL624677,6996,9615.0,Intermediate,1,,,50588,N,1,,
11112,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,BAO_0000218,CHEMBL624678,6996,9615.0,Intermediate,1,,,50588,N,1,,
11113,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL624679,6996,9615.0,Intermediate,1,,,50588,N,1,,
11114,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL624680,6996,9615.0,Intermediate,1,,,50588,N,1,,
11115,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,BAO_0000218,CHEMBL624849,11732,,Autocuration,1,,,22224,U,0,,
11116,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,BAO_0000218,CHEMBL624850,11732,,Autocuration,1,,,22224,U,0,,
11117,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,BAO_0000218,CHEMBL874399,11732,,Autocuration,1,,,22224,U,0,,
11118,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,BAO_0000218,CHEMBL624851,11732,,Autocuration,1,,,22224,U,0,,
11119,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,BAO_0000218,CHEMBL624852,11732,,Autocuration,1,,,22224,U,0,,
11120,,Oral bioavailability in rat (dose 10 mg/kg),,BAO_0000218,CHEMBL624853,13359,10116.0,Autocuration,1,,,22224,U,0,,
11121,,Oral bioavailability in rat (Sprague-Dawley),,BAO_0000218,CHEMBL624854,16618,10116.0,Autocuration,1,,,22224,U,0,,
11122,,Oral bioavailability in rat,,BAO_0000218,CHEMBL624855,13960,10116.0,Autocuration,1,,,22224,U,0,,
11123,,Oral bioavailability in rats was determined in vivo,,BAO_0000218,CHEMBL624856,13917,10116.0,Autocuration,1,,,22224,U,0,,
11124,,Oral bioavailability in dog,,BAO_0000218,CHEMBL882957,14266,9615.0,Autocuration,1,,,22224,U,0,,
11125,,Oral bioavailability of compound in monkey,,BAO_0000218,CHEMBL624857,12359,314293.0,Autocuration,1,,,22224,U,0,,
11126,,Oral bioavailability of compound in rat,,BAO_0000218,CHEMBL622202,12359,10116.0,Intermediate,1,,,50597,N,1,,
11127,,Bioavailability in rat of PMEA prodrug,,BAO_0000218,CHEMBL622203,12359,10116.0,Autocuration,1,,,22224,U,0,,
11128,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,BAO_0000218,CHEMBL625522,12359,10116.0,Intermediate,1,,,50597,N,1,,
11129,,Serum conc at 3 hours following 25 mg/kg dose,,BAO_0000218,CHEMBL622868,10791,9544.0,Autocuration,1,,,22224,U,0,,
11130,,Urine conc 0-5 hours following 25 mg/kg dose,,BAO_0000218,CHEMBL622869,10791,9544.0,Autocuration,1,,,22224,U,0,1088.0,
11131,,Urine conc 0-24 hours following 25 mg/kg dose,,BAO_0000218,CHEMBL622870,10791,9544.0,Autocuration,1,,,22224,U,0,1088.0,
11132,,Oral bioavailability in African green monkeys; 20-25,,BAO_0000218,CHEMBL622871,138,9534.0,Autocuration,1,,,22224,U,0,,
11133,,Oral bioavailability in cynomolgus monkey.,,BAO_0000218,CHEMBL620560,14521,9541.0,Intermediate,1,,,100710,N,1,,
11134,,Oral bioavailability in dog,,BAO_0000218,CHEMBL620561,13953,9615.0,Autocuration,1,,,22224,U,0,,
11135,,Oral bioavailability in dog at 10 mg/kg oral dose,,BAO_0000218,CHEMBL620562,12836,9615.0,Intermediate,1,,,50588,N,1,,
11136,,Oral bioavailability in hamster at 10 mg/kg oral dose,,BAO_0000218,CHEMBL620563,12836,10026.0,Intermediate,1,,,100712,N,1,,
11137,,Oral bioavailability in rat at 10 mg/kg oral dose,,BAO_0000218,CHEMBL620564,12836,10116.0,Intermediate,1,,,50597,N,1,,
11138,,Oral bioavailability in rat,,BAO_0000218,CHEMBL872265,14521,10116.0,Autocuration,1,,,22224,U,0,,
11139,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620565,13953,10116.0,Autocuration,1,,,22224,U,0,,
11140,,Oral bioavailability,,BAO_0000218,CHEMBL620566,6799,9347.0,Autocuration,1,,,22224,U,0,,
11141,,Oral bioavailability was determined; range 49-102%,,BAO_0000218,CHEMBL620567,11311,,Autocuration,1,,,22224,U,0,,
11142,,Oral bioavailability was determined in dogs,,BAO_0000218,CHEMBL620568,4013,9615.0,Intermediate,1,,,50588,N,1,,
11143,,Oral bioavailability in rat,,BAO_0000218,CHEMBL620569,4013,10116.0,Autocuration,1,,,22224,U,0,,
11144,,Oral bioavailability,,BAO_0000218,CHEMBL620570,17591,9347.0,Autocuration,1,,,22224,U,0,,
11145,,Oral bioavailability was determined; Not orally available,,BAO_0000218,CHEMBL620571,17591,,Autocuration,1,,,22224,U,0,,
11146,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,BAO_0000218,CHEMBL620572,15011,10090.0,Intermediate,1,,,50594,N,1,,
11147,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,BAO_0000218,CHEMBL620573,15011,10090.0,Autocuration,1,,,22224,U,0,,
11148,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,BAO_0000218,CHEMBL620574,15011,10090.0,Autocuration,1,,,22224,U,0,,
11149,,Oral bioavailability in Rhesus monkey,,BAO_0000218,CHEMBL620575,9552,9544.0,Autocuration,1,,,22224,U,0,,
11150,,Oral bioavailability in dog (female mongrel),,BAO_0000218,CHEMBL620576,9552,9615.0,Autocuration,1,,,22224,U,0,,
11151,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,BAO_0000218,CHEMBL875846,3639,,Autocuration,1,,,22224,U,0,,
11152,,Oral bioavailability in dog,,BAO_0000218,CHEMBL620577,13397,9615.0,Autocuration,1,,,22224,U,0,,
11153,,Percentage Bioavailability was evaluated.,,BAO_0000218,CHEMBL620578,3031,,Autocuration,1,,,22224,U,0,,
11154,,Bioavailability in rat administered i.d.,,BAO_0000218,CHEMBL620579,12818,10116.0,Autocuration,1,,,22224,U,0,,
11155,,Bioavailability,,BAO_0000218,CHEMBL621248,4847,9347.0,Autocuration,1,,,22224,U,0,,
11156,,Bioavailability in dog (male Beagle) i.v. administration,,BAO_0000218,CHEMBL625390,12421,9615.0,Autocuration,1,,,22224,U,0,,
11157,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,BAO_0000218,CHEMBL625391,11966,10116.0,Autocuration,1,,,22224,U,0,,
11158,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,BAO_0000218,CHEMBL872266,11218,9443.0,Autocuration,1,,,22224,U,0,,
11159,,Oral bioavailability in rat (Sprague-Dawley) (male),,BAO_0000218,CHEMBL625392,13129,10116.0,Autocuration,1,,,22224,U,0,,
11160,,The oral bioavailability was measured on rats after oral administration,,BAO_0000218,CHEMBL625393,12350,10116.0,Intermediate,1,,,50597,N,1,,
11161,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,BAO_0000218,CHEMBL625394,2231,10116.0,Intermediate,1,,,50597,N,1,,
11162,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,BAO_0000218,CHEMBL625395,2231,9544.0,Intermediate,1,,,50797,N,1,,
11163,,Bioavailability in rat (dose 10 mg/kg i.d.),,BAO_0000218,CHEMBL625396,12187,10116.0,Autocuration,1,,,22224,U,0,,
11164,,Bioavailability in dog (male Beagle) i.v. administration,,BAO_0000218,CHEMBL625397,12421,9615.0,Autocuration,1,,,22224,U,0,,
11165,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625398,13256,10090.0,Intermediate,1,,,50594,N,1,,
11166,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625399,13256,10090.0,Intermediate,1,,,50594,N,1,178.0,
11167,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL626074,13256,10090.0,Intermediate,1,,,50594,N,1,2037.0,
11168,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL626075,13256,10090.0,Intermediate,1,,,50594,N,1,,
11169,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,BAO_0000218,CHEMBL626076,2231,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11170,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,BAO_0000218,CHEMBL626077,2231,9544.0,Intermediate,1,,,50797,N,1,1969.0,
11171,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,BAO_0000218,CHEMBL626078,12178,10116.0,Intermediate,1,,,50597,N,1,178.0,
11172,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,BAO_0000218,CHEMBL625846,12178,,Autocuration,1,,,22224,U,0,178.0,
11173,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,BAO_0000218,CHEMBL625847,12178,,Autocuration,1,,,22224,U,0,178.0,
11174,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,BAO_0000218,CHEMBL625848,15633,10116.0,Expert,1,,,50597,N,1,,
11175,,Maximum concentration of compound in plasma administered orally to rats,,BAO_0000218,CHEMBL625849,14258,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11176,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,BAO_0000218,CHEMBL626023,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11177,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,BAO_0000218,CHEMBL626024,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11178,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,BAO_0000218,CHEMBL626025,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11179,,Maximum concentration after 10 mg/kg by oral administration,,BAO_0000218,CHEMBL626026,5566,,Autocuration,1,,,22224,U,0,,
11180,,Maximum concentration at a dose of 1.5 mg/kg,,BAO_0000218,CHEMBL626027,16935,,Autocuration,1,,,22224,U,0,,
11181,,Maximum concentration at a dose of 2.0 mg/kg,,BAO_0000218,CHEMBL626028,16935,,Autocuration,1,,,22224,U,0,,
11182,,Maximum concentration in dog plasma,,BAO_0000218,CHEMBL626029,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11183,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,BAO_0000218,CHEMBL626030,12536,,Autocuration,1,,,22224,U,0,1969.0,
11184,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,BAO_0000218,CHEMBL626031,12536,,Autocuration,1,,,22224,U,0,1969.0,
11185,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,BAO_0000218,CHEMBL626032,12536,,Autocuration,1,,,22224,U,0,1969.0,
11186,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,BAO_0000218,CHEMBL626033,12536,,Autocuration,1,,,22224,U,0,1969.0,
11187,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,BAO_0000218,CHEMBL626034,12536,,Autocuration,1,,,22224,U,0,1969.0,
11188,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,BAO_0000218,CHEMBL626035,9994,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11189,,Maximum concentration in plasma at Tmax,,BAO_0000218,CHEMBL626036,1434,,Autocuration,1,,,22224,U,0,1969.0,
11190,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,BAO_0000218,CHEMBL626037,12836,9615.0,Expert,1,,,50588,N,1,1969.0,
11191,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,BAO_0000218,CHEMBL626038,12836,10026.0,Intermediate,1,,,100712,N,1,1969.0,
11192,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,BAO_0000218,CHEMBL626039,12836,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11193,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,BAO_0000218,CHEMBL626040,12545,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11194,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,BAO_0000218,CHEMBL626041,13856,9986.0,Intermediate,1,,,50592,N,1,1969.0,
11195,,Maximum concentration was calculated,,BAO_0000218,CHEMBL626042,3550,,Autocuration,1,,,22224,U,0,,
11196,,Maximum concentration was calculated.,,BAO_0000218,CHEMBL626043,2632,,Autocuration,1,,,22224,U,0,,
11197,,Maximum concentration at a peroral dose of 10 mg/kg,,BAO_0000218,CHEMBL626044,5566,,Autocuration,1,,,22224,U,0,,
11198,,Maximum concentration of the drug at 10 uM/dg administered perorally,,BAO_0000218,CHEMBL626045,11883,,Autocuration,1,,,22224,U,0,,
11199,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,BAO_0000218,CHEMBL626046,11883,,Autocuration,1,,,22224,U,0,,
11200,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,BAO_0000218,CHEMBL626047,14122,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11201,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,BAO_0000218,CHEMBL626048,14122,10026.0,Intermediate,1,,,100712,N,1,1969.0,
11202,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,BAO_0000218,CHEMBL626049,14122,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11203,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,BAO_0000218,CHEMBL626050,12542,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11204,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,BAO_0000218,CHEMBL874541,12542,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11205,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,BAO_0000218,CHEMBL622826,12542,10026.0,Intermediate,1,,,100712,N,1,1969.0,
11206,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,BAO_0000218,CHEMBL622827,12542,10026.0,Intermediate,1,,,100712,N,1,1969.0,
11207,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,BAO_0000218,CHEMBL622828,12542,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11208,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,BAO_0000218,CHEMBL622829,14080,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11209,,Maximum concentration reached following intravenous administration in male rat,,BAO_0000218,CHEMBL876806,11911,10116.0,Intermediate,1,,,50597,N,1,,
11210,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,BAO_0000218,CHEMBL622830,13204,9615.0,Intermediate,1,,,50588,N,1,,
11211,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,BAO_0000218,CHEMBL622831,13204,10116.0,Intermediate,1,,,50597,N,1,,
11212,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,BAO_0000218,CHEMBL626794,14346,9615.0,Intermediate,1,,,50588,N,1,,
11213,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL626795,14346,10116.0,Intermediate,1,,,50597,N,1,,
11214,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL626796,14346,10116.0,Intermediate,1,,,50597,N,1,,
11215,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL626797,14346,10116.0,Intermediate,1,,,50597,N,1,,
11216,,Maximum drug concentration is determined after oral dosing in rats.,,BAO_0000218,CHEMBL626798,14127,10116.0,Intermediate,1,,,50597,N,1,,
11217,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,BAO_0000218,CHEMBL626799,14339,9615.0,Intermediate,1,,,50588,N,1,,
11218,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,BAO_0000218,CHEMBL626800,14339,9615.0,Intermediate,1,,,50588,N,1,,
11219,,Maximum plasma concentration,,BAO_0000218,CHEMBL626801,13494,,Autocuration,1,,,22224,U,0,1969.0,
11220,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,BAO_0000218,CHEMBL876816,14925,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11221,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,BAO_0000218,CHEMBL626802,14474,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11222,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,BAO_0000218,CHEMBL626803,14474,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11223,,Maximum plasma concentration following oral administration of 30 umol/kg,,BAO_0000218,CHEMBL626804,13917,,Autocuration,1,,,22224,U,0,1969.0,
11224,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,BAO_0000218,CHEMBL626805,9796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11225,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626309,9796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11226,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626310,9796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11227,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626311,9796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11228,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626312,9796,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11229,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626313,9796,10116.0,Intermediate,1,,,50597,N,1,995.0,
11230,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626314,9796,10116.0,Intermediate,1,,,50597,N,1,995.0,
11231,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626315,9796,10116.0,Intermediate,1,,,50597,N,1,995.0,
11232,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626316,9796,10116.0,Intermediate,1,,,50597,N,1,995.0,
11233,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,BAO_0000218,CHEMBL626317,9796,10116.0,Intermediate,1,,,50597,N,1,995.0,
11234,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,CHEMBL626318,8363,10116.0,Intermediate,1,,,50597,N,1,,
11235,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,CHEMBL626319,8363,10116.0,Intermediate,1,,,50597,N,1,,
11236,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,CHEMBL626320,8363,10116.0,Intermediate,1,,,50597,N,1,,
11237,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,CHEMBL875053,8363,10116.0,Intermediate,1,,,50597,N,1,,
11238,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,CHEMBL626321,8363,10116.0,Intermediate,1,,,50597,N,1,,
11239,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,CHEMBL626322,8363,10116.0,Intermediate,1,,,50597,N,1,,
11240,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,CHEMBL626323,8363,10116.0,Intermediate,1,,,50597,N,1,,
11241,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,CHEMBL626324,8363,10116.0,Intermediate,1,,,50597,N,1,,
11242,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,CHEMBL626325,8363,10116.0,Intermediate,1,,,50597,N,1,,
11243,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,CHEMBL626326,8363,10116.0,Intermediate,1,,,50597,N,1,,
11244,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,BAO_0000218,CHEMBL626327,8363,10116.0,Intermediate,1,,,50597,N,1,,
11245,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,BAO_0000218,CHEMBL626328,8363,10116.0,Intermediate,1,,,50597,N,1,,
11246,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626329,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11247,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626330,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11248,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626331,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11249,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626332,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11250,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626333,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11251,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626334,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11252,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL626335,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11253,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624798,8684,10116.0,Intermediate,1,,,50597,N,1,178.0,
11254,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624799,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11255,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624800,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11256,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624801,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11257,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624802,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11258,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624803,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11259,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624804,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11260,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624805,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11261,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,BAO_0000218,CHEMBL624806,8684,10116.0,Intermediate,1,,,50597,N,1,955.0,
11262,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624807,8684,10116.0,Intermediate,1,,,50597,N,1,,
11263,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624808,8684,10116.0,Intermediate,1,,,50597,N,1,,
11264,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624809,8684,10116.0,Intermediate,1,,,50597,N,1,,
11265,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624810,8684,10116.0,Intermediate,1,,,50597,N,1,,
11266,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL877618,8684,10116.0,Intermediate,1,,,50597,N,1,,
11267,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624811,8684,10116.0,Intermediate,1,,,50597,N,1,,
11268,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624812,8684,10116.0,Intermediate,1,,,50597,N,1,,
11269,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624813,8684,10116.0,Intermediate,1,,,50597,N,1,,
11270,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624814,8684,10116.0,Intermediate,1,,,50597,N,1,,
11271,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624815,8684,10116.0,Intermediate,1,,,50597,N,1,,
11272,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624816,8684,10116.0,Intermediate,1,,,50597,N,1,,
11273,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624817,8684,10116.0,Intermediate,1,,,50597,N,1,,
11274,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL624818,6996,9615.0,Intermediate,1,,,50588,N,1,,
11275,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,BAO_0000218,CHEMBL624819,6996,9615.0,Intermediate,1,,,50588,N,1,,
11276,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL624820,6996,9615.0,Intermediate,1,,,50588,N,1,,
11277,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL624821,6996,9615.0,Intermediate,1,,,50588,N,1,,
11278,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,CHEMBL624822,6996,9615.0,Intermediate,1,,,50588,N,1,,
11279,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL624823,6996,9615.0,Intermediate,1,,,50588,N,1,,
11280,,Observed diffusion coefficient in organic solvent for Escherichia coli,,BAO_0000218,CHEMBL624824,15599,562.0,Intermediate,1,,,50212,N,1,,
11281,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL624825,9614,10116.0,Intermediate,1,,,50597,N,1,178.0,
11282,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624826,9614,10116.0,Intermediate,1,,,50597,N,1,178.0,
11283,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL876817,9614,10116.0,Intermediate,1,,,50597,N,1,2081.0,
11284,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624827,9614,10116.0,Intermediate,1,,,50597,N,1,2081.0,
11285,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL624828,9614,10116.0,Intermediate,1,,,50597,N,1,,
11286,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624829,9614,10116.0,Intermediate,1,,,50597,N,1,,
11287,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL624830,9614,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11288,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624831,9614,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11289,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL624832,9614,10116.0,Intermediate,1,,,50597,N,1,2081.0,
11290,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624833,9614,10116.0,Intermediate,1,,,50597,N,1,2081.0,
11291,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624834,9614,10116.0,Intermediate,1,,,50597,N,1,,
11292,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL624835,9614,10116.0,Intermediate,1,,,50597,N,1,,
11293,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,BAO_0000218,CHEMBL624836,9614,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11294,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,BAO_0000218,CHEMBL624837,9614,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11295,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL624838,9071,10116.0,Intermediate,1,,,50597,N,1,178.0,
11296,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,BAO_0000218,CHEMBL622188,9071,10116.0,Intermediate,1,,,50597,N,1,178.0,
11297,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL622189,9071,10116.0,Intermediate,1,,,50597,N,1,948.0,
11298,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,BAO_0000218,CHEMBL622190,9071,10116.0,Intermediate,1,,,50597,N,1,948.0,
11299,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,BAO_0000218,CHEMBL625170,9071,10116.0,Intermediate,1,,,50597,N,1,948.0,
11300,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL625171,9071,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11301,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL625172,9071,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11302,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,BAO_0000218,CHEMBL625173,9071,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11303,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL625174,9071,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11304,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,BAO_0000218,CHEMBL625175,9071,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11305,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,BAO_0000218,CHEMBL625176,9071,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11306,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL625177,9071,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11307,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,BAO_0000218,CHEMBL625178,9071,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11308,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,BAO_0000218,CHEMBL625179,9071,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11309,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,BAO_0000218,CHEMBL625180,9071,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11310,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,BAO_0000218,CHEMBL625181,10677,,Autocuration,1,,,22224,U,0,,
11311,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,BAO_0000218,CHEMBL625182,9750,10090.0,Intermediate,1,,,50594,N,1,1088.0,
11312,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL625183,8319,10116.0,Intermediate,1,,,50597,N,1,,
11313,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL875848,8319,10116.0,Intermediate,1,,,50597,N,1,,
11314,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL622260,8319,10116.0,Intermediate,1,,,50597,N,1,,
11315,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL622261,8319,10116.0,Intermediate,1,,,50597,N,1,,
11316,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL622262,8319,10116.0,Intermediate,1,,,50597,N,1,,
11317,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL622263,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11318,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL622418,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11319,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL622419,8319,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11320,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623388,13256,10090.0,Intermediate,1,,,50594,N,1,,
11321,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623389,13256,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11322,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623390,13256,10090.0,Intermediate,1,,,50594,N,1,,
11323,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623391,13256,10090.0,Intermediate,1,,,50594,N,1,,
11324,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623392,13256,10090.0,Intermediate,1,,,50594,N,1,178.0,
11325,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623393,13256,10090.0,Intermediate,1,,,50594,N,1,2037.0,
11326,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL623394,13256,10090.0,Intermediate,1,,,50594,N,1,,
11327,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL618885,13256,10090.0,Intermediate,1,,,50594,N,1,,
11328,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL618886,13256,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11329,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL618887,13256,10090.0,Intermediate,1,,,50594,N,1,,
11330,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619535,13256,10090.0,Intermediate,1,,,50594,N,1,,
11331,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619536,13256,10090.0,Intermediate,1,,,50594,N,1,178.0,
11332,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619537,13256,10090.0,Intermediate,1,,,50594,N,1,2037.0,
11333,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619705,13256,10090.0,Intermediate,1,,,50594,N,1,,
11334,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619706,13256,10090.0,Intermediate,1,,,50594,N,1,,
11335,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619707,13256,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11336,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL619708,13256,10090.0,Intermediate,1,,,50594,N,1,,
11337,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625219,13256,10090.0,Intermediate,1,,,50594,N,1,,
11338,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625220,13256,10090.0,Intermediate,1,,,50594,N,1,178.0,
11339,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625221,13256,10090.0,Intermediate,1,,,50594,N,1,2037.0,
11340,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625222,13256,10090.0,Intermediate,1,,,50594,N,1,,
11341,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625223,13256,10090.0,Intermediate,1,,,50594,N,1,,
11342,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625224,13256,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11343,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,BAO_0000218,CHEMBL625225,13256,10090.0,Intermediate,1,,,50594,N,1,,
11344,,Biodistribution in Rat blood after 24 hours of iv administration,,BAO_0000218,CHEMBL625226,8829,10116.0,Intermediate,1,,,50597,N,1,178.0,
11345,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,BAO_0000218,CHEMBL625227,8829,10116.0,Intermediate,1,,,50597,N,1,178.0,
11346,,Biodistribution in Rat blood after 30 minutes of iv administration,,BAO_0000218,CHEMBL625228,8829,10116.0,Intermediate,1,,,50597,N,1,178.0,
11347,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL875354,8829,10116.0,Intermediate,1,,,50597,N,1,178.0,
11348,,Biodistribution in Rat blood after 5 minutes of iv administration,,BAO_0000218,CHEMBL625229,8829,10116.0,Intermediate,1,,,50597,N,1,178.0,
11349,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL625230,8829,10116.0,Intermediate,1,,,50597,N,1,178.0,
11350,,Biodistribution in Rat heart after 24 hours of iv administration,,BAO_0000218,CHEMBL625231,8829,10116.0,Intermediate,1,,,50597,N,1,948.0,
11351,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,BAO_0000218,CHEMBL625900,8829,10116.0,Intermediate,1,,,50597,N,1,948.0,
11352,,Biodistribution in Rat heart after 30 minutes of iv administration,,BAO_0000218,CHEMBL625901,8829,10116.0,Intermediate,1,,,50597,N,1,948.0,
11353,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL625902,8829,10116.0,Intermediate,1,,,50597,N,1,948.0,
11354,,Biodistribution in Rat heart after 5 minutes of iv administration,,BAO_0000218,CHEMBL625903,8829,10116.0,Intermediate,1,,,50597,N,1,948.0,
11355,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL625904,8829,10116.0,Intermediate,1,,,50597,N,1,948.0,
11356,,Biodistribution in Rat liver after 24 hours of iv administration,,BAO_0000218,CHEMBL625905,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11357,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,BAO_0000218,CHEMBL627861,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11358,,Biodistribution in Rat liver after 30 minutes of iv administration,,BAO_0000218,CHEMBL627862,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11359,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL627863,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11360,,Biodistribution in Rat liver after 30 minutes of iv administration,,BAO_0000218,CHEMBL627769,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11361,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,BAO_0000218,CHEMBL627770,13249,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11362,,Cmax in cynomolgus monkey (PO dose),,BAO_0000218,CHEMBL627771,13622,9541.0,Intermediate,1,,,100710,N,1,,
11363,,Cmax in rat (PO dose),,BAO_0000218,CHEMBL627772,13622,10116.0,Intermediate,1,,,50597,N,1,,
11364,,Cmax in rat (PO dose),,BAO_0000218,CHEMBL627773,13622,10116.0,Intermediate,1,,,50597,N,1,,
11365,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,BAO_0000218,CHEMBL621922,13494,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11366,,Cmax in rat plasma after oral dose (10 mg/kg),,BAO_0000218,CHEMBL621923,12170,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11367,,Cmax in plasma after oral dose (10 mg/kg),,BAO_0000218,CHEMBL621924,12170,,Autocuration,1,,,22224,U,0,1969.0,
11368,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,BAO_0000218,CHEMBL621925,17025,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11369,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,BAO_0000218,CHEMBL621926,17025,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11370,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,BAO_0000218,CHEMBL621927,17025,9986.0,Intermediate,1,,,50592,N,1,1969.0,
11371,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,BAO_0000218,CHEMBL621928,17025,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11372,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,BAO_0000218,CHEMBL621929,14187,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11373,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,BAO_0000218,CHEMBL621930,14816,10090.0,Intermediate,1,,,50594,N,1,1969.0,
11374,,Maximum plasma concentration after oral dosing in rat,,BAO_0000218,CHEMBL621931,17820,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11375,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621932,14380,,Autocuration,1,,,22224,U,0,1969.0,
11376,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621933,14380,,Autocuration,1,,,22224,U,0,1969.0,
11377,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,BAO_0000218,CHEMBL621934,14691,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11378,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,BAO_0000218,CHEMBL621935,14691,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11379,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,BAO_0000218,CHEMBL621936,13375,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11380,,Maximum plasma concentration was determined,,BAO_0000218,CHEMBL621937,6236,,Autocuration,1,,,22224,U,0,1969.0,
11381,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621938,14380,,Autocuration,1,,,22224,U,0,1969.0,
11382,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621939,14380,,Autocuration,1,,,22224,U,0,1969.0,
11383,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621940,14380,,Autocuration,1,,,22224,U,0,1969.0,
11384,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621941,14380,,Autocuration,1,,,22224,U,0,1969.0,
11385,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL621942,14380,,Autocuration,1,,,22224,U,0,1969.0,
11386,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL626178,14380,,Autocuration,1,,,22224,U,0,1969.0,
11387,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL626179,14380,,Autocuration,1,,,22224,U,0,1969.0,
11388,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL626180,14380,,Autocuration,1,,,22224,U,0,1969.0,
11389,,Plasma Cmax in rat (PO dose),,BAO_0000218,CHEMBL626181,13622,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11390,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,BAO_0000218,CHEMBL626182,15372,10116.0,Intermediate,1,,,50597,N,1,,
11391,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,BAO_0000218,CHEMBL626183,15372,10116.0,Intermediate,1,,,50597,N,1,,
11392,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,BAO_0000218,CHEMBL626184,15372,10116.0,Intermediate,1,,,50597,N,1,,
11393,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,BAO_0000218,CHEMBL626185,15372,10116.0,Intermediate,1,,,50597,N,1,,
11394,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,BAO_0000218,CHEMBL626186,14925,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11395,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,BAO_0000218,CHEMBL877589,14925,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11396,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,BAO_0000218,CHEMBL626187,11883,,Autocuration,1,,,22224,U,0,,
11397,,Maximum concentration of the drug at 20 uM/dg administered perorally,,BAO_0000218,CHEMBL626188,11883,,Autocuration,1,,,22224,U,0,,
11398,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,BAO_0000218,CHEMBL626189,13391,,Autocuration,1,,,22224,U,0,,
11399,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,CHEMBL626855,13391,,Autocuration,1,,,22224,U,0,178.0,
11400,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,CHEMBL623781,13391,,Autocuration,1,,,22224,U,0,178.0,
11401,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,CHEMBL623782,13391,,Autocuration,1,,,22224,U,0,178.0,
11402,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,BAO_0000218,CHEMBL623783,16360,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11403,,Cmax in dog plasma after 1mg/kg oral dose,,BAO_0000218,CHEMBL623784,3673,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11404,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,BAO_0000218,CHEMBL623785,14431,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11405,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,BAO_0000218,CHEMBL623786,14431,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11406,,Oral maximum concentration in rat,,BAO_0000218,CHEMBL623787,14964,10116.0,Intermediate,1,,,50597,N,1,,
11407,,Oral maximum concentration in rat,,BAO_0000218,CHEMBL623788,14964,10116.0,Intermediate,1,,,50597,N,1,,
11408,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,BAO_0000218,CHEMBL623789,14209,10090.0,Intermediate,1,,,50594,N,1,1969.0,
11409,,Peak concentration in blood after intravenous administration to mice,,BAO_0000218,CHEMBL623790,11355,10090.0,Intermediate,1,,,50594,N,1,178.0,
11410,,Peak concentration in blood after peroral administration to mice,,BAO_0000218,CHEMBL623791,11355,10090.0,Intermediate,1,,,50594,N,1,178.0,
11411,,Peak concentration in rat plasma was determined,,BAO_0000218,CHEMBL623792,11966,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11412,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,BAO_0000218,CHEMBL623793,8918,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11413,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,BAO_0000218,CHEMBL623794,8918,10090.0,Intermediate,1,,,50594,N,1,1969.0,
11414,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,BAO_0000218,CHEMBL623795,8918,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11415,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623796,8684,10116.0,Intermediate,1,,,50597,N,1,,
11416,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623797,8684,10116.0,Intermediate,1,,,50597,N,1,,
11417,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623798,8684,10116.0,Intermediate,1,,,50597,N,1,,
11418,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623799,8684,10116.0,Intermediate,1,,,50597,N,1,,
11419,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624490,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11420,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624491,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11421,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624492,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11422,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624493,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11423,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL877595,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11424,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624494,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11425,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624495,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11426,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624681,8684,10116.0,Intermediate,1,,,50597,N,1,160.0,
11427,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624682,8684,10116.0,Intermediate,1,,,50597,N,1,,
11428,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624683,8684,10116.0,Intermediate,1,,,50597,N,1,,
11429,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624684,8684,10116.0,Intermediate,1,,,50597,N,1,,
11430,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624685,8684,10116.0,Intermediate,1,,,50597,N,1,,
11431,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624686,8684,10116.0,Intermediate,1,,,50597,N,1,,
11432,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624687,8684,10116.0,Intermediate,1,,,50597,N,1,,
11433,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624688,8684,10116.0,Intermediate,1,,,50597,N,1,,
11434,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL627161,8684,10116.0,Intermediate,1,,,50597,N,1,,
11435,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL622127,8684,10116.0,Intermediate,1,,,50597,N,1,,
11436,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL622128,8684,10116.0,Intermediate,1,,,50597,N,1,,
11437,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL874384,8684,10116.0,Intermediate,1,,,50597,N,1,,
11438,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624898,8684,10116.0,Intermediate,1,,,50597,N,1,,
11439,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624899,8684,10116.0,Intermediate,1,,,50597,N,1,,
11440,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624900,8684,10116.0,Intermediate,1,,,50597,N,1,,
11441,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624901,8684,10116.0,Intermediate,1,,,50597,N,1,,
11442,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624902,8684,10116.0,Intermediate,1,,,50597,N,1,,
11443,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624903,8684,10116.0,Intermediate,1,,,50597,N,1,,
11444,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624904,8684,10116.0,Intermediate,1,,,50597,N,1,,
11445,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624905,8684,10116.0,Intermediate,1,,,50597,N,1,,
11446,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624906,8684,10116.0,Intermediate,1,,,50597,N,1,,
11447,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624907,8684,10116.0,Intermediate,1,,,50597,N,1,,
11448,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624908,8684,10116.0,Intermediate,1,,,50597,N,1,,
11449,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624909,8684,10116.0,Intermediate,1,,,50597,N,1,,
11450,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624910,8684,10116.0,Intermediate,1,,,50597,N,1,,
11451,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624911,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11452,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL874388,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11453,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL624912,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11454,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL622930,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11455,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623121,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11456,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623122,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11457,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623123,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11458,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623124,8684,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11459,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623125,8684,10116.0,Intermediate,1,,,50597,N,1,,
11460,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623126,8684,10116.0,Intermediate,1,,,50597,N,1,,
11461,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623127,8684,10116.0,Intermediate,1,,,50597,N,1,,
11462,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623128,8684,10116.0,Intermediate,1,,,50597,N,1,,
11463,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623129,8684,10116.0,Intermediate,1,,,50597,N,1,,
11464,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623130,8684,10116.0,Intermediate,1,,,50597,N,1,,
11465,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623131,8684,10116.0,Intermediate,1,,,50597,N,1,,
11466,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL623132,8684,10116.0,Intermediate,1,,,50597,N,1,,
11467,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623133,8319,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11468,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623134,8319,10116.0,Intermediate,1,,,50597,N,1,,
11469,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL874389,8319,10116.0,Intermediate,1,,,50597,N,1,,
11470,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL623135,8319,10116.0,Intermediate,1,,,50597,N,1,,
11471,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623136,8319,10116.0,Intermediate,1,,,50597,N,1,,
11472,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL623137,8319,10116.0,Intermediate,1,,,50597,N,1,,
11473,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623138,8319,10116.0,Intermediate,1,,,50597,N,1,,
11474,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL623139,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11475,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623140,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11476,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL623141,8319,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11477,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623142,8319,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11478,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL623143,8319,10116.0,Intermediate,1,,,50597,N,1,,
11479,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,BAO_0000218,CHEMBL623144,14571,10090.0,Intermediate,1,,,50594,N,1,1088.0,
11480,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,BAO_0000218,CHEMBL623405,14571,10116.0,Intermediate,1,,,50597,N,1,1088.0,
11481,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624074,8319,10116.0,Intermediate,1,,,50597,N,1,,
11482,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624075,8319,10116.0,Intermediate,1,,,50597,N,1,,
11483,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624076,8319,10116.0,Intermediate,1,,,50597,N,1,,
11484,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624077,8319,10116.0,Intermediate,1,,,50597,N,1,,
11485,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624078,8319,10116.0,Intermediate,1,,,50597,N,1,,
11486,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624079,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11487,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624261,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11488,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624262,8319,10116.0,Intermediate,1,,,50597,N,1,,
11489,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624263,8319,10116.0,Intermediate,1,,,50597,N,1,,
11490,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624264,8319,10116.0,Intermediate,1,,,50597,N,1,,
11491,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624265,8319,10116.0,Intermediate,1,,,50597,N,1,,
11492,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624266,8319,10116.0,Intermediate,1,,,50597,N,1,,
11493,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624267,8319,10116.0,Intermediate,1,,,50597,N,1,,
11494,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624268,8319,10116.0,Intermediate,1,,,50597,N,1,,
11495,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL875227,8319,10116.0,Intermediate,1,,,50597,N,1,,
11496,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624269,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11497,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624270,8319,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11498,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,BAO_0000218,CHEMBL624271,8319,10116.0,Intermediate,1,,,50597,N,1,,
11499,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624272,8319,10116.0,Intermediate,1,,,50597,N,1,,
11500,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,BAO_0000218,CHEMBL624273,8319,10116.0,Intermediate,1,,,50597,N,1,,
11501,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,BAO_0000218,CHEMBL624274,12064,10116.0,Intermediate,1,,,50597,N,1,1088.0,
11502,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,BAO_0000218,CHEMBL624275,12064,10116.0,Intermediate,1,,,50597,N,1,1088.0,
11503,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,BAO_0000218,CHEMBL624276,12064,10116.0,Intermediate,1,,,50597,N,1,1088.0,
11504,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,BAO_0000218,CHEMBL624277,12038,10116.0,Intermediate,1,,,50597,N,1,1088.0,
11505,,% dose converted to 2-amino-5-chlorophenyl sulfate,,BAO_0000019,CHEMBL624278,14314,,Autocuration,1,,,22224,U,0,,
11506,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,BAO_0000019,CHEMBL624279,14314,,Autocuration,1,,,22224,U,0,,
11507,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,CHEMBL624280,11488,10116.0,Intermediate,1,,,50597,N,1,1988.0,
11508,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,CHEMBL624281,11488,10116.0,Intermediate,1,,,50597,N,1,1988.0,
11509,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,CHEMBL622933,11488,10116.0,Intermediate,1,,,50597,N,1,1988.0,
11510,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,CHEMBL622934,11488,10116.0,Intermediate,1,,,50597,N,1,1988.0,
11511,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL622935,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11512,,Biodistribution in Rat liver after 5 minutes of iv administration,,BAO_0000218,CHEMBL622936,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11513,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL875228,8829,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11514,,Biodistribution in Rat lung after 24 hours of iv administration,,BAO_0000218,CHEMBL622937,8829,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11515,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,BAO_0000218,CHEMBL622938,8829,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11516,,Biodistribution in Rat lung after 30 minutes of iv administration,,BAO_0000218,CHEMBL619736,8829,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11517,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL625117,8829,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11518,,Biodistribution in Rat lung after 5 minutes of iv administration,,BAO_0000218,CHEMBL625118,8829,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11519,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,BAO_0000218,CHEMBL625119,8829,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11520,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,BAO_0000218,CHEMBL625120,14972,10116.0,Intermediate,1,,,50597,N,1,2037.0,
11521,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,BAO_0000218,CHEMBL625121,14972,10116.0,Intermediate,1,,,50597,N,1,,
11522,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,BAO_0000218,CHEMBL625122,14972,10116.0,Intermediate,1,,,50597,N,1,10000006.0,
11523,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL622204,14608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11524,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL877503,14608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11525,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL627127,14608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11526,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL627128,14608,,Autocuration,1,,,22224,U,0,10000000.0,
11527,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL627129,14608,,Autocuration,1,,,22224,U,0,10000000.0,
11528,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL627130,14608,,Autocuration,1,,,22224,U,0,10000000.0,
11529,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL627131,14608,10116.0,Intermediate,1,,,50597,N,1,955.0,
11530,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL627132,14608,10116.0,Intermediate,1,,,50597,N,1,955.0,
11531,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL627133,14608,10116.0,Intermediate,1,,,50597,N,1,955.0,
11532,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL627134,14608,10116.0,Intermediate,1,,,50597,N,1,2037.0,
11533,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL627135,14608,10116.0,Intermediate,1,,,50597,N,1,2037.0,
11534,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL627136,14608,10116.0,Intermediate,1,,,50597,N,1,2037.0,
11535,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL628435,14608,10116.0,Intermediate,1,,,50597,N,1,,
11536,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL628436,14608,10116.0,Intermediate,1,,,50597,N,1,,
11537,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL628437,14608,10116.0,Intermediate,1,,,50597,N,1,,
11538,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL628438,14608,10116.0,Intermediate,1,,,50597,N,1,948.0,
11539,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL628439,14608,10116.0,Intermediate,1,,,50597,N,1,948.0,
11540,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL628440,14608,10116.0,Intermediate,1,,,50597,N,1,948.0,
11541,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL628441,14608,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
11542,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL628442,14608,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
11543,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL628443,14608,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
11544,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL628444,14608,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11545,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL628445,14608,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11546,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL877504,14608,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11547,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL628446,14608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11548,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL626874,14608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11549,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL626875,14608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11550,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL626876,14608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11551,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL626877,14608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11552,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL626878,14608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11553,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL626879,14608,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11554,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,BAO_0000218,CHEMBL626880,8918,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11555,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,BAO_0000218,CHEMBL626881,8918,10090.0,Intermediate,1,,,50594,N,1,1969.0,
11556,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,BAO_0000218,CHEMBL626882,8918,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11557,,Peak plasma concentration was measured in dogs,,BAO_0000218,CHEMBL626883,14470,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11558,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,CHEMBL626884,14393,10116.0,Intermediate,1,,,50597,N,1,,
11559,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,BAO_0000218,CHEMBL626885,14886,10116.0,Intermediate,1,,,50597,N,1,,
11560,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,BAO_0000218,CHEMBL626886,14886,10116.0,Intermediate,1,,,50597,N,1,,
11561,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,BAO_0000218,CHEMBL626887,14886,10116.0,Intermediate,1,,,50597,N,1,,
11562,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,CHEMBL626888,14393,10116.0,Intermediate,1,,,50597,N,1,,
11563,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,BAO_0000218,CHEMBL626889,13465,9615.0,Intermediate,1,,,50588,N,1,,
11564,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,BAO_0000218,CHEMBL626761,13465,314293.0,Autocuration,1,,,22224,U,0,,
11565,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,BAO_0000218,CHEMBL626762,13465,9615.0,Intermediate,1,,,50588,N,1,,
11566,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,BAO_0000218,CHEMBL626763,13465,9615.0,Intermediate,1,,,50588,N,1,,
11567,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,BAO_0000218,CHEMBL626764,13465,10116.0,Intermediate,1,,,50597,N,1,,
11568,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,BAO_0000218,CHEMBL626765,13465,10116.0,Intermediate,1,,,50597,N,1,,
11569,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,BAO_0000218,CHEMBL626766,13465,9615.0,Intermediate,1,,,50588,N,1,,
11570,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,BAO_0000218,CHEMBL626767,13465,10116.0,Intermediate,1,,,50597,N,1,,
11571,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,BAO_0000218,CHEMBL626768,13465,10116.0,Intermediate,1,,,50597,N,1,,
11572,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,BAO_0000218,CHEMBL626769,13465,9615.0,Intermediate,1,,,50588,N,1,,
11573,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,BAO_0000218,CHEMBL874463,13465,9615.0,Intermediate,1,,,50588,N,1,,
11574,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,BAO_0000218,CHEMBL626770,13465,314293.0,Autocuration,1,,,22224,U,0,,
11575,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,BAO_0000218,CHEMBL626771,13465,314293.0,Autocuration,1,,,22224,U,0,,
11576,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,BAO_0000218,CHEMBL626772,13465,10116.0,Intermediate,1,,,50597,N,1,,
11577,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,BAO_0000218,CHEMBL626773,14731,9541.0,Intermediate,1,,,100710,N,1,,
11578,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,BAO_0000218,CHEMBL626774,14731,10090.0,Intermediate,1,,,50594,N,1,,
11579,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,BAO_0000218,CHEMBL626775,13376,9615.0,Intermediate,1,,,50588,N,1,,
11580,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,BAO_0000218,CHEMBL626776,13376,9615.0,Intermediate,1,,,50588,N,1,,
11581,,Maximum concentration (Cmax) in rat when administered orally,,BAO_0000218,CHEMBL626777,14443,10116.0,Intermediate,1,,,50597,N,1,,
11582,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,BAO_0000218,CHEMBL626778,13465,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11583,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,BAO_0000218,CHEMBL626779,16359,10116.0,Autocuration,1,,,22224,U,0,,
11584,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,BAO_0000218,CHEMBL626780,16359,10116.0,Autocuration,1,,,22224,U,0,,
11585,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,BAO_0000218,CHEMBL626781,15618,,Autocuration,1,,,22224,U,0,1969.0,
11586,,Pharmacokinetic profile Cmax was evaluated in rats,,BAO_0000218,CHEMBL632164,14554,10116.0,Intermediate,1,,,50597,N,1,,
11587,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,BAO_0000218,CHEMBL632165,11537,9615.0,Intermediate,1,,,50588,N,1,,
11588,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,BAO_0000218,CHEMBL632166,11537,10090.0,Intermediate,1,,,50594,N,1,,
11589,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,BAO_0000218,CHEMBL632167,11537,9615.0,Intermediate,1,,,50588,N,1,,
11590,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,BAO_0000218,CHEMBL632168,11537,10090.0,Intermediate,1,,,50594,N,1,,
11591,,Cmax in rat plasma,,BAO_0000218,CHEMBL632169,2021,10116.0,Autocuration,1,,,22224,U,0,1969.0,
11592,,Cmax in dog plasma after 30mg/kg oral dose,,BAO_0000218,CHEMBL632170,5932,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11593,,Cmax in rat plasma after 30mg/kg oral dose,,BAO_0000218,CHEMBL632171,5932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11594,,Plasma level in rats at 30 mg/kg,,BAO_0000218,CHEMBL632172,17320,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11595,,Tested for maximum plasma concentration in mice,,BAO_0000218,CHEMBL632173,15831,10090.0,Intermediate,1,,,50594,N,1,1969.0,
11596,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL632174,15078,10116.0,Intermediate,1,,,50597,N,1,,
11597,,The Cmax values in female wistar rats.,,BAO_0000218,CHEMBL632175,14941,10116.0,Intermediate,1,,,50597,N,1,,
11598,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,BAO_0000218,CHEMBL632176,15343,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11599,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,BAO_0000218,CHEMBL632177,15343,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11600,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,BAO_0000218,CHEMBL632178,14856,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11601,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,BAO_0000218,CHEMBL632179,13129,10116.0,Intermediate,1,,,50597,N,1,,
11602,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,BAO_0000218,CHEMBL632180,13098,10116.0,Intermediate,1,,,50597,N,1,178.0,
11603,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,BAO_0000218,CHEMBL632181,13098,10116.0,Intermediate,1,,,50597,N,1,178.0,
11604,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,BAO_0000218,CHEMBL632182,13098,10116.0,Intermediate,1,,,50597,N,1,178.0,
11605,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,BAO_0000218,CHEMBL632183,15478,10090.0,Autocuration,1,,,22224,U,0,178.0,
11606,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,BAO_0000218,CHEMBL632184,15341,9615.0,Intermediate,1,,,50588,N,1,,
11607,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,BAO_0000218,CHEMBL874470,15341,10116.0,Intermediate,1,,,50597,N,1,,
11608,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631302,8684,10116.0,Intermediate,1,,,50597,N,1,,
11609,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631303,8684,10116.0,Intermediate,1,,,50597,N,1,,
11610,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631304,8684,10116.0,Intermediate,1,,,50597,N,1,,
11611,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631305,8684,10116.0,Intermediate,1,,,50597,N,1,,
11612,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631306,8684,10116.0,Intermediate,1,,,50597,N,1,,
11613,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631307,8684,10116.0,Intermediate,1,,,50597,N,1,,
11614,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL631308,8684,10116.0,Intermediate,1,,,50597,N,1,,
11615,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625557,8684,10116.0,Intermediate,1,,,50597,N,1,,
11616,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625558,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11617,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625559,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11618,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625560,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11619,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625561,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11620,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625562,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11621,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL875320,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11622,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625563,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11623,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625564,8684,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11624,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625565,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11625,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625566,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11626,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625567,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11627,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL625568,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11628,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL628217,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11629,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL628218,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11630,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL628219,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11631,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,BAO_0000218,CHEMBL628220,8684,10116.0,Intermediate,1,,,50597,N,1,995.0,
11632,,Distribution in the blood after 120 min of intravenous administration,,BAO_0000019,CHEMBL628221,8926,,Autocuration,1,,,22224,U,0,,
11633,,Distribution in the blood after 15 min of intravenous administration,,BAO_0000019,CHEMBL628222,8926,,Autocuration,1,,,22224,U,0,,
11634,,Distribution in the blood after 30 min of intravenous administration,,BAO_0000019,CHEMBL628223,8926,,Autocuration,1,,,22224,U,0,,
11635,,Distribution in the blood after 5 min of intravenous administration,,BAO_0000019,CHEMBL628224,8926,,Autocuration,1,,,22224,U,0,,
11636,,Distribution in the blood after 60 min of intravenous administration,,BAO_0000019,CHEMBL628225,8926,,Autocuration,1,,,22224,U,0,,
11637,,Distribution in the blood after 90 min of intravenous administration,,BAO_0000019,CHEMBL628226,8926,,Autocuration,1,,,22224,U,0,,
11638,,Distribution in the bone after 120 min of intravenous administration,,BAO_0000019,CHEMBL628227,8926,,Autocuration,1,,,22224,U,0,,
11639,,Distribution in the bone after 15 min of intravenous administration,,BAO_0000019,CHEMBL875481,8926,,Autocuration,1,,,22224,U,0,,
11640,,Distribution in the bone after 30 min of intravenous administration,,BAO_0000019,CHEMBL628228,8926,,Autocuration,1,,,22224,U,0,,
11641,,Distribution in the bone after 5 min of intravenous administration,,BAO_0000019,CHEMBL628229,8926,,Autocuration,1,,,22224,U,0,,
11642,,Distribution in the bone after 60 min of intravenous administration,,BAO_0000019,CHEMBL628230,8926,,Autocuration,1,,,22224,U,0,,
11643,,Distribution in the bone after 90 min of intravenous administration,,BAO_0000019,CHEMBL628231,8926,,Autocuration,1,,,22224,U,0,,
11644,,Distribution in the heart after 120 min of intravenous administration,,BAO_0000019,CHEMBL628232,8926,,Autocuration,1,,,22224,U,0,,
11645,,Distribution in the heart after 15 min of intravenous administration,,BAO_0000019,CHEMBL628233,8926,,Autocuration,1,,,22224,U,0,,
11646,,Distribution in the heart after 30 min of intravenous administration,,BAO_0000019,CHEMBL628234,8926,,Autocuration,1,,,22224,U,0,,
11647,,Distribution in the heart after 5 min of intravenous administration,,BAO_0000019,CHEMBL628235,8926,,Autocuration,1,,,22224,U,0,,
11648,,Distribution in the heart after 60 min of intravenous administration,,BAO_0000019,CHEMBL628236,8926,,Autocuration,1,,,22224,U,0,,
11649,,Distribution in the heart after 90 min of intravenous administration,,BAO_0000019,CHEMBL628237,8926,,Autocuration,1,,,22224,U,0,,
11650,,Distribution in the kidneys after 120 min of intravenous administration,,BAO_0000019,CHEMBL628238,8926,,Autocuration,1,,,22224,U,0,,
11651,,Distribution in the kidneys after 15 min of intravenous administration,,BAO_0000019,CHEMBL628239,8926,,Autocuration,1,,,22224,U,0,,
11652,,Distribution in the kidneys after 30 min of intravenous administration,,BAO_0000019,CHEMBL628240,8926,,Autocuration,1,,,22224,U,0,,
11653,,Distribution in the kidneys after 5 min of intravenous administration,,BAO_0000019,CHEMBL628241,8926,,Autocuration,1,,,22224,U,0,,
11654,,Distribution in the kidneys after 60 min of intravenous administration,,BAO_0000019,CHEMBL628242,8926,,Autocuration,1,,,22224,U,0,,
11655,,Distribution in the kidneys after 90 min of intravenous administration,,BAO_0000019,CHEMBL875482,8926,,Autocuration,1,,,22224,U,0,,
11656,,Distribution in the liver after 120 min of intravenous administration,,BAO_0000019,CHEMBL628243,8926,,Autocuration,1,,,22224,U,0,,
11657,,Distribution in the liver after 15 min of intravenous administration,,BAO_0000019,CHEMBL628244,8926,,Autocuration,1,,,22224,U,0,,
11658,,Distribution in the liver after 30 min of intravenous administration,,BAO_0000019,CHEMBL628245,8926,,Autocuration,1,,,22224,U,0,,
11659,,Distribution in the liver after 5 min of intravenous administration,,BAO_0000019,CHEMBL628246,8926,,Autocuration,1,,,22224,U,0,,
11660,,Distribution in the liver after 60 min of intravenous administration,,BAO_0000019,CHEMBL628247,8926,,Autocuration,1,,,22224,U,0,,
11661,,Distribution in the liver after 90 min of intravenous administration,,BAO_0000019,CHEMBL628248,8926,,Autocuration,1,,,22224,U,0,,
11662,,Distribution in the lung after 120 min of intravenous administration,,BAO_0000019,CHEMBL628249,8926,,Autocuration,1,,,22224,U,0,,
11663,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,BAO_0000218,CHEMBL625452,14839,10090.0,Intermediate,1,,,50594,N,1,,
11664,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,BAO_0000218,CHEMBL625453,14839,10090.0,Intermediate,1,,,50594,N,1,,
11665,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,BAO_0000218,CHEMBL625454,14839,10090.0,Intermediate,1,,,50594,N,1,,
11666,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,BAO_0000218,CHEMBL623844,14839,10090.0,Intermediate,1,,,50594,N,1,,
11667,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,BAO_0000218,CHEMBL623845,12178,10116.0,Intermediate,1,,,50597,N,1,,
11668,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,BAO_0000218,CHEMBL623846,12178,10116.0,Intermediate,1,,,50597,N,1,,
11669,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,BAO_0000218,CHEMBL623847,12178,,Autocuration,1,,,22224,U,0,,
11670,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,CHEMBL623848,12186,9541.0,Intermediate,1,,,100710,N,1,,
11671,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,BAO_0000218,CHEMBL623849,12186,9541.0,Intermediate,1,,,100710,N,1,,
11672,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,CHEMBL623850,12186,9541.0,Intermediate,1,,,100710,N,1,,
11673,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,BAO_0000218,CHEMBL623851,12186,9541.0,Intermediate,1,,,100710,N,1,,
11674,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,CHEMBL623852,12187,314293.0,Autocuration,1,,,22224,U,0,,
11675,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,BAO_0000218,CHEMBL624551,12187,9669.0,Intermediate,1,,,50506,N,1,,
11676,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,BAO_0000218,CHEMBL624552,12187,9669.0,Intermediate,1,,,50506,N,1,,
11677,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,CHEMBL624553,12187,314293.0,Autocuration,1,,,22224,U,0,,
11678,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,BAO_0000218,CHEMBL624554,12187,314293.0,Autocuration,1,,,22224,U,0,,
11679,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,BAO_0000218,CHEMBL624555,12187,10116.0,Intermediate,1,,,50597,N,1,,
11680,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,BAO_0000218,CHEMBL624741,12187,10116.0,Intermediate,1,,,50597,N,1,,
11681,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,BAO_0000218,CHEMBL624742,14122,9615.0,Intermediate,1,,,50588,N,1,,
11682,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,BAO_0000218,CHEMBL624743,14122,10026.0,Intermediate,1,,,100712,N,1,,
11683,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,BAO_0000218,CHEMBL877606,14122,10116.0,Intermediate,1,,,50597,N,1,,
11684,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,BAO_0000218,CHEMBL624744,13391,,Autocuration,1,,,22224,U,0,,
11685,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,CHEMBL624745,13391,,Autocuration,1,,,22224,U,0,178.0,
11686,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,CHEMBL624746,13391,,Autocuration,1,,,22224,U,0,178.0,
11687,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,BAO_0000218,CHEMBL624747,13391,,Autocuration,1,,,22224,U,0,178.0,
11688,,Oral absorption expressed as Area under curve was determined,,BAO_0000019,CHEMBL624748,16360,,Autocuration,1,,,22224,U,0,,
11689,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,BAO_0000218,CHEMBL622504,3673,9615.0,Intermediate,1,,,50588,N,1,,
11690,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,BAO_0000218,CHEMBL622505,14122,9615.0,Intermediate,1,,,50588,N,1,,
11691,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,BAO_0000218,CHEMBL622506,14122,10026.0,Intermediate,1,,,100712,N,1,,
11692,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,BAO_0000218,CHEMBL622507,14122,10026.0,Intermediate,1,,,100712,N,1,,
11693,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,BAO_0000218,CHEMBL622508,14122,10116.0,Intermediate,1,,,50597,N,1,,
11694,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,BAO_0000019,CHEMBL622509,13889,,Autocuration,1,,,22224,U,0,,
11695,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,CHEMBL622510,14393,10116.0,Intermediate,1,,,50597,N,1,,
11696,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,BAO_0000218,CHEMBL622511,17279,10116.0,Intermediate,1,,,50597,N,1,,
11697,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,BAO_0000218,CHEMBL622512,14548,9541.0,Intermediate,1,,,100710,N,1,,
11698,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,BAO_0000218,CHEMBL622513,14548,9541.0,Intermediate,1,,,100710,N,1,,
11699,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,BAO_0000218,CHEMBL622514,14548,9541.0,Intermediate,1,,,100710,N,1,,
11700,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,BAO_0000218,CHEMBL622515,14548,9615.0,Intermediate,1,,,50588,N,1,,
11701,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,BAO_0000218,CHEMBL622516,14548,9615.0,Intermediate,1,,,50588,N,1,,
11702,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,BAO_0000218,CHEMBL622517,14548,10116.0,Intermediate,1,,,50597,N,1,,
11703,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,BAO_0000218,CHEMBL622518,14548,10116.0,Intermediate,1,,,50597,N,1,,
11704,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,BAO_0000218,CHEMBL622519,14548,10116.0,Intermediate,1,,,50597,N,1,,
11705,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL622520,14608,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11706,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL622521,14608,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11707,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL625113,14608,10090.0,Intermediate,1,,,50594,N,1,14.0,
11708,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL625114,14608,10116.0,Intermediate,1,,,50597,N,1,14.0,
11709,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL874397,14608,10116.0,Intermediate,1,,,50597,N,1,14.0,
11710,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL625115,14608,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11711,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL625116,14608,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11712,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL623932,14608,10116.0,Intermediate,1,,,50597,N,1,2106.0,
11713,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL623933,14608,10116.0,Intermediate,1,,,50597,N,1,2435.0,
11714,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL623934,14608,10116.0,Intermediate,1,,,50597,N,1,2435.0,
11715,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL623935,14608,10116.0,Intermediate,1,,,50597,N,1,2435.0,
11716,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,BAO_0000218,CHEMBL623936,14608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
11717,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,BAO_0000218,CHEMBL623937,14608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
11718,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,BAO_0000218,CHEMBL623938,14608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
11719,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL623939,15383,10090.0,Intermediate,1,,,50594,N,1,,
11720,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,CHEMBL623940,15383,10090.0,Intermediate,1,,,50594,N,1,,
11721,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,CHEMBL623941,15383,10090.0,Intermediate,1,,,50594,N,1,,
11722,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL627216,15383,10090.0,Intermediate,1,,,50594,N,1,,
11723,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL623942,15383,10090.0,Intermediate,1,,,50594,N,1,,
11724,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL618793,15383,10090.0,Intermediate,1,,,50594,N,1,955.0,
11725,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618794,15383,10090.0,Intermediate,1,,,50594,N,1,955.0,
11726,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL618795,15383,10090.0,Intermediate,1,,,50594,N,1,955.0,
11727,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618796,15383,10090.0,Intermediate,1,,,50594,N,1,,
11728,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL618797,15383,10090.0,Intermediate,1,,,50594,N,1,,
11729,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,BAO_0000218,CHEMBL618798,15383,10090.0,Intermediate,1,,,50594,N,1,2113.0,
11730,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL618799,15383,10090.0,Intermediate,1,,,50594,N,1,2113.0,
11731,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,CHEMBL618800,15383,10090.0,Intermediate,1,,,50594,N,1,2113.0,
11732,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,CHEMBL618801,15383,10090.0,Intermediate,1,,,50594,N,1,2113.0,
11733,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618802,15383,10090.0,Intermediate,1,,,50594,N,1,2113.0,
11734,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL618803,15383,10090.0,Intermediate,1,,,50594,N,1,2113.0,
11735,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,BAO_0000218,CHEMBL618804,15383,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11736,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL618805,15383,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11737,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,CHEMBL618806,15383,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11738,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,CHEMBL618807,15383,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11739,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618808,15383,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11740,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL618809,15383,10090.0,Intermediate,1,,,50594,N,1,2107.0,
11741,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL618810,15383,10090.0,Intermediate,1,,,50594,N,1,2385.0,
11742,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,BAO_0000218,CHEMBL618811,15383,10090.0,Intermediate,1,,,50594,N,1,2385.0,
11743,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,CHEMBL875844,15383,10090.0,Intermediate,1,,,50594,N,1,2385.0,
11744,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618812,15383,10090.0,Intermediate,1,,,50594,N,1,2385.0,
11745,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL618813,15383,10090.0,Intermediate,1,,,50594,N,1,2385.0,
11746,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL618814,15383,10090.0,Intermediate,1,,,50594,N,1,,
11747,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618815,15383,10090.0,Intermediate,1,,,50594,N,1,,
11748,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL618816,15383,10090.0,Intermediate,1,,,50594,N,1,,
11749,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL618817,15383,10090.0,Intermediate,1,,,50594,N,1,,
11750,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL620544,15383,10090.0,Intermediate,1,,,50594,N,1,,
11751,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,BAO_0000218,CHEMBL626230,15341,10116.0,Intermediate,1,,,50597,N,1,,
11752,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,BAO_0000218,CHEMBL626231,15341,10116.0,Intermediate,1,,,50597,N,1,,
11753,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,BAO_0000218,CHEMBL626232,15341,10116.0,Intermediate,1,,,50597,N,1,,
11754,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,BAO_0000218,CHEMBL626233,14906,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11755,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,BAO_0000218,CHEMBL626234,14906,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11756,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,BAO_0000218,CHEMBL875341,14906,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11757,,The maximum plasma concentration (100 mg/kg) administered orally in human,,BAO_0000218,CHEMBL626235,14215,9606.0,Intermediate,1,,,50587,N,1,1969.0,
11758,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,BAO_0000218,CHEMBL626236,14215,9481.0,Autocuration,1,,,22224,U,0,1969.0,
11759,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,BAO_0000218,CHEMBL626237,14215,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11760,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,BAO_0000218,CHEMBL626238,14215,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11761,,The maximum plasma concentration (200 mg/kg) administered orally in human,,BAO_0000218,CHEMBL622412,14215,9606.0,Intermediate,1,,,50587,N,1,1969.0,
11762,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,BAO_0000218,CHEMBL623114,14215,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11763,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,BAO_0000218,CHEMBL623115,14215,9481.0,Autocuration,1,,,22224,U,0,1969.0,
11764,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,BAO_0000218,CHEMBL623116,14215,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11765,,The maximum plasma concentration (30 mg/kg) administered orally in dog,,BAO_0000218,CHEMBL623117,14215,9615.0,Autocuration,1,,,22224,U,0,1969.0,
11766,,The maximum plasma concentration (400 mg/kg) administered orally in human,,BAO_0000218,CHEMBL623118,14215,9606.0,Intermediate,1,,,50587,N,1,1969.0,
11767,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,BAO_0000218,CHEMBL623119,14215,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11768,,The maximum plasma concentration (50 mg/kg) administered orally in rat,,BAO_0000218,CHEMBL623120,14215,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11769,,The maximum plasma concentration (800 mg/kg) administered orally in human,,BAO_0000218,CHEMBL623286,14215,9606.0,Intermediate,1,,,50587,N,1,1969.0,
11770,,The maximum plasma concentration was measured on rats,,BAO_0000218,CHEMBL623287,14067,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11771,,The maximum plasma concentration was measured on rats after oral administration,,BAO_0000218,CHEMBL623288,12350,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11772,,Plasma drug Cmax in rat (PO dose),,BAO_0000218,CHEMBL623289,14813,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11773,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,BAO_0000218,CHEMBL623290,12536,,Autocuration,1,,,22224,U,0,,
11774,,maximum Plasma concentration in Dog was determined after Peroral administration,,BAO_0000218,CHEMBL623291,14169,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11775,,maximum Plasma concentration in Rats was determined after Peroral administration,,BAO_0000218,CHEMBL623292,14169,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11776,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,BAO_0000218,CHEMBL623293,15604,9615.0,Intermediate,1,,,50588,N,1,1969.0,
11777,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,BAO_0000218,CHEMBL623294,15604,314293.0,Autocuration,1,,,22224,U,0,1969.0,
11778,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,BAO_0000218,CHEMBL623295,15604,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11779,,maximum concentration was measured when administered through oral route in mice,,BAO_0000218,CHEMBL623296,14387,10090.0,Intermediate,1,,,50594,N,1,,
11780,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,BAO_0000218,CHEMBL875349,15115,10090.0,Intermediate,1,,,50594,N,1,,
11781,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,BAO_0000019,CHEMBL623297,15115,314293.0,Autocuration,1,,,22224,U,0,,
11782,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,BAO_0000019,CHEMBL623298,15115,314293.0,Autocuration,1,,,22224,U,0,,
11783,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,BAO_0000019,CHEMBL623299,15115,314293.0,Autocuration,1,,,22224,U,0,,
11784,,Pharmacokinetic parameter was evaluated in rats,,BAO_0000218,CHEMBL623300,16359,10116.0,Intermediate,1,,,50597,N,1,,
11785,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,BAO_0000218,CHEMBL623301,12829,10090.0,Intermediate,1,,,50594,N,1,,
11786,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,BAO_0000218,CHEMBL623302,12829,10090.0,Intermediate,1,,,50594,N,1,,
11787,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,BAO_0000218,CHEMBL623303,12829,10090.0,Intermediate,1,,,50594,N,1,,
11788,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,BAO_0000218,CHEMBL623304,12829,10090.0,Intermediate,1,,,50594,N,1,,
11789,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,BAO_0000218,CHEMBL623305,12829,10090.0,Intermediate,1,,,50594,N,1,,
11790,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,CHEMBL623306,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11791,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,CHEMBL623307,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11792,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,CHEMBL623308,15137,10116.0,Intermediate,1,,,50597,N,1,1969.0,
11793,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,BAO_0000218,CHEMBL623309,15137,10090.0,Intermediate,1,,,50594,N,1,1969.0,
11794,,Plasma Concentration after 120 min of oral administration to mice,,BAO_0000218,CHEMBL623310,13509,10090.0,Intermediate,1,,,50594,N,1,,
11795,,Plasma Concentration after 30 min of oral administration to mice,,BAO_0000218,CHEMBL623311,13509,10090.0,Intermediate,1,,,50594,N,1,,
11796,,Plasma Concentration after 60 min of oral administration to mice,,BAO_0000218,CHEMBL623312,13509,9541.0,Intermediate,1,,,100710,N,1,,
11797,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,BAO_0000218,CHEMBL875350,13509,10090.0,Intermediate,1,,,50594,N,1,,
11798,,Plasma Concentration after 90 min of oral administration to mice,,BAO_0000218,CHEMBL628635,13509,10090.0,Intermediate,1,,,50594,N,1,,
11799,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,BAO_0000218,CHEMBL628636,12064,10116.0,Intermediate,1,,,50597,N,1,,
11800,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,BAO_0000218,CHEMBL628637,12064,10116.0,Intermediate,1,,,50597,N,1,,
11801,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,BAO_0000218,CHEMBL628058,12064,10116.0,Intermediate,1,,,50597,N,1,,
11802,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,BAO_0000218,CHEMBL628059,10677,10116.0,Intermediate,1,,,50597,N,1,,
11803,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,BAO_0000218,CHEMBL628060,10677,10116.0,Intermediate,1,,,50597,N,1,,
11804,,Distribution in the lung after 15 min of intravenous administration,,BAO_0000019,CHEMBL628061,8926,,Autocuration,1,,,22224,U,0,,
11805,,Distribution in the lung after 30 min of intravenous administration,,BAO_0000019,CHEMBL628062,8926,,Autocuration,1,,,22224,U,0,,
11806,,Distribution in the lung after 5 min of intravenous administration,,BAO_0000019,CHEMBL628063,8926,,Autocuration,1,,,22224,U,0,,
11807,,Distribution in the lung after 60 min of intravenous administration,,BAO_0000019,CHEMBL628064,8926,,Autocuration,1,,,22224,U,0,,
11808,,Distribution in the lung after 90 min of intravenous administration,,BAO_0000019,CHEMBL628065,8926,,Autocuration,1,,,22224,U,0,,
11809,,Distribution in the muscle after 120 min of intravenous administration,,BAO_0000019,CHEMBL628066,8926,,Autocuration,1,,,22224,U,0,2385.0,
11810,,Distribution in the muscle after 15 min of intravenous administration,,BAO_0000019,CHEMBL628067,8926,,Autocuration,1,,,22224,U,0,2385.0,
11811,,Distribution in the muscle after 30 min of intravenous administration,,BAO_0000218,CHEMBL874646,8926,10090.0,Intermediate,1,,,50594,N,1,2385.0,
11812,,Distribution in the muscle after 5 min of intravenous administration,,BAO_0000019,CHEMBL628068,8926,,Autocuration,1,,,22224,U,0,2385.0,
11813,,Distribution in the muscle after 60 min of intravenous administration,,BAO_0000019,CHEMBL628069,8926,,Autocuration,1,,,22224,U,0,2385.0,
11814,,Distribution in the muscle after 90 min of intravenous administration,,BAO_0000019,CHEMBL628070,8926,,Autocuration,1,,,22224,U,0,2385.0,
11815,,Distribution in the spleen after 120 min of intravenous administration,,BAO_0000019,CHEMBL628071,8926,,Autocuration,1,,,22224,U,0,2106.0,
11816,,Distribution in the spleen after 15 min of intravenous administration,,BAO_0000019,CHEMBL628072,8926,,Autocuration,1,,,22224,U,0,2106.0,
11817,,Distribution in the spleen after 30 min of intravenous administration,,BAO_0000019,CHEMBL628073,8926,,Autocuration,1,,,22224,U,0,2106.0,
11818,,Distribution in the spleen after 5 min of intravenous administration,,BAO_0000019,CHEMBL628074,8926,,Autocuration,1,,,22224,U,0,2106.0,
11819,,Distribution in the spleen after 60 min of intravenous administration,,BAO_0000019,CHEMBL628075,8926,,Autocuration,1,,,22224,U,0,2106.0,
11820,,Distribution in the spleen after 90 min of intravenous administration,,BAO_0000019,CHEMBL628076,8926,,Autocuration,1,,,22224,U,0,2106.0,
11821,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,BAO_0000218,CHEMBL628077,7570,10116.0,Intermediate,1,,,50597,N,1,1235.0,
11822,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,BAO_0000218,CHEMBL628078,7570,10116.0,Intermediate,1,,,50597,N,1,178.0,
11823,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,BAO_0000218,CHEMBL628079,7570,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11824,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,BAO_0000218,CHEMBL628080,7570,10116.0,Intermediate,1,,,50597,N,1,992.0,
11825,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,BAO_0000218,CHEMBL628081,7570,10116.0,Intermediate,1,,,50597,N,1,2046.0,
11826,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,BAO_0000218,CHEMBL628082,7570,10116.0,Intermediate,1,,,50597,N,1,1235.0,
11827,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,BAO_0000218,CHEMBL874647,7570,10116.0,Intermediate,1,,,50597,N,1,178.0,
11828,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,BAO_0000218,CHEMBL626406,7570,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11829,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,BAO_0000218,CHEMBL626407,7570,10116.0,Intermediate,1,,,50597,N,1,992.0,
11830,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,BAO_0000218,CHEMBL626408,7570,10116.0,Intermediate,1,,,50597,N,1,2046.0,
11831,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,BAO_0000218,CHEMBL626409,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11832,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,BAO_0000218,CHEMBL626410,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11833,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,BAO_0000218,CHEMBL626411,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11834,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,BAO_0000218,CHEMBL626412,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11835,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,BAO_0000218,CHEMBL626413,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11836,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,BAO_0000218,CHEMBL626414,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11837,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,BAO_0000218,CHEMBL626415,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11838,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,BAO_0000218,CHEMBL626416,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11839,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,BAO_0000218,CHEMBL627062,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11840,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,BAO_0000218,CHEMBL627063,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11841,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,BAO_0000218,CHEMBL627064,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11842,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,BAO_0000218,CHEMBL627227,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11843,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,BAO_0000218,CHEMBL627228,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11844,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,BAO_0000218,CHEMBL627229,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11845,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,BAO_0000218,CHEMBL625792,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11846,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,BAO_0000218,CHEMBL625793,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11847,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,BAO_0000218,CHEMBL625794,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11848,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,BAO_0000218,CHEMBL625795,8608,10116.0,Intermediate,1,,,50597,N,1,178.0,
11849,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,BAO_0000218,CHEMBL625796,13792,10090.0,Intermediate,1,,,50594,N,1,,
11850,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,BAO_0000218,CHEMBL625797,13376,9615.0,Intermediate,1,,,50588,N,1,,
11851,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,BAO_0000218,CHEMBL625798,13376,9615.0,Intermediate,1,,,50588,N,1,,
11852,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL875613,14380,,Autocuration,1,,,22224,U,0,,
11853,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL625799,14380,,Autocuration,1,,,22224,U,0,,
11854,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL625800,14380,,Autocuration,1,,,22224,U,0,,
11855,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL625801,14380,,Autocuration,1,,,22224,U,0,,
11856,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL625802,14380,,Autocuration,1,,,22224,U,0,,
11857,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL625803,14380,,Autocuration,1,,,22224,U,0,,
11858,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,BAO_0000019,CHEMBL625804,14380,,Autocuration,1,,,22224,U,0,,
11859,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,BAO_0000218,CHEMBL622530,14380,,Autocuration,1,,,22224,U,0,,
11860,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,BAO_0000218,CHEMBL622531,13701,10090.0,Intermediate,1,,,50594,N,1,,
11861,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,BAO_0000218,CHEMBL622532,13701,10090.0,Intermediate,1,,,50594,N,1,,
11862,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,CHEMBL623176,13701,10090.0,Intermediate,1,,,50594,N,1,,
11863,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,BAO_0000218,CHEMBL623177,13701,10090.0,Intermediate,1,,,50594,N,1,,
11864,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,BAO_0000218,CHEMBL623178,13701,10090.0,Intermediate,1,,,50594,N,1,,
11865,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,BAO_0000218,CHEMBL623179,13701,10090.0,Intermediate,1,,,50594,N,1,,
11866,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,BAO_0000218,CHEMBL623180,13701,10090.0,Intermediate,1,,,50594,N,1,,
11867,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,BAO_0000218,CHEMBL623181,13701,10090.0,Intermediate,1,,,50594,N,1,,
11868,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,CHEMBL624131,13701,10090.0,Intermediate,1,,,50594,N,1,,
11869,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,BAO_0000218,CHEMBL624132,13701,10090.0,Intermediate,1,,,50594,N,1,,
11870,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,CHEMBL624133,13701,10090.0,Intermediate,1,,,50594,N,1,,
11871,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,BAO_0000218,CHEMBL624846,13701,10090.0,Intermediate,1,,,50594,N,1,,
11872,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,BAO_0000218,CHEMBL624847,13701,10090.0,Intermediate,1,,,50594,N,1,,
11873,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,BAO_0000218,CHEMBL624848,13701,10090.0,Intermediate,1,,,50594,N,1,,
11874,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,BAO_0000218,CHEMBL625012,13701,10090.0,Intermediate,1,,,50594,N,1,,
11875,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,CHEMBL625013,13701,10090.0,Intermediate,1,,,50594,N,1,,
11876,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,BAO_0000218,CHEMBL625014,13701,10090.0,Intermediate,1,,,50594,N,1,,
11877,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,BAO_0000218,CHEMBL625015,13701,10090.0,Intermediate,1,,,50594,N,1,,
11878,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,BAO_0000218,CHEMBL625016,13701,10090.0,Intermediate,1,,,50594,N,1,,
11879,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,BAO_0000218,CHEMBL625017,13701,10090.0,Intermediate,1,,,50594,N,1,,
11880,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,BAO_0000218,CHEMBL625018,13701,10090.0,Intermediate,1,,,50594,N,1,,
11881,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,BAO_0000218,CHEMBL625019,13701,10090.0,Intermediate,1,,,50594,N,1,,
11882,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,BAO_0000218,CHEMBL625020,13701,10090.0,Intermediate,1,,,50594,N,1,,
11883,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,BAO_0000218,CHEMBL625021,13701,10090.0,Intermediate,1,,,50594,N,1,,
11884,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,CHEMBL625022,14393,10116.0,Intermediate,1,,,50597,N,1,,
11885,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,BAO_0000218,CHEMBL625023,14731,10090.0,Intermediate,1,,,50594,N,1,,
11886,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,BAO_0000218,CHEMBL625024,14731,9541.0,Intermediate,1,,,100710,N,1,,
11887,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,BAO_0000218,CHEMBL627626,14731,9541.0,Intermediate,1,,,100710,N,1,,
11888,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,BAO_0000218,CHEMBL627627,13758,,Autocuration,1,,,22224,U,0,955.0,
11889,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,BAO_0000218,CHEMBL627628,13758,,Autocuration,1,,,22224,U,0,1977.0,
11890,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,BAO_0000218,CHEMBL627629,13758,,Autocuration,1,,,22224,U,0,955.0,
11891,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,BAO_0000218,CHEMBL627630,13758,,Autocuration,1,,,22224,U,0,1977.0,
11892,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,BAO_0000019,CHEMBL627631,16359,,Autocuration,1,,,22224,U,0,,
11893,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,BAO_0000218,CHEMBL629515,16359,,Autocuration,1,,,22224,U,0,,
11894,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL629516,15383,10090.0,Intermediate,1,,,50594,N,1,2106.0,
11895,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL629517,15383,10090.0,Intermediate,1,,,50594,N,1,2106.0,
11896,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL629518,15383,10090.0,Intermediate,1,,,50594,N,1,2106.0,
11897,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,BAO_0000218,CHEMBL877499,15383,10090.0,Intermediate,1,,,50594,N,1,,
11898,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,BAO_0000218,CHEMBL629519,15383,10090.0,Intermediate,1,,,50594,N,1,,
11899,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,BAO_0000218,CHEMBL629520,15383,10090.0,Intermediate,1,,,50594,N,1,,
11900,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,BAO_0000218,CHEMBL629521,15383,10090.0,Intermediate,1,,,50594,N,1,,
11901,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,BAO_0000218,CHEMBL629522,14439,10090.0,Intermediate,1,,,50594,N,1,,
11902,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,BAO_0000218,CHEMBL629523,14439,10090.0,Intermediate,1,,,50594,N,1,,
11903,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,BAO_0000218,CHEMBL629524,14439,10090.0,Intermediate,1,,,50594,N,1,,
11904,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,BAO_0000218,CHEMBL629525,14439,10090.0,Intermediate,1,,,50594,N,1,,
11905,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,BAO_0000218,CHEMBL629526,14439,10090.0,Intermediate,1,,,50594,N,1,,
11906,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,BAO_0000218,CHEMBL629527,14439,10090.0,Intermediate,1,,,50594,N,1,,
11907,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,BAO_0000218,CHEMBL629528,14439,10090.0,Intermediate,1,,,50594,N,1,,
11908,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,BAO_0000218,CHEMBL629529,14439,10090.0,Intermediate,1,,,50594,N,1,,
11909,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,BAO_0000218,CHEMBL629530,14439,10090.0,Intermediate,1,,,50594,N,1,,
11910,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,BAO_0000218,CHEMBL629531,14439,10090.0,Intermediate,1,,,50594,N,1,,
11911,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,BAO_0000218,CHEMBL628656,14439,10090.0,Intermediate,1,,,50594,N,1,,
11912,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,BAO_0000218,CHEMBL628657,14439,10090.0,Intermediate,1,,,50594,N,1,,
11913,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628658,13751,10116.0,Intermediate,1,,,50597,N,1,,
11914,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628659,13751,10116.0,Intermediate,1,,,50597,N,1,,
11915,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL877500,13751,10116.0,Intermediate,1,,,50597,N,1,,
11916,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628660,13751,10116.0,Intermediate,1,,,50597,N,1,,
11917,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628661,13751,10116.0,Intermediate,1,,,50597,N,1,,
11918,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628662,13751,10116.0,Intermediate,1,,,50597,N,1,,
11919,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628663,13751,10116.0,Intermediate,1,,,50597,N,1,,
11920,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628664,13751,10116.0,Intermediate,1,,,50597,N,1,,
11921,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628665,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11922,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628666,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11923,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628667,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11924,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628668,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11925,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628669,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11926,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628670,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11927,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628671,13751,10116.0,Intermediate,1,,,50597,N,1,178.0,
11928,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL628672,13751,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
11929,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL630300,13751,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
11930,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629787,13751,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
11931,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629788,13751,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
11932,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629789,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
11933,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629790,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
11934,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629791,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
11935,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629792,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
11936,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629793,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
11937,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629794,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
11938,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,BAO_0000218,CHEMBL874459,10677,10116.0,Intermediate,1,,,50597,N,1,,
11939,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,BAO_0000218,CHEMBL629795,10677,10116.0,Intermediate,1,,,50597,N,1,,
11940,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,BAO_0000218,CHEMBL629796,10677,10116.0,Intermediate,1,,,50597,N,1,,
11941,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,BAO_0000218,CHEMBL629797,10677,10116.0,Intermediate,1,,,50597,N,1,,
11942,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,BAO_0000218,CHEMBL629798,10677,10116.0,Intermediate,1,,,50597,N,1,,
11943,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629799,10911,10116.0,Intermediate,1,,,50597,N,1,2369.0,
11944,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629800,10911,10116.0,Intermediate,1,,,50597,N,1,2369.0,
11945,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629801,10911,10116.0,Intermediate,1,,,50597,N,1,2369.0,
11946,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,BAO_0000218,CHEMBL629802,10911,10116.0,Intermediate,1,,,50597,N,1,2369.0,
11947,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629803,10911,10116.0,Intermediate,1,,,50597,N,1,2369.0,
11948,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629804,10911,10116.0,Intermediate,1,,,50597,N,1,178.0,
11949,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629805,10911,10116.0,Intermediate,1,,,50597,N,1,178.0,
11950,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629806,10911,10116.0,Intermediate,1,,,50597,N,1,178.0,
11951,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629807,10911,10116.0,Intermediate,1,,,50597,N,1,178.0,
11952,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629808,10911,10116.0,Intermediate,1,,,50597,N,1,178.0,
11953,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629809,10911,10116.0,Intermediate,1,,,50597,N,1,955.0,
11954,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629810,10911,10116.0,Intermediate,1,,,50597,N,1,955.0,
11955,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629811,10911,10116.0,Intermediate,1,,,50597,N,1,955.0,
11956,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629812,10911,10116.0,Intermediate,1,,,50597,N,1,955.0,
11957,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629813,10911,10116.0,Intermediate,1,,,50597,N,1,955.0,
11958,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL874460,10911,10116.0,Intermediate,1,,,50597,N,1,955.0,
11959,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629814,10911,10116.0,Intermediate,1,,,50597,N,1,,
11960,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629815,10911,10116.0,Intermediate,1,,,50597,N,1,,
11961,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629816,10911,10116.0,Intermediate,1,,,50597,N,1,,
11962,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL629817,10911,10116.0,Intermediate,1,,,50597,N,1,,
11963,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626643,10911,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11964,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626644,10911,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11965,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626806,10911,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11966,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626807,10911,10116.0,Intermediate,1,,,50597,N,1,2113.0,
11967,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627261,10911,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11968,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627262,10911,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11969,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627263,10911,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11970,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627264,10911,10116.0,Intermediate,1,,,50597,N,1,2107.0,
11971,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627265,10911,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11972,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627266,10911,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11973,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627267,10911,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11974,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627268,10911,10116.0,Intermediate,1,,,50597,N,1,2048.0,
11975,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627269,10911,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11976,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627270,10911,10116.0,Intermediate,1,,,50597,N,1,2385.0,
11977,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,BAO_0000218,CHEMBL627271,8608,10116.0,Intermediate,1,,,50597,N,1,,
11978,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,BAO_0000218,CHEMBL627946,8608,10116.0,Intermediate,1,,,50597,N,1,,
11979,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,BAO_0000218,CHEMBL875472,8608,10116.0,Intermediate,1,,,50597,N,1,,
11980,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,BAO_0000218,CHEMBL627947,8608,10116.0,Intermediate,1,,,50597,N,1,,
11981,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,BAO_0000218,CHEMBL627948,8608,10116.0,Intermediate,1,,,50597,N,1,,
11982,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,BAO_0000218,CHEMBL628113,8608,10116.0,Intermediate,1,,,50597,N,1,,
11983,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,BAO_0000218,CHEMBL628114,8608,10116.0,Intermediate,1,,,50597,N,1,,
11984,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,BAO_0000218,CHEMBL628115,8608,10116.0,Intermediate,1,,,50597,N,1,,
11985,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,BAO_0000218,CHEMBL628116,8608,10116.0,Intermediate,1,,,50597,N,1,,
11986,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,BAO_0000218,CHEMBL628117,8608,10116.0,Intermediate,1,,,50597,N,1,,
11987,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,BAO_0000218,CHEMBL628118,8608,10116.0,Intermediate,1,,,50597,N,1,,
11988,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,BAO_0000218,CHEMBL628119,8608,10116.0,Intermediate,1,,,50597,N,1,,
11989,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,BAO_0000218,CHEMBL628120,8608,10116.0,Intermediate,1,,,50597,N,1,,
11990,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,BAO_0000218,CHEMBL628121,8608,10116.0,Intermediate,1,,,50597,N,1,,
11991,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,BAO_0000218,CHEMBL628122,8608,10116.0,Intermediate,1,,,50597,N,1,,
11992,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,BAO_0000218,CHEMBL627297,8608,10116.0,Intermediate,1,,,50597,N,1,,
11993,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,BAO_0000218,CHEMBL627298,8608,10116.0,Intermediate,1,,,50597,N,1,,
11994,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,BAO_0000218,CHEMBL627299,8608,10116.0,Intermediate,1,,,50597,N,1,,
11995,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,BAO_0000218,CHEMBL627300,8608,10116.0,Intermediate,1,,,50597,N,1,,
11996,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,BAO_0000218,CHEMBL627301,8608,10116.0,Intermediate,1,,,50597,N,1,,
11997,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,BAO_0000218,CHEMBL627302,8608,10116.0,Intermediate,1,,,50597,N,1,,
11998,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,BAO_0000218,CHEMBL627303,8608,10116.0,Intermediate,1,,,50597,N,1,,
11999,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,BAO_0000218,CHEMBL627304,8608,10116.0,Intermediate,1,,,50597,N,1,,
12000,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,BAO_0000218,CHEMBL627305,8608,10116.0,Intermediate,1,,,50597,N,1,,
12001,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,BAO_0000218,CHEMBL627306,8608,10116.0,Intermediate,1,,,50597,N,1,,
12002,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,BAO_0000218,CHEMBL623982,8608,10116.0,Intermediate,1,,,50597,N,1,,
12003,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,BAO_0000218,CHEMBL623983,8608,10116.0,Intermediate,1,,,50597,N,1,,
12004,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,BAO_0000218,CHEMBL623984,8608,10116.0,Intermediate,1,,,50597,N,1,,
12005,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,BAO_0000218,CHEMBL623985,8608,10116.0,Intermediate,1,,,50597,N,1,,
12006,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,BAO_0000218,CHEMBL623986,8608,10116.0,Intermediate,1,,,50597,N,1,,
12007,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,BAO_0000218,CHEMBL623987,8608,10116.0,Intermediate,1,,,50597,N,1,,
12008,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,BAO_0000218,CHEMBL623988,8608,10116.0,Intermediate,1,,,50597,N,1,,
12009,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,BAO_0000218,CHEMBL623989,8608,10116.0,Intermediate,1,,,50597,N,1,,
12010,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,BAO_0000218,CHEMBL622215,8608,10116.0,Intermediate,1,,,50597,N,1,,
12011,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,BAO_0000218,CHEMBL622216,8608,10116.0,Intermediate,1,,,50597,N,1,,
12012,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,BAO_0000218,CHEMBL877481,8608,10116.0,Intermediate,1,,,50597,N,1,,
12013,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,BAO_0000218,CHEMBL622217,16359,,Autocuration,1,,,22224,U,0,,
12014,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,BAO_0000218,CHEMBL622218,13701,10090.0,Intermediate,1,,,50594,N,1,,
12015,,Pharmacokinetic profile AUC was evaluated in rats,,BAO_0000218,CHEMBL622219,14554,10116.0,Intermediate,1,,,50597,N,1,,
12016,,Pharmacokinetic property (Area under curve),,BAO_0000019,CHEMBL622220,6241,,Autocuration,1,,,22224,U,0,,
12017,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,BAO_0000218,CHEMBL622221,11537,9615.0,Intermediate,1,,,50588,N,1,,
12018,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,BAO_0000218,CHEMBL622222,11537,10090.0,Intermediate,1,,,50594,N,1,,
12019,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,BAO_0000218,CHEMBL622223,11537,9615.0,Intermediate,1,,,50588,N,1,,
12020,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,BAO_0000218,CHEMBL622224,11537,10090.0,Intermediate,1,,,50594,N,1,,
12021,,Plasma concentration (AUC) was determined,,BAO_0000019,CHEMBL622225,13118,,Autocuration,1,,,22224,U,0,,
12022,,Plasma concentration (AUC) was determined; Not detectable,,BAO_0000019,CHEMBL622226,13118,,Autocuration,1,,,22224,U,0,,
12023,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,BAO_0000218,CHEMBL624154,9562,10141.0,Intermediate,1,,,50512,N,1,,
12024,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,BAO_0000218,CHEMBL624155,10363,10116.0,Intermediate,1,,,50597,N,1,,
12025,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,BAO_0000218,CHEMBL624156,10363,10116.0,Intermediate,1,,,50597,N,1,,
12026,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,BAO_0000218,CHEMBL624157,10363,10116.0,Intermediate,1,,,50597,N,1,,
12027,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,BAO_0000218,CHEMBL624158,10363,10116.0,Intermediate,1,,,50597,N,1,,
12028,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,BAO_0000218,CHEMBL624159,12504,10116.0,Intermediate,1,,,50597,N,1,,
12029,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,BAO_0000218,CHEMBL624160,12504,10116.0,Intermediate,1,,,50597,N,1,,
12030,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,BAO_0000218,CHEMBL624161,12504,10116.0,Intermediate,1,,,50597,N,1,,
12031,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,BAO_0000218,CHEMBL624162,12504,10116.0,Intermediate,1,,,50597,N,1,,
12032,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,BAO_0000218,CHEMBL624163,13317,9615.0,Intermediate,1,,,50588,N,1,,
12033,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL624164,15078,10116.0,Intermediate,1,,,50597,N,1,,
12034,,The AUC(0-infinity) values in female wistar rats.,,BAO_0000218,CHEMBL624165,14941,10116.0,Intermediate,1,,,50597,N,1,,
12035,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL624166,15078,10116.0,Intermediate,1,,,50597,N,1,,
12036,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,BAO_0000218,CHEMBL624167,15078,10116.0,Intermediate,1,,,50597,N,1,,
12037,,The AUC(0-t)values in female wistar rats.,,BAO_0000218,CHEMBL624168,14941,10116.0,Intermediate,1,,,50597,N,1,,
12038,,The Area under the concentration time curve of compound was measured on rats,,BAO_0000218,CHEMBL624169,14067,10116.0,Intermediate,1,,,50597,N,1,,
12039,,The area under curve (100 mg/kg) administered orally in humans,,BAO_0000218,CHEMBL624170,14215,9606.0,Intermediate,1,,,50587,N,1,,
12040,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,BAO_0000218,CHEMBL624171,14215,9481.0,Autocuration,1,,,22224,U,0,,
12041,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,BAO_0000218,CHEMBL624172,14215,314293.0,Autocuration,1,,,22224,U,0,,
12042,,The area under curve (15 mg/kg) administered intravenously in dog,,BAO_0000218,CHEMBL624173,14215,9615.0,Intermediate,1,,,50588,N,1,,
12043,,The area under curve (200 mg/kg) administered orally in humans,,BAO_0000218,CHEMBL877488,14215,9606.0,Intermediate,1,,,50587,N,1,,
12044,,The area under curve (25 mg/kg) administered intravenously in rat,,BAO_0000218,CHEMBL624174,14215,10116.0,Intermediate,1,,,50597,N,1,,
12045,,The area under curve (25 mg/kg) administered orally in marmoset,,BAO_0000218,CHEMBL624175,14215,9481.0,Autocuration,1,,,22224,U,0,,
12046,,The area under curve (25 mg/kg) administered orally in monkey,,BAO_0000218,CHEMBL624176,14215,314293.0,Autocuration,1,,,22224,U,0,,
12047,,The area under curve (30 mg/kg) administered orally in dog,,BAO_0000218,CHEMBL624177,14215,9615.0,Intermediate,1,,,50588,N,1,,
12048,,The area under curve (400 mg/kg) administered orally in humans,,BAO_0000218,CHEMBL624178,14215,9606.0,Intermediate,1,,,50587,N,1,,
12049,,The area under curve (50 mg/kg) administered orally in fasted rat,,BAO_0000218,CHEMBL624179,14215,10116.0,Intermediate,1,,,50597,N,1,,
12050,,The area under curve (50 mg/kg) administered orally in rat,,BAO_0000218,CHEMBL627689,14215,10116.0,Intermediate,1,,,50597,N,1,,
12051,,The area under curve (800 mg/kg) administered orally in humans,,BAO_0000218,CHEMBL627690,14215,9606.0,Intermediate,1,,,50587,N,1,,
12052,,The compound was evaluated for area under the curve,,BAO_0000019,CHEMBL627691,11324,,Autocuration,1,,,22224,U,0,,
12053,,The compound was evaluated for area under the curve in marmosets,,BAO_0000019,CHEMBL627692,11324,9481.0,Autocuration,1,,,22224,U,0,,
12054,,The compound was evaluated for area under the curve in marmosets,,BAO_0000019,CHEMBL627693,11324,9481.0,Autocuration,1,,,22224,U,0,,
12055,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,CHEMBL627694,13875,10116.0,Intermediate,1,,,50597,N,1,,
12056,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,CHEMBL627695,13875,10116.0,Intermediate,1,,,50597,N,1,,
12057,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,BAO_0000218,CHEMBL627696,13875,,Autocuration,1,,,22224,U,0,,
12058,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,CHEMBL627697,13875,10116.0,Intermediate,1,,,50597,N,1,,
12059,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,CHEMBL627698,13875,10116.0,Intermediate,1,,,50597,N,1,,
12060,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,BAO_0000218,CHEMBL627699,13875,10116.0,Intermediate,1,,,50597,N,1,,
12061,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,BAO_0000218,CHEMBL627700,13807,10116.0,Intermediate,1,,,50597,N,1,,
12062,,Total drug exposure is determined after oral dosing in rats.,,BAO_0000218,CHEMBL627701,14127,10116.0,Intermediate,1,,,50597,N,1,,
12063,,Total drug exposure (5 mg/kg) when administered intravenously,,BAO_0000218,CHEMBL627702,15116,,Autocuration,1,,,22224,U,0,,
12064,,Total drug exposure (5 mg/kg) when administered orally,,BAO_0000218,CHEMBL627703,15116,,Autocuration,1,,,22224,U,0,,
12065,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,BAO_0000218,CHEMBL626873,15604,314293.0,Autocuration,1,,,22224,U,0,,
12066,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,BAO_0000218,CHEMBL629583,15604,10116.0,Intermediate,1,,,50597,N,1,,
12067,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,BAO_0000218,CHEMBL629584,15604,9615.0,Intermediate,1,,,50588,N,1,,
12068,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,BAO_0000218,CHEMBL629585,15604,9615.0,Intermediate,1,,,50588,N,1,,
12069,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629586,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
12070,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629587,13751,10116.0,Intermediate,1,,,50597,N,1,955.0,
12071,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629588,13751,10116.0,Intermediate,1,,,50597,N,1,,
12072,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629589,13751,10116.0,Intermediate,1,,,50597,N,1,,
12073,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629590,13751,10116.0,Intermediate,1,,,50597,N,1,,
12074,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629591,13751,10116.0,Intermediate,1,,,50597,N,1,,
12075,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629592,13751,10116.0,Intermediate,1,,,50597,N,1,,
12076,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629593,13751,10116.0,Intermediate,1,,,50597,N,1,,
12077,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629594,13751,10116.0,Intermediate,1,,,50597,N,1,,
12078,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL629595,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12079,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL630290,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12080,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627137,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12081,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627138,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12082,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627139,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12083,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627140,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12084,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627141,13751,10116.0,Intermediate,1,,,50597,N,1,948.0,
12085,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627142,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12086,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627143,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12087,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL874449,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12088,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627144,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12089,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627145,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12090,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627146,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12091,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627147,13751,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12092,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627148,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12093,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627149,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12094,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL632160,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12095,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL632161,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12096,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL632162,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12097,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL632163,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12098,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL874469,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12099,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627182,13751,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12100,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627183,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12101,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627184,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12102,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627185,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12103,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627186,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12104,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627187,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12105,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627188,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12106,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627189,13751,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12107,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627190,13751,10116.0,Intermediate,1,,,50597,N,1,,
12108,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627191,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12109,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627192,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12110,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL627193,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12111,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL874590,10911,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12112,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627194,10911,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12113,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627195,10911,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12114,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627196,10911,10116.0,Intermediate,1,,,50597,N,1,992.0,
12115,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627197,10911,10116.0,Intermediate,1,,,50597,N,1,992.0,
12116,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627198,10911,10116.0,Intermediate,1,,,50597,N,1,992.0,
12117,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,BAO_0000218,CHEMBL627199,10911,10116.0,Intermediate,1,,,50597,N,1,992.0,
12118,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627200,10911,10116.0,Intermediate,1,,,50597,N,1,992.0,
12119,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627201,10911,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12120,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627202,10911,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12121,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627203,10911,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12122,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627204,10911,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12123,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627205,10911,10116.0,Intermediate,1,,,50597,N,1,2106.0,
12124,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627206,10911,10116.0,Intermediate,1,,,50597,N,1,2106.0,
12125,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627207,10911,10116.0,Intermediate,1,,,50597,N,1,2106.0,
12126,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627208,10911,10116.0,Intermediate,1,,,50597,N,1,2106.0,
12127,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627209,10911,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12128,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627210,10911,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12129,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627211,10911,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12130,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627212,10911,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12131,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL627213,10911,10116.0,Intermediate,1,,,50597,N,1,995.0,
12132,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626599,10911,10116.0,Intermediate,1,,,50597,N,1,995.0,
12133,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626600,10911,10116.0,Intermediate,1,,,50597,N,1,995.0,
12134,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,BAO_0000218,CHEMBL626601,10911,10116.0,Intermediate,1,,,50597,N,1,995.0,
12135,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,BAO_0000019,CHEMBL627484,8081,,Autocuration,1,,,22224,U,0,,
12136,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,BAO_0000218,CHEMBL627485,17248,9541.0,Intermediate,1,,,100710,N,1,1969.0,
12137,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,BAO_0000218,CHEMBL628147,17248,9541.0,Intermediate,1,,,100710,N,1,1969.0,
12138,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,BAO_0000218,CHEMBL628148,17248,9541.0,Intermediate,1,,,100710,N,1,1969.0,
12139,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,BAO_0000218,CHEMBL628149,17248,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12140,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,BAO_0000218,CHEMBL628150,17248,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12141,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,BAO_0000218,CHEMBL628318,17248,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12142,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,BAO_0000218,CHEMBL628319,17248,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12143,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,BAO_0000218,CHEMBL875609,15592,9615.0,Intermediate,1,,,50588,N,1,,
12144,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,BAO_0000019,CHEMBL628320,7040,,Autocuration,1,,,22224,U,0,,
12145,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,BAO_0000019,CHEMBL628321,7040,,Autocuration,1,,,22224,U,0,,
12146,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,BAO_0000019,CHEMBL628322,7040,,Autocuration,1,,,22224,U,0,,
12147,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,BAO_0000019,CHEMBL628323,7040,,Autocuration,1,,,22224,U,0,,
12148,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,BAO_0000019,CHEMBL628324,7040,,Autocuration,1,,,22224,U,0,,
12149,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,BAO_0000019,CHEMBL628325,7040,,Autocuration,1,,,22224,U,0,,
12150,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,BAO_0000019,CHEMBL628326,7040,,Autocuration,1,,,22224,U,0,,
12151,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,BAO_0000218,CHEMBL628327,9614,9615.0,Intermediate,1,,,50588,N,1,1236.0,
12152,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,BAO_0000218,CHEMBL628328,9614,9615.0,Intermediate,1,,,50588,N,1,1236.0,
12153,,"Concentration of compound in blood of dog 1, after administering intravenously",,BAO_0000218,CHEMBL628329,9614,9615.0,Intermediate,1,,,50588,N,1,178.0,
12154,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,BAO_0000218,CHEMBL628330,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12155,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,BAO_0000218,CHEMBL628331,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12156,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,BAO_0000218,CHEMBL628332,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12157,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,BAO_0000218,CHEMBL628333,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12158,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,BAO_0000218,CHEMBL628334,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12159,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,BAO_0000218,CHEMBL628335,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12160,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,BAO_0000218,CHEMBL628336,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12161,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,BAO_0000218,CHEMBL628337,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12162,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,BAO_0000218,CHEMBL628338,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12163,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,BAO_0000218,CHEMBL875610,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12164,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,BAO_0000218,CHEMBL628339,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12165,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,BAO_0000218,CHEMBL628340,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12166,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,BAO_0000218,CHEMBL628341,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12167,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,BAO_0000218,CHEMBL622214,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12168,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,BAO_0000218,CHEMBL623167,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12169,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,BAO_0000218,CHEMBL623168,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12170,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,BAO_0000218,CHEMBL623169,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12171,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,BAO_0000218,CHEMBL623170,8608,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12172,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,BAO_0000218,CHEMBL627224,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12173,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,BAO_0000218,CHEMBL875634,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12174,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,BAO_0000218,CHEMBL627225,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12175,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,BAO_0000218,CHEMBL627226,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12176,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,BAO_0000218,CHEMBL626083,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12177,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,BAO_0000218,CHEMBL626084,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12178,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,BAO_0000218,CHEMBL626085,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12179,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,BAO_0000218,CHEMBL626086,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12180,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,BAO_0000218,CHEMBL626087,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12181,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,BAO_0000218,CHEMBL626088,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12182,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,BAO_0000218,CHEMBL626089,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12183,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,BAO_0000218,CHEMBL626090,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12184,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,BAO_0000218,CHEMBL626091,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12185,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,BAO_0000218,CHEMBL626092,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12186,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,BAO_0000218,CHEMBL626093,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12187,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,BAO_0000218,CHEMBL626094,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12188,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,BAO_0000218,CHEMBL626095,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12189,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,BAO_0000218,CHEMBL626096,8608,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12190,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,BAO_0000218,CHEMBL626097,15604,314293.0,Autocuration,1,,,22224,U,0,,
12191,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,BAO_0000218,CHEMBL626098,15604,10116.0,Intermediate,1,,,50597,N,1,,
12192,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,BAO_0000218,CHEMBL626099,1806,,Autocuration,1,,,22224,U,0,1969.0,
12193,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,BAO_0000218,CHEMBL626100,1806,,Autocuration,1,,,22224,U,0,1969.0,
12194,,AUC 0-inf in dog,,BAO_0000218,CHEMBL626101,17237,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12195,,AUC 0-inf in guinea pig,,BAO_0000218,CHEMBL626102,17237,10141.0,Intermediate,1,,,50512,N,1,1969.0,
12196,,AUC 0-t in dog,,BAO_0000218,CHEMBL626103,17237,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12197,,AUC 0-t in guinea pig,,BAO_0000218,CHEMBL628391,17237,10141.0,Intermediate,1,,,50512,N,1,1969.0,
12198,,The compound was tested for brain to plasma partition in rat,,BAO_0000218,CHEMBL628392,15194,10116.0,Intermediate,1,,,50597,N,1,,
12199,,The compound was tested for brain to plasma partition in rat.,,BAO_0000218,CHEMBL628393,15194,10116.0,Intermediate,1,,,50597,N,1,,
12200,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,BAO_0000019,CHEMBL628394,8787,,Autocuration,1,,,22224,U,0,178.0,
12201,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL628395,17025,9615.0,Intermediate,1,,,50588,N,1,,
12202,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL628396,17025,314293.0,Autocuration,1,,,22224,U,0,,
12203,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL628397,17025,9986.0,Intermediate,1,,,50592,N,1,,
12204,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL628398,17025,10116.0,Intermediate,1,,,50597,N,1,,
12205,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,BAO_0000218,CHEMBL628399,4236,9544.0,Intermediate,1,,,50797,N,1,,
12206,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,BAO_0000218,CHEMBL628400,15343,9615.0,Intermediate,1,,,50588,N,1,,
12207,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,BAO_0000218,CHEMBL874907,15343,10116.0,Intermediate,1,,,50597,N,1,,
12208,,Area under curve of the compound was determined,,BAO_0000019,CHEMBL628401,17720,,Autocuration,1,,,22224,U,0,,
12209,,AUC in monkeys at a dose of 1 mg/kg,,BAO_0000218,CHEMBL628402,17788,314293.0,Autocuration,1,,,22224,U,0,1969.0,
12210,,AUC in rats at a dose of 1 mg/kg,,BAO_0000218,CHEMBL628403,17788,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12211,,Compound was evaluated for the overall absorbance loss at pH of 2,,BAO_0000019,CHEMBL628404,8778,,Autocuration,1,,,22224,U,0,,
12212,,Compound was evaluated for the overall absorbance loss at pH of 4,,BAO_0000019,CHEMBL628405,8778,,Autocuration,1,,,22224,U,0,,
12213,,Compound was evaluated for the overall absorbance loss at pH of 7,,BAO_0000019,CHEMBL628406,8778,,Autocuration,1,,,22224,U,0,,
12214,,Compound was evaluated for its absorption in the rats,,BAO_0000218,CHEMBL628407,2249,10116.0,Intermediate,1,,,50597,N,1,,
12215,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,BAO_0000218,CHEMBL628408,8881,10116.0,Intermediate,1,,,50597,N,1,1088.0,
12216,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,BAO_0000218,CHEMBL629171,8881,10116.0,Intermediate,1,,,50597,N,1,1088.0,
12217,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,BAO_0000218,CHEMBL629172,8881,10116.0,Intermediate,1,,,50597,N,1,1088.0,
12218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,BAO_0000218,CHEMBL629173,8881,10116.0,Intermediate,1,,,50597,N,1,1088.0,
12219,,In vitro percent permeability into rat ileum,,BAO_0000218,CHEMBL629174,15286,10116.0,Intermediate,1,,,50597,N,1,,
12220,,In vitro percent permeability into rat ileum; Range is 10-17,,BAO_0000218,CHEMBL629175,15286,10116.0,Intermediate,1,,,50597,N,1,,
12221,,In vitro percent permeability into rat ileum; Range is 10-18,,BAO_0000218,CHEMBL629176,15286,10116.0,Intermediate,1,,,50597,N,1,,
12222,,In vitro percent permeability into rat ileum; Range is 10-19,,BAO_0000218,CHEMBL629177,15286,10116.0,Intermediate,1,,,50597,N,1,,
12223,,In vitro percent permeability into rat ileum; Range is 12-15,,BAO_0000218,CHEMBL629178,15286,10116.0,Intermediate,1,,,50597,N,1,,
12224,,In vitro percent permeability into rat ileum; Range is 13-19,,BAO_0000218,CHEMBL631869,15286,10116.0,Intermediate,1,,,50597,N,1,,
12225,,In vitro percent permeability into rat ileum; Range is 14-17,,BAO_0000218,CHEMBL631870,15286,10116.0,Intermediate,1,,,50597,N,1,,
12226,,In vitro percent permeability into rat ileum; Range is 15-18,,BAO_0000218,CHEMBL631871,15286,10116.0,Intermediate,1,,,50597,N,1,,
12227,,In vitro percent permeability into rat ileum; Range is 2-5,,BAO_0000218,CHEMBL631872,15286,10116.0,Intermediate,1,,,50597,N,1,,
12228,,In vitro percent permeability into rat ileum; Range is 23-42,,BAO_0000221,CHEMBL875775,15286,,Autocuration,1,,,22224,U,0,2116.0,
12229,,In vitro percent permeability into rat ileum; Range is 28-36,,BAO_0000218,CHEMBL631873,15286,10116.0,Intermediate,1,,,50597,N,1,,
12230,,In vitro percent permeability into rat ileum; Range is 29-35,,BAO_0000218,CHEMBL631874,15286,10116.0,Intermediate,1,,,50597,N,1,,
12231,,In vitro percent permeability into rat ileum; Range is 46-66,,BAO_0000218,CHEMBL631875,15286,10116.0,Intermediate,1,,,50597,N,1,,
12232,,In vitro percent permeability into rat ileum; Range is 50-68,,BAO_0000218,CHEMBL631876,15286,10116.0,Intermediate,1,,,50597,N,1,,
12233,,In vitro percent permeability into rat ileum; Range is 78-81,,BAO_0000218,CHEMBL631877,15286,10116.0,Intermediate,1,,,50597,N,1,,
12234,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,BAO_0000218,CHEMBL631878,15286,10116.0,Intermediate,1,,,50597,N,1,,
12235,,In vitro percent permeability into rat ileum; nd indicates not detected,,BAO_0000218,CHEMBL631879,15286,10116.0,Intermediate,1,,,50597,N,1,,
12236,,In vitro percent permeability into rat ileum; nt indicates not detected,,BAO_0000218,CHEMBL631880,15286,10116.0,Intermediate,1,,,50597,N,1,,
12237,,In vitro percent permeability into rat ileum; nt indicates not tested,,BAO_0000218,CHEMBL631881,15286,10116.0,Intermediate,1,,,50597,N,1,,
12238,,Compound was tested for oral absorption in bile-duct cannulated rats,,BAO_0000218,CHEMBL631882,13770,10116.0,Intermediate,1,,,50597,N,1,,
12239,,Compound was tested for oral absorption in bile-duct cannulated rats.,,BAO_0000218,CHEMBL630749,13770,10116.0,Intermediate,1,,,50597,N,1,,
12240,,Oral absorption using Caco-2 cell monolayers.,,BAO_0000218,CHEMBL630750,5202,9606.0,Intermediate,1,,,50587,N,1,,
12241,,Percent of the drug absorbed after administration to humans was determined,,BAO_0000218,CHEMBL630253,14920,9606.0,Intermediate,1,,,50587,N,1,,
12242,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,BAO_0000218,CHEMBL630254,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12243,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,BAO_0000218,CHEMBL630255,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12244,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,BAO_0000218,CHEMBL630256,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12245,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,BAO_0000218,CHEMBL875781,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12246,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL630257,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12247,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,BAO_0000218,CHEMBL630258,13751,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12248,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,BAO_0000218,CHEMBL630259,15807,10116.0,Intermediate,1,,,50597,N,1,,
12249,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,BAO_0000218,CHEMBL630260,15807,10116.0,Intermediate,1,,,50597,N,1,2435.0,
12250,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,BAO_0000218,CHEMBL630261,15807,10116.0,Intermediate,1,,,50597,N,1,2435.0,
12251,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,BAO_0000218,CHEMBL630262,14950,10116.0,Intermediate,1,,,50597,N,1,,
12252,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,BAO_0000218,CHEMBL630263,14950,10116.0,Intermediate,1,,,50597,N,1,,
12253,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,BAO_0000218,CHEMBL630264,14950,10116.0,Intermediate,1,,,50597,N,1,,
12254,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,BAO_0000218,CHEMBL630265,14950,10116.0,Intermediate,1,,,50597,N,1,,
12255,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,BAO_0000218,CHEMBL630266,14950,10116.0,Intermediate,1,,,50597,N,1,,
12256,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,BAO_0000218,CHEMBL630267,14950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12257,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,BAO_0000218,CHEMBL630268,14950,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12258,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,BAO_0000218,CHEMBL630269,14950,10116.0,Intermediate,1,,,50597,N,1,,
12259,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,BAO_0000218,CHEMBL630270,14950,10116.0,Intermediate,1,,,50597,N,1,,
12260,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,BAO_0000218,CHEMBL630141,14950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12261,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,BAO_0000218,CHEMBL630142,14950,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12262,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,BAO_0000218,CHEMBL630143,14950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12263,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,BAO_0000218,CHEMBL630144,14950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12264,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,BAO_0000218,CHEMBL630145,14950,10116.0,Intermediate,1,,,50597,N,1,2367.0,
12265,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,BAO_0000218,CHEMBL630146,14950,10116.0,Intermediate,1,,,50597,N,1,2367.0,
12266,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,BAO_0000218,CHEMBL630147,14950,10116.0,Intermediate,1,,,50597,N,1,,
12267,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,BAO_0000218,CHEMBL630148,14950,10116.0,Intermediate,1,,,50597,N,1,,
12268,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,BAO_0000218,CHEMBL630149,14950,10116.0,Intermediate,1,,,50597,N,1,,
12269,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,BAO_0000218,CHEMBL630150,14950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
12270,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,BAO_0000218,CHEMBL630151,14950,10116.0,Intermediate,1,,,50597,N,1,2106.0,
12271,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,BAO_0000218,CHEMBL632031,14950,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12272,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,BAO_0000218,CHEMBL632032,14950,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12273,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,BAO_0000218,CHEMBL632033,14950,10116.0,Intermediate,1,,,50597,N,1,,
12274,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,BAO_0000218,CHEMBL632034,14950,10116.0,Intermediate,1,,,50597,N,1,,
12275,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,BAO_0000218,CHEMBL632035,14950,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12276,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,BAO_0000218,CHEMBL632036,14950,10116.0,Intermediate,1,,,50597,N,1,,
12277,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,BAO_0000218,CHEMBL632037,14950,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12278,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,BAO_0000218,CHEMBL632038,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12279,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,BAO_0000218,CHEMBL632039,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12280,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,BAO_0000218,CHEMBL632040,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12281,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,BAO_0000218,CHEMBL632041,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12282,,"Concentration of compound in blood of dog 2, after administering intravenously",,BAO_0000218,CHEMBL632042,9614,9615.0,Intermediate,1,,,50588,N,1,178.0,
12283,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,BAO_0000218,CHEMBL632043,9614,9615.0,Intermediate,1,,,50588,N,1,,
12284,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,BAO_0000218,CHEMBL632044,9614,9615.0,Intermediate,1,,,50588,N,1,,
12285,,"Concentration of compound in liver of dog 1, after administering intravenously",,BAO_0000218,CHEMBL632045,9614,9615.0,Intermediate,1,,,50588,N,1,2107.0,
12286,,"Concentration of compound in liver of dog 2, after administering intravenously",,BAO_0000218,CHEMBL632046,9614,9615.0,Intermediate,1,,,50588,N,1,2107.0,
12287,,"Concentration of compound in lung of dog 1, after administering intravenously",,BAO_0000218,CHEMBL632047,9614,9615.0,Intermediate,1,,,50588,N,1,2048.0,
12288,,"Concentration of compound in lung of dog 2, after administering intravenously",,BAO_0000218,CHEMBL632048,9614,9615.0,Intermediate,1,,,50588,N,1,2048.0,
12289,,"Concentration of compound in muscle of dog 1, after administering intravenously",,BAO_0000218,CHEMBL632049,9614,9615.0,Intermediate,1,,,50588,N,1,2385.0,
12290,,"Concentration of compound in muscle of dog 2, after administering intravenously",,BAO_0000218,CHEMBL876418,9614,9615.0,Intermediate,1,,,50588,N,1,2385.0,
12291,,"Concentration of compound in spleen of dog 1,after administering intravenously",,BAO_0000218,CHEMBL632050,9614,9615.0,Intermediate,1,,,50588,N,1,2106.0,
12292,,"Concentration of compound in spleen of dog 2, after administering intravenously",,BAO_0000218,CHEMBL632051,9614,9615.0,Intermediate,1,,,50588,N,1,2106.0,
12293,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,BAO_0000218,CHEMBL632052,10353,,Autocuration,1,,,22224,U,0,,
12294,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,BAO_0000218,CHEMBL632053,10353,,Autocuration,1,,,22224,U,0,,
12295,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,BAO_0000218,CHEMBL632054,10353,,Autocuration,1,,,22224,U,0,,
12296,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,BAO_0000218,CHEMBL632055,10353,,Autocuration,1,,,22224,U,0,,
12297,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,BAO_0000218,CHEMBL631181,10353,,Autocuration,1,,,22224,U,0,,
12298,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,BAO_0000218,CHEMBL631182,9196,,Autocuration,1,,,22224,U,0,,
12299,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,CHEMBL631183,9196,,Autocuration,1,,,22224,U,0,,
12300,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL631184,9196,,Autocuration,1,,,22224,U,0,,
12301,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL629774,9196,,Autocuration,1,,,22224,U,0,,
12302,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,CHEMBL629775,9196,,Autocuration,1,,,22224,U,0,,
12303,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL876549,9196,,Autocuration,1,,,22224,U,0,,
12304,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL628172,9196,,Autocuration,1,,,22224,U,0,,
12305,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,CHEMBL628173,9196,,Autocuration,1,,,22224,U,0,,
12306,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,BAO_0000218,CHEMBL628174,9196,,Autocuration,1,,,22224,U,0,,
12307,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,BAO_0000218,CHEMBL628175,9196,,Autocuration,1,,,22224,U,0,,
12308,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL628176,9196,,Autocuration,1,,,22224,U,0,,
12309,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL628177,9196,,Autocuration,1,,,22224,U,0,,
12310,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL628178,9196,,Autocuration,1,,,22224,U,0,,
12311,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,CHEMBL628179,9196,,Autocuration,1,,,22224,U,0,,
12312,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,BAO_0000218,CHEMBL628180,9196,,Autocuration,1,,,22224,U,0,,
12313,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,BAO_0000218,CHEMBL628181,9196,,Autocuration,1,,,22224,U,0,,
12314,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL628182,9196,,Autocuration,1,,,22224,U,0,,
12315,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,CHEMBL628183,9196,,Autocuration,1,,,22224,U,0,,
12316,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,BAO_0000218,CHEMBL628184,9196,,Autocuration,1,,,22224,U,0,,
12317,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL628185,9196,,Autocuration,1,,,22224,U,0,,
12318,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL875617,9196,,Autocuration,1,,,22224,U,0,,
12319,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,BAO_0000218,CHEMBL628186,9196,,Autocuration,1,,,22224,U,0,,
12320,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL628187,9196,,Autocuration,1,,,22224,U,0,,
12321,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL628188,9196,,Autocuration,1,,,22224,U,0,,
12322,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,CHEMBL628189,9196,,Autocuration,1,,,22224,U,0,,
12323,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,BAO_0000218,CHEMBL628190,9196,,Autocuration,1,,,22224,U,0,,
12324,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL628191,9196,,Autocuration,1,,,22224,U,0,,
12325,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,BAO_0000218,CHEMBL626513,9196,,Autocuration,1,,,22224,U,0,,
12326,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,BAO_0000218,CHEMBL626514,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12327,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,BAO_0000218,CHEMBL626515,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12328,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,BAO_0000218,CHEMBL626516,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12329,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,BAO_0000218,CHEMBL626517,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12330,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,BAO_0000218,CHEMBL626518,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12331,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,BAO_0000218,CHEMBL626519,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12332,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,BAO_0000218,CHEMBL626520,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12333,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,BAO_0000218,CHEMBL626521,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12334,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,BAO_0000218,CHEMBL626522,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12335,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,BAO_0000218,CHEMBL626523,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12336,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,BAO_0000218,CHEMBL626524,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12337,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,BAO_0000218,CHEMBL626688,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12338,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,BAO_0000218,CHEMBL626689,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12339,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,BAO_0000218,CHEMBL626690,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12340,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,BAO_0000218,CHEMBL626691,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12341,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,BAO_0000218,CHEMBL627319,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12342,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,BAO_0000218,CHEMBL624052,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12343,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,BAO_0000218,CHEMBL624053,8608,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12344,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL624054,8085,10116.0,Intermediate,1,,,50597,N,1,,
12345,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL624055,8085,10116.0,Intermediate,1,,,50597,N,1,,
12346,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL624056,8085,10116.0,Intermediate,1,,,50597,N,1,,
12347,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL624057,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12348,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL622281,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12349,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL622282,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12350,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL622283,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12351,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL622284,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12352,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL622285,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12353,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,BAO_0000218,CHEMBL622286,8085,10116.0,Intermediate,1,,,50597,N,1,995.0,
12354,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,BAO_0000100,CHEMBL622287,7657,,Autocuration,1,,,22224,U,0,,
12355,,Partition coefficient (logD7.4),,BAO_0000218,CHEMBL622288,8935,10090.0,Intermediate,1,,,50594,N,1,,
12356,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,BAO_0000218,CHEMBL622289,13792,10090.0,Intermediate,1,,,50594,N,1,,
12357,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,BAO_0000218,CHEMBL622290,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
12358,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,BAO_0000218,CHEMBL622291,13792,10090.0,Intermediate,1,,,50594,N,1,,
12359,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,BAO_0000218,CHEMBL622292,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
12360,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,BAO_0000218,CHEMBL622293,13792,10090.0,Intermediate,1,,,50594,N,1,,
12361,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,BAO_0000218,CHEMBL622294,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
12362,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,BAO_0000218,CHEMBL622295,13792,10090.0,Intermediate,1,,,50594,N,1,,
12363,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,BAO_0000218,CHEMBL622296,13792,10116.0,Intermediate,1,,,50597,N,1,955.0,
12364,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,BAO_0000218,CHEMBL874409,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12365,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,BAO_0000218,CHEMBL622297,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12366,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,BAO_0000218,CHEMBL622298,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12367,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,BAO_0000218,CHEMBL622299,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12368,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,BAO_0000218,CHEMBL622300,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12369,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,BAO_0000218,CHEMBL622301,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12370,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,BAO_0000218,CHEMBL622302,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12371,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,BAO_0000218,CHEMBL622303,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12372,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,BAO_0000218,CHEMBL622304,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12373,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,BAO_0000218,CHEMBL622305,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12374,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,BAO_0000218,CHEMBL622306,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12375,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,BAO_0000218,CHEMBL626864,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12376,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,BAO_0000218,CHEMBL626865,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12377,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,BAO_0000218,CHEMBL626866,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12378,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,BAO_0000218,CHEMBL626867,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12379,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,BAO_0000218,CHEMBL626868,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12380,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,BAO_0000218,CHEMBL626869,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12381,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,BAO_0000218,CHEMBL626870,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12382,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,BAO_0000218,CHEMBL626871,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12383,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,BAO_0000218,CHEMBL626872,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12384,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,BAO_0000218,CHEMBL632185,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12385,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,BAO_0000218,CHEMBL632186,14103,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12386,,Amount of acetic acid produced by the compound,,BAO_0000019,CHEMBL629310,12904,,Autocuration,1,,,22224,U,0,,
12387,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,BAO_0000019,CHEMBL629311,12904,,Autocuration,1,,,22224,U,0,,
12388,,Log of (Cbrain/Cblood) in rats,,BAO_0000218,CHEMBL629312,9663,10116.0,Intermediate,1,,,50597,N,1,,
12389,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,BAO_0000221,CHEMBL629313,7652,,Autocuration,1,,,22224,U,0,,
12390,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,BAO_0000221,CHEMBL629314,7652,,Autocuration,1,,,22224,U,0,,
12391,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,BAO_0000221,CHEMBL629315,7652,,Autocuration,1,,,22224,U,0,,
12392,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,BAO_0000219,CHEMBL629316,7652,,Autocuration,1,,,22224,U,0,,
12393,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,BAO_0000221,CHEMBL629317,7652,,Autocuration,1,,,22224,U,0,,
12394,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629318,7652,,Autocuration,1,,,22224,U,0,,
12395,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,BAO_0000019,CHEMBL877497,7652,,Autocuration,1,,,22224,U,0,,
12396,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629319,7652,,Autocuration,1,,,22224,U,0,,
12397,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629320,7652,,Autocuration,1,,,22224,U,0,,
12398,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629496,7652,,Autocuration,1,,,22224,U,0,,
12399,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629497,7652,,Autocuration,1,,,22224,U,0,,
12400,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629498,7652,,Autocuration,1,,,22224,U,0,,
12401,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629499,7652,,Autocuration,1,,,22224,U,0,,
12402,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629500,7652,,Autocuration,1,,,22224,U,0,,
12403,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629501,7652,,Autocuration,1,,,22224,U,0,,
12404,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,BAO_0000019,CHEMBL629502,7652,,Autocuration,1,,,22224,U,0,,
12405,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,BAO_0000218,CHEMBL629503,8267,,Autocuration,1,,,22224,U,0,,
12406,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,BAO_0000218,CHEMBL629504,8267,9615.0,Intermediate,1,,,50588,N,1,,
12407,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,BAO_0000019,CHEMBL629505,14479,,Autocuration,1,,,22224,U,0,,
12408,,Compound was evaluated for total body clearance,,BAO_0000019,CHEMBL629506,17515,,Autocuration,1,,,22224,U,0,,
12409,,Compound was evaluated for volume of distribution at steady state,,BAO_0000019,CHEMBL629507,17515,,Autocuration,1,,,22224,U,0,,
12410,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,BAO_0000019,CHEMBL877498,8142,,Autocuration,1,,,22224,U,0,,
12411,,Percentage of the diamine which is monoprotonated at pH 7.4,,BAO_0000019,CHEMBL629508,14849,,Autocuration,1,,,22224,U,0,,
12412,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,BAO_0000019,CHEMBL629509,7653,,Autocuration,1,,,22224,U,0,,
12413,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,BAO_0000218,CHEMBL629510,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12414,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,BAO_0000218,CHEMBL629511,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12415,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,CHEMBL629512,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12416,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,CHEMBL629513,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12417,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,BAO_0000218,CHEMBL629514,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12418,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,CHEMBL628447,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12419,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,BAO_0000218,CHEMBL628448,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12420,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,BAO_0000218,CHEMBL628449,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12421,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,BAO_0000218,CHEMBL631119,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12422,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,BAO_0000218,CHEMBL631120,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12423,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,BAO_0000218,CHEMBL631121,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12424,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,BAO_0000218,CHEMBL874458,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12425,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,CHEMBL631122,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12426,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,CHEMBL631123,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12427,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,CHEMBL631124,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12428,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,BAO_0000218,CHEMBL631125,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12429,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,CHEMBL631290,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12430,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,CHEMBL631291,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12431,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,CHEMBL631292,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12432,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,BAO_0000218,CHEMBL631293,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12433,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,BAO_0000218,CHEMBL631294,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12434,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,BAO_0000218,CHEMBL631295,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12435,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,BAO_0000218,CHEMBL631296,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12436,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,BAO_0000218,CHEMBL631297,8631,10116.0,Intermediate,1,,,50597,N,1,178.0,
12437,,Maximum biodistribution (Bmax) was determined.,,BAO_0000218,CHEMBL631298,10263,,Autocuration,1,,,22224,U,0,,
12438,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,CHEMBL631299,12364,10090.0,Intermediate,1,,,50594,N,1,,
12439,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,CHEMBL631300,12364,10090.0,Intermediate,1,,,50594,N,1,,
12440,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,CHEMBL631301,12364,10090.0,Intermediate,1,,,50594,N,1,,
12441,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,BAO_0000218,CHEMBL630291,12364,10090.0,Intermediate,1,,,50594,N,1,,
12442,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,CHEMBL630292,14793,,Autocuration,1,,,22224,U,0,,
12443,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,CHEMBL630293,14793,,Autocuration,1,,,22224,U,0,,
12444,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,BAO_0000218,CHEMBL630294,14793,,Autocuration,1,,,22224,U,0,,
12445,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,CHEMBL630295,14793,,Autocuration,1,,,22224,U,0,,
12446,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,CHEMBL630296,14793,,Autocuration,1,,,22224,U,0,,
12447,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,CHEMBL626782,14793,,Autocuration,1,,,22224,U,0,,
12448,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,CHEMBL626783,14793,,Autocuration,1,,,22224,U,0,,
12449,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,CHEMBL626784,14793,,Autocuration,1,,,22224,U,0,,
12450,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,CHEMBL626785,14793,,Autocuration,1,,,22224,U,0,,
12451,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,CHEMBL626786,14793,,Autocuration,1,,,22224,U,0,,
12452,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL626787,9196,,Autocuration,1,,,22224,U,0,,
12453,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,BAO_0000218,CHEMBL626788,9196,,Autocuration,1,,,22224,U,0,,
12454,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL625927,9196,,Autocuration,1,,,22224,U,0,,
12455,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL625928,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12456,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,CHEMBL625929,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12457,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,BAO_0000218,CHEMBL625930,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12458,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,BAO_0000218,CHEMBL625931,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12459,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,BAO_0000218,CHEMBL627230,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12460,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627231,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12461,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,CHEMBL627232,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12462,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,BAO_0000218,CHEMBL627233,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12463,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL875470,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12464,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627234,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12465,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627235,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12466,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627236,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12467,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627237,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12468,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627238,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12469,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627239,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12470,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627240,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12471,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627241,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12472,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627242,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12473,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,BAO_0000218,CHEMBL627243,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12474,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,CHEMBL627244,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12475,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627245,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12476,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627246,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12477,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627247,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12478,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627248,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12479,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627249,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12480,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL625569,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12481,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL625570,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12482,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL625571,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12483,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,CHEMBL625572,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12484,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,CHEMBL625573,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12485,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,BAO_0000218,CHEMBL625574,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12486,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,BAO_0000218,CHEMBL626245,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12487,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL626246,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12488,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL626247,9196,,Autocuration,1,,,22224,U,0,,
12489,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,CHEMBL626248,9196,,Autocuration,1,,,22224,U,0,,
12490,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,CHEMBL626249,9196,,Autocuration,1,,,22224,U,0,,
12491,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL626420,9196,,Autocuration,1,,,22224,U,0,,
12492,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,CHEMBL626421,9196,,Autocuration,1,,,22224,U,0,,
12493,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,CHEMBL626422,9196,,Autocuration,1,,,22224,U,0,,
12494,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL626423,9196,,Autocuration,1,,,22224,U,0,,
12495,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL626424,9196,,Autocuration,1,,,22224,U,0,,
12496,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,BAO_0000218,CHEMBL626425,12023,9615.0,Intermediate,1,,,50588,N,1,,
12497,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,BAO_0000218,CHEMBL875476,12023,10116.0,Intermediate,1,,,50597,N,1,,
12498,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,BAO_0000218,CHEMBL626426,12023,9541.0,Intermediate,1,,,100710,N,1,,
12499,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,BAO_0000100,CHEMBL626427,10580,,Autocuration,1,,,22224,U,0,,
12500,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,BAO_0000100,CHEMBL626428,10580,,Autocuration,1,,,22224,U,0,,
12501,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,BAO_0000019,CHEMBL626429,16032,,Autocuration,1,,,22224,U,0,,
12502,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,BAO_0000019,CHEMBL625025,16032,,Autocuration,1,,,22224,U,0,1088.0,
12503,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL625026,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12504,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL625027,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12505,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL874410,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12506,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL625028,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12507,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL625029,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12508,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL625030,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12509,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL625031,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12510,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL625032,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12511,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL625033,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12512,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL625034,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12513,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624872,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12514,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624873,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12515,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624874,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12516,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624875,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12517,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624876,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12518,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624877,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12519,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624878,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12520,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624879,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12521,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624880,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12522,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624881,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12523,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,BAO_0000218,CHEMBL624882,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12524,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624883,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12525,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624884,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12526,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624885,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12527,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624886,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12528,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624887,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12529,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624888,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12530,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624889,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12531,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624890,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12532,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL621964,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12533,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL621965,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12534,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL621966,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12535,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL621967,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12536,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL622164,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12537,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,BAO_0000019,CHEMBL623097,7653,,Autocuration,1,,,22224,U,0,,
12538,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,BAO_0000019,CHEMBL623098,7653,,Autocuration,1,,,22224,U,0,,
12539,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,BAO_0000019,CHEMBL623099,7653,,Autocuration,1,,,22224,U,0,,
12540,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,BAO_0000019,CHEMBL623100,7653,,Autocuration,1,,,22224,U,0,,
12541,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,BAO_0000218,CHEMBL628673,9104,10116.0,Intermediate,1,,,50597,N,1,,
12542,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,BAO_0000218,CHEMBL628674,9104,10116.0,Intermediate,1,,,50597,N,1,,
12543,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,BAO_0000218,CHEMBL628675,9104,10116.0,Intermediate,1,,,50597,N,1,,
12544,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,BAO_0000218,CHEMBL627644,9104,10116.0,Intermediate,1,,,50597,N,1,,
12545,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,BAO_0000218,CHEMBL627645,9104,10116.0,Intermediate,1,,,50597,N,1,,
12546,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,BAO_0000218,CHEMBL627646,9104,10116.0,Intermediate,1,,,50597,N,1,,
12547,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,BAO_0000218,CHEMBL627647,9104,10116.0,Intermediate,1,,,50597,N,1,,
12548,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,BAO_0000218,CHEMBL627648,9104,10116.0,Intermediate,1,,,50597,N,1,,
12549,,Free level in rat plasma,,BAO_0000218,CHEMBL627649,12902,10116.0,Intermediate,1,,,50597,N,1,,
12550,,Level reaching in blood plasma of rat or human was determined,,BAO_0000019,CHEMBL628313,6614,,Autocuration,1,,,22224,U,0,,
12551,,Log (Cbrain/Cblood) in rats,,BAO_0000218,CHEMBL628314,9663,10116.0,Intermediate,1,,,50597,N,1,,
12552,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,BAO_0000019,CHEMBL628315,17658,,Autocuration,1,,,22224,U,0,,
12553,,Mean percentage of compound transport through membrane; expressed as membrane transport,,BAO_0000019,CHEMBL628316,17658,,Autocuration,1,,,22224,U,0,,
12554,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,BAO_0000218,CHEMBL628317,14314,,Autocuration,1,,,22224,U,0,,
12555,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,BAO_0000019,CHEMBL628473,7385,,Autocuration,1,,,22224,U,0,,
12556,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,BAO_0000019,CHEMBL628474,7385,,Autocuration,1,,,22224,U,0,,
12557,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,BAO_0000019,CHEMBL628475,7385,,Autocuration,1,,,22224,U,0,,
12558,,Net water uptake by a carrier mediated transport (%cm) mechanism,,BAO_0000019,CHEMBL628476,1329,,Autocuration,1,,,22224,U,0,,
12559,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,CHEMBL628477,12187,314293.0,Autocuration,1,,,22224,U,0,,
12560,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,BAO_0000218,CHEMBL628478,12187,9669.0,Intermediate,1,,,50506,N,1,,
12561,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,BAO_0000218,CHEMBL628479,12187,9669.0,Intermediate,1,,,50506,N,1,,
12562,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,CHEMBL628480,12187,314293.0,Autocuration,1,,,22224,U,0,,
12563,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,BAO_0000218,CHEMBL628481,12187,314293.0,Autocuration,1,,,22224,U,0,,
12564,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,BAO_0000218,CHEMBL628482,12187,10116.0,Intermediate,1,,,50597,N,1,,
12565,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,BAO_0000218,CHEMBL628483,12187,10116.0,Intermediate,1,,,50597,N,1,,
12566,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,BAO_0000218,CHEMBL628484,9278,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12567,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,BAO_0000218,CHEMBL628485,9278,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12568,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,BAO_0000218,CHEMBL628486,9278,9541.0,Intermediate,1,,,100710,N,1,1969.0,
12569,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,BAO_0000218,CHEMBL628487,9278,9606.0,Intermediate,1,,,50587,N,1,1969.0,
12570,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,BAO_0000218,CHEMBL628488,9278,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12571,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,BAO_0000218,CHEMBL628489,9278,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12572,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,BAO_0000218,CHEMBL628490,9278,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12573,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,CHEMBL628491,12186,9541.0,Intermediate,1,,,100710,N,1,,
12574,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,BAO_0000218,CHEMBL877507,12186,9541.0,Intermediate,1,,,100710,N,1,,
12575,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,BAO_0000218,CHEMBL628492,12186,,Autocuration,1,,,22224,U,0,,
12576,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,BAO_0000019,CHEMBL628493,12041,314293.0,Autocuration,1,,,22224,U,0,,
12577,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,BAO_0000019,CHEMBL628494,12041,314293.0,Autocuration,1,,,22224,U,0,,
12578,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,BAO_0000019,CHEMBL628495,12041,314293.0,Autocuration,1,,,22224,U,0,,
12579,,Permeability in Caco-2 assay at 10E-6,,BAO_0000218,CHEMBL628496,6737,9606.0,Intermediate,1,,,50587,N,1,,
12580,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,BAO_0000218,CHEMBL628497,13758,,Autocuration,1,,,22224,U,0,955.0,
12581,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,BAO_0000218,CHEMBL628498,13758,,Autocuration,1,,,22224,U,0,955.0,
12582,,Plasma protein binding was determined,,BAO_0000019,CHEMBL628499,5676,,Autocuration,1,,,22224,U,0,,
12583,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,CHEMBL627656,14793,,Autocuration,1,,,22224,U,0,,
12584,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,CHEMBL627657,14793,,Autocuration,1,,,22224,U,0,,
12585,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,CHEMBL626808,14793,,Autocuration,1,,,22224,U,0,,
12586,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,CHEMBL626809,14793,,Autocuration,1,,,22224,U,0,,
12587,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,CHEMBL626810,14793,,Autocuration,1,,,22224,U,0,,
12588,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,BAO_0000218,CHEMBL626811,14793,,Autocuration,1,,,22224,U,0,,
12589,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,BAO_0000218,CHEMBL874465,14793,,Autocuration,1,,,22224,U,0,,
12590,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,CHEMBL626812,14793,,Autocuration,1,,,22224,U,0,,
12591,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,BAO_0000218,CHEMBL626813,14793,,Autocuration,1,,,22224,U,0,,
12592,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,BAO_0000218,CHEMBL626814,14793,,Autocuration,1,,,22224,U,0,,
12593,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,BAO_0000019,CHEMBL626815,14000,,Autocuration,1,,,22224,U,0,,
12594,,Partition coefficient (logP),,BAO_0000019,CHEMBL628566,5948,,Autocuration,1,,,22224,U,0,,
12595,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,BAO_0000100,CHEMBL628567,13824,,Autocuration,1,,,22229,U,0,,
12596,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL628568,10778,,Autocuration,1,,,22229,U,0,,
12597,,C max in dog,,BAO_0000218,CHEMBL628569,17237,9615.0,Intermediate,1,,,50588,N,1,,
12598,,C max in guinea pig,,BAO_0000218,CHEMBL628570,17237,10141.0,Intermediate,1,,,50512,N,1,,
12599,,C max value was evaluated,,BAO_0000218,CHEMBL628571,2809,,Autocuration,1,,,22224,U,0,,
12600,,Cmax value after oral dose of 0.1 mg//kg,,BAO_0000218,CHEMBL628572,11954,,Autocuration,1,,,22224,U,0,,
12601,,Cmax value after oral dose of 0.3 mg/kg,,BAO_0000218,CHEMBL628573,11954,,Autocuration,1,,,22224,U,0,,
12602,,Cmax value after oral dose of 1 mg/kg,,BAO_0000218,CHEMBL628574,11954,,Autocuration,1,,,22224,U,0,,
12603,,Cmax value after oral dose of 10 mg/kg,,BAO_0000218,CHEMBL628575,11954,,Autocuration,1,,,22224,U,0,,
12604,,Cmax value after oral dose of 23.4 mg/kg,,BAO_0000218,CHEMBL628576,11954,,Autocuration,1,,,22224,U,0,,
12605,,Cmax value after oral dose of 3 mg/kg,,BAO_0000218,CHEMBL628577,11954,,Autocuration,1,,,22224,U,0,,
12606,,Cmax value after oral dose of 3.87 mg/kg,,BAO_0000218,CHEMBL628578,11954,,Autocuration,1,,,22224,U,0,,
12607,,Cmax value in female Beagle dogs,,BAO_0000218,CHEMBL874466,12768,9615.0,Intermediate,1,,,50588,N,1,,
12608,,Cmax value in male rats,,BAO_0000218,CHEMBL628579,12768,10116.0,Intermediate,1,,,50597,N,1,,
12609,,Cmax value in rat plasma when administered 20 mg/kg perorally,,BAO_0000218,CHEMBL628580,12780,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12610,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,BAO_0000218,CHEMBL628581,15592,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12611,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,BAO_0000218,CHEMBL628582,15592,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12612,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL628583,17025,9615.0,Intermediate,1,,,50588,N,1,,
12613,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL625782,17025,314293.0,Autocuration,1,,,22224,U,0,,
12614,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL625783,17025,9986.0,Intermediate,1,,,50592,N,1,,
12615,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL625784,17025,10116.0,Intermediate,1,,,50597,N,1,,
12616,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,BAO_0000218,CHEMBL625785,4236,9544.0,Intermediate,1,,,50797,N,1,1969.0,
12617,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,BAO_0000218,CHEMBL625786,15791,10116.0,Intermediate,1,,,50597,N,1,,
12618,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,BAO_0000019,CHEMBL874467,11149,,Autocuration,1,,,22224,U,0,,
12619,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,BAO_0000218,CHEMBL625787,15592,9615.0,Intermediate,1,,,50588,N,1,,
12620,,cytotoxicity against HIV protease enzyme.,,BAO_0000218,CHEMBL625964,15778,12721.0,Intermediate,1,,,50677,N,1,,
12621,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,BAO_0000218,CHEMBL625965,12745,10090.0,Intermediate,1,,,50594,N,1,,
12622,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,BAO_0000218,CHEMBL625966,12745,10090.0,Intermediate,1,,,50594,N,1,,
12623,,The plasma clearance in dog.,,BAO_0000218,CHEMBL625967,13941,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12624,,The plasma clearance in rat.,,BAO_0000218,CHEMBL625968,13941,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12625,,Clearance from plasma in male Sprague-Dawley rats,,BAO_0000218,CHEMBL625969,16449,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12626,,Clearance from plasma in male cynomolgus monkeys,,BAO_0000218,CHEMBL625970,16449,9541.0,Intermediate,1,,,100710,N,1,1969.0,
12627,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,BAO_0000218,CHEMBL625971,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12628,,Clearance of compound in dog plasma,,BAO_0000218,CHEMBL625972,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12629,,Clearance of compound in human plasma,,BAO_0000218,CHEMBL625973,14224,9606.0,Intermediate,1,,,50587,N,1,1969.0,
12630,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,BAO_0000218,CHEMBL625974,14317,9615.0,Intermediate,1,,,50588,N,1,,
12631,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,BAO_0000218,CHEMBL625975,14317,9615.0,Intermediate,1,,,50588,N,1,,
12632,,"Clearance (10 mg/kg, intravenously) in dog plasma",,BAO_0000218,CHEMBL625976,14224,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12633,,Clearance value in dog,,BAO_0000218,CHEMBL625977,17237,9615.0,Intermediate,1,,,50588,N,1,,
12634,,Clearance value in guinea pig,,BAO_0000218,CHEMBL625978,17237,10141.0,Intermediate,1,,,50512,N,1,,
12635,,Clearance values in rats after iv administration.,,BAO_0000218,CHEMBL874468,14187,10116.0,Intermediate,1,,,50597,N,1,,
12636,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,BAO_0000218,CHEMBL625421,4806,,Autocuration,1,,,22224,U,0,1969.0,
12637,,In vivo clearance (5 mg/kg) was determined in rabbits,,BAO_0000218,CHEMBL625422,15025,9986.0,Intermediate,1,,,50592,N,1,,
12638,,Plasma Clearance rate was determined for the compound in rats,,BAO_0000218,CHEMBL625423,13197,10116.0,Intermediate,1,,,50597,N,1,,
12639,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,BAO_0000218,CHEMBL625424,13197,9520.0,Autocuration,1,,,22224,U,0,,
12640,,Plasma clearance in rat,,BAO_0000218,CHEMBL625425,13960,10116.0,Intermediate,1,,,50597,N,1,,
12641,,Plasma clearance of the compound,,BAO_0000218,CHEMBL625426,17820,,Autocuration,1,,,22224,U,0,,
12642,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,BAO_0000218,CHEMBL625427,14706,10141.0,Intermediate,1,,,50512,N,1,,
12643,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,BAO_0000218,CHEMBL625428,14706,10141.0,Intermediate,1,,,50512,N,1,,
12644,,Plasma clearance was determined,,BAO_0000218,CHEMBL625429,6504,,Autocuration,1,,,22224,U,0,,
12645,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,BAO_0000218,CHEMBL625430,14925,9615.0,Intermediate,1,,,50588,N,1,,
12646,,Plasma clearance rate was determined for the compound in rats,,BAO_0000218,CHEMBL625431,13197,10116.0,Intermediate,1,,,50597,N,1,,
12647,,Plasma clearance rate was determined for the compound in squirrel monkeys,,BAO_0000218,CHEMBL627307,13197,9520.0,Autocuration,1,,,22224,U,0,,
12648,,Slow clearance (CL) was determined,,BAO_0000218,CHEMBL627308,3437,,Autocuration,1,,,22224,U,0,,
12649,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL627309,9196,,Autocuration,1,,,22224,U,0,,
12650,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,BAO_0000218,CHEMBL627310,9196,,Autocuration,1,,,22224,U,0,,
12651,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,CHEMBL627311,9196,,Autocuration,1,,,22224,U,0,,
12652,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL627312,9196,,Autocuration,1,,,22224,U,0,,
12653,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,CHEMBL627313,9196,,Autocuration,1,,,22224,U,0,,
12654,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,CHEMBL627314,9196,,Autocuration,1,,,22224,U,0,,
12655,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL627315,9196,,Autocuration,1,,,22224,U,0,,
12656,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL627316,9196,,Autocuration,1,,,22224,U,0,,
12657,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,BAO_0000218,CHEMBL627317,9196,,Autocuration,1,,,22224,U,0,,
12658,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,CHEMBL627318,9196,,Autocuration,1,,,22224,U,0,,
12659,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,CHEMBL627999,9196,,Autocuration,1,,,22224,U,0,,
12660,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,BAO_0000218,CHEMBL628000,9196,,Autocuration,1,,,22224,U,0,,
12661,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,CHEMBL628001,9196,,Autocuration,1,,,22224,U,0,,
12662,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL628002,9196,,Autocuration,1,,,22224,U,0,,
12663,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,CHEMBL625610,9196,,Autocuration,1,,,22224,U,0,,
12664,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL625611,9196,,Autocuration,1,,,22224,U,0,,
12665,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,BAO_0000218,CHEMBL625612,9196,,Autocuration,1,,,22224,U,0,,
12666,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,BAO_0000218,CHEMBL625613,9196,,Autocuration,1,,,22224,U,0,,
12667,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,BAO_0000218,CHEMBL875479,9196,,Autocuration,1,,,22224,U,0,,
12668,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,BAO_0000218,CHEMBL625614,9196,,Autocuration,1,,,22224,U,0,,
12669,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,BAO_0000218,CHEMBL625615,9196,,Autocuration,1,,,22224,U,0,,
12670,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,BAO_0000218,CHEMBL626302,9196,,Autocuration,1,,,22224,U,0,,
12671,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL626303,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12672,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,BAO_0000218,CHEMBL627420,8374,10116.0,Intermediate,1,,,50597,N,1,178.0,
12673,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,BAO_0000218,CHEMBL627421,13477,10116.0,Intermediate,1,,,50597,N,1,,
12674,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,BAO_0000218,CHEMBL625695,13477,10116.0,Intermediate,1,,,50597,N,1,,
12675,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,BAO_0000218,CHEMBL625696,13477,10116.0,Intermediate,1,,,50597,N,1,,
12676,,Distribution of compound in mice brain was measured after 1 hr,,BAO_0000218,CHEMBL875606,10009,10090.0,Intermediate,1,,,50594,N,1,955.0,
12677,,Distribution of compound in mice brain was measured after 24 hr r,,BAO_0000218,CHEMBL625697,10009,10090.0,Intermediate,1,,,50594,N,1,955.0,
12678,,Distribution of compound in mice brain was measured after 2 hr,,BAO_0000218,CHEMBL625698,10009,10090.0,Intermediate,1,,,50594,N,1,955.0,
12679,,Distribution of compound in mice brain was measured after 3 hr,,BAO_0000218,CHEMBL625699,10009,10090.0,Intermediate,1,,,50594,N,1,955.0,
12680,,Distribution of compound in mice brain was measured after 6 hr,,BAO_0000218,CHEMBL625700,10009,10090.0,Intermediate,1,,,50594,N,1,955.0,
12681,,Distribution of compound in mice liver was measured after 1 hr,,BAO_0000218,CHEMBL625701,10009,10090.0,Intermediate,1,,,50594,N,1,,
12682,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,BAO_0000218,CHEMBL625702,10009,10090.0,Intermediate,1,,,50594,N,1,,
12683,,Distribution of compound in mice liver was measured after 2 hr,,BAO_0000218,CHEMBL625703,10009,10090.0,Intermediate,1,,,50594,N,1,,
12684,,Distribution of compound in mice liver was measured after 3 hr,,BAO_0000218,CHEMBL625704,10009,10090.0,Intermediate,1,,,50594,N,1,,
12685,,Distribution of compound in mice liver was measured after 6 hr,,BAO_0000218,CHEMBL625705,10009,10090.0,Intermediate,1,,,50594,N,1,,
12686,,Distribution in dog adrenal medulla 30 min after administration.,,BAO_0000218,CHEMBL625706,8170,9615.0,Intermediate,1,,,50588,N,1,1236.0,
12687,,Distribution in dog adrenal medulla 72 hours after administration.,,BAO_0000218,CHEMBL625707,8170,9615.0,Intermediate,1,,,50588,N,1,1236.0,
12688,,Distribution in female dog Ovary 24 hours after administration.,,BAO_0000218,CHEMBL625708,8170,9615.0,Intermediate,1,,,50588,N,1,,
12689,,Distribution in female dog Ovary 72 hours after administration.,,BAO_0000218,CHEMBL625709,8170,9615.0,Intermediate,1,,,50588,N,1,,
12690,,Distribution in female dog adipose 24 hours after administration.,,BAO_0000218,CHEMBL624180,8170,9615.0,Intermediate,1,,,50588,N,1,,
12691,,Distribution in female dog adipose 72 hours after administration.,,BAO_0000218,CHEMBL624181,8170,9615.0,Intermediate,1,,,50588,N,1,,
12692,,Distribution in female dog adrenal cortex 72 hours after administration.,,BAO_0000218,CHEMBL624182,8170,9615.0,Intermediate,1,,,50588,N,1,1235.0,
12693,,Distribution in female dog adrenal cortex 72 hours after administration.,,BAO_0000218,CHEMBL624183,8170,9615.0,Intermediate,1,,,50588,N,1,1235.0,
12694,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624184,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12695,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL877489,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12696,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624185,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12697,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624186,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12698,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624187,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12699,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624188,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12700,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624189,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12701,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624190,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12702,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624191,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12703,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624192,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12704,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624193,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12705,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624194,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12706,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624891,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12707,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL624892,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12708,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL624893,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12709,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL627632,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12710,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL627633,8594,10116.0,Intermediate,1,,,50597,N,1,,
12711,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL627634,8594,10116.0,Intermediate,1,,,50597,N,1,,
12712,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL627635,8594,10116.0,Intermediate,1,,,50597,N,1,,
12713,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL627636,8594,10116.0,Intermediate,1,,,50597,N,1,,
12714,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL626816,8594,10116.0,Intermediate,1,,,50597,N,1,,
12715,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626817,8594,10116.0,Intermediate,1,,,50597,N,1,,
12716,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL626818,8594,10116.0,Intermediate,1,,,50597,N,1,,
12717,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626819,8594,10116.0,Intermediate,1,,,50597,N,1,,
12718,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL626820,8594,10116.0,Intermediate,1,,,50597,N,1,,
12719,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626821,8594,10116.0,Intermediate,1,,,50597,N,1,,
12720,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626822,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12721,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626823,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12722,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL626824,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12723,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626825,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12724,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,BAO_0000218,CHEMBL626826,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12725,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626827,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12726,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL626828,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12727,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626829,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12728,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626830,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12729,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL627150,8594,10116.0,Intermediate,1,,,50597,N,1,,
12730,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL627151,8594,10116.0,Intermediate,1,,,50597,N,1,,
12731,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,BAO_0000218,CHEMBL627152,8594,10116.0,Intermediate,1,,,50597,N,1,,
12732,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,BAO_0000218,CHEMBL627153,8594,10116.0,Intermediate,1,,,50597,N,1,,
12733,,Rate of acetate production by the compound was determined,,BAO_0000019,CHEMBL627154,12904,,Autocuration,1,,,22224,U,0,,
12734,,Rate of acetate production by the compound was determined; Not determined,,BAO_0000019,CHEMBL627155,12904,,Autocuration,1,,,22224,U,0,,
12735,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,BAO_0000019,CHEMBL627156,3730,,Autocuration,1,,,22224,U,0,,
12736,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,BAO_0000019,CHEMBL627157,3627,,Autocuration,1,,,22224,U,0,,
12737,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,BAO_0000218,CHEMBL627158,13799,9986.0,Intermediate,1,,,50592,N,1,,
12738,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,BAO_0000218,CHEMBL627159,13799,9986.0,Intermediate,1,,,50592,N,1,1969.0,
12739,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,CHEMBL627160,13799,10090.0,Intermediate,1,,,50594,N,1,,
12740,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,CHEMBL628540,13799,10116.0,Intermediate,1,,,50597,N,1,,
12741,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,CHEMBL628541,13799,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12742,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,BAO_0000218,CHEMBL628542,13799,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12743,,Solubility after at a pH 1.2,,BAO_0000100,CHEMBL628543,6629,,Autocuration,1,,,22229,U,0,,
12744,,Solubility after at pH 1.2,,BAO_0000100,CHEMBL628544,6629,,Autocuration,1,,,22229,U,0,,
12745,,Solubility after injection of water,,BAO_0000100,CHEMBL628545,6629,,Autocuration,1,,,22229,U,0,,
12746,,Statistical significance of IC 50 values; Expressed as R value,,BAO_0000019,CHEMBL628546,14000,,Autocuration,1,,,22224,U,0,,
12747,,Systemic availability with respect to methyldopa was determined,,BAO_0000019,CHEMBL874455,8267,,Autocuration,1,,,22224,U,0,,
12748,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,BAO_0000218,CHEMBL628547,13799,10116.0,Intermediate,1,,,50597,N,1,,
12749,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,BAO_0000218,CHEMBL628548,13799,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12750,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL628549,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12751,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL628550,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12752,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,BAO_0000218,CHEMBL628551,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12753,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,BAO_0000218,CHEMBL628552,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12754,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,BAO_0000218,CHEMBL628553,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12755,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,BAO_0000218,CHEMBL628554,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12756,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,CHEMBL628555,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12757,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,CHEMBL628556,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12758,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL628557,7132,9986.0,Intermediate,1,,,50592,N,1,2113.0,
12759,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL628558,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12760,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,BAO_0000218,CHEMBL628559,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12761,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL628560,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12762,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,BAO_0000218,CHEMBL874456,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12763,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,BAO_0000218,CHEMBL628561,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12764,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,BAO_0000218,CHEMBL628562,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12765,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,BAO_0000218,CHEMBL628563,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12766,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,BAO_0000218,CHEMBL628564,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12767,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,CHEMBL628565,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12768,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,CHEMBL631248,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12769,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,BAO_0000218,CHEMBL631249,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
12770,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL627214,7132,9986.0,Intermediate,1,,,50592,N,1,2113.0,
12771,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL874591,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12772,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,BAO_0000218,CHEMBL627215,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12773,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,BAO_0000218,CHEMBL625471,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
12774,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,BAO_0000218,CHEMBL625472,7132,9986.0,Intermediate,1,,,50592,N,1,,
12775,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,BAO_0000218,CHEMBL625473,7132,9986.0,Intermediate,1,,,50592,N,1,,
12776,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,BAO_0000218,CHEMBL625474,13317,9615.0,Intermediate,1,,,50588,N,1,,
12777,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,BAO_0000218,CHEMBL625475,15341,9615.0,Intermediate,1,,,50588,N,1,,
12778,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,BAO_0000218,CHEMBL625476,15341,10116.0,Intermediate,1,,,50597,N,1,,
12779,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,BAO_0000218,CHEMBL625477,15341,10116.0,Intermediate,1,,,50597,N,1,,
12780,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,BAO_0000218,CHEMBL625478,15341,10116.0,Intermediate,1,,,50597,N,1,,
12781,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,BAO_0000218,CHEMBL625479,12801,10116.0,Intermediate,1,,,50597,N,1,,
12782,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,BAO_0000218,CHEMBL625480,12801,10116.0,Intermediate,1,,,50597,N,1,,
12783,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,BAO_0000218,CHEMBL625481,14856,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12784,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,BAO_0000218,CHEMBL625482,14062,10116.0,Intermediate,1,,,50597,N,1,,
12785,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,BAO_0000218,CHEMBL625483,14062,10116.0,Intermediate,1,,,50597,N,1,,
12786,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,BAO_0000218,CHEMBL625484,14062,10116.0,Intermediate,1,,,50597,N,1,,
12787,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,BAO_0000218,CHEMBL625485,14062,10116.0,Intermediate,1,,,50597,N,1,,
12788,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,BAO_0000218,CHEMBL625486,14346,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12789,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL625487,14346,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12790,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL625488,14346,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12791,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL625489,14346,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12792,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL625490,14346,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12793,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,BAO_0000218,CHEMBL625491,14346,9615.0,Intermediate,1,,,50588,N,1,1969.0,
12794,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,BAO_0000218,CHEMBL625492,14346,10116.0,Intermediate,1,,,50597,N,1,1969.0,
12795,,plasma clearance in human,,BAO_0000218,CHEMBL625493,15711,9606.0,Intermediate,1,,,50587,N,1,1969.0,
12796,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,BAO_0000218,CHEMBL625494,14886,10116.0,Intermediate,1,,,50597,N,1,,
12797,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,BAO_0000218,CHEMBL625495,14886,10116.0,Intermediate,1,,,50597,N,1,,
12798,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,BAO_0000218,CHEMBL625496,14886,10116.0,Intermediate,1,,,50597,N,1,,
12799,,1-Octanol/water partition coefficient measured at 7.4,,BAO_0000100,CHEMBL625497,4115,,Autocuration,1,,,22229,U,0,,
12800,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625498,13733,,Autocuration,1,,,22229,U,0,,
12801,,Partition coefficient (logP),,BAO_0000019,CHEMBL625499,12102,,Autocuration,1,,,22224,U,0,,
12802,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625500,12676,,Autocuration,1,,,22229,U,0,,
12803,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625501,13733,,Autocuration,1,,,22229,U,0,,
12804,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625502,13740,,Autocuration,1,,,22229,U,0,,
12805,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,BAO_0000100,CHEMBL625503,12766,,Autocuration,1,,,22229,U,0,,
12806,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625504,2764,,Autocuration,1,,,22229,U,0,,
12807,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625505,12355,,Autocuration,1,,,22229,U,0,,
12808,,Calculated partition coefficient of the compound,,BAO_0000100,CHEMBL625506,11314,,Autocuration,1,,,22229,U,0,,
12809,,Partition coefficient (logP),,BAO_0000019,CHEMBL625507,12706,,Autocuration,1,,,22224,U,0,,
12810,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625508,12645,,Autocuration,1,,,22229,U,0,,
12811,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625509,13668,,Autocuration,1,,,22229,U,0,,
12812,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625510,12819,,Autocuration,1,,,22229,U,0,,
12813,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL883125,13668,,Autocuration,1,,,22229,U,0,,
12814,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625511,13017,,Autocuration,1,,,22229,U,0,,
12815,,Partition coefficient of the compound,,BAO_0000019,CHEMBL874650,2448,,Autocuration,1,,,22224,U,0,,
12816,,Partition coefficient of the compound,,BAO_0000019,CHEMBL625512,11526,,Autocuration,1,,,22224,U,0,,
12817,,Partition coefficient of compound was determined,,BAO_0000019,CHEMBL625513,12426,,Autocuration,1,,,22224,U,0,,
12818,,Partition coefficient was determined,,BAO_0000019,CHEMBL625514,2448,,Autocuration,1,,,22224,U,0,,
12819,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625515,12001,,Autocuration,1,,,22229,U,0,,
12820,,partition coefficient of compound was determined,,BAO_0000100,CHEMBL625516,12426,,Autocuration,1,,,22229,U,0,,
12821,,The total body administered intravenously in dog,,BAO_0000218,CHEMBL625517,13204,9615.0,Intermediate,1,,,50588,N,1,,
12822,,The total body administered intravenously in rats,,BAO_0000218,CHEMBL625518,13204,10116.0,Intermediate,1,,,50597,N,1,,
12823,,Time taken for the administration to female NIH mice weighing 25-30 g.,,BAO_0000218,CHEMBL625519,13889,10090.0,Intermediate,1,,,50594,N,1,,
12824,,Time taken for the administration,,BAO_0000019,CHEMBL625520,13889,,Autocuration,1,,,22224,U,0,,
12825,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL874651,17025,9615.0,Intermediate,1,,,50588,N,1,,
12826,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL625521,17025,314293.0,Autocuration,1,,,22224,U,0,,
12827,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL623171,17025,9986.0,Intermediate,1,,,50592,N,1,,
12828,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,BAO_0000218,CHEMBL623853,17025,10116.0,Intermediate,1,,,50597,N,1,,
12829,,Plasma clearance for the compound was determined.,,BAO_0000019,CHEMBL623854,15067,,Autocuration,1,,,22224,U,0,,
12830,,CLog P value of the compound,,BAO_0000100,CHEMBL874405,3091,,Autocuration,1,,,22224,U,0,,
12831,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL623855,15592,,Autocuration,1,,,22229,U,0,,
12832,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL623856,14738,,Autocuration,1,,,22229,U,0,,
12833,,ClogP value of the compound; nd ='no data',,BAO_0000100,CHEMBL623857,14738,,Autocuration,1,,,22224,U,0,,
12834,,ClogP value of the compound; nd ='not determined',,BAO_0000100,CHEMBL623858,14738,,Autocuration,1,,,22224,U,0,,
12835,,CLog P was determined,,BAO_0000100,CHEMBL623859,6076,,Autocuration,1,,,22224,U,0,,
12836,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL839829,17840,,Autocuration,1,,,22229,U,0,,
12837,,CLogP was calculated,,BAO_0000019,CHEMBL623860,13589,,Autocuration,1,,,22224,U,0,,
12838,,CLogP value was determined,,BAO_0000019,CHEMBL623861,17655,,Autocuration,1,,,22224,U,0,,
12839,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,BAO_0000019,CHEMBL623862,5867,,Autocuration,1,,,22224,U,0,,
12840,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL874406,5867,,Autocuration,1,,,22229,U,0,,
12841,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL623863,10783,,Autocuration,1,,,22229,U,0,,
12842,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624021,14849,,Autocuration,1,,,22229,U,0,,
12843,,Distribution in female dog adrenal medulla 24 hours after administration.,,BAO_0000218,CHEMBL624022,8170,9615.0,Intermediate,1,,,50588,N,1,1236.0,
12844,,Distribution in female dog adrenal medulla 72 hours after administration.,,BAO_0000218,CHEMBL624023,8170,9615.0,Intermediate,1,,,50588,N,1,1236.0,
12845,,Distribution in female dog bile 24 hours after administration.,,BAO_0000218,CHEMBL624024,8170,9615.0,Intermediate,1,,,50588,N,1,,
12846,,Distribution in female dog bile 72 hr after administration.,,BAO_0000218,CHEMBL624025,8170,9615.0,Intermediate,1,,,50588,N,1,,
12847,,Distribution in female dog blood 24 hours after administration.,,BAO_0000218,CHEMBL624026,8170,9615.0,Intermediate,1,,,50588,N,1,,
12848,,Distribution in female dog blood 72 hours after administration.,,BAO_0000218,CHEMBL624027,8170,9615.0,Intermediate,1,,,50588,N,1,,
12849,,Distribution in female dog heart 24 hours after administration.,,BAO_0000218,CHEMBL624028,8170,9615.0,Intermediate,1,,,50588,N,1,,
12850,,Distribution in female dog heart 72 hours after administration.,,BAO_0000218,CHEMBL624029,8170,9615.0,Intermediate,1,,,50588,N,1,,
12851,,Distribution in female dog kidney 24 hours after administration.,,BAO_0000218,CHEMBL624030,8170,9615.0,Intermediate,1,,,50588,N,1,,
12852,,Distribution in female dog kidney 72 hours after administration.,,BAO_0000218,CHEMBL624031,8170,9615.0,Intermediate,1,,,50588,N,1,,
12853,,Distribution in female dog large intestine 24 hours after administration.,,BAO_0000218,CHEMBL624032,8170,9615.0,Intermediate,1,,,50588,N,1,160.0,
12854,,Distribution in female dog large intestine 72 hours after administration.,,BAO_0000218,CHEMBL874407,8170,9615.0,Intermediate,1,,,50588,N,1,160.0,
12855,,Distribution in female dog liver 24 hours after administration.,,BAO_0000218,CHEMBL624033,8170,9615.0,Intermediate,1,,,50588,N,1,,
12856,,Distribution in female dog liver 72 hours after administration.,,BAO_0000218,CHEMBL624034,8170,9615.0,Intermediate,1,,,50588,N,1,,
12857,,Distribution in female dog lung 24 hours after administration.,,BAO_0000218,CHEMBL624035,8170,9615.0,Intermediate,1,,,50588,N,1,,
12858,,Distribution in female dog lung 72 hours after administration.,,BAO_0000218,CHEMBL624036,8170,9615.0,Intermediate,1,,,50588,N,1,,
12859,,Distribution in female dog muscle 24 hours after administration.,,BAO_0000218,CHEMBL624037,8170,9615.0,Intermediate,1,,,50588,N,1,2385.0,
12860,,Distribution in female dog muscle 72 hours after administration.,,BAO_0000218,CHEMBL624038,8170,9615.0,Intermediate,1,,,50588,N,1,2385.0,
12861,,Distribution in female dog pancreas 24 hours after administration.,,BAO_0000218,CHEMBL624039,8170,9615.0,Intermediate,1,,,50588,N,1,,
12862,,Distribution in female dog pancreas 72 hours after administration.,,BAO_0000218,CHEMBL624040,8170,9615.0,Intermediate,1,,,50588,N,1,,
12863,,Distribution in female dog small intestine 24 hours after administration.,,BAO_0000218,CHEMBL624041,8170,9615.0,Intermediate,1,,,50588,N,1,160.0,
12864,,Distribution in female dog small intestine 72 hours after administration.,,BAO_0000218,CHEMBL624042,8170,9615.0,Intermediate,1,,,50588,N,1,160.0,
12865,,Distribution in female dog spleen 24 hours after administration.,,BAO_0000218,CHEMBL624043,8170,9615.0,Intermediate,1,,,50588,N,1,2106.0,
12866,,Distribution in female dog spleen 72 hours after administration.,,BAO_0000218,CHEMBL624044,8170,9615.0,Intermediate,1,,,50588,N,1,2106.0,
12867,,Distribution in female dog stomach 24 hours after administration.,,BAO_0000218,CHEMBL624045,8170,9615.0,Intermediate,1,,,50588,N,1,945.0,
12868,,Distribution in female dog stomach 72 hours after administration.,,BAO_0000218,CHEMBL624046,8170,9615.0,Intermediate,1,,,50588,N,1,945.0,
12869,,Distribution in female dog thyroid 24 hours after administration.,,BAO_0000218,CHEMBL624047,8170,9615.0,Intermediate,1,,,50588,N,1,2046.0,
12870,,Distribution in female dog thyroid 72 hours after administration.,,BAO_0000218,CHEMBL624048,8170,9615.0,Intermediate,1,,,50588,N,1,2046.0,
12871,,Distribution in female dog urine 24 hours after administration.,,BAO_0000218,CHEMBL874408,8170,9615.0,Intermediate,1,,,50588,N,1,1088.0,
12872,,Distribution in female dog urine 72 hr after administration.,,BAO_0000218,CHEMBL624049,8170,9615.0,Intermediate,1,,,50588,N,1,1088.0,
12873,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,BAO_0000218,CHEMBL624050,14283,,Autocuration,1,,,22224,U,0,1969.0,
12874,,Plasma concentration at 7 hr after intravenous dosing,,BAO_0000019,CHEMBL624051,5623,,Autocuration,1,,,22224,U,0,,
12875,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,BAO_0000218,CHEMBL623278,13477,10116.0,Intermediate,1,,,50597,N,1,,
12876,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,BAO_0000218,CHEMBL623279,13477,10116.0,Intermediate,1,,,50597,N,1,,
12877,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,BAO_0000218,CHEMBL623280,13477,10116.0,Intermediate,1,,,50597,N,1,,
12878,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,BAO_0000218,CHEMBL623963,13477,10116.0,Intermediate,1,,,50597,N,1,,
12879,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,BAO_0000218,CHEMBL623964,13477,10116.0,Intermediate,1,,,50597,N,1,,
12880,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,BAO_0000218,CHEMBL623965,13477,10116.0,Intermediate,1,,,50597,N,1,,
12881,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,BAO_0000218,CHEMBL623966,13477,10116.0,Intermediate,1,,,50597,N,1,,
12882,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,BAO_0000218,CHEMBL874415,13477,10116.0,Intermediate,1,,,50597,N,1,,
12883,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,BAO_0000218,CHEMBL623967,13477,10116.0,Intermediate,1,,,50597,N,1,,
12884,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,BAO_0000218,CHEMBL623968,13477,10116.0,Intermediate,1,,,50597,N,1,,
12885,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,BAO_0000218,CHEMBL623969,13477,10116.0,Intermediate,1,,,50597,N,1,,
12886,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,BAO_0000218,CHEMBL628409,13477,10116.0,Intermediate,1,,,50597,N,1,,
12887,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,BAO_0000218,CHEMBL628410,13477,10116.0,Intermediate,1,,,50597,N,1,,
12888,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,BAO_0000218,CHEMBL628411,13477,10116.0,Intermediate,1,,,50597,N,1,,
12889,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,BAO_0000218,CHEMBL628412,13477,10116.0,Intermediate,1,,,50597,N,1,,
12890,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,BAO_0000019,CHEMBL628413,12553,,Autocuration,1,,,22224,U,0,,
12891,,The concentration in plasmat; Not determined,,BAO_0000019,CHEMBL628414,14548,,Autocuration,1,,,22224,U,0,1969.0,
12892,,Tissue level at 10 mg/kg/po in wistar rats in blood,,BAO_0000218,CHEMBL628415,14393,10116.0,Intermediate,1,,,50597,N,1,,
12893,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,BAO_0000218,CHEMBL628416,14393,10116.0,Intermediate,1,,,50597,N,1,,
12894,,Tissue level at 10 mg/kg/po in wistar rats in heart,,BAO_0000218,CHEMBL628417,14393,10116.0,Intermediate,1,,,50597,N,1,,
12895,,Tissue level at 10 mg/kg/po in wistar rats in liver,,BAO_0000218,CHEMBL874908,14393,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12896,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,BAO_0000218,CHEMBL628418,14393,10116.0,Intermediate,1,,,50597,N,1,,
12897,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,BAO_0000218,CHEMBL628419,14393,10116.0,Intermediate,1,,,50597,N,1,2385.0,
12898,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,BAO_0000218,CHEMBL628420,14393,10116.0,Intermediate,1,,,50597,N,1,,
12899,,Water solubility at 37 degree C.,,BAO_0000019,CHEMBL628421,1629,,Autocuration,1,,,22224,U,0,,
12900,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,BAO_0000100,CHEMBL626726,8194,,Autocuration,1,,,22229,U,0,,
12901,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,BAO_0000100,CHEMBL626727,8194,,Autocuration,1,,,22229,U,0,,
12902,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626728,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12903,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626729,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12904,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626730,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12905,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626731,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12906,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626732,8594,10116.0,Intermediate,1,,,50597,N,1,178.0,
12907,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626733,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12908,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626734,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12909,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626735,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12910,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL874909,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12911,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626736,8594,10116.0,Intermediate,1,,,50597,N,1,948.0,
12912,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL626737,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12913,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630999,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12914,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631000,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12915,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631001,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12916,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631002,8594,10116.0,Intermediate,1,,,50597,N,1,2113.0,
12917,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631003,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12918,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631004,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12919,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631005,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12920,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631006,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12921,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631007,8594,10116.0,Intermediate,1,,,50597,N,1,2107.0,
12922,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631008,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12923,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631009,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12924,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631010,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12925,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631011,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12926,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL631012,8594,10116.0,Intermediate,1,,,50597,N,1,2048.0,
12927,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630271,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12928,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630272,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12929,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630273,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12930,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630274,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12931,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630275,8594,10116.0,Intermediate,1,,,50597,N,1,2046.0,
12932,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL875782,8594,10116.0,Intermediate,1,,,50597,N,1,,
12933,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630276,8594,10116.0,Intermediate,1,,,50597,N,1,,
12934,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630277,8594,10116.0,Intermediate,1,,,50597,N,1,,
12935,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630278,8594,10116.0,Intermediate,1,,,50597,N,1,,
12936,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,BAO_0000218,CHEMBL630279,8594,10116.0,Intermediate,1,,,50597,N,1,,
12937,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,BAO_0000019,CHEMBL630280,8151,,Autocuration,1,,,22224,U,0,,
12938,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000019,CHEMBL630281,8151,,Autocuration,1,,,22224,U,0,,
12939,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,BAO_0000218,CHEMBL630282,7132,9986.0,Intermediate,1,,,50592,N,1,,
12940,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,BAO_0000218,CHEMBL630283,7132,9986.0,Intermediate,1,,,50592,N,1,,
12941,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,BAO_0000019,CHEMBL630284,5797,,Autocuration,1,,,22224,U,0,,
12942,,Alkylating activity was determined,,BAO_0000019,CHEMBL630285,7849,,Autocuration,1,,,22224,U,0,,
12943,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,BAO_0000251,CHEMBL630286,14220,,Autocuration,1,,Microsomes,22224,U,0,,
12944,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,BAO_0000218,CHEMBL630069,8650,9986.0,Intermediate,1,,,50592,N,1,,
12945,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,BAO_0000218,CHEMBL630070,8650,9986.0,Intermediate,1,,,50592,N,1,,
12946,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,BAO_0000218,CHEMBL630071,8650,9986.0,Intermediate,1,,,50592,N,1,,
12947,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,BAO_0000218,CHEMBL630072,8650,9986.0,Intermediate,1,,,50592,N,1,,
12948,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,BAO_0000218,CHEMBL875110,8650,9986.0,Intermediate,1,,,50592,N,1,,
12949,,Compound was tested for antidiuretic activity in rats,,BAO_0000218,CHEMBL630073,7116,10116.0,Intermediate,1,,,50597,N,1,,
12950,,Compound was tested for inactivation kinetic values,,BAO_0000019,CHEMBL630074,14131,,Autocuration,1,,,22224,U,0,,
12951,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,BAO_0000218,CHEMBL630075,7415,,Autocuration,1,,,22224,U,0,,
12952,,Dissociation rate calculated from the first-order equation using the t1/2 value,,BAO_0000019,CHEMBL630076,13178,,Autocuration,1,,,22224,U,0,,
12953,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,BAO_0000100,CHEMBL630077,8815,,Autocuration,1,,,22229,U,0,,
12954,,Aqueous solubility was measured,,BAO_0000100,CHEMBL630078,1450,,Autocuration,1,,,22229,U,0,,
12955,,Aqueous solubility was measured at a pH 4,,BAO_0000100,CHEMBL630079,1450,,Autocuration,1,,,22229,U,0,,
12956,,Aqueous solubility (pH 7),,BAO_0000100,CHEMBL630080,1450,,Autocuration,1,,,22229,U,0,,
12957,,Aqueous solubility was measured at a pH 9,,BAO_0000100,CHEMBL630081,1450,,Autocuration,1,,,22229,U,0,,
12958,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,BAO_0000019,CHEMBL630082,12711,,Autocuration,1,,,22224,U,0,,
12959,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,BAO_0000019,CHEMBL630083,12711,,Autocuration,1,,,22224,U,0,,
12960,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,BAO_0000019,CHEMBL630084,12711,,Autocuration,1,,,22224,U,0,,
12961,,Aqueous solubility of the compound,,BAO_0000100,CHEMBL629198,15032,,Autocuration,1,,,22229,U,0,,
12962,,Aqueous solubility at 37 degree Celsius at pH 7.38,,BAO_0000100,CHEMBL629199,9964,,Autocuration,1,,,22229,U,0,,
12963,,Aqueous solubility in pH 7.4 phosphate buffer,,BAO_0000100,CHEMBL629200,14962,,Autocuration,1,,,22229,U,0,,
12964,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,BAO_0000218,CHEMBL629201,12487,9615.0,Intermediate,1,,,50588,N,1,,
12965,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,BAO_0000218,CHEMBL629202,12487,9615.0,Intermediate,1,,,50588,N,1,,
12966,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,CHEMBL875111,10026,9606.0,Intermediate,1,,,50587,N,1,,
12967,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,CHEMBL629203,10026,9606.0,Intermediate,1,,,50587,N,1,,
12968,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,CHEMBL629204,10026,9606.0,Intermediate,1,,,50587,N,1,,
12969,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,CHEMBL629205,10026,9606.0,Intermediate,1,,,50587,N,1,,
12970,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000218,CHEMBL629206,10026,9606.0,Intermediate,1,,,50587,N,1,,
12971,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,BAO_0000019,CHEMBL631185,10026,,Autocuration,1,,,22224,U,0,,
12972,,Compound was evaluated for the average bile flow rat in rats,,BAO_0000218,CHEMBL631186,7415,10116.0,Intermediate,1,,,50597,N,1,,
12973,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,BAO_0000218,CHEMBL631187,17025,9986.0,Intermediate,1,,,50592,N,1,,
12974,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,BAO_0000218,CHEMBL631188,17025,9986.0,Intermediate,1,,,50592,N,1,,
12975,,Average half life period was determined,,BAO_0000019,CHEMBL876419,10184,,Autocuration,1,,,22224,U,0,,
12976,,Average half life period was determined,,BAO_0000019,CHEMBL631189,10184,,Autocuration,1,,,22224,U,0,,
12977,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,BAO_0000218,CHEMBL631190,8613,10298.0,Intermediate,1,,,50602,N,1,,
12978,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,BAO_0000218,CHEMBL631191,8613,10298.0,Intermediate,1,,,50602,N,1,,
12979,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,BAO_0000218,CHEMBL631192,8613,10298.0,Intermediate,1,,,50602,N,1,,
12980,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,BAO_0000218,CHEMBL632400,8613,10298.0,Intermediate,1,,,50602,N,1,,
12981,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,BAO_0000218,CHEMBL630564,8613,10298.0,Intermediate,1,,,50602,N,1,,
12982,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,BAO_0000218,CHEMBL630565,8613,10298.0,Intermediate,1,,,50602,N,1,,
12983,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,BAO_0000218,CHEMBL630566,8613,10298.0,Intermediate,1,,,50602,N,1,,
12984,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,BAO_0000218,CHEMBL631229,8613,10298.0,Intermediate,1,,,50602,N,1,,
12985,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,BAO_0000218,CHEMBL631230,8613,10298.0,Intermediate,1,,,50602,N,1,,
12986,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL876428,6030,,Autocuration,1,,,22229,U,0,,
12987,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631231,6147,,Autocuration,1,,,22229,U,0,,
12988,,Calculated partition coefficient (clogP) (MacLogP),,BAO_0000100,CHEMBL631232,14556,,Autocuration,1,,,22229,U,0,,
12989,,Hydrophilicity was determined,,BAO_0000019,CHEMBL631233,768,,Autocuration,1,,,22224,U,0,,
12990,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631234,14452,,Autocuration,1,,,22229,U,0,,
12991,,Increased absorption was determined,,BAO_0000019,CHEMBL883126,5237,,Autocuration,1,,,22224,U,0,,
12992,,Lipophilicity value was evaluated,,BAO_0000100,CHEMBL631235,14378,,Autocuration,1,,,22224,U,0,,
12993,,Log P value of the compound.,,BAO_0000100,CHEMBL631236,14418,,Autocuration,1,,,22224,U,0,,
12994,,Partition coefficient of compound was determined,,BAO_0000019,CHEMBL631237,5249,,Autocuration,1,,,22224,U,0,,
12995,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631238,14621,,Autocuration,1,,,22229,U,0,,
12996,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL876429,12542,,Autocuration,1,,,22229,U,0,,
12997,,Partition coefficient was measured by medchem software; Not calculated,,BAO_0000019,CHEMBL631414,12542,,Autocuration,1,,,22224,U,0,,
12998,,Partition coefficient was measured by octanol-water using standard shake-flask method,,BAO_0000100,CHEMBL631415,12542,,Autocuration,1,,,22224,U,0,,
12999,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631416,15462,,Autocuration,1,,,22229,U,0,,
13000,,Partition coefficient (logP),,BAO_0000019,CHEMBL631417,14884,,Autocuration,1,,,22224,U,0,,
13001,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631418,16526,,Autocuration,1,,,22229,U,0,,
13002,,The Octanol/Water partition coefficient CLogP,,BAO_0000100,CHEMBL631419,13693,,Autocuration,1,,,22229,U,0,,
13003,,The pharmacokinetic parameter C Log p was reported,,BAO_0000019,CHEMBL631420,13693,,Autocuration,1,,,22224,U,0,,
13004,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631421,13779,,Autocuration,1,,,22229,U,0,,
13005,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631422,14772,,Autocuration,1,,,22229,U,0,,
13006,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL631423,14393,,Autocuration,1,,,22229,U,0,,
13007,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,CHEMBL876430,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13008,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,BAO_0000218,CHEMBL631424,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13009,,Compound was administered intravenously in dog to evaluate plasma clearance values,,BAO_0000218,CHEMBL631425,13744,9615.0,Intermediate,1,,,50588,N,1,1969.0,
13010,,Compound was administered intravenously in monkey to evaluate plasma clearance values,,BAO_0000218,CHEMBL631426,13744,314293.0,Autocuration,1,,,22224,U,0,1969.0,
13011,,Compound was administered intravenously in mouse to evaluate plasma clearance values,,BAO_0000218,CHEMBL631427,13744,10090.0,Intermediate,1,,,50594,N,1,1969.0,
13012,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,BAO_0000218,CHEMBL631428,13207,9615.0,Intermediate,1,,,50588,N,1,1969.0,
13013,,Intrinsic clearance in Rhesus liver microsome,,BAO_0000218,CHEMBL631429,5669,9544.0,Intermediate,1,,Microsomes,50797,N,1,2107.0,
13014,,Intrinsic clearance in dog liver microsome,,BAO_0000218,CHEMBL631430,5669,9615.0,Intermediate,1,,Microsomes,50588,N,1,2107.0,
13015,,Intrinsic clearance in rat liver microsome,,BAO_0000218,CHEMBL631431,5669,10116.0,Intermediate,1,,Microsomes,50597,N,1,2107.0,
13016,,Low plasma clearance was calculated in rhesus monkey,,BAO_0000218,CHEMBL631432,4853,9544.0,Intermediate,1,,,50797,N,1,1969.0,
13017,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,BAO_0000218,CHEMBL631433,16452,9615.0,Intermediate,1,,,50588,N,1,,
13018,,Plasma clearance after intravenous dose of 0.3 mg/kg,,BAO_0000218,CHEMBL631434,11954,,Autocuration,1,,,22224,U,0,,
13019,,Plasma clearance after intravenous dose of 1 mg/kg,,BAO_0000218,CHEMBL631435,11954,,Autocuration,1,,,22224,U,0,,
13020,,Plasma clearance after intravenous dose of 3 mg/kg,,BAO_0000218,CHEMBL631436,11954,,Autocuration,1,,,22224,U,0,,
13021,,Plasma clearance after intravenous dose of 3.87 mg/kg,,BAO_0000218,CHEMBL631437,11954,,Autocuration,1,,,22224,U,0,,
13022,,Plasma clearance after peroral administration at 10 mpk in Rat,,BAO_0000218,CHEMBL631438,5669,10116.0,Intermediate,1,,,50597,N,1,,
13023,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,BAO_0000218,CHEMBL876431,5669,9544.0,Intermediate,1,,,50797,N,1,,
13024,,Plasma clearance after peroral administration at 10 mpk in dog,,BAO_0000218,CHEMBL631439,5669,9615.0,Intermediate,1,,,50588,N,1,,
13025,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,BAO_0000218,CHEMBL631440,13662,10116.0,Intermediate,1,,,50597,N,1,,
13026,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,BAO_0000019,CHEMBL631441,8272,,Autocuration,1,,,22224,U,0,,
13027,,Critical Micellar concentration was determined,,BAO_0000019,CHEMBL631442,13410,,Autocuration,1,,,22224,U,0,,
13028,,Critical Micellar concentration of the compound. was determined,,BAO_0000019,CHEMBL626525,13410,,Autocuration,1,,,22224,U,0,,
13029,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,BAO_0000019,CHEMBL627168,12628,,Autocuration,1,,,22224,U,0,,
13030,,Critical micellar concentration was measured in water by the dye solubilization method,,BAO_0000019,CHEMBL875618,9675,,Autocuration,1,,,22224,U,0,,
13031,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,BAO_0000019,CHEMBL626612,12628,,Autocuration,1,,,22224,U,0,,
13032,,CMR value (relative to BAY K 8644),,BAO_0000019,CHEMBL626613,12766,,Autocuration,1,,,22224,U,0,,
13033,,Carbamoylating activity was determined,,BAO_0000019,CHEMBL626614,7849,,Autocuration,1,,,22224,U,0,,
13034,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,BAO_0000218,CHEMBL626615,12187,314293.0,Autocuration,1,,,22224,U,0,,
13035,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,BAO_0000019,CHEMBL626616,2040,,Autocuration,1,,,22224,U,0,,
13036,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,BAO_0000019,CHEMBL626617,2040,,Autocuration,1,,,22224,U,0,,
13037,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,BAO_0000218,CHEMBL626618,14180,9615.0,Intermediate,1,,,50588,N,1,1969.0,
13038,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,BAO_0000218,CHEMBL626619,14180,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13039,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,BAO_0000218,CHEMBL626620,14474,9615.0,Intermediate,1,,,50588,N,1,,
13040,,"Clearance rate at 5.5 mg/kg, iv, in rat",,BAO_0000218,CHEMBL626621,14474,10116.0,Intermediate,1,,,50597,N,1,,
13041,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,BAO_0000218,CHEMBL626622,14548,9541.0,Intermediate,1,,,100710,N,1,,
13042,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,BAO_0000218,CHEMBL626623,14548,9541.0,Intermediate,1,,,100710,N,1,,
13043,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,BAO_0000218,CHEMBL626624,14548,9615.0,Intermediate,1,,,50588,N,1,,
13044,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,BAO_0000218,CHEMBL626625,14548,10116.0,Intermediate,1,,,50597,N,1,,
13045,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,BAO_0000218,CHEMBL626626,6125,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13046,,Tested for the total clearance of the compound,,BAO_0000218,CHEMBL626627,6874,,Autocuration,1,,,22224,U,0,,
13047,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,BAO_0000218,CHEMBL626628,15343,9615.0,Intermediate,1,,,50588,N,1,,
13048,,Total body clearance was determined,,BAO_0000218,CHEMBL626629,6236,,Autocuration,1,,,22224,U,0,,
13049,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,BAO_0000218,CHEMBL626630,11510,10116.0,Intermediate,1,,,50597,N,1,,
13050,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,BAO_0000218,CHEMBL626631,11510,10116.0,Intermediate,1,,,50597,N,1,,
13051,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,BAO_0000100,CHEMBL626632,8194,,Autocuration,1,,,22229,U,0,,
13052,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,BAO_0000100,CHEMBL626633,8194,,Autocuration,1,,,22229,U,0,,
13053,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,BAO_0000100,CHEMBL626634,8194,,Autocuration,1,,,22229,U,0,,
13054,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,BAO_0000100,CHEMBL626635,8194,,Autocuration,1,,,22229,U,0,,
13055,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,BAO_0000100,CHEMBL626636,8194,,Autocuration,1,,,22229,U,0,,
13056,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,BAO_0000100,CHEMBL626637,8194,,Autocuration,1,,,22229,U,0,,
13057,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,BAO_0000218,CHEMBL626638,13273,4754.0,Intermediate,1,,,50339,N,1,,
13058,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,BAO_0000218,CHEMBL626639,13273,4754.0,Intermediate,1,,,50339,N,1,,
13059,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,BAO_0000218,CHEMBL626640,13273,4754.0,Intermediate,1,,,50339,N,1,,
13060,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,BAO_0000218,CHEMBL626641,13273,4754.0,Intermediate,1,,,50339,N,1,,
13061,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,BAO_0000218,CHEMBL627272,13273,4754.0,Intermediate,1,,,50339,N,1,,
13062,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,BAO_0000218,CHEMBL627273,13273,4754.0,Intermediate,1,,,50339,N,1,,
13063,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,BAO_0000218,CHEMBL627441,13273,4754.0,Intermediate,1,,,50339,N,1,,
13064,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,BAO_0000218,CHEMBL628355,13273,4754.0,Intermediate,1,,,50339,N,1,,
13065,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,BAO_0000218,CHEMBL628356,13273,4754.0,Intermediate,1,,,50339,N,1,,
13066,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,BAO_0000218,CHEMBL628357,13273,4754.0,Intermediate,1,,,50339,N,1,,
13067,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,BAO_0000218,CHEMBL628358,13273,4754.0,Intermediate,1,,,50339,N,1,,
13068,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,BAO_0000218,CHEMBL622307,13273,4754.0,Intermediate,1,,,50339,N,1,,
13069,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,BAO_0000019,CHEMBL622527,13118,,Autocuration,1,,,22224,U,0,,
13070,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,BAO_0000019,CHEMBL622528,13118,,Autocuration,1,,,22224,U,0,,
13071,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,BAO_0000019,CHEMBL622529,13118,,Autocuration,1,,,22224,U,0,,
13072,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,BAO_0000019,CHEMBL622992,13118,,Autocuration,1,,,22224,U,0,,
13073,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,BAO_0000019,CHEMBL622993,13118,,Autocuration,1,,,22224,U,0,,
13074,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,BAO_0000019,CHEMBL622994,13118,,Autocuration,1,,,22224,U,0,,
13075,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,BAO_0000218,CHEMBL622995,10633,10116.0,Intermediate,1,,,50597,N,1,,
13076,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,BAO_0000218,CHEMBL622996,10633,10116.0,Intermediate,1,,,50597,N,1,,
13077,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,BAO_0000218,CHEMBL622997,10633,10116.0,Intermediate,1,,,50597,N,1,,
13078,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,BAO_0000218,CHEMBL622998,10633,10116.0,Intermediate,1,,,50597,N,1,,
13079,,Cp max following ip administration at 1 mg/kg,,BAO_0000218,CHEMBL622999,5767,,Autocuration,1,,,22224,U,0,,
13080,,Maximum concentration in plasma was reported at 0.5 hour,,BAO_0000218,CHEMBL623000,3302,,Autocuration,1,,,22224,U,0,1969.0,
13081,,Maximum concentration in plasma was reported at 2 hour,,BAO_0000218,CHEMBL623001,3302,,Autocuration,1,,,22224,U,0,1969.0,
13082,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,BAO_0000218,CHEMBL623002,12467,10090.0,Intermediate,1,,,50594,N,1,,
13083,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,BAO_0000100,CHEMBL623003,11778,,Autocuration,1,,,22229,U,0,,
13084,,Steady state concentration was evaluated,,BAO_0000019,CHEMBL623004,4321,,Autocuration,1,,,22224,U,0,,
13085,,Partition coefficient (logP),,BAO_0000019,CHEMBL623005,14884,,Autocuration,1,,,22224,U,0,,
13086,,Partition coefficient (logD7.4),,BAO_0000019,CHEMBL623006,15234,,Autocuration,1,,,22224,U,0,,
13087,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,BAO_0000218,CHEMBL623007,14198,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13088,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,BAO_0000218,CHEMBL623008,14198,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
13089,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,CHEMBL876654,14198,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13090,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,BAO_0000218,CHEMBL623009,14198,10116.0,Intermediate,1,,,50597,N,1,,
13091,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,BAO_0000218,CHEMBL623010,14198,10116.0,Intermediate,1,,,50597,N,1,,
13092,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,BAO_0000218,CHEMBL623011,14198,10116.0,Intermediate,1,,,50597,N,1,948.0,
13093,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,BAO_0000218,CHEMBL623012,14198,10116.0,Intermediate,1,,,50597,N,1,160.0,
13094,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,BAO_0000019,CHEMBL623013,8151,,Autocuration,1,,,22224,U,0,,
13095,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000019,CHEMBL623014,8151,,Autocuration,1,,,22224,U,0,,
13096,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,BAO_0000019,CHEMBL623015,8151,,Autocuration,1,,,22224,U,0,1088.0,
13097,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,BAO_0000019,CHEMBL623016,8151,,Autocuration,1,,,22224,U,0,1088.0,
13098,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,BAO_0000019,CHEMBL624858,8151,,Autocuration,1,,,22224,U,0,1088.0,
13099,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,BAO_0000218,CHEMBL624859,8151,10116.0,Intermediate,1,,,50597,N,1,,
13100,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,BAO_0000218,CHEMBL624860,8151,10116.0,Intermediate,1,,,50597,N,1,,
13101,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,BAO_0000218,CHEMBL624861,8151,10116.0,Intermediate,1,,,50597,N,1,,
13102,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,BAO_0000218,CHEMBL624862,8151,10116.0,Intermediate,1,,,50597,N,1,,
13103,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,BAO_0000218,CHEMBL624863,8151,10116.0,Intermediate,1,,,50597,N,1,,
13104,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,BAO_0000218,CHEMBL876655,8151,10116.0,Intermediate,1,,,50597,N,1,,
13105,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,BAO_0000218,CHEMBL624864,6996,9615.0,Intermediate,1,,,50588,N,1,,
13106,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,BAO_0000218,CHEMBL624865,6996,9615.0,Intermediate,1,,,50588,N,1,,
13107,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,BAO_0000218,CHEMBL624866,6996,9615.0,Intermediate,1,,,50588,N,1,,
13108,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,BAO_0000218,CHEMBL624867,6996,9615.0,Expert,1,,,50588,N,1,,
13109,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,BAO_0000218,CHEMBL624868,6996,9615.0,Intermediate,1,,,50588,N,1,,
13110,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,BAO_0000218,CHEMBL628450,6996,9615.0,Intermediate,1,,,50588,N,1,,
13111,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,BAO_0000218,CHEMBL628451,6996,9615.0,Intermediate,1,,,50588,N,1,,
13112,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,BAO_0000218,CHEMBL628452,6996,9615.0,Intermediate,1,,,50588,N,1,,
13113,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,BAO_0000218,CHEMBL628453,6996,9615.0,Intermediate,1,,,50588,N,1,,
13114,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,BAO_0000218,CHEMBL628454,6996,9615.0,Intermediate,1,,,50588,N,1,,
13115,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,BAO_0000218,CHEMBL628455,6996,9615.0,Intermediate,1,,,50588,N,1,,
13116,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,BAO_0000218,CHEMBL628456,6996,9615.0,Intermediate,1,,,50588,N,1,,
13117,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,BAO_0000218,CHEMBL628457,6996,9615.0,Intermediate,1,,,50588,N,1,,
13118,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,BAO_0000218,CHEMBL877505,6996,9615.0,Intermediate,1,,,50588,N,1,,
13119,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,BAO_0000218,CHEMBL628458,6996,9615.0,Intermediate,1,,,50588,N,1,,
13120,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,BAO_0000218,CHEMBL628459,6996,9615.0,Intermediate,1,,,50588,N,1,,
13121,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,BAO_0000218,CHEMBL628460,6996,9615.0,Intermediate,1,,,50588,N,1,,
13122,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,BAO_0000218,CHEMBL628461,6996,9615.0,Intermediate,1,,,50588,N,1,,
13123,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,BAO_0000218,CHEMBL628462,6996,,Autocuration,1,,,22224,U,0,,
13124,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,CHEMBL628463,6996,9615.0,Intermediate,1,,,50588,N,1,,
13125,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,BAO_0000218,CHEMBL625666,6996,10116.0,Expert,1,,,50597,N,1,,
13126,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,CHEMBL625667,6996,,Autocuration,1,,,22224,U,0,,
13127,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,CHEMBL625668,6996,10116.0,Expert,1,,,50597,N,1,,
13128,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,BAO_0000218,CHEMBL625669,6996,10116.0,Intermediate,1,,,50597,N,1,,
13129,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,BAO_0000019,CHEMBL625670,7114,,Autocuration,1,,,22224,U,0,,
13130,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,BAO_0000218,CHEMBL625671,7114,10116.0,Intermediate,1,,,50597,N,1,,
13131,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,BAO_0000218,CHEMBL625672,8613,10298.0,Intermediate,1,,,50602,N,1,,
13132,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,BAO_0000218,CHEMBL625673,8613,10298.0,Intermediate,1,,,50602,N,1,,
13133,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,BAO_0000218,CHEMBL625674,8613,10298.0,Intermediate,1,,,50602,N,1,,
13134,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,BAO_0000218,CHEMBL625675,8613,10298.0,Intermediate,1,,,50602,N,1,,
13135,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,BAO_0000218,CHEMBL627637,8613,10298.0,Intermediate,1,,,50602,N,1,,
13136,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,BAO_0000218,CHEMBL627638,8613,10298.0,Intermediate,1,,,50602,N,1,,
13137,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,BAO_0000218,CHEMBL627639,8613,10298.0,Intermediate,1,,,50602,N,1,,
13138,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,BAO_0000218,CHEMBL627640,8613,10298.0,Intermediate,1,,,50602,N,1,,
13139,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,BAO_0000218,CHEMBL627641,8613,10298.0,Intermediate,1,,,50602,N,1,,
13140,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,BAO_0000218,CHEMBL627642,8613,10298.0,Intermediate,1,,,50602,N,1,,
13141,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,BAO_0000218,CHEMBL877506,8613,10298.0,Intermediate,1,,,50602,N,1,,
13142,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,BAO_0000218,CHEMBL627275,8613,10090.0,Intermediate,1,,,50594,N,1,,
13143,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,BAO_0000218,CHEMBL627643,11219,9669.0,Intermediate,1,,,50506,N,1,,
13144,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,BAO_0000218,CHEMBL631246,11219,9669.0,Intermediate,1,,,50506,N,1,,
13145,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,BAO_0000218,CHEMBL631247,11219,9669.0,Intermediate,1,,,50506,N,1,,
13146,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,BAO_0000218,CHEMBL629532,11219,9669.0,Intermediate,1,,,50506,N,1,,
13147,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,BAO_0000218,CHEMBL629533,11219,9669.0,Intermediate,1,,,50506,N,1,,
13148,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,BAO_0000218,CHEMBL629534,11219,9669.0,Intermediate,1,,,50506,N,1,,
13149,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,BAO_0000218,CHEMBL629535,11219,9669.0,Intermediate,1,,,50506,N,1,,
13150,,Pharmacokinetic parameter :drug bound to plasma was reported,,BAO_0000019,CHEMBL625932,14837,,Autocuration,1,,,22224,U,0,,
13151,,compound was evaluated for drug bound in plasma,,BAO_0000019,CHEMBL625933,14837,,Autocuration,1,,,22224,U,0,,
13152,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,BAO_0000218,CHEMBL625934,15343,10116.0,Intermediate,1,,,50597,N,1,,
13153,,Bioavailability,,BAO_0000218,CHEMBL625935,13761,9347.0,Autocuration,1,,,22224,U,0,,
13154,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,BAO_0000218,CHEMBL625936,14810,10116.0,Intermediate,1,,,50597,N,1,,
13155,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,BAO_0000218,CHEMBL625937,14810,10116.0,Intermediate,1,,,50597,N,1,,
13156,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,BAO_0000218,CHEMBL625938,13249,9615.0,Intermediate,1,,,50588,N,1,,
13157,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,BAO_0000218,CHEMBL625939,9267,10116.0,Intermediate,1,,,50597,N,1,1970.0,
13158,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,BAO_0000218,CHEMBL625940,9267,10116.0,Intermediate,1,,,50597,N,1,1970.0,
13159,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,BAO_0000218,CHEMBL874464,9267,10116.0,Intermediate,1,,,50597,N,1,1970.0,
13160,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,BAO_0000218,CHEMBL625941,9267,10116.0,Intermediate,1,,,50597,N,1,1970.0,
13161,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,BAO_0000218,CHEMBL625942,9267,10116.0,Intermediate,1,,,50597,N,1,1970.0,
13162,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,BAO_0000218,CHEMBL625943,9267,10116.0,Intermediate,1,,,50597,N,1,1970.0,
13163,,In vitro protein binding in human serum at 5 ug/ml,,BAO_0000218,CHEMBL625944,15549,9606.0,Intermediate,1,,,50587,N,1,1977.0,
13164,,Serum protein binding ability was measured,,BAO_0000019,CHEMBL625945,10929,,Autocuration,1,,,22224,U,0,,
13165,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,BAO_0000019,CHEMBL625946,15444,,Autocuration,1,,,22224,U,0,,
13166,,Oral bioavailability in dog,,BAO_0000218,CHEMBL625947,12860,9615.0,Autocuration,1,,,22224,U,0,,
13167,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,BAO_0000218,CHEMBL625948,12170,10116.0,Intermediate,1,,,50597,N,1,,
13168,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,BAO_0000218,CHEMBL625949,15173,,Autocuration,1,,,22224,U,0,,
13169,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,BAO_0000218,CHEMBL625950,15173,,Autocuration,1,,,22224,U,0,,
13170,,Oral bioavailability (dose 15 mg/kg i.v.),,BAO_0000218,CHEMBL625951,15173,9347.0,Autocuration,1,,,22224,U,0,,
13171,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,BAO_0000218,CHEMBL625952,15173,,Autocuration,1,,,22224,U,0,,
13172,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,BAO_0000218,CHEMBL625953,15173,,Autocuration,1,,,22224,U,0,,
13173,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,BAO_0000218,CHEMBL625954,15173,,Autocuration,1,,,22224,U,0,,
13174,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,BAO_0000218,CHEMBL882959,15173,,Autocuration,1,,,22224,U,0,,
13175,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,BAO_0000218,CHEMBL625955,11767,9615.0,Intermediate,1,,,50588,N,1,,
13176,,Bioavailability in ferret,,BAO_0000218,CHEMBL625956,11219,9669.0,Autocuration,1,,,22224,U,0,,
13177,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,BAO_0000218,CHEMBL625957,12186,9541.0,Intermediate,1,,,100710,N,1,,
13178,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,BAO_0000218,CHEMBL625958,11510,10116.0,Intermediate,1,,,50597,N,1,,
13179,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,BAO_0000218,CHEMBL625959,11510,10116.0,Intermediate,1,,,50597,N,1,,
13180,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,BAO_0000218,CHEMBL626642,11510,10116.0,Intermediate,1,,,50597,N,1,,
13181,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,BAO_0000218,CHEMBL631330,11510,10116.0,Intermediate,1,,,50597,N,1,,
13182,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,BAO_0000218,CHEMBL631331,11510,10116.0,Intermediate,1,,,50597,N,1,,
13183,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,BAO_0000218,CHEMBL631332,11510,10116.0,Intermediate,1,,,50597,N,1,,
13184,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,BAO_0000218,CHEMBL631333,11510,10116.0,Intermediate,1,,,50597,N,1,,
13185,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,BAO_0000218,CHEMBL632018,11510,10116.0,Intermediate,1,,,50597,N,1,,
13186,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,BAO_0000218,CHEMBL632019,11510,10116.0,Intermediate,1,,,50597,N,1,,
13187,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,BAO_0000218,CHEMBL632020,11510,10116.0,Intermediate,1,,,50597,N,1,,
13188,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,BAO_0000218,CHEMBL632021,11510,10116.0,Intermediate,1,,,50597,N,1,,
13189,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,BAO_0000218,CHEMBL632022,11510,10116.0,Intermediate,1,,,50597,N,1,,
13190,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,BAO_0000218,CHEMBL632023,11510,10116.0,Intermediate,1,,,50597,N,1,,
13191,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,BAO_0000218,CHEMBL632024,11510,10116.0,Intermediate,1,,,50597,N,1,,
13192,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,BAO_0000218,CHEMBL874472,11510,10116.0,Intermediate,1,,,50597,N,1,,
13193,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,BAO_0000218,CHEMBL632025,11510,10116.0,Intermediate,1,,,50597,N,1,,
13194,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,BAO_0000218,CHEMBL632026,11510,10116.0,Intermediate,1,,,50597,N,1,,
13195,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,BAO_0000218,CHEMBL632027,11510,10116.0,Intermediate,1,,,50597,N,1,,
13196,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,BAO_0000218,CHEMBL632028,11510,10116.0,Intermediate,1,,,50597,N,1,,
13197,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,BAO_0000218,CHEMBL626430,11510,10116.0,Intermediate,1,,,50597,N,1,,
13198,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,BAO_0000218,CHEMBL626431,11510,10116.0,Intermediate,1,,,50597,N,1,,
13199,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,BAO_0000218,CHEMBL626432,11510,10116.0,Intermediate,1,,,50597,N,1,,
13200,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,BAO_0000218,CHEMBL626433,11510,10116.0,Intermediate,1,,,50597,N,1,,
13201,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,BAO_0000218,CHEMBL626434,11510,10116.0,Intermediate,1,,,50597,N,1,,
13202,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,BAO_0000218,CHEMBL627280,11510,10116.0,Intermediate,1,,,50597,N,1,,
13203,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,BAO_0000218,CHEMBL627281,11510,10116.0,Intermediate,1,,,50597,N,1,,
13204,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,BAO_0000218,CHEMBL627282,11510,10116.0,Intermediate,1,,,50597,N,1,,
13205,,Total body clearance was measured at given dose,,BAO_0000019,CHEMBL627283,7199,,Autocuration,1,,,22224,U,0,,
13206,,Total body clearance was measured at given dose.,,BAO_0000218,CHEMBL627284,7199,,Autocuration,1,,,22224,U,0,,
13207,,Metabolic clearance from the body in rat,,BAO_0000218,CHEMBL627285,7095,10116.0,Intermediate,1,,,50597,N,1,,
13208,,Renal clearance from the body,,BAO_0000218,CHEMBL627286,7095,,Autocuration,1,,,22224,U,0,,
13209,,Renal clearance from the body in rat,,BAO_0000218,CHEMBL875477,7095,10116.0,Intermediate,1,,,50597,N,1,,
13210,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,BAO_0000218,CHEMBL627287,12528,10116.0,Intermediate,1,,,50597,N,1,,
13211,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,BAO_0000218,CHEMBL627288,12528,9615.0,Intermediate,1,,,50588,N,1,,
13212,,Total clearance from the body in rat,,BAO_0000218,CHEMBL627289,7095,10116.0,Intermediate,1,,,50597,N,1,,
13213,,Clearance into cortex from rat plasma or PBS,,BAO_0000218,CHEMBL627290,14223,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13214,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,BAO_0000218,CHEMBL627291,13569,,Autocuration,1,,,22224,U,0,,
13215,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,BAO_0000218,CHEMBL627292,13569,,Autocuration,1,,,22224,U,0,,
13216,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,BAO_0000218,CHEMBL627293,13569,,Autocuration,1,,,22224,U,0,,
13217,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,BAO_0000218,CHEMBL627294,13569,,Autocuration,1,,,22224,U,0,,
13218,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,BAO_0000218,CHEMBL875478,13569,,Autocuration,1,,,22224,U,0,,
13219,,Clearance was determined,,BAO_0000218,CHEMBL627295,13979,,Autocuration,1,,,22224,U,0,,
13220,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,BAO_0000218,CHEMBL627296,14315,10090.0,Intermediate,1,,,50594,N,1,,
13221,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,BAO_0000218,CHEMBL626119,14315,9986.0,Intermediate,1,,,50592,N,1,,
13222,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,BAO_0000218,CHEMBL626120,14315,10116.0,Intermediate,1,,,50597,N,1,,
13223,,Clearance in rat after iv dose (100 ug/kg),,BAO_0000218,CHEMBL626121,12174,10116.0,Intermediate,1,,,50597,N,1,,
13224,,Clearance in guinea pig,,BAO_0000218,CHEMBL626122,12797,10141.0,Autocuration,1,,,22224,U,0,,
13225,,Compound was evaluated for clearance in rat,,BAO_0000218,CHEMBL626123,12797,10116.0,Intermediate,1,,,50597,N,1,,
13226,,Compound was evaluated for the clearance in dog,,BAO_0000218,CHEMBL623456,12797,9615.0,Intermediate,1,,,50588,N,1,,
13227,,Compound was evaluated for the clearance in rat,,BAO_0000218,CHEMBL623457,12797,10116.0,Intermediate,1,,,50597,N,1,,
13228,,Compound was tested in vivo for clearance after iv administration in the rat,,BAO_0000218,CHEMBL623458,11500,10116.0,Intermediate,1,,,50597,N,1,,
13229,,IV clearance determined at an iv dose of 14 mg/kg,,BAO_0000218,CHEMBL623459,15173,,Autocuration,1,,,22224,U,0,,
13230,,IV clearance determined at an iv dose of 15.2 mg/kg,,BAO_0000218,CHEMBL875484,15173,,Autocuration,1,,,22224,U,0,,
13231,,IV clearance determined at an iv dose of 15 mg/kg,,BAO_0000218,CHEMBL623460,15173,,Autocuration,1,,,22224,U,0,,
13232,,IV clearance determined at an peroral dose of 30 mg/kg.,,BAO_0000218,CHEMBL623461,15173,,Autocuration,1,,,22224,U,0,,
13233,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,BAO_0000218,CHEMBL623462,15173,,Autocuration,1,,,22224,U,0,,
13234,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,BAO_0000218,CHEMBL627386,15173,,Autocuration,1,,,22224,U,0,,
13235,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,BAO_0000218,CHEMBL627387,14198,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13236,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,BAO_0000218,CHEMBL627388,14198,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13237,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,BAO_0000218,CHEMBL627389,14198,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13238,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,BAO_0000218,CHEMBL627390,14198,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13239,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,BAO_0000218,CHEMBL627391,14198,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13240,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,CHEMBL627392,14198,10116.0,Intermediate,1,,,50597,N,1,,
13241,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,BAO_0000218,CHEMBL627393,14198,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13242,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,BAO_0000218,CHEMBL627394,14198,10116.0,Intermediate,1,,,50597,N,1,3126.0,
13243,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,BAO_0000218,CHEMBL627395,14198,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
13244,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,CHEMBL875485,14198,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13245,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,BAO_0000218,CHEMBL627396,14198,10116.0,Intermediate,1,,,50597,N,1,,
13246,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,BAO_0000218,CHEMBL627397,14198,10116.0,Intermediate,1,,,50597,N,1,,
13247,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,BAO_0000218,CHEMBL627398,14198,10116.0,Intermediate,1,,,50597,N,1,948.0,
13248,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,BAO_0000218,CHEMBL627399,14198,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
13249,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,BAO_0000218,CHEMBL627400,14198,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13250,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,BAO_0000218,CHEMBL627401,14198,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13251,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,BAO_0000218,CHEMBL627402,14198,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13252,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,BAO_0000218,CHEMBL627403,14198,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13253,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,BAO_0000218,CHEMBL627404,14198,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13254,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,CHEMBL623101,14198,10116.0,Intermediate,1,,,50597,N,1,,
13255,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,BAO_0000218,CHEMBL877480,14198,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13256,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,BAO_0000218,CHEMBL623102,14198,10116.0,Intermediate,1,,,50597,N,1,3126.0,
13257,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,BAO_0000218,CHEMBL623103,14198,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
13258,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,CHEMBL623104,14198,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13259,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,BAO_0000218,CHEMBL623105,14198,10116.0,Intermediate,1,,,50597,N,1,,
13260,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,BAO_0000218,CHEMBL623106,14198,10116.0,Intermediate,1,,,50597,N,1,,
13261,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,BAO_0000218,CHEMBL623107,14198,10116.0,Intermediate,1,,,50597,N,1,948.0,
13262,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,BAO_0000218,CHEMBL623108,14198,10116.0,Intermediate,1,,,50597,N,1,160.0,
13263,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,BAO_0000218,CHEMBL623109,14198,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13264,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,BAO_0000218,CHEMBL623110,14198,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13265,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,BAO_0000218,CHEMBL623111,14198,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13266,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,BAO_0000218,CHEMBL625060,14198,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13267,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,BAO_0000218,CHEMBL625061,14198,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13268,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,CHEMBL625062,14198,10116.0,Intermediate,1,,,50597,N,1,,
13269,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,BAO_0000218,CHEMBL625063,14198,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13270,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,BAO_0000218,CHEMBL625064,14198,10116.0,Intermediate,1,,,50597,N,1,3126.0,
13271,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,BAO_0000218,CHEMBL625065,14198,10116.0,Intermediate,1,,,50597,N,1,10000001.0,
13272,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,BAO_0000218,CHEMBL625066,14198,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13273,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,BAO_0000218,CHEMBL625067,14198,10116.0,Intermediate,1,,,50597,N,1,,
13274,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,BAO_0000218,CHEMBL625068,14198,10116.0,Intermediate,1,,,50597,N,1,,
13275,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,BAO_0000218,CHEMBL622159,14198,10116.0,Intermediate,1,,,50597,N,1,948.0,
13276,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,BAO_0000218,CHEMBL622160,14198,10116.0,Intermediate,1,,,50597,N,1,160.0,
13277,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,BAO_0000218,CHEMBL622161,14198,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13278,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,BAO_0000218,CHEMBL622162,14198,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13279,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,BAO_0000218,CHEMBL622163,14198,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13280,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,BAO_0000218,CHEMBL622313,14198,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13281,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,BAO_0000218,CHEMBL622314,14198,10116.0,Intermediate,1,,,50597,N,1,,
13282,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,BAO_0000218,CHEMBL622315,14198,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13283,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,BAO_0000218,CHEMBL622316,14198,10116.0,Intermediate,1,,,50597,N,1,3126.0,
13284,,Normal diffusion coefficient in water for Escherichia coli,,BAO_0000218,CHEMBL877486,15599,562.0,Intermediate,1,,,50212,N,1,,
13285,,Average max percent decrease in RVR (renal vascular resistance) was determined,,BAO_0000019,CHEMBL622317,8204,,Autocuration,1,,,22224,U,0,,
13286,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,BAO_0000019,CHEMBL622318,8204,,Autocuration,1,,,22224,U,0,,
13287,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,BAO_0000019,CHEMBL622319,6154,,Autocuration,1,,,22224,U,0,,
13288,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,BAO_0000019,CHEMBL622320,6154,,Autocuration,1,,,22224,U,0,,
13289,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,BAO_0000019,CHEMBL622321,6154,,Autocuration,1,,,22224,U,0,,
13290,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,BAO_0000019,CHEMBL622322,6154,,Autocuration,1,,,22224,U,0,,
13291,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,BAO_0000019,CHEMBL622323,7114,,Autocuration,1,,,22224,U,0,,
13292,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,BAO_0000218,CHEMBL622324,7114,10116.0,Intermediate,1,,,50597,N,1,,
13293,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,BAO_0000218,CHEMBL622325,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13294,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,BAO_0000218,CHEMBL622326,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13295,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,BAO_0000218,CHEMBL877487,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13296,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,BAO_0000218,CHEMBL622327,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13297,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,BAO_0000218,CHEMBL622328,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13298,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,BAO_0000218,CHEMBL622329,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13299,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,BAO_0000218,CHEMBL622330,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13300,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,BAO_0000218,CHEMBL622331,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13301,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,BAO_0000218,CHEMBL622332,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13302,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,BAO_0000218,CHEMBL622333,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13303,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,BAO_0000218,CHEMBL627658,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13304,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,BAO_0000218,CHEMBL630428,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13305,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,BAO_0000218,CHEMBL630429,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13306,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,BAO_0000218,CHEMBL630430,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13307,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,BAO_0000218,CHEMBL630431,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13308,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,BAO_0000218,CHEMBL630432,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13309,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,BAO_0000218,CHEMBL630433,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13310,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,BAO_0000218,CHEMBL630434,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13311,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,BAO_0000218,CHEMBL629372,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13312,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,BAO_0000218,CHEMBL629553,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13313,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,BAO_0000218,CHEMBL629554,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13314,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,BAO_0000218,CHEMBL874447,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13315,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,BAO_0000218,CHEMBL629555,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13316,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,BAO_0000218,CHEMBL629556,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13317,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,BAO_0000218,CHEMBL629557,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13318,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,BAO_0000218,CHEMBL629558,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13319,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,BAO_0000218,CHEMBL629559,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13320,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,BAO_0000218,CHEMBL629560,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13321,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,BAO_0000218,CHEMBL629561,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13322,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,BAO_0000218,CHEMBL629562,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13323,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,BAO_0000218,CHEMBL629563,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13324,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,BAO_0000218,CHEMBL629564,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13325,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,BAO_0000218,CHEMBL629565,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13326,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,BAO_0000218,CHEMBL629566,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13327,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,BAO_0000218,CHEMBL629567,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13328,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,BAO_0000218,CHEMBL629568,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13329,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,BAO_0000218,CHEMBL629569,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13330,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,BAO_0000218,CHEMBL629570,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13331,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,BAO_0000218,CHEMBL629571,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13332,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,BAO_0000218,CHEMBL629572,12170,10116.0,Autocuration,1,,,22224,U,0,,
13333,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,BAO_0000218,CHEMBL629573,12170,10116.0,Autocuration,1,,,22224,U,0,,
13334,,Bioavailability (dose 20 mg/kg),,BAO_0000218,CHEMBL629574,4985,9347.0,Autocuration,1,,,22224,U,0,,
13335,,Bioavailability in dog,,BAO_0000218,CHEMBL629575,15145,9615.0,Autocuration,1,,,22224,U,0,,
13336,,Bioavailability in rat (Sprague-Dawley) (male),,BAO_0000218,CHEMBL874448,14080,10116.0,Autocuration,1,,,22224,U,0,,
13337,,Bioavailability in monkey (dose 10 mg/kg i.d.),,BAO_0000218,CHEMBL629576,11219,9443.0,Autocuration,1,,,22224,U,0,,
13338,,Bioavailability in rat,,BAO_0000218,CHEMBL629577,15145,10116.0,Autocuration,1,,,22224,U,0,,
13339,,Bioavailability in rat,,BAO_0000218,CHEMBL629578,15145,10116.0,Autocuration,1,,,22224,U,0,,
13340,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,BAO_0000218,CHEMBL629579,1202,9615.0,Autocuration,1,,,22224,U,0,,
13341,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,BAO_0000218,CHEMBL882958,1202,9615.0,Autocuration,1,,,22224,U,0,,
13342,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,BAO_0000218,CHEMBL629580,1202,9598.0,Intermediate,1,,,50505,N,1,,
13343,,Bioavailability,,BAO_0000218,CHEMBL629581,4026,9347.0,Autocuration,1,,,22224,U,0,,
13344,,Bioavailability in squirrel monkey,,BAO_0000218,CHEMBL629582,1492,9520.0,Autocuration,1,,,22224,U,0,,
13345,,Bioavailability was evaluated in dog,,BAO_0000218,CHEMBL628522,12793,9615.0,Intermediate,1,,,50588,N,1,,
13346,,Bioavailability was evaluated in hamster,,BAO_0000218,CHEMBL625432,12793,10026.0,Intermediate,1,,,100712,N,1,,
13347,,Bioavailability in rat,,BAO_0000218,CHEMBL625433,12793,10116.0,Autocuration,1,,,22224,U,0,,
13348,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,BAO_0000218,CHEMBL625434,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13349,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,BAO_0000218,CHEMBL625435,14793,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13350,,Bioavailability in rat (dose 10 mg/kg p.o.),,BAO_0000218,CHEMBL625436,14793,10116.0,Autocuration,1,,,22224,U,0,,
13351,,Bioavailability was measured in cynomolgus monkeys.,,BAO_0000218,CHEMBL874588,14731,9541.0,Intermediate,1,,,100710,N,1,,
13352,,Bioavailability was measured in nude mice.,,BAO_0000218,CHEMBL625437,14731,10090.0,Intermediate,1,,,50594,N,1,,
13353,,Bioavailability in ferret (dose 10 mg/kg i.d.),,BAO_0000218,CHEMBL625438,12187,9669.0,Autocuration,1,,,22224,U,0,,
13354,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,BAO_0000218,CHEMBL625439,12187,314293.0,Autocuration,1,,,22224,U,0,,
13355,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,BAO_0000218,CHEMBL625440,12187,314293.0,Autocuration,1,,,22224,U,0,,
13356,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,BAO_0000218,CHEMBL625441,12187,314293.0,Autocuration,1,,,22224,U,0,,
13357,,Bioavailability in rat (dose 10 mg/kg i.d.),,BAO_0000218,CHEMBL625442,12187,10116.0,Autocuration,1,,,22224,U,0,,
13358,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,BAO_0000218,CHEMBL625443,12187,10116.0,Intermediate,1,,,50597,N,1,,
13359,,Bioavailability was determined; extremely poor,,BAO_0000218,CHEMBL625444,17431,,Autocuration,1,,,22224,U,0,,
13360,,% bioavailability in mice after oral administration of prodrug,,BAO_0000218,CHEMBL625445,13318,10090.0,Intermediate,1,,,50594,N,1,,
13361,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,BAO_0000218,CHEMBL625446,9025,9615.0,Intermediate,1,,,50588,N,1,,
13362,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,BAO_0000218,CHEMBL882960,9025,9615.0,Intermediate,1,,,50588,N,1,,
13363,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,BAO_0000218,CHEMBL625447,9025,9615.0,Intermediate,1,,,50588,N,1,,
13364,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,BAO_0000218,CHEMBL625448,9025,9615.0,Intermediate,1,,,50588,N,1,,
13365,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,BAO_0000218,CHEMBL625449,9025,9615.0,Intermediate,1,,,50588,N,1,,
13366,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,BAO_0000218,CHEMBL874589,9025,9615.0,Intermediate,1,,,50588,N,1,,
13367,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,BAO_0000218,CHEMBL625450,9025,9615.0,Intermediate,1,,,50588,N,1,,
13368,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,BAO_0000218,CHEMBL625451,9025,9615.0,Intermediate,1,,,50588,N,1,,
13369,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,BAO_0000218,CHEMBL626584,9025,9615.0,Intermediate,1,,,50588,N,1,,
13370,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,BAO_0000218,CHEMBL626585,9025,9615.0,Intermediate,1,,,50588,N,1,,
13371,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,BAO_0000218,CHEMBL626586,9025,9615.0,Intermediate,1,,,50588,N,1,,
13372,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,BAO_0000218,CHEMBL626587,9025,9615.0,Intermediate,1,,,50588,N,1,,
13373,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,BAO_0000218,CHEMBL626588,9025,9615.0,Intermediate,1,,,50588,N,1,,
13374,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,BAO_0000218,CHEMBL626589,9025,9615.0,Intermediate,1,,,50588,N,1,,
13375,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,BAO_0000218,CHEMBL626590,9025,9615.0,Intermediate,1,,,50588,N,1,,
13376,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,BAO_0000218,CHEMBL626591,9025,9615.0,Intermediate,1,,,50588,N,1,,
13377,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,BAO_0000218,CHEMBL627181,9025,9615.0,Intermediate,1,,,50588,N,1,,
13378,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,BAO_0000218,CHEMBL628083,9025,9615.0,Intermediate,1,,,50588,N,1,,
13379,,IV clearance determined at an peroral dose of 15 mg/kg.,,BAO_0000218,CHEMBL628084,15173,,Autocuration,1,,,22224,U,0,,
13380,,Mouse oral clearance was measured against Hymenolepiasis nana.,,BAO_0000218,CHEMBL628085,7732,102285.0,Expert,1,,,50064,N,1,,
13381,,Mouse oral clearance was measured against Nematospiroides dubius,,BAO_0000218,CHEMBL628086,7732,6339.0,Expert,1,,,50545,N,1,,
13382,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,BAO_0000218,CHEMBL628087,7732,,Autocuration,1,,,22224,U,0,,
13383,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,BAO_0000218,CHEMBL628088,7732,10090.0,Intermediate,1,,,50594,N,1,,
13384,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,BAO_0000218,CHEMBL628089,7732,,Autocuration,1,,,22224,U,0,,
13385,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL628090,8328,,Autocuration,1,,,22224,U,0,,
13386,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL628091,8328,,Autocuration,1,,,22224,U,0,,
13387,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL628092,8328,,Autocuration,1,,,22224,U,0,,
13388,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL628093,8328,,Autocuration,1,,,22224,U,0,,
13389,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL875607,8328,,Autocuration,1,,,22224,U,0,,
13390,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL625710,8328,,Autocuration,1,,,22224,U,0,,
13391,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL625711,8328,,Autocuration,1,,,22224,U,0,,
13392,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL625712,8328,,Autocuration,1,,,22224,U,0,,
13393,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,BAO_0000218,CHEMBL625713,8328,,Autocuration,1,,,22224,U,0,,
13394,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,BAO_0000218,CHEMBL625714,13376,9615.0,Intermediate,1,,,50588,N,1,,
13395,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,BAO_0000218,CHEMBL625715,13477,9544.0,Intermediate,1,,,50797,N,1,,
13396,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,BAO_0000218,CHEMBL625716,13477,10116.0,Intermediate,1,,,50597,N,1,,
13397,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,BAO_0000218,CHEMBL625717,13477,10116.0,Intermediate,1,,,50597,N,1,,
13398,,Plasma clearance was determined for the compound in rats,,BAO_0000218,CHEMBL625718,13313,10116.0,Intermediate,1,,,50597,N,1,,
13399,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,BAO_0000218,CHEMBL625719,12504,10116.0,Intermediate,1,,,50597,N,1,,
13400,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,BAO_0000218,CHEMBL625720,12504,10116.0,Intermediate,1,,,50597,N,1,,
13401,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,BAO_0000218,CHEMBL625721,12504,10116.0,Intermediate,1,,,50597,N,1,,
13402,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,BAO_0000218,CHEMBL625722,12504,10116.0,Intermediate,1,,,50597,N,1,,
13403,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,BAO_0000218,CHEMBL625723,13129,10116.0,Intermediate,1,,,50597,N,1,,
13404,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,BAO_0000218,CHEMBL625724,7732,6339.0,Intermediate,1,,,50545,N,1,,
13405,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,BAO_0000218,CHEMBL625725,7732,6339.0,Intermediate,1,,,50545,N,1,,
13406,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,BAO_0000218,CHEMBL625726,7732,6339.0,Intermediate,1,,,50545,N,1,,
13407,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,BAO_0000218,CHEMBL875608,7732,6339.0,Intermediate,1,,,50545,N,1,,
13408,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,BAO_0000218,CHEMBL625727,7732,6339.0,Intermediate,1,,,50545,N,1,,
13409,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,BAO_0000218,CHEMBL625728,9278,10116.0,Autocuration,1,,,22224,U,0,1088.0,
13410,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,BAO_0000218,CHEMBL625729,9278,10116.0,Autocuration,1,,,22224,U,0,,
13411,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,BAO_0000218,CHEMBL625730,9278,10116.0,Autocuration,1,,,22224,U,0,,
13412,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,BAO_0000218,CHEMBL625731,9278,10116.0,Autocuration,1,,,22224,U,0,1088.0,
13413,,Urinary clearance was determined in rat at 25 mg/kg os dosage,,BAO_0000218,CHEMBL626417,9278,10116.0,Autocuration,1,,,22224,U,0,1088.0,
13414,,Urinary clearance was determined at 100 mg/kg oral dosage in human,,BAO_0000218,CHEMBL626418,9278,9606.0,Intermediate,1,,,50587,N,1,1088.0,
13415,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,BAO_0000218,CHEMBL626419,9278,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13416,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,BAO_0000218,CHEMBL626592,5932,9615.0,Intermediate,1,,,50588,N,1,1969.0,
13417,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,BAO_0000218,CHEMBL626593,5932,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13418,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,BAO_0000218,CHEMBL626594,5182,10116.0,Intermediate,1,,,50597,N,1,,
13419,,Clearance rate in dogs,,BAO_0000218,CHEMBL625035,10499,9615.0,Intermediate,1,,,50588,N,1,,
13420,,Compound was measured for intrinsic clearance,,BAO_0000019,CHEMBL625036,6051,,Autocuration,1,,,22224,U,0,,
13421,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625037,17508,,Autocuration,1,,,22229,U,0,,
13422,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625038,6228,,Autocuration,1,,,22229,U,0,,
13423,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625039,6231,,Autocuration,1,,,22229,U,0,,
13424,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625040,17740,,Autocuration,1,,,22229,U,0,,
13425,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625041,6495,,Autocuration,1,,,22229,U,0,,
13426,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625042,2171,,Autocuration,1,,,22229,U,0,,
13427,,Partition coefficient of the compound,,BAO_0000019,CHEMBL874411,3255,,Autocuration,1,,,22224,U,0,,
13428,,Permeability,,BAO_0000019,CHEMBL625043,6821,,Autocuration,1,,,22224,U,0,,
13429,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625044,2685,,Autocuration,1,,,22229,U,0,,
13430,,Partition coefficient (logD),,BAO_0000019,CHEMBL625045,17584,,Autocuration,1,,,22224,U,0,,
13431,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,BAO_0000100,CHEMBL625046,13824,,Autocuration,1,,,22229,U,0,,
13432,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,BAO_0000100,CHEMBL625047,13824,,Autocuration,1,,,22229,U,0,,
13433,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625048,16479,,Autocuration,1,,,22229,U,0,,
13434,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625049,11997,,Autocuration,1,,,22229,U,0,,
13435,,Calculated logarithm of partition coefficient (P) was determined,,BAO_0000100,CHEMBL625050,2988,,Autocuration,1,,,22229,U,0,,
13436,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625051,931,,Autocuration,1,,,22229,U,0,,
13437,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL874412,4381,,Autocuration,1,,,22229,U,0,,
13438,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625052,4397,,Autocuration,1,,,22229,U,0,,
13439,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL625053,5889,,Autocuration,1,,,22229,U,0,,
13440,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,BAO_0000019,CHEMBL623250,6154,,Autocuration,1,,,22224,U,0,,
13441,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,BAO_0000019,CHEMBL623251,6154,,Autocuration,1,,,22224,U,0,,
13442,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,BAO_0000019,CHEMBL623252,6154,,Autocuration,1,,,22224,U,0,,
13443,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,BAO_0000019,CHEMBL623253,6154,,Autocuration,1,,,22224,U,0,,
13444,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,BAO_0000019,CHEMBL623254,6154,,Autocuration,1,,,22224,U,0,,
13445,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,BAO_0000019,CHEMBL623255,6154,,Autocuration,1,,,22224,U,0,,
13446,,Percent degradation of compound at a pH of 1 over a 18 hr period,,BAO_0000019,CHEMBL626831,6887,,Autocuration,1,,,22224,U,0,,
13447,,Percent degradation of compound at pH of 1 over an 18 hr period,,BAO_0000019,CHEMBL877494,6887,,Autocuration,1,,,22224,U,0,,
13448,,Delta Logarithm of Partition Coefficient value was determined.,,BAO_0000019,CHEMBL626832,14116,,Autocuration,1,,,22224,U,0,,
13449,,Delta logPoct-cyc,,BAO_0000019,CHEMBL626833,11137,,Autocuration,1,,,22224,U,0,,
13450,,Lipophilicity estimated on reversed phase TLC,,BAO_0000100,CHEMBL626834,7230,,Autocuration,1,,,22224,U,0,,
13451,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,BAO_0000019,CHEMBL626835,15741,,Autocuration,1,,,22224,U,0,,
13452,,Delta logPoct-cyc,,BAO_0000019,CHEMBL626836,9663,,Autocuration,1,,,22224,U,0,,
13453,,Change in logarithm of partition coefficient of the compound,,BAO_0000100,CHEMBL626837,9663,,Autocuration,1,,,22229,U,0,,
13454,,Delta logD (pH 6.5),,BAO_0000019,CHEMBL626838,13807,,Autocuration,1,,,22224,U,0,,
13455,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,BAO_0000100,CHEMBL626839,13807,,Autocuration,1,,,22224,U,0,,
13456,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,BAO_0000019,CHEMBL626840,17425,,Autocuration,1,,,22224,U,0,,
13457,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,BAO_0000019,CHEMBL626841,12143,,Autocuration,1,,,22224,U,0,,
13458,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,BAO_0000219,CHEMBL626842,12608,,Autocuration,1,,,22224,U,0,,
13459,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,BAO_0000219,CHEMBL626843,12608,,Autocuration,1,,,22224,U,0,,
13460,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,BAO_0000218,CHEMBL626844,8649,10116.0,Intermediate,1,,,50597,N,1,,
13461,,Amount of deuterium retained was reported after normal workup in rats,,BAO_0000218,CHEMBL877495,8649,10116.0,Intermediate,1,,,50597,N,1,,
13462,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,BAO_0000218,CHEMBL626845,8649,10116.0,Intermediate,1,,,50597,N,1,,
13463,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,BAO_0000218,CHEMBL626846,8649,10116.0,Intermediate,1,,,50597,N,1,,
13464,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,BAO_0000218,CHEMBL626847,8649,10116.0,Intermediate,1,,,50597,N,1,,
13465,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,BAO_0000218,CHEMBL628677,8649,10116.0,Intermediate,1,,,50597,N,1,,
13466,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,BAO_0000218,CHEMBL628678,8649,10116.0,Intermediate,1,,,50597,N,1,,
13467,,Compound was subjected to electrochemical oxidation,,BAO_0000019,CHEMBL628679,9659,,Autocuration,1,,,22224,U,0,,
13468,,Compound was subjected to photochemical oxidation,,BAO_0000019,CHEMBL628680,9659,,Autocuration,1,,,22224,U,0,,
13469,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,BAO_0000019,CHEMBL628681,9659,,Autocuration,1,,,22224,U,0,,
13470,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,BAO_0000019,CHEMBL628682,9659,,Autocuration,1,,,22224,U,0,,
13471,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,BAO_0000019,CHEMBL628683,9659,,Autocuration,1,,,22224,U,0,,
13472,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,BAO_0000218,CHEMBL628684,9607,10116.0,Intermediate,1,,,50597,N,1,,
13473,,Dissociation constant (pKa),,BAO_0000100,CHEMBL877501,7057,,Autocuration,1,,,22229,U,0,,
13474,,Dissociation constant value of the compound; ND means not determined.,,BAO_0000100,CHEMBL628685,7057,,Autocuration,1,,,22224,U,0,,
13475,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,BAO_0000218,CHEMBL628686,7911,10116.0,Intermediate,1,,,50597,N,1,178.0,
13476,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,CHEMBL628687,7911,10116.0,Intermediate,1,,,50597,N,1,178.0,
13477,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,BAO_0000218,CHEMBL628688,7911,10116.0,Intermediate,1,,,50597,N,1,,
13478,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,CHEMBL628689,7911,10116.0,Intermediate,1,,,50597,N,1,,
13479,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,BAO_0000218,CHEMBL628690,7911,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13480,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,BAO_0000218,CHEMBL629363,7911,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13481,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,BAO_0000218,CHEMBL629364,7911,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13482,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,CHEMBL629365,7911,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13483,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,BAO_0000218,CHEMBL629366,7911,10116.0,Intermediate,1,,,50597,N,1,,
13484,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,BAO_0000218,CHEMBL629367,7911,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13485,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,BAO_0000218,CHEMBL629368,7911,10116.0,Intermediate,1,,,50597,N,1,1988.0,
13486,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,BAO_0000218,CHEMBL877502,7911,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13487,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,BAO_0000218,CHEMBL629369,13792,10090.0,Intermediate,1,,,50594,N,1,2037.0,
13488,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,BAO_0000218,CHEMBL629370,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
13489,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,BAO_0000218,CHEMBL629371,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13490,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,BAO_0000218,CHEMBL626276,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13491,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,BAO_0000218,CHEMBL626277,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13492,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,BAO_0000218,CHEMBL631250,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13493,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,BAO_0000218,CHEMBL631251,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13494,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,BAO_0000218,CHEMBL631252,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13495,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,BAO_0000218,CHEMBL631253,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13496,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,BAO_0000218,CHEMBL631254,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13497,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,BAO_0000218,CHEMBL631255,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13498,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,BAO_0000218,CHEMBL631256,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13499,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,BAO_0000218,CHEMBL631257,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13500,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,BAO_0000218,CHEMBL628009,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13501,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,BAO_0000218,CHEMBL628010,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13502,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,BAO_0000218,CHEMBL628011,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13503,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,BAO_0000218,CHEMBL628012,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13504,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,BAO_0000218,CHEMBL628013,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13505,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,BAO_0000218,CHEMBL628014,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13506,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,BAO_0000218,CHEMBL628015,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13507,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,BAO_0000218,CHEMBL628016,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13508,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,BAO_0000218,CHEMBL874461,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13509,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,BAO_0000218,CHEMBL628017,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13510,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,BAO_0000218,CHEMBL628018,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13511,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,BAO_0000218,CHEMBL628019,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13512,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,BAO_0000218,CHEMBL628020,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13513,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,BAO_0000218,CHEMBL628021,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13514,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,BAO_0000218,CHEMBL628022,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13515,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,BAO_0000218,CHEMBL628023,8133,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13516,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,BAO_0000218,CHEMBL628024,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13517,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,BAO_0000218,CHEMBL628025,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13518,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,BAO_0000218,CHEMBL628026,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13519,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,BAO_0000218,CHEMBL628027,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13520,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,BAO_0000218,CHEMBL628028,8133,314293.0,Autocuration,1,,,22224,U,0,1088.0,
13521,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,BAO_0000218,CHEMBL628029,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13522,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,BAO_0000218,CHEMBL628030,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13523,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,BAO_0000218,CHEMBL628031,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13524,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,BAO_0000218,CHEMBL628032,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13525,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,BAO_0000218,CHEMBL628033,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13526,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,BAO_0000218,CHEMBL628034,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13527,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,BAO_0000218,CHEMBL628035,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13528,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,BAO_0000218,CHEMBL628036,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13529,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,BAO_0000218,CHEMBL874462,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13530,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,BAO_0000218,CHEMBL628037,9025,9615.0,Intermediate,1,,,50588,N,1,,
13531,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,BAO_0000218,CHEMBL628123,9025,9615.0,Intermediate,1,,,50588,N,1,,
13532,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,BAO_0000218,CHEMBL628124,9025,9615.0,Intermediate,1,,,50588,N,1,,
13533,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,BAO_0000218,CHEMBL628125,9025,9615.0,Intermediate,1,,,50588,N,1,,
13534,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,BAO_0000218,CHEMBL628126,9025,9615.0,Intermediate,1,,,50588,N,1,,
13535,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,BAO_0000218,CHEMBL628127,9025,9615.0,Intermediate,1,,,50588,N,1,,
13536,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,BAO_0000218,CHEMBL628128,9025,9615.0,Intermediate,1,,,50588,N,1,,
13537,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,BAO_0000218,CHEMBL628129,9025,9615.0,Intermediate,1,,,50588,N,1,,
13538,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,BAO_0000218,CHEMBL628130,9025,9615.0,Intermediate,1,,,50588,N,1,,
13539,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,BAO_0000218,CHEMBL628131,9025,9615.0,Intermediate,1,,,50588,N,1,,
13540,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,BAO_0000218,CHEMBL628132,9025,9615.0,Intermediate,1,,,50588,N,1,,
13541,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,BAO_0000218,CHEMBL628133,9025,9615.0,Intermediate,1,,,50588,N,1,,
13542,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,BAO_0000218,CHEMBL628134,9025,9615.0,Intermediate,1,,,50588,N,1,,
13543,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,BAO_0000218,CHEMBL628135,9025,9615.0,Intermediate,1,,,50588,N,1,,
13544,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,BAO_0000218,CHEMBL628136,9025,9615.0,Intermediate,1,,,50588,N,1,,
13545,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,BAO_0000218,CHEMBL628137,9025,9615.0,Intermediate,1,,,50588,N,1,,
13546,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,BAO_0000218,CHEMBL628138,9025,9615.0,Intermediate,1,,,50588,N,1,,
13547,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,BAO_0000218,CHEMBL628139,9025,9615.0,Intermediate,1,,,50588,N,1,,
13548,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,BAO_0000218,CHEMBL628140,9025,9615.0,Intermediate,1,,,50588,N,1,,
13549,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,BAO_0000218,CHEMBL628141,9025,9615.0,Intermediate,1,,,50588,N,1,,
13550,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,BAO_0000218,CHEMBL628142,9025,9615.0,Intermediate,1,,,50588,N,1,,
13551,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,BAO_0000218,CHEMBL628143,9025,9615.0,Intermediate,1,,,50588,N,1,,
13552,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,BAO_0000218,CHEMBL628144,9025,9615.0,Intermediate,1,,,50588,N,1,,
13553,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,BAO_0000218,CHEMBL628145,9025,9615.0,Intermediate,1,,,50588,N,1,,
13554,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,BAO_0000218,CHEMBL628146,9025,9615.0,Intermediate,1,,,50588,N,1,,
13555,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,BAO_0000218,CHEMBL625355,9025,9615.0,Intermediate,1,,,50588,N,1,,
13556,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,BAO_0000218,CHEMBL625356,9025,9615.0,Intermediate,1,,,50588,N,1,,
13557,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,BAO_0000218,CHEMBL625357,9025,9615.0,Intermediate,1,,,50588,N,1,,
13558,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,BAO_0000218,CHEMBL625527,9025,9615.0,Intermediate,1,,,50588,N,1,,
13559,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,BAO_0000218,CHEMBL875473,9025,9615.0,Intermediate,1,,,50588,N,1,,
13560,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,BAO_0000218,CHEMBL625528,9025,9615.0,Intermediate,1,,,50588,N,1,,
13561,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,BAO_0000218,CHEMBL626304,9025,10116.0,Intermediate,1,,,50597,N,1,,
13562,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,BAO_0000218,CHEMBL624138,9025,9615.0,Intermediate,1,,,50588,N,1,1637.0,
13563,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624139,6448,,Autocuration,1,,,22229,U,0,,
13564,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624140,17221,,Autocuration,1,,,22229,U,0,,
13565,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624141,6545,,Autocuration,1,,,22229,U,0,,
13566,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624142,577,,Autocuration,1,,,22229,U,0,,
13567,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624143,6285,,Autocuration,1,,,22229,U,0,,
13568,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624144,6500,,Autocuration,1,,,22229,U,0,,
13569,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624145,6716,,Autocuration,1,,,22229,U,0,,
13570,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624146,13658,,Autocuration,1,,,22229,U,0,,
13571,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624147,6549,,Autocuration,1,,,22229,U,0,,
13572,,Calculated partition coefficient (clogP) (MacLogP),,BAO_0000100,CHEMBL883123,14685,,Autocuration,1,,,22229,U,0,,
13573,,Partition coefficient (logP),,BAO_0000019,CHEMBL624148,6893,,Autocuration,1,,,22224,U,0,,
13574,,Kinetic parameter was determined,,BAO_0000019,CHEMBL874416,3687,,Autocuration,1,,,22224,U,0,,
13575,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624149,4207,,Autocuration,1,,,22229,U,0,,
13576,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL624150,4626,,Autocuration,1,,,22229,U,0,,
13577,,Lipophilicity was determined,,BAO_0000100,CHEMBL624151,1021,,Autocuration,1,,,22224,U,0,,
13578,,Lipophilicity was determined,,BAO_0000100,CHEMBL624152,3777,,Autocuration,1,,,22224,U,0,,
13579,,Lipophilicity was determined,,BAO_0000100,CHEMBL622139,17533,,Autocuration,1,,,22224,U,0,,
13580,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL622140,6524,,Autocuration,1,,,22229,U,0,,
13581,,Lipophilicity was determined,,BAO_0000100,CHEMBL622141,17533,,Autocuration,1,,,22224,U,0,,
13582,,Lipophilicity in octanol-water,,BAO_0000100,CHEMBL622142,6480,,Autocuration,1,,,22224,U,0,,
13583,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL622143,17606,,Autocuration,1,,,22229,U,0,,
13584,,Octanol-water partition coefficient was determined,,BAO_0000100,CHEMBL622144,6863,,Autocuration,1,,,22229,U,0,,
13585,,Partition coefficient (logP),,BAO_0000019,CHEMBL877473,1356,,Autocuration,1,,,22224,U,0,,
13586,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL622145,3326,,Autocuration,1,,,22229,U,0,,
13587,,Partition coefficient was determined; ND means not determined,,BAO_0000019,CHEMBL622146,1356,,Autocuration,1,,,22224,U,0,,
13588,,Calculated partition coefficient (clogP),,BAO_0000100,CHEMBL622147,12984,,Autocuration,1,,,22229,U,0,,
13589,,Partition coefficient of the compound,,BAO_0000019,CHEMBL622148,17363,,Autocuration,1,,,22224,U,0,,
13590,,Permeability was determined,,BAO_0000019,CHEMBL883124,6827,,Autocuration,1,,,22224,U,0,,
13591,,The compound was evaluated for the partition coefficient,,BAO_0000100,CHEMBL622149,261,,Autocuration,1,,,22229,U,0,,
13592,,Partition coefficient (logP),,BAO_0000019,CHEMBL622150,2685,,Autocuration,1,,,22224,U,0,,
13593,,The lipophilicity was reported,,BAO_0000100,CHEMBL622151,414,,Autocuration,1,,,22224,U,0,,
13594,,logarithm of the octanol-water partition coefficient for the compound,,BAO_0000100,CHEMBL622152,15769,,Autocuration,1,,,22229,U,0,,
13595,,Clogp value was determined,,BAO_0000019,CHEMBL622153,17248,,Autocuration,1,,,22224,U,0,,
13596,,Clp at a dose of 1.5 mg/kg,,BAO_0000218,CHEMBL877474,16935,,Autocuration,1,,,22224,U,0,,
13597,,Clp at a dose of 2.0 mg/kg,,BAO_0000218,CHEMBL622154,16935,,Autocuration,1,,,22224,U,0,,
13598,,"Clp, plasma clearance at a dose of 10 mg/kg",,BAO_0000218,CHEMBL622155,14832,,Autocuration,1,,,22224,U,0,1969.0,
13599,,"Clp, plasma clearance at a dose of 50 mg/kg",,BAO_0000218,CHEMBL622156,14832,,Autocuration,1,,,22224,U,0,1969.0,
13600,,Compound was tested for plasma clearance in rat,,BAO_0000218,CHEMBL622157,2399,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13601,,Compound was tested for plasma clearance in rat; Not determined,,BAO_0000218,CHEMBL622158,2399,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13602,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,BAO_0000218,CHEMBL622807,6227,10116.0,Intermediate,1,,,50597,N,1,,
13603,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,BAO_0000218,CHEMBL622808,6227,9544.0,Intermediate,1,,,50797,N,1,,
13604,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,BAO_0000218,CHEMBL622809,5623,,Autocuration,1,,,22224,U,0,,
13605,,Plasma clearance determined,,BAO_0000218,CHEMBL622810,4854,,Autocuration,1,,,22224,U,0,,
13606,,Plasma clearance after iv administration at 3 mg/kg in hamster,,BAO_0000218,CHEMBL876653,4493,10026.0,Intermediate,1,,,100712,N,1,,
13607,,Plasma clearance after iv administration at 4 mg/kg in hamster,,BAO_0000218,CHEMBL622811,4493,10026.0,Intermediate,1,,,100712,N,1,,
13608,,Rate of clearance in rat was determined,,BAO_0000218,CHEMBL622986,14956,10116.0,Intermediate,1,,,50597,N,1,,
13609,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,BAO_0000218,CHEMBL622987,15372,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13610,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,BAO_0000218,CHEMBL622988,15372,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13611,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,BAO_0000218,CHEMBL622989,15372,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13612,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,BAO_0000218,CHEMBL622990,15372,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13613,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,BAO_0000218,CHEMBL622991,15604,314293.0,Autocuration,1,,,22224,U,0,1969.0,
13614,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,BAO_0000218,CHEMBL622227,15604,10116.0,Intermediate,1,,,50597,N,1,1969.0,
13615,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,BAO_0000218,CHEMBL622228,15604,9615.0,Intermediate,1,,,50588,N,1,1969.0,
13616,,Clpl value in rat,,BAO_0000218,CHEMBL622229,14964,10116.0,Intermediate,1,,,50597,N,1,,
13617,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,BAO_0000218,CHEMBL622230,15240,10141.0,Intermediate,1,,,50512,N,1,,
13618,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,BAO_0000218,CHEMBL622231,16449,10116.0,Intermediate,1,,,50597,N,1,,
13619,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,BAO_0000218,CHEMBL622232,16449,9541.0,Intermediate,1,,,100710,N,1,,
13620,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,BAO_0000218,CHEMBL622233,12902,,Autocuration,1,,,22224,U,0,,
13621,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,BAO_0000218,CHEMBL622234,12902,,Autocuration,1,,,22224,U,0,,
13622,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,BAO_0000218,CHEMBL622235,12902,,Autocuration,1,,,22224,U,0,,
13623,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,BAO_0000218,CHEMBL622236,12902,,Autocuration,1,,,22224,U,0,,
13624,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,BAO_0000218,CHEMBL622237,12902,,Autocuration,1,,,22224,U,0,,
13625,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,BAO_0000218,CHEMBL877482,12902,,Autocuration,1,,,22224,U,0,,
13626,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,BAO_0000218,CHEMBL622238,12902,,Autocuration,1,,,22224,U,0,,
13627,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,BAO_0000218,CHEMBL622239,12902,,Autocuration,1,,,22224,U,0,,
13628,,Cmax was calculated as maximum concentration reached in the blood,,BAO_0000218,CHEMBL622240,11149,,Autocuration,1,,,22224,U,0,178.0,
13629,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,BAO_0000218,CHEMBL622241,11149,,Autocuration,1,,,22224,U,0,178.0,
13630,,Cmax was determine after peroral administration at 10 mpk in Rat,,BAO_0000218,CHEMBL631013,5669,10116.0,Intermediate,1,,,50597,N,1,,
13631,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,BAO_0000218,CHEMBL631014,5669,9544.0,Intermediate,1,,,50797,N,1,,
13632,,Cmax was determine after peroral administration at 10 mpk in dog,,BAO_0000218,CHEMBL631015,5669,9615.0,Intermediate,1,,,50588,N,1,,
13633,,Cmax was determine after peroral administration at 160 mpk in Rat,,BAO_0000218,CHEMBL631016,5669,10116.0,Intermediate,1,,,50597,N,1,,
13634,,Cmax was determine after peroral administration at 20 mpk in Rat,,BAO_0000218,CHEMBL631017,5669,10116.0,Intermediate,1,,,50597,N,1,,
13635,,Cmax was determine after peroral administration at 50 mpk in Rat,,BAO_0000218,CHEMBL631018,5669,10116.0,Intermediate,1,,,50597,N,1,,
13636,,Cmax was determined,,BAO_0000218,CHEMBL631019,4236,,Autocuration,1,,,22224,U,0,,
13637,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,BAO_0000218,CHEMBL875761,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
13638,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,BAO_0000218,CHEMBL631020,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
13639,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,BAO_0000218,CHEMBL631669,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
13640,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,BAO_0000218,CHEMBL631670,13792,10090.0,Intermediate,1,,,50594,N,1,955.0,
13641,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,BAO_0000218,CHEMBL631671,13792,10090.0,Intermediate,1,,,50594,N,1,2435.0,
13642,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,BAO_0000218,CHEMBL631672,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13643,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,BAO_0000218,CHEMBL631673,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13644,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,BAO_0000218,CHEMBL631856,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13645,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,BAO_0000218,CHEMBL631857,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13646,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,BAO_0000218,CHEMBL631858,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13647,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,BAO_0000218,CHEMBL631859,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13648,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,BAO_0000218,CHEMBL631860,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13649,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,BAO_0000218,CHEMBL631861,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13650,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,BAO_0000218,CHEMBL631862,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13651,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,BAO_0000218,CHEMBL631863,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13652,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,BAO_0000218,CHEMBL631864,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13653,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,BAO_0000218,CHEMBL631865,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13654,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,BAO_0000218,CHEMBL631866,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13655,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,BAO_0000218,CHEMBL629360,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13656,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,BAO_0000218,CHEMBL629361,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13657,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,BAO_0000218,CHEMBL629362,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13658,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,BAO_0000218,CHEMBL630740,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13659,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,BAO_0000218,CHEMBL630741,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13660,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,BAO_0000218,CHEMBL630742,8418,10116.0,Intermediate,1,,,50597,N,1,178.0,
13661,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,BAO_0000218,CHEMBL630743,8418,10116.0,Intermediate,1,,,50597,N,1,,
13662,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,BAO_0000218,CHEMBL630744,8418,10116.0,Intermediate,1,,,50597,N,1,,
13663,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,BAO_0000218,CHEMBL630745,8418,10116.0,Intermediate,1,,,50597,N,1,,
13664,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,BAO_0000218,CHEMBL630746,8418,10116.0,Intermediate,1,,,50597,N,1,,
13665,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,BAO_0000218,CHEMBL630747,8418,10116.0,Intermediate,1,,,50597,N,1,,
13666,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,BAO_0000218,CHEMBL630748,8418,10116.0,Intermediate,1,,,50597,N,1,,
13667,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,BAO_0000218,CHEMBL632056,8418,10116.0,Intermediate,1,,,50597,N,1,,
13668,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,BAO_0000218,CHEMBL632057,8418,10116.0,Intermediate,1,,,50597,N,1,,
13669,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,BAO_0000218,CHEMBL632058,8418,10116.0,Intermediate,1,,,50597,N,1,,
13670,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,BAO_0000218,CHEMBL632059,8418,10116.0,Intermediate,1,,,50597,N,1,,
13671,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,BAO_0000218,CHEMBL632060,8418,10116.0,Intermediate,1,,,50597,N,1,,
13672,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,BAO_0000218,CHEMBL632061,8418,10116.0,Intermediate,1,,,50597,N,1,,
13673,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,BAO_0000218,CHEMBL629207,8418,10116.0,Intermediate,1,,,50597,N,1,,
13674,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,BAO_0000218,CHEMBL629208,8418,10116.0,Intermediate,1,,,50597,N,1,,
13675,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,BAO_0000218,CHEMBL629209,8418,10116.0,Intermediate,1,,,50597,N,1,,
13676,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,BAO_0000218,CHEMBL629210,8418,10116.0,Intermediate,1,,,50597,N,1,,
13677,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,BAO_0000218,CHEMBL629211,8418,10116.0,Intermediate,1,,,50597,N,1,,
13678,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,BAO_0000218,CHEMBL629212,8418,10116.0,Intermediate,1,,,50597,N,1,,
13679,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,BAO_0000218,CHEMBL629213,8418,10116.0,Intermediate,1,,,50597,N,1,,
13680,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,BAO_0000218,CHEMBL629214,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13681,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,BAO_0000218,CHEMBL629215,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13682,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,BAO_0000218,CHEMBL635154,8133,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13683,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL629216,6996,10116.0,Intermediate,1,,,50597,N,1,,
13684,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,BAO_0000218,CHEMBL629217,6996,10116.0,Intermediate,1,,,50597,N,1,,
13685,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL629218,6996,10116.0,Intermediate,1,,,50597,N,1,,
13686,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL629219,6996,10116.0,Intermediate,1,,,50597,N,1,,
13687,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL629220,6996,10116.0,Intermediate,1,,,50597,N,1,,
13688,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL629221,6996,10116.0,Intermediate,1,,,50597,N,1,,
13689,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL631127,6996,10116.0,Intermediate,1,,,50597,N,1,,
13690,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,BAO_0000218,CHEMBL631128,6996,10116.0,Intermediate,1,,,50597,N,1,,
13691,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL631129,6996,10116.0,Intermediate,1,,,50597,N,1,,
13692,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL631130,6996,10116.0,Intermediate,1,,,50597,N,1,,
13693,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL631131,6996,10116.0,Intermediate,1,,,50597,N,1,,
13694,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL631132,6996,10116.0,Intermediate,1,,,50597,N,1,,
13695,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL631133,6996,10116.0,Intermediate,1,,,50597,N,1,,
13696,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,BAO_0000218,CHEMBL631134,6996,10116.0,Intermediate,1,,,50597,N,1,,
13697,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL875120,6996,10116.0,Intermediate,1,,,50597,N,1,,
13698,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL631135,6996,10116.0,Intermediate,1,,,50597,N,1,,
13699,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL631136,6996,10116.0,Intermediate,1,,,50597,N,1,,
13700,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL631137,6996,10116.0,Intermediate,1,,,50597,N,1,,
13701,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL631138,6996,10116.0,Intermediate,1,,,50597,N,1,,
13702,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,BAO_0000218,CHEMBL631139,6996,10116.0,Intermediate,1,,,50597,N,1,,
13703,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL631140,6996,10116.0,Intermediate,1,,,50597,N,1,,
13704,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,BAO_0000218,CHEMBL631141,6996,10116.0,Intermediate,1,,,50597,N,1,,
13705,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,BAO_0000218,CHEMBL631142,6996,10116.0,Intermediate,1,,,50597,N,1,,
13706,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,BAO_0000218,CHEMBL631143,6996,10116.0,Intermediate,1,,,50597,N,1,,
13707,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,BAO_0000218,CHEMBL631144,6996,10116.0,Intermediate,1,,,50597,N,1,,
13708,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,BAO_0000218,CHEMBL631145,6996,9615.0,Intermediate,1,,,50588,N,1,,
13709,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL631146,6996,9615.0,Intermediate,1,,,50588,N,1,,
13710,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,BAO_0000218,CHEMBL631147,6996,9615.0,Intermediate,1,,,50588,N,1,,
13711,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL631148,6996,9615.0,Intermediate,1,,,50588,N,1,,
13712,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL631149,6996,9615.0,Intermediate,1,,,50588,N,1,,
13713,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL631150,6996,9615.0,Intermediate,1,,,50588,N,1,,
13714,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL631151,6996,9615.0,Intermediate,1,,,50588,N,1,,
13715,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL631152,6996,9615.0,Intermediate,1,,,50588,N,1,,
13716,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL631443,6996,9615.0,Intermediate,1,,,50588,N,1,,
13717,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL631444,6996,9615.0,Intermediate,1,,,50588,N,1,,
13718,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL631445,6996,9615.0,Intermediate,1,,,50588,N,1,,
13719,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,BAO_0000218,CHEMBL631446,6996,9615.0,Intermediate,1,,,50588,N,1,,
13720,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,BAO_0000218,CHEMBL631447,6996,9615.0,Intermediate,1,,,50588,N,1,,
13721,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,BAO_0000218,CHEMBL631448,6996,9615.0,Intermediate,1,,,50588,N,1,,
13722,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,BAO_0000218,CHEMBL631449,6996,9615.0,Intermediate,1,,,50588,N,1,,
13723,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,BAO_0000218,CHEMBL631450,6996,9615.0,Intermediate,1,,,50588,N,1,,
13724,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,BAO_0000218,CHEMBL629724,6996,9615.0,Intermediate,1,,,50588,N,1,,
13725,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL629725,9716,10090.0,Intermediate,1,,,50594,N,1,14.0,
13726,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL629726,9716,10090.0,Intermediate,1,,,50594,N,1,14.0,
13727,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL629727,9716,10090.0,Intermediate,1,,,50594,N,1,2106.0,
13728,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630404,9716,10090.0,Intermediate,1,,,50594,N,1,2106.0,
13729,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630405,9716,10090.0,Intermediate,1,,,50594,N,1,2106.0,
13730,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630406,9716,10090.0,Intermediate,1,,,50594,N,1,2106.0,
13731,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630407,9716,10090.0,Intermediate,1,,,50594,N,1,945.0,
13732,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630573,9716,10090.0,Intermediate,1,,,50594,N,1,945.0,
13733,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630574,9716,10090.0,Intermediate,1,,,50594,N,1,945.0,
13734,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630575,9716,10090.0,Intermediate,1,,,50594,N,1,945.0,
13735,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630576,9716,10090.0,Intermediate,1,,,50594,N,1,,
13736,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630577,9716,10090.0,Intermediate,1,,,50594,N,1,,
13737,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630578,9716,10090.0,Intermediate,1,,,50594,N,1,,
13738,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,BAO_0000218,CHEMBL630579,9716,10090.0,Intermediate,1,,,50594,N,1,,
13739,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,BAO_0000218,CHEMBL630580,12192,10090.0,Intermediate,1,,,50594,N,1,2113.0,
13740,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,BAO_0000218,CHEMBL630581,12192,10090.0,Intermediate,1,,,50594,N,1,2113.0,
13741,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,BAO_0000218,CHEMBL630582,12192,10090.0,Intermediate,1,,,50594,N,1,2113.0,
13742,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,BAO_0000218,CHEMBL630583,12192,10090.0,Intermediate,1,,,50594,N,1,,
13743,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,BAO_0000218,CHEMBL630584,12192,10090.0,Intermediate,1,,,50594,N,1,,
13744,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,BAO_0000218,CHEMBL630585,12192,10090.0,Intermediate,1,,,50594,N,1,,
13745,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,BAO_0000218,CHEMBL630586,12192,10090.0,Intermediate,1,,,50594,N,1,,
13746,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,BAO_0000218,CHEMBL630587,12192,10090.0,Intermediate,1,,,50594,N,1,,
13747,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,BAO_0000218,CHEMBL630588,12192,10090.0,Intermediate,1,,,50594,N,1,,
13748,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,BAO_0000218,CHEMBL630589,12192,10090.0,Intermediate,1,,,50594,N,1,,
13749,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,BAO_0000218,CHEMBL630590,12192,10090.0,Intermediate,1,,,50594,N,1,,
13750,,Removal of 238-Plutonium(IV) in feces at 24 h,,BAO_0000019,CHEMBL630591,12192,,Autocuration,1,,,22224,U,0,1988.0,
13751,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,BAO_0000019,CHEMBL630592,12192,,Autocuration,1,,,22224,U,0,1988.0,
13752,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,BAO_0000019,CHEMBL630593,12192,,Autocuration,1,,,22224,U,0,,
13753,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,BAO_0000019,CHEMBL630594,12192,,Autocuration,1,,,22224,U,0,,
13754,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,BAO_0000019,CHEMBL630595,12192,,Autocuration,1,,,22224,U,0,1088.0,
13755,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,BAO_0000019,CHEMBL630596,12192,,Autocuration,1,,,22224,U,0,1088.0,
13756,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,BAO_0000019,CHEMBL630597,12192,,Autocuration,1,,,22224,U,0,1088.0,
13757,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,BAO_0000019,CHEMBL630598,12192,,Autocuration,1,,,22224,U,0,1088.0,
13758,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,BAO_0000019,CHEMBL630599,12192,,Autocuration,1,,,22224,U,0,1088.0,
13759,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,BAO_0000019,CHEMBL630600,12192,,Autocuration,1,,,22224,U,0,1088.0,
13760,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,BAO_0000019,CHEMBL630601,12192,,Autocuration,1,,,22224,U,0,1088.0,
13761,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,BAO_0000019,CHEMBL630602,12192,,Autocuration,1,,,22224,U,0,1088.0,
13762,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,BAO_0000019,CHEMBL630603,12192,,Autocuration,1,,,22224,U,0,1088.0,
13763,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,BAO_0000019,CHEMBL630604,12192,,Autocuration,1,,,22224,U,0,1088.0,
13764,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL624869,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
13765,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL624870,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
13766,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL623189,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
13767,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623190,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
13768,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623191,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
13769,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623192,12017,10116.0,Intermediate,1,,,50597,N,1,,
13770,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623193,12017,10116.0,Intermediate,1,,,50597,N,1,,
13771,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL623194,12017,10116.0,Intermediate,1,,,50597,N,1,,
13772,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623195,12017,10116.0,Intermediate,1,,,50597,N,1,,
13773,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623196,12017,10116.0,Intermediate,1,,,50597,N,1,,
13774,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,BAO_0000218,CHEMBL623197,11836,10116.0,Intermediate,1,,,50597,N,1,,
13775,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623198,11836,10116.0,Intermediate,1,,,50597,N,1,,
13776,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,BAO_0000218,CHEMBL623199,11836,10116.0,Intermediate,1,,,50597,N,1,,
13777,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623200,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13778,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623201,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13779,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623202,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13780,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623203,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13781,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623204,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13782,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,BAO_0000218,CHEMBL623205,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13783,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623206,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13784,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,BAO_0000218,CHEMBL623207,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13785,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,BAO_0000218,CHEMBL623208,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13786,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623209,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13787,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,BAO_0000218,CHEMBL623210,11836,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13788,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623211,11836,10116.0,Intermediate,1,,,50597,N,1,,
13789,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,BAO_0000218,CHEMBL623212,11836,10116.0,Intermediate,1,,,50597,N,1,995.0,
13790,,Tested in vitro for intrinsic activity relative to quinpirole,,BAO_0000019,CHEMBL623213,12640,,Autocuration,1,,,22224,U,0,,
13791,,"Relative ion enhancement, determined in pulsed ultrafiltration",,BAO_0000019,CHEMBL623214,14218,,Autocuration,1,,,22224,U,0,,
13792,,% ionization at the pH 7.4 at 37 degree Centigrade,,BAO_0000019,CHEMBL623215,11296,,Autocuration,1,,,22224,U,0,,
13793,,Percentage ionization was measured,,BAO_0000019,CHEMBL623216,10929,,Autocuration,1,,,22224,U,0,,
13794,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,BAO_0000218,CHEMBL623217,13841,9913.0,Intermediate,1,,,50591,N,1,,
13795,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,BAO_0000019,CHEMBL623218,10431,,Autocuration,1,,,22224,U,0,,
13796,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,BAO_0000019,CHEMBL623913,10431,,Autocuration,1,,,22224,U,0,,
13797,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,BAO_0000019,CHEMBL623914,10431,,Autocuration,1,,,22224,U,0,,
13798,,Compound was evaluated for the partition coefficient in octanol/water,,BAO_0000100,CHEMBL623915,8826,,Autocuration,1,,,22229,U,0,,
13799,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,BAO_0000100,CHEMBL624080,8826,,Autocuration,1,,,22229,U,0,,
13800,,Equilibrium constant measured by the pulse radiolysis at pH 7,,BAO_0000019,CHEMBL624081,9884,,Autocuration,1,,,22224,U,0,,
13801,,In vitro hydrolytic rate constant determined in human blood,,BAO_0000218,CHEMBL624082,9827,9606.0,Intermediate,1,,,50587,N,1,,
13802,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,BAO_0000218,CHEMBL625054,10009,9606.0,Intermediate,1,,,50587,N,1,,
13803,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,BAO_0000019,CHEMBL877485,10009,,Autocuration,1,,,22224,U,0,,
13804,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,BAO_0000218,CHEMBL625055,10009,10090.0,Intermediate,1,,,50594,N,1,,
13805,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,BAO_0000218,CHEMBL625056,10009,10090.0,Intermediate,1,,,50594,N,1,,
13806,,In vitro oxidation of compound in presence of human plasma,,BAO_0000218,CHEMBL625057,10009,9606.0,Intermediate,1,,,50587,N,1,,
13807,,In vitro oxidation of compound in presence of hydrogen peroxide,,BAO_0000019,CHEMBL625058,10009,,Autocuration,1,,,22224,U,0,,
13808,,In vitro oxidation of compound in presence of mouse brain homogenate,,BAO_0000218,CHEMBL625059,10009,10090.0,Intermediate,1,,,50594,N,1,,
13809,,In vitro oxidation of compound in presence of mouse liver homogenate,,BAO_0000218,CHEMBL629536,10009,10090.0,Intermediate,1,,,50594,N,1,,
13810,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,BAO_0000218,CHEMBL629537,11510,10116.0,Intermediate,1,,,50597,N,1,,
13811,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,BAO_0000218,CHEMBL629538,11510,10116.0,Intermediate,1,,,50597,N,1,,
13812,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,BAO_0000218,CHEMBL629539,11510,10116.0,Intermediate,1,,,50597,N,1,,
13813,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,BAO_0000218,CHEMBL874445,11510,10116.0,Intermediate,1,,,50597,N,1,,
13814,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,BAO_0000218,CHEMBL629540,11510,10116.0,Intermediate,1,,,50597,N,1,,
13815,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,BAO_0000218,CHEMBL629541,11510,10116.0,Intermediate,1,,,50597,N,1,,
13816,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,BAO_0000218,CHEMBL629542,11510,10116.0,Intermediate,1,,,50597,N,1,,
13817,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,BAO_0000218,CHEMBL630243,11510,10116.0,Intermediate,1,,,50597,N,1,,
13818,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,BAO_0000218,CHEMBL630244,11510,10116.0,Intermediate,1,,,50597,N,1,,
13819,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,BAO_0000218,CHEMBL630245,11510,10116.0,Intermediate,1,,,50597,N,1,,
13820,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,BAO_0000218,CHEMBL630246,11510,10116.0,Intermediate,1,,,50597,N,1,,
13821,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,BAO_0000218,CHEMBL630247,11510,10116.0,Intermediate,1,,,50597,N,1,,
13822,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,BAO_0000218,CHEMBL630248,11510,10116.0,Intermediate,1,,,50597,N,1,,
13823,,Biodistribution in rat blood at 240 minutes after dose administration.,,BAO_0000218,CHEMBL630249,13100,10116.0,Intermediate,1,,,50597,N,1,178.0,
13824,,Biodistribution in rat blood at 30 minutes after dose administration.,,BAO_0000218,CHEMBL630250,13100,10116.0,Intermediate,1,,,50597,N,1,178.0,
13825,,Biodistribution in rat blood at 360 minutes after dose administration.,,BAO_0000218,CHEMBL630251,13100,10116.0,Intermediate,1,,,50597,N,1,178.0,
13826,,Biodistribution in rat blood at 3 hr after dose administration.,,BAO_0000218,CHEMBL630252,13100,10116.0,Intermediate,1,,,50597,N,1,178.0,
13827,,Biodistribution in rat blood at 60 minutes after dose administration.,,BAO_0000218,CHEMBL630408,13100,10116.0,Intermediate,1,,,50597,N,1,178.0,
13828,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,BAO_0000218,CHEMBL630409,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13829,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL874446,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13830,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,BAO_0000218,CHEMBL630410,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13831,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,BAO_0000218,CHEMBL630411,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13832,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,BAO_0000218,CHEMBL630412,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13833,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,BAO_0000218,CHEMBL630413,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13834,,Biodistribution in rat cerebellum at 3 hr after dose administration.,,BAO_0000218,CHEMBL630414,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13835,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,BAO_0000218,CHEMBL630415,13100,10116.0,Intermediate,1,,,50597,N,1,2037.0,
13836,,Biodistribution in rat cortex at 120 minutes after dose administration.,,BAO_0000218,CHEMBL630416,13100,10116.0,Intermediate,1,,,50597,N,1,,
13837,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL630417,13100,10116.0,Intermediate,1,,,50597,N,1,,
13838,,Biodistribution in rat cortex at 15 minutes after dose administration.,,BAO_0000218,CHEMBL630418,13100,10116.0,Intermediate,1,,,50597,N,1,,
13839,,Biodistribution in rat cortex at 240 minutes after dose administration.,,BAO_0000218,CHEMBL630419,13100,10116.0,Intermediate,1,,,50597,N,1,,
13840,,Biodistribution in rat cortex at 30 minutes after dose administration.,,BAO_0000218,CHEMBL630420,13100,10116.0,Intermediate,1,,,50597,N,1,,
13841,,Biodistribution in rat cortex at 360 minutes after dose administration.,,BAO_0000218,CHEMBL630421,13100,10116.0,Intermediate,1,,,50597,N,1,,
13842,,Biodistribution in rat cortex at 3 hr after dose administration.,,BAO_0000218,CHEMBL630422,13100,10116.0,Intermediate,1,,,50597,N,1,,
13843,,Biodistribution in rat cortex at 60 minutes after dose administration.,,BAO_0000218,CHEMBL630423,13100,10116.0,Intermediate,1,,,50597,N,1,,
13844,,Biodistribution in rat heart at 120 minutes after dose administration.,,BAO_0000218,CHEMBL630424,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13845,,Biodistribution in rat heart at 15 minutes after dose administration.,,BAO_0000218,CHEMBL630425,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13846,,Biodistribution in rat heart at 240 minutes after dose administration.,,BAO_0000218,CHEMBL629462,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13847,,Biodistribution in rat heart at 30 minutes after dose administration.,,BAO_0000218,CHEMBL630426,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13848,,Biodistribution in rat heart at 360 minutes after dose administration.,,BAO_0000218,CHEMBL630427,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13849,,Biodistribution in rat heart at 3 hr after dose administration.,,BAO_0000218,CHEMBL625877,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13850,,Biodistribution in rat heart at 60 minutes after dose administration.,,BAO_0000218,CHEMBL625878,13100,10116.0,Intermediate,1,,,50597,N,1,948.0,
13851,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL625879,13100,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
13852,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,BAO_0000218,CHEMBL625880,13100,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
13853,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,BAO_0000218,CHEMBL625881,13100,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
13854,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,BAO_0000218,CHEMBL625882,13100,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
13855,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,BAO_0000218,CHEMBL625883,13100,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
13856,,Biodistribution in rat kidney at 120 minutes after dose administration.,,BAO_0000218,CHEMBL625884,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13857,,Biodistribution in rat kidney at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL625885,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13858,,Biodistribution in rat kidney at 15 minutes after dose administration.,,BAO_0000218,CHEMBL628649,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13859,,Biodistribution in rat kidney at 240 minutes after dose administration.,,BAO_0000218,CHEMBL628650,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13860,,Biodistribution in rat kidney at 30 minutes after dose administration.,,BAO_0000218,CHEMBL628651,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13861,,Biodistribution in rat kidney at 360 minutes after dose administration.,,BAO_0000218,CHEMBL628652,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13862,,Biodistribution in rat kidney at 60 minutes after dose administration.,,BAO_0000218,CHEMBL628653,13100,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13863,,Biodistribution in rat liver at 120 minutes after dose administration.,,BAO_0000218,CHEMBL628654,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13864,,Biodistribution in rat liver at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL628655,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13865,,Biodistribution in rat liver at 15 minutes after dose administration.,,BAO_0000218,CHEMBL625238,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13866,,Biodistribution in rat liver at 240 minutes after dose administration.,,BAO_0000218,CHEMBL625239,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13867,,Biodistribution in rat liver at 30 minutes after dose administration.,,BAO_0000218,CHEMBL625240,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13868,,Biodistribution in rat liver at 360 minutes after dose administration.,,BAO_0000218,CHEMBL625241,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13869,,Biodistribution in rat liver at 60 minutes after dose administration.,,BAO_0000218,CHEMBL625242,13100,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13870,,Biodistribution in rat lung at 120 minutes after dose administration.,,BAO_0000218,CHEMBL874587,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13871,,Biodistribution in rat lung at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL625405,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13872,,Biodistribution in rat lung at 15 minutes after dose administration.,,BAO_0000218,CHEMBL625406,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13873,,Biodistribution in rat lung at 240 minutes after dose administration.,,BAO_0000218,CHEMBL625407,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13874,,Biodistribution in rat lung at 30 minutes after dose administration.,,BAO_0000218,CHEMBL625408,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13875,,Biodistribution in rat lung at 360 minutes after dose administration.,,BAO_0000218,CHEMBL625409,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13876,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,BAO_0000218,CHEMBL625410,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13877,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,BAO_0000218,CHEMBL625411,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13878,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,BAO_0000218,CHEMBL625412,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13879,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,BAO_0000218,CHEMBL625413,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13880,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,BAO_0000218,CHEMBL625414,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13881,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,BAO_0000218,CHEMBL625415,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13882,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,BAO_0000218,CHEMBL625416,12361,10116.0,Intermediate,1,,,50597,N,1,1515.0,
13883,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,BAO_0000218,CHEMBL625417,12712,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13884,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,BAO_0000218,CHEMBL625418,7415,10116.0,Intermediate,1,,,50597,N,1,1988.0,
13885,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,BAO_0000218,CHEMBL625419,7415,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13886,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,BAO_0000218,CHEMBL625420,7415,10116.0,Intermediate,1,,,50597,N,1,,
13887,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,BAO_0000218,CHEMBL626996,7415,10116.0,Intermediate,1,,,50597,N,1,,
13888,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,BAO_0000218,CHEMBL626997,7415,10116.0,Intermediate,1,,,50597,N,1,1988.0,
13889,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,BAO_0000218,CHEMBL626998,7415,10116.0,Intermediate,1,,,50597,N,1,1088.0,
13890,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,BAO_0000218,CHEMBL626999,7415,10116.0,Intermediate,1,,,50597,N,1,,
13891,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,BAO_0000218,CHEMBL627000,8050,10090.0,Intermediate,1,,,50594,N,1,,
13892,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,BAO_0000218,CHEMBL627001,8050,10090.0,Intermediate,1,,,50594,N,1,,
13893,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,BAO_0000218,CHEMBL627002,8050,10090.0,Intermediate,1,,,50594,N,1,,
13894,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,BAO_0000218,CHEMBL627003,8050,10090.0,Intermediate,1,,,50594,N,1,,
13895,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,CHEMBL627004,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13896,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,CHEMBL627005,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13897,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,CHEMBL874594,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13898,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,CHEMBL627006,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13899,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,CHEMBL627007,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13900,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,CHEMBL627884,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13901,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,CHEMBL627885,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13902,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,CHEMBL627886,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13903,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,CHEMBL627887,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13904,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,BAO_0000218,CHEMBL627888,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13905,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,BAO_0000218,CHEMBL628057,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13906,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,BAO_0000218,CHEMBL627405,8050,10090.0,Intermediate,1,,,50594,N,1,1088.0,
13907,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,BAO_0000218,CHEMBL627406,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13908,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,BAO_0000218,CHEMBL627407,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13909,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,BAO_0000218,CHEMBL627408,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13910,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,BAO_0000218,CHEMBL627409,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13911,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,BAO_0000218,CHEMBL875486,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13912,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL627410,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13913,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,BAO_0000218,CHEMBL627411,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13914,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,BAO_0000218,CHEMBL627412,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13915,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,BAO_0000218,CHEMBL627413,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13916,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,BAO_0000218,CHEMBL627414,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13917,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,CHEMBL627415,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13918,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,BAO_0000218,CHEMBL627416,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13919,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,CHEMBL627417,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13920,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,CHEMBL627418,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13921,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL627419,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13922,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,BAO_0000218,CHEMBL627320,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13923,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,BAO_0000218,CHEMBL627321,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
13924,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627322,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13925,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627323,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13926,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL627491,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13927,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627492,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13928,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627493,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
13929,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627494,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13930,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627495,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13931,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL627496,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13932,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627497,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13933,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627498,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
13934,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627499,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13935,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL627500,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13936,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL627501,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13937,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625616,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13938,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625617,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
13939,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625618,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13940,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625619,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13941,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL625620,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13942,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625621,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13943,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625622,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
13944,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625788,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13945,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625789,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13946,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL625790,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13947,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL625791,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13948,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL622334,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13949,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL622335,12017,10116.0,Intermediate,1,,,50597,N,1,2046.0,
13950,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL622336,12017,10116.0,Intermediate,1,,,50597,N,1,2046.0,
13951,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL622337,12017,10116.0,Intermediate,1,,,50597,N,1,2046.0,
13952,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL622338,12017,10116.0,Intermediate,1,,,50597,N,1,2046.0,
13953,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL622339,12017,10116.0,Intermediate,1,,,50597,N,1,2046.0,
13954,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL624153,12017,10116.0,Intermediate,1,,,50597,N,1,,
13955,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL628430,12017,10116.0,Intermediate,1,,,50597,N,1,,
13956,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL628431,12017,10116.0,Intermediate,1,,,50597,N,1,,
13957,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL628432,12017,10116.0,Intermediate,1,,,50597,N,1,,
13958,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL628433,12017,10116.0,Intermediate,1,,,50597,N,1,,
13959,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,CHEMBL628434,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13960,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,CHEMBL626789,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13961,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,BAO_0000218,CHEMBL626790,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13962,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,CHEMBL626791,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13963,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,CHEMBL626792,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13964,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,CHEMBL626793,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
13965,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,BAO_0000218,CHEMBL627436,11510,10116.0,Intermediate,1,,,50597,N,1,,
13966,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,BAO_0000218,CHEMBL627437,11510,10116.0,Intermediate,1,,,50597,N,1,,
13967,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,BAO_0000218,CHEMBL627438,11510,10116.0,Intermediate,1,,,50597,N,1,,
13968,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,BAO_0000218,CHEMBL627439,11510,10116.0,Intermediate,1,,,50597,N,1,,
13969,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,BAO_0000218,CHEMBL627440,11510,10116.0,Intermediate,1,,,50597,N,1,,
13970,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,BAO_0000218,CHEMBL627602,11510,10116.0,Intermediate,1,,,50597,N,1,,
13971,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,BAO_0000218,CHEMBL627603,11510,10116.0,Intermediate,1,,,50597,N,1,,
13972,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,BAO_0000218,CHEMBL627604,11510,10116.0,Intermediate,1,,,50597,N,1,,
13973,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,BAO_0000218,CHEMBL627605,11510,10116.0,Intermediate,1,,,50597,N,1,,
13974,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,BAO_0000218,CHEMBL627606,11510,10116.0,Intermediate,1,,,50597,N,1,,
13975,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,BAO_0000218,CHEMBL627607,11510,10116.0,Intermediate,1,,,50597,N,1,,
13976,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,BAO_0000218,CHEMBL627608,11510,10116.0,Intermediate,1,,,50597,N,1,,
13977,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,BAO_0000218,CHEMBL627609,11510,10116.0,Intermediate,1,,,50597,N,1,,
13978,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,BAO_0000218,CHEMBL627610,11510,10116.0,Intermediate,1,,,50597,N,1,,
13979,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,BAO_0000218,CHEMBL627611,11510,10116.0,Intermediate,1,,,50597,N,1,,
13980,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,BAO_0000218,CHEMBL627612,11510,10116.0,Intermediate,1,,,50597,N,1,,
13981,,Octanol:water partition coefficient is evaluated,,BAO_0000100,CHEMBL627613,8362,,Autocuration,1,,,22229,U,0,,
13982,,Partition coefficient in 1-octanol/water system,,BAO_0000100,CHEMBL627614,8257,,Autocuration,1,,,22224,U,0,,
13983,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,BAO_0000100,CHEMBL627615,8257,,Autocuration,1,,,22224,U,0,,
13984,,Partition coefficient in octanol/water system was determined,,BAO_0000100,CHEMBL627616,9468,,Autocuration,1,,,22224,U,0,,
13985,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,BAO_0000100,CHEMBL627617,9468,,Autocuration,1,,,22224,U,0,,
13986,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,BAO_0000019,CHEMBL627618,10568,,Autocuration,1,,,22224,U,0,,
13987,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,BAO_0000019,CHEMBL627619,10568,,Autocuration,1,,,22224,U,0,,
13988,,Pseudo-first-order rate constant of the compound,,BAO_0000019,CHEMBL627620,15359,,Autocuration,1,,,22224,U,0,,
13989,,Pseudo-first-order rate constant with 1-min time point,,BAO_0000019,CHEMBL627621,15359,,Autocuration,1,,,22224,U,0,,
13990,,Pseudo-first-order rate constant without 1-min time point,,BAO_0000019,CHEMBL627622,15359,,Autocuration,1,,,22224,U,0,,
13991,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,BAO_0000019,CHEMBL627623,10431,,Autocuration,1,,,22224,U,0,,
13992,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,BAO_0000019,CHEMBL627624,10431,,Autocuration,1,,,22224,U,0,,
13993,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,BAO_0000019,CHEMBL627625,10431,,Autocuration,1,,,22224,U,0,,
13994,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,BAO_0000019,CHEMBL628523,15704,,Autocuration,1,,,22224,U,0,,
13995,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,BAO_0000019,CHEMBL628524,15287,,Autocuration,1,,,22224,U,0,,
13996,,The efflux rate constant of the compound,,BAO_0000019,CHEMBL628525,7516,,Autocuration,1,,,22224,U,0,,
13997,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,BAO_0000019,CHEMBL625732,12973,,Autocuration,1,,,22224,U,0,,
13998,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,BAO_0000019,CHEMBL625733,12973,,Autocuration,1,,,22224,U,0,,
13999,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,BAO_0000019,CHEMBL625734,12973,,Autocuration,1,,,22224,U,0,,
14000,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,BAO_0000019,CHEMBL625913,12973,,Autocuration,1,,,22224,U,0,,
14001,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,BAO_0000019,CHEMBL625914,8696,,Autocuration,1,,,22224,U,0,,
14002,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,BAO_0000019,CHEMBL625915,15052,,Autocuration,1,,,22224,U,0,,
14003,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,BAO_0000019,CHEMBL625916,15052,,Autocuration,1,,,22224,U,0,,
14004,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,BAO_0000019,CHEMBL625917,10503,,Autocuration,1,,,22224,U,0,,
14005,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625918,8354,,Autocuration,1,,,22224,U,0,,
14006,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625919,8354,,Autocuration,1,,,22224,U,0,,
14007,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625920,8354,,Autocuration,1,,,22224,U,0,,
14008,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL874453,8354,,Autocuration,1,,,22224,U,0,,
14009,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625921,8354,,Autocuration,1,,,22224,U,0,,
14010,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,BAO_0000019,CHEMBL625922,10503,,Autocuration,1,,,22224,U,0,,
14011,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625923,8354,,Autocuration,1,,,22224,U,0,,
14012,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625924,8354,,Autocuration,1,,,22224,U,0,,
14013,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625925,8354,,Autocuration,1,,,22224,U,0,,
14014,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL625926,8354,,Autocuration,1,,,22224,U,0,,
14015,,Biodistribution in rat lung at 60 minutes after dose administration.,,BAO_0000218,CHEMBL627704,13100,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14016,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,BAO_0000218,CHEMBL627705,13100,10116.0,Intermediate,1,,,50597,N,1,,
14017,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,BAO_0000218,CHEMBL627706,13100,10116.0,Intermediate,1,,,50597,N,1,,
14018,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,BAO_0000218,CHEMBL627707,13100,10116.0,Intermediate,1,,,50597,N,1,,
14019,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,BAO_0000218,CHEMBL627708,13100,10116.0,Intermediate,1,,,50597,N,1,,
14020,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,BAO_0000218,CHEMBL628361,13100,10116.0,Intermediate,1,,,50597,N,1,,
14021,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,BAO_0000218,CHEMBL628362,13100,10116.0,Intermediate,1,,,50597,N,1,,
14022,,Biodistribution in rat striatum at 120 minutes after dose administration.,,BAO_0000218,CHEMBL628363,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14023,,Biodistribution in rat striatum at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL628364,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14024,,Biodistribution in rat striatum at 15 minutes after dose administration.,,BAO_0000218,CHEMBL628365,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14025,,Biodistribution in rat striatum at 240 minutes after dose administration.,,BAO_0000218,CHEMBL874454,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14026,,Biodistribution in rat striatum at 30 minutes after dose administration.,,BAO_0000218,CHEMBL628531,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14027,,Biodistribution in rat striatum at 360 minutes after dose administration.,,BAO_0000218,CHEMBL628532,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14028,,Biodistribution in rat striatum at 3 hr after dose administration.,,BAO_0000218,CHEMBL628533,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14029,,Biodistribution in rat striatum at 60 minutes after dose administration.,,BAO_0000218,CHEMBL628534,13100,10116.0,Intermediate,1,,,50597,N,1,2435.0,
14030,,Biodistribution in rat thyroid at 120 minutes after dose administration.,,BAO_0000218,CHEMBL628535,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14031,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL628536,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14032,,Biodistribution in rat thyroid at 15 minutes after dose administration.,,BAO_0000218,CHEMBL628537,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14033,,Biodistribution in rat thyroid at 240 minutes after dose administration.,,BAO_0000218,CHEMBL628538,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14034,,Biodistribution in rat thyroid at 30 minutes after dose administration.,,BAO_0000218,CHEMBL628539,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14035,,Biodistribution in rat thyroid at 360 minutes after dose administration.,,BAO_0000218,CHEMBL630297,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14036,,Biodistribution in rat thyroid at 60 minutes after dose administration.,,BAO_0000218,CHEMBL630298,13100,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14037,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,BAO_0000218,CHEMBL630299,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14038,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,BAO_0000218,CHEMBL628094,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14039,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,BAO_0000218,CHEMBL628095,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14040,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,BAO_0000218,CHEMBL874648,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14041,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,BAO_0000218,CHEMBL628096,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14042,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,BAO_0000218,CHEMBL628097,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14043,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,BAO_0000218,CHEMBL628098,13100,10116.0,Intermediate,1,,,50597,N,1,955.0,
14044,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,BAO_0000019,CHEMBL628099,13331,,Autocuration,1,,,22224,U,0,,
14045,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,BAO_0000019,CHEMBL628100,13331,,Autocuration,1,,,22224,U,0,,
14046,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,BAO_0000019,CHEMBL628101,13331,,Autocuration,1,,,22224,U,0,,
14047,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,BAO_0000019,CHEMBL628102,13331,,Autocuration,1,,,22224,U,0,,
14048,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,BAO_0000019,CHEMBL628103,13331,,Autocuration,1,,,22224,U,0,,
14049,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,BAO_0000019,CHEMBL628104,13331,,Autocuration,1,,,22224,U,0,,
14050,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,BAO_0000019,CHEMBL628105,13331,,Autocuration,1,,,22224,U,0,,
14051,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,BAO_0000019,CHEMBL628106,13331,,Autocuration,1,,,22224,U,0,,
14052,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,BAO_0000218,CHEMBL628107,10086,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14053,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,BAO_0000218,CHEMBL628108,10086,,Autocuration,1,,,22224,U,0,1088.0,
14054,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,BAO_0000218,CHEMBL628109,10086,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14055,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,BAO_0000218,CHEMBL625299,10086,,Autocuration,1,,,22224,U,0,1088.0,
14056,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,BAO_0000218,CHEMBL625300,10086,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14057,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,BAO_0000218,CHEMBL625301,10086,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14058,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,BAO_0000218,CHEMBL625302,10086,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14059,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,BAO_0000218,CHEMBL874649,10086,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14060,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,BAO_0000218,CHEMBL625303,13248,10116.0,Intermediate,1,,,50597,N,1,,
14061,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,BAO_0000218,CHEMBL625463,13248,10116.0,Intermediate,1,,,50597,N,1,,
14062,,In vitro metabolism in human liver microsomes,,BAO_0000218,CHEMBL625464,14527,9606.0,Intermediate,1,,,50587,N,1,2107.0,
14063,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,BAO_0000218,CHEMBL625465,3008,9606.0,Intermediate,1,,,50587,N,1,,
14064,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,CHEMBL625466,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14065,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,BAO_0000218,CHEMBL625467,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14066,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,BAO_0000218,CHEMBL625468,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14067,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,BAO_0000218,CHEMBL625469,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14068,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,BAO_0000218,CHEMBL625470,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14069,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,BAO_0000218,CHEMBL632418,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14070,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,CHEMBL627250,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14071,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,BAO_0000218,CHEMBL627251,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14072,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,BAO_0000218,CHEMBL627252,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14073,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,BAO_0000218,CHEMBL627253,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14074,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,BAO_0000218,CHEMBL627254,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14075,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,BAO_0000218,CHEMBL875471,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14076,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,BAO_0000218,CHEMBL627255,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14077,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,BAO_0000218,CHEMBL627256,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14078,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,BAO_0000218,CHEMBL627257,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14079,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,BAO_0000218,CHEMBL627258,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14080,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,BAO_0000218,CHEMBL627259,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14081,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,BAO_0000218,CHEMBL627260,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14082,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,BAO_0000218,CHEMBL623256,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14083,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,BAO_0000218,CHEMBL874413,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14084,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,BAO_0000218,CHEMBL623257,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14085,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,BAO_0000218,CHEMBL623258,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14086,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,BAO_0000218,CHEMBL623259,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14087,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,BAO_0000218,CHEMBL623260,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14088,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,BAO_0000218,CHEMBL623261,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14089,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,BAO_0000218,CHEMBL623262,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14090,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,BAO_0000218,CHEMBL623263,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14091,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,BAO_0000218,CHEMBL623264,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14092,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,BAO_0000218,CHEMBL623265,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14093,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,BAO_0000218,CHEMBL623266,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14094,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,BAO_0000218,CHEMBL623267,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14095,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,BAO_0000218,CHEMBL623268,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14096,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,CHEMBL623269,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14097,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,CHEMBL623270,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14098,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,BAO_0000218,CHEMBL623271,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14099,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,BAO_0000218,CHEMBL623272,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14100,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,BAO_0000218,CHEMBL623273,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14101,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,BAO_0000218,CHEMBL623274,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14102,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,BAO_0000218,CHEMBL874414,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14103,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,BAO_0000218,CHEMBL623275,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14104,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,BAO_0000218,CHEMBL629150,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14105,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL623276,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14106,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,BAO_0000218,CHEMBL623277,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14107,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,BAO_0000218,CHEMBL623112,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14108,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,BAO_0000218,CHEMBL623113,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14109,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,BAO_0000218,CHEMBL623800,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14110,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,BAO_0000218,CHEMBL623801,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14111,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,BAO_0000218,CHEMBL623802,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14112,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623803,12017,10116.0,Intermediate,1,,,50597,N,1,995.0,
14113,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623970,12017,10116.0,Intermediate,1,,,50597,N,1,995.0,
14114,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL623971,12017,10116.0,Intermediate,1,,,50597,N,1,995.0,
14115,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623972,14045,10116.0,Intermediate,1,,,50597,N,1,178.0,
14116,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623973,14045,10116.0,Intermediate,1,,,50597,N,1,178.0,
14117,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623974,14045,10116.0,Intermediate,1,,,50597,N,1,178.0,
14118,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623975,14045,10116.0,Intermediate,1,,,50597,N,1,178.0,
14119,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623976,14045,10116.0,Intermediate,1,,,50597,N,1,955.0,
14120,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623977,14045,10116.0,Intermediate,1,,,50597,N,1,955.0,
14121,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623978,14045,10116.0,Intermediate,1,,,50597,N,1,955.0,
14122,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623979,14045,10116.0,Intermediate,1,,,50597,N,1,955.0,
14123,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623980,14045,10116.0,Intermediate,1,,,50597,N,1,,
14124,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL623981,14045,10116.0,Intermediate,1,,,50597,N,1,,
14125,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL626278,14045,10116.0,Intermediate,1,,,50597,N,1,,
14126,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,BAO_0000218,CHEMBL626279,14045,10116.0,Intermediate,1,,,50597,N,1,,
14127,,Biodistribution in mice bladder plus excreted urine was determined,,BAO_0000218,CHEMBL626280,14045,10090.0,Intermediate,1,,,50594,N,1,,
14128,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,BAO_0000218,CHEMBL626281,14045,10090.0,Intermediate,1,,,50594,N,1,,
14129,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,BAO_0000218,CHEMBL626282,14045,10090.0,Intermediate,1,,,50594,N,1,,
14130,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,BAO_0000218,CHEMBL626283,14045,10090.0,Intermediate,1,,,50594,N,1,,
14131,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,BAO_0000218,CHEMBL626284,14045,10090.0,Intermediate,1,,,50594,N,1,,
14132,,"Percentage biodistribution in mouse brain, 10 minutes post injection",,BAO_0000218,CHEMBL626285,14045,10090.0,Intermediate,1,,,50594,N,1,955.0,
14133,,"Percentage biodistribution in mouse brain, 30 minutes post injection",,BAO_0000218,CHEMBL626286,14045,10090.0,Intermediate,1,,,50594,N,1,955.0,
14134,,"Percentage biodistribution in mouse brain, 5 minutes post injection",,BAO_0000218,CHEMBL626287,14045,10090.0,Intermediate,1,,,50594,N,1,955.0,
14135,,"Percentage biodistribution in mouse brain, 60 minutes post injection",,BAO_0000218,CHEMBL626288,14045,10090.0,Intermediate,1,,,50594,N,1,955.0,
14136,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,BAO_0000218,CHEMBL626289,14045,10090.0,Intermediate,1,,,50594,N,1,,
14137,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,BAO_0000218,CHEMBL626290,14045,10090.0,Intermediate,1,,,50594,N,1,,
14138,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,BAO_0000218,CHEMBL626291,14045,10090.0,Intermediate,1,,,50594,N,1,,
14139,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,BAO_0000218,CHEMBL839888,14045,10090.0,Intermediate,1,,,50594,N,1,,
14140,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,BAO_0000218,CHEMBL626292,14045,10090.0,Intermediate,1,,,50594,N,1,160.0,
14141,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,BAO_0000218,CHEMBL626293,14045,10090.0,Intermediate,1,,,50594,N,1,160.0,
14142,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,BAO_0000218,CHEMBL626294,14045,10090.0,Intermediate,1,,,50594,N,1,160.0,
14143,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,BAO_0000218,CHEMBL626295,14045,10090.0,Intermediate,1,,,50594,N,1,160.0,
14144,,"Percentage biodistribution in mouse liver, 10 minutes post injection",,BAO_0000218,CHEMBL627659,14045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14145,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,BAO_0000218,CHEMBL627660,14045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14146,,"Percentage biodistribution in mouse liver, 5 minutes post injection",,BAO_0000218,CHEMBL627661,14045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14147,,Biodistribution in mice liver at 60 minutes of post injection,,BAO_0000218,CHEMBL627662,14045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14148,,Biodistribution in mice lungs at 10 min of post injection,,BAO_0000218,CHEMBL627663,14045,10090.0,Intermediate,1,,,50594,N,1,2048.0,
14149,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,BAO_0000218,CHEMBL627664,14045,10090.0,Intermediate,1,,,50594,N,1,,
14150,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,BAO_0000218,CHEMBL627665,14045,10090.0,Intermediate,1,,,50594,N,1,,
14151,,Biodistribution in mice lungs at 60 min of post injection,,BAO_0000218,CHEMBL627666,14045,10090.0,Intermediate,1,,,50594,N,1,2048.0,
14152,,Percentage biodistribution in mouse spleen,,BAO_0000218,CHEMBL627667,14045,10090.0,Intermediate,1,,,50594,N,1,2106.0,
14153,,Percentage biodistribution in mouse stomach,,BAO_0000218,CHEMBL627668,14045,10090.0,Intermediate,1,,,50594,N,1,945.0,
14154,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,BAO_0000218,CHEMBL627669,11745,10090.0,Intermediate,1,,,50594,N,1,1088.0,
14155,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,BAO_0000218,CHEMBL627670,13257,,Autocuration,1,,,22224,U,0,1255.0,
14156,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,BAO_0000218,CHEMBL627671,13257,,Autocuration,1,,,22224,U,0,178.0,
14157,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,BAO_0000218,CHEMBL627672,13257,,Autocuration,1,,,22224,U,0,1474.0,
14158,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,BAO_0000218,CHEMBL627673,13257,,Autocuration,1,,,22224,U,0,,
14159,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,BAO_0000218,CHEMBL627674,13257,,Autocuration,1,,,22224,U,0,2113.0,
14160,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,BAO_0000218,CHEMBL627675,13257,,Autocuration,1,,,22224,U,0,2107.0,
14161,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,BAO_0000218,CHEMBL627676,13257,,Autocuration,1,,,22224,U,0,2048.0,
14162,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,BAO_0000218,CHEMBL627677,13257,,Autocuration,1,,,22224,U,0,2385.0,
14163,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL627678,8354,,Autocuration,1,,,22224,U,0,,
14164,,Affinity for protein binding expressed as association constant in fresh rat serum,,BAO_0000218,CHEMBL627679,7095,10116.0,Intermediate,1,,,50597,N,1,1977.0,
14165,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,BAO_0000019,CHEMBL627680,12185,,Autocuration,1,,,22224,U,0,,
14166,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,BAO_0000019,CHEMBL627681,12185,,Autocuration,1,,,22224,U,0,,
14167,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,BAO_0000019,CHEMBL627682,12185,,Autocuration,1,,,22224,U,0,,
14168,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,BAO_0000019,CHEMBL627683,12185,,Autocuration,1,,,22224,U,0,,
14169,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,BAO_0000019,CHEMBL627684,12686,,Autocuration,1,,,22224,U,0,,
14170,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,BAO_0000019,CHEMBL874441,12686,,Autocuration,1,,,22224,U,0,,
14171,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,BAO_0000019,CHEMBL627685,12686,,Autocuration,1,,,22224,U,0,,
14172,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,BAO_0000019,CHEMBL627686,12686,,Autocuration,1,,,22224,U,0,,
14173,,Apparent rate constant Koff for inactivation of dTMP synthase.,,BAO_0000019,CHEMBL627687,8057,,Autocuration,1,,,22224,U,0,,
14174,,The irreversible inhibitor activity by second order rate equation.,,BAO_0000019,CHEMBL627688,15778,,Autocuration,1,,,22224,U,0,,
14175,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,BAO_0000218,CHEMBL628038,12375,10116.0,Intermediate,1,,,50597,N,1,,
14176,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,BAO_0000218,CHEMBL628039,12375,10116.0,Intermediate,1,,,50597,N,1,,
14177,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,BAO_0000218,CHEMBL628040,12375,10116.0,Intermediate,1,,,50597,N,1,,
14178,,Dissociation rate calculated from the first-order equation using t1/2 value,,BAO_0000019,CHEMBL628041,13588,,Autocuration,1,,,22224,U,0,,
14179,,The compound was tested for Binding constant against DNA,,BAO_0000019,CHEMBL630226,15039,,Autocuration,1,,,22224,U,0,,
14180,,First order rate constant for cyclization of the compound,,BAO_0000019,CHEMBL628042,9500,,Autocuration,1,,,22224,U,0,,
14181,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,BAO_0000019,CHEMBL625232,10014,,Autocuration,1,,,22224,U,0,,
14182,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,BAO_0000019,CHEMBL625233,10014,,Autocuration,1,,,22224,U,0,,
14183,,Hydrolysis rate constant was determined,,BAO_0000019,CHEMBL625979,568,,Autocuration,1,,,22224,U,0,,
14184,,Observed first order rate constant,,BAO_0000019,CHEMBL625980,10026,,Autocuration,1,,,22224,U,0,,
14185,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,BAO_0000019,CHEMBL625981,10281,,Autocuration,1,,,22224,U,0,,
14186,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,BAO_0000019,CHEMBL625982,10281,,Autocuration,1,,,22224,U,0,,
14187,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,BAO_0000019,CHEMBL625983,9680,,Autocuration,1,,,22224,U,0,,
14188,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625984,13028,,Autocuration,1,,,22224,U,0,,
14189,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625985,13028,,Autocuration,1,,,22224,U,0,,
14190,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625986,13028,,Autocuration,1,,,22224,U,0,,
14191,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625987,13028,,Autocuration,1,,,22224,U,0,,
14192,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625988,13028,,Autocuration,1,,,22224,U,0,,
14193,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625989,13028,,Autocuration,1,,,22224,U,0,,
14194,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625990,13028,,Autocuration,1,,,22224,U,0,,
14195,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625991,13028,,Autocuration,1,,,22224,U,0,,
14196,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625992,13028,,Autocuration,1,,,22224,U,0,,
14197,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL625993,13028,,Autocuration,1,,,22224,U,0,,
14198,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL631973,13028,,Autocuration,1,,,22224,U,0,,
14199,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632143,13028,,Autocuration,1,,,22224,U,0,,
14200,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632144,13028,,Autocuration,1,,,22224,U,0,,
14201,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632145,13028,,Autocuration,1,,,22224,U,0,,
14202,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632146,13028,,Autocuration,1,,,22224,U,0,,
14203,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632147,13028,,Autocuration,1,,,22224,U,0,,
14204,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632148,13028,,Autocuration,1,,,22224,U,0,,
14205,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632149,13028,,Autocuration,1,,,22224,U,0,,
14206,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632150,13028,,Autocuration,1,,,22224,U,0,,
14207,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL632151,13028,,Autocuration,1,,,22224,U,0,,
14208,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,BAO_0000218,CHEMBL632152,3008,9606.0,Intermediate,1,,,50587,N,1,,
14209,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,BAO_0000218,CHEMBL632153,4509,9606.0,Intermediate,1,,,50587,N,1,,
14210,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,BAO_0000218,CHEMBL632154,4509,9606.0,Intermediate,1,,,50587,N,1,,
14211,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL632155,8613,10298.0,Intermediate,1,,,50602,N,1,,
14212,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,BAO_0000218,CHEMBL632156,8613,10298.0,Intermediate,1,,,50602,N,1,,
14213,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL632157,8613,10298.0,Intermediate,1,,,50602,N,1,,
14214,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL632158,8613,10298.0,Intermediate,1,,,50602,N,1,,
14215,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,BAO_0000218,CHEMBL632159,8613,10298.0,Intermediate,1,,,50602,N,1,,
14216,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL626305,8613,10298.0,Intermediate,1,,,50602,N,1,,
14217,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,BAO_0000218,CHEMBL626306,8613,10298.0,Intermediate,1,,,50602,N,1,,
14218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL626307,8613,10298.0,Intermediate,1,,,50602,N,1,,
14219,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL626308,8613,10298.0,Intermediate,1,,,50602,N,1,,
14220,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL626479,8613,10298.0,Intermediate,1,,,50602,N,1,,
14221,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,BAO_0000218,CHEMBL626480,8613,10298.0,Intermediate,1,,,50602,N,1,,
14222,,Calculated partition coefficient (clogP) (MlogP),,BAO_0000100,CHEMBL626481,6021,,Autocuration,1,,,22229,U,0,,
14223,,Equipotent potent ratio relative to carbachol (nicotinic activity),,BAO_0000019,CHEMBL626482,9348,,Autocuration,1,,,22224,U,0,,
14224,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,BAO_0000218,CHEMBL626483,15592,9615.0,Intermediate,1,,,50588,N,1,,
14225,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,BAO_0000218,CHEMBL626484,15592,9615.0,Intermediate,1,,,50588,N,1,,
14226,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,BAO_0000100,CHEMBL626485,15592,,Autocuration,1,,,22229,U,0,,
14227,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,BAO_0000100,CHEMBL626486,15592,,Autocuration,1,,,22229,U,0,,
14228,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,BAO_0000100,CHEMBL626487,15592,,Autocuration,1,,,22229,U,0,,
14229,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,BAO_0000218,CHEMBL626488,15592,9615.0,Intermediate,1,,,50588,N,1,1969.0,
14230,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,BAO_0000218,CHEMBL626489,7095,10116.0,Intermediate,1,,,50597,N,1,1977.0,
14231,,Area under the MAP curve measured over 5 min; ND means Not determined,,BAO_0000019,CHEMBL626490,16618,,Autocuration,1,,,22224,U,0,,
14232,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,BAO_0000100,CHEMBL626491,16835,,Autocuration,1,,,22224,U,0,,
14233,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,BAO_0000100,CHEMBL626492,15284,,Autocuration,1,,,22229,U,0,,
14234,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,BAO_0000019,CHEMBL626493,15750,,Autocuration,1,,,22224,U,0,,
14235,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,BAO_0000218,CHEMBL626494,16618,10116.0,Intermediate,1,,,50597,N,1,,
14236,,Half life after oral tested,,BAO_0000218,CHEMBL626495,16618,,Autocuration,1,,,22224,U,0,,
14237,,Half life was determined in plasma of rat; NT indicates not tested,,BAO_0000218,CHEMBL626496,15812,10116.0,Intermediate,1,,,50597,N,1,1969.0,
14238,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,BAO_0000218,CHEMBL626497,16618,10116.0,Intermediate,1,,,50597,N,1,,
14239,,Oral bioavailability after oral tested,,BAO_0000218,CHEMBL626498,16618,,Autocuration,1,,,22224,U,0,,
14240,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,BAO_0000218,CHEMBL626499,13098,10116.0,Intermediate,1,,,50597,N,1,,
14241,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,BAO_0000218,CHEMBL626500,13098,10116.0,Intermediate,1,,,50597,N,1,,
14242,,half life was determined in plasma of rat; NT indicates not tested,,BAO_0000218,CHEMBL626501,15812,10116.0,Intermediate,1,,,50597,N,1,1969.0,
14243,,half life was determined in plasma of rat; NT means not tested,,BAO_0000218,CHEMBL626502,15812,10116.0,Intermediate,1,,,50597,N,1,1969.0,
14244,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,BAO_0000218,CHEMBL626503,11510,10116.0,Intermediate,1,,,50597,N,1,,
14245,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,BAO_0000218,CHEMBL626504,11510,10116.0,Intermediate,1,,,50597,N,1,,
14246,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,BAO_0000218,CHEMBL626505,11510,10116.0,Intermediate,1,,,50597,N,1,,
14247,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,BAO_0000218,CHEMBL626506,11510,10116.0,Intermediate,1,,,50597,N,1,,
14248,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,BAO_0000218,CHEMBL626507,11510,10116.0,Intermediate,1,,,50597,N,1,,
14249,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,BAO_0000218,CHEMBL626508,11510,10116.0,Intermediate,1,,,50597,N,1,,
14250,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,BAO_0000218,CHEMBL626509,11510,10116.0,Intermediate,1,,,50597,N,1,,
14251,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,BAO_0000218,CHEMBL875480,11510,10116.0,Intermediate,1,,,50597,N,1,,
14252,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,BAO_0000218,CHEMBL626510,11510,10116.0,Intermediate,1,,,50597,N,1,,
14253,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,BAO_0000218,CHEMBL626511,11510,10116.0,Intermediate,1,,,50597,N,1,,
14254,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,BAO_0000218,CHEMBL626512,11510,10116.0,Intermediate,1,,,50597,N,1,,
14255,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,BAO_0000218,CHEMBL628208,11510,10116.0,Intermediate,1,,,50597,N,1,,
14256,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,BAO_0000218,CHEMBL628209,11510,10116.0,Intermediate,1,,,50597,N,1,,
14257,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,BAO_0000218,CHEMBL628210,11510,10116.0,Intermediate,1,,,50597,N,1,,
14258,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,BAO_0000218,CHEMBL628211,11510,10116.0,Intermediate,1,,,50597,N,1,,
14259,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,BAO_0000218,CHEMBL628212,11510,10116.0,Intermediate,1,,,50597,N,1,,
14260,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,BAO_0000218,CHEMBL628213,11510,10116.0,Intermediate,1,,,50597,N,1,,
14261,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,BAO_0000218,CHEMBL628214,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14262,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,BAO_0000218,CHEMBL628215,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14263,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,BAO_0000218,CHEMBL628216,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14264,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,BAO_0000218,CHEMBL626595,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14265,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,BAO_0000218,CHEMBL626596,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14266,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,BAO_0000218,CHEMBL626597,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14267,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,BAO_0000218,CHEMBL626598,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14268,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,BAO_0000218,CHEMBL622242,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14269,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,BAO_0000218,CHEMBL622243,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14270,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,BAO_0000218,CHEMBL622244,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14271,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,BAO_0000218,CHEMBL622245,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14272,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,BAO_0000218,CHEMBL622246,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14273,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,CHEMBL622247,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14274,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,BAO_0000218,CHEMBL622248,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14275,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,BAO_0000218,CHEMBL877483,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14276,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,BAO_0000218,CHEMBL622249,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14277,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,BAO_0000218,CHEMBL622250,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14278,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,BAO_0000218,CHEMBL622251,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14279,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,BAO_0000218,CHEMBL622252,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14280,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,BAO_0000218,CHEMBL622253,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14281,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,BAO_0000218,CHEMBL622254,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14282,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL622255,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14283,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,BAO_0000218,CHEMBL622256,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14284,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,BAO_0000218,CHEMBL622257,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14285,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,BAO_0000218,CHEMBL622258,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14286,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,BAO_0000218,CHEMBL622259,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14287,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,CHEMBL622927,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14288,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,CHEMBL622928,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14289,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,CHEMBL622929,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14290,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,CHEMBL623182,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14291,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,BAO_0000218,CHEMBL623183,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14292,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,BAO_0000218,CHEMBL623184,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14293,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,BAO_0000218,CHEMBL623185,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14294,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,BAO_0000218,CHEMBL877484,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14295,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,CHEMBL627274,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14296,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,BAO_0000218,CHEMBL623186,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14297,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,BAO_0000218,CHEMBL623187,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14298,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,BAO_0000218,CHEMBL623188,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14299,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,BAO_0000218,CHEMBL628055,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14300,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,BAO_0000218,CHEMBL628056,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14301,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,BAO_0000218,CHEMBL628200,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14302,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,BAO_0000218,CHEMBL628201,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14303,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,BAO_0000218,CHEMBL628202,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14304,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,BAO_0000218,CHEMBL628203,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14305,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,BAO_0000218,CHEMBL628204,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14306,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,BAO_0000218,CHEMBL628205,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14307,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,BAO_0000218,CHEMBL628206,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14308,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,BAO_0000218,CHEMBL628207,13257,,Autocuration,1,,,22224,U,0,2367.0,
14309,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,BAO_0000218,CHEMBL627220,13257,,Autocuration,1,,,22224,U,0,2367.0,
14310,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,BAO_0000218,CHEMBL627221,13257,,Autocuration,1,,,22224,U,0,2385.0,
14311,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,BAO_0000218,CHEMBL627222,13257,,Autocuration,1,,,22224,U,0,2367.0,
14312,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,BAO_0000218,CHEMBL627223,13257,,Autocuration,1,,,22224,U,0,,
14313,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,BAO_0000218,CHEMBL632062,13257,,Autocuration,1,,,22224,U,0,2385.0,
14314,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,BAO_0000218,CHEMBL632063,13257,,Autocuration,1,,,22224,U,0,2106.0,
14315,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,BAO_0000218,CHEMBL632064,13257,,Autocuration,1,,,22224,U,0,1255.0,
14316,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,BAO_0000218,CHEMBL632065,13257,,Autocuration,1,,,22224,U,0,178.0,
14317,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,BAO_0000218,CHEMBL632066,13257,,Autocuration,1,,,22224,U,0,1474.0,
14318,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,BAO_0000218,CHEMBL632067,13257,,Autocuration,1,,,22224,U,0,,
14319,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,BAO_0000218,CHEMBL629188,13257,,Autocuration,1,,,22224,U,0,2113.0,
14320,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,BAO_0000218,CHEMBL629189,13257,,Autocuration,1,,,22224,U,0,2107.0,
14321,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,BAO_0000218,CHEMBL629190,13257,,Autocuration,1,,,22224,U,0,2048.0,
14322,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,BAO_0000218,CHEMBL629191,13257,,Autocuration,1,,,22224,U,0,2385.0,
14323,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,BAO_0000218,CHEMBL629192,13257,,Autocuration,1,,,22224,U,0,2367.0,
14324,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,BAO_0000218,CHEMBL629193,13257,,Autocuration,1,,,22224,U,0,2385.0,
14325,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,BAO_0000218,CHEMBL629194,13257,,Autocuration,1,,,22224,U,0,2367.0,
14326,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,BAO_0000218,CHEMBL629195,13257,,Autocuration,1,,,22224,U,0,,
14327,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,BAO_0000218,CHEMBL629373,13257,,Autocuration,1,,,22224,U,0,2385.0,
14328,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,BAO_0000218,CHEMBL629374,13257,,Autocuration,1,,,22224,U,0,2106.0,
14329,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,BAO_0000218,CHEMBL629375,13257,,Autocuration,1,,,22224,U,0,2367.0,
14330,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,BAO_0000218,CHEMBL629376,13257,,Autocuration,1,,,22224,U,0,1255.0,
14331,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,BAO_0000218,CHEMBL629377,13257,,Autocuration,1,,,22224,U,0,178.0,
14332,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,BAO_0000218,CHEMBL629378,13257,,Autocuration,1,,,22224,U,0,1474.0,
14333,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,BAO_0000218,CHEMBL629379,13257,,Autocuration,1,,,22224,U,0,,
14334,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,BAO_0000218,CHEMBL629151,13257,,Autocuration,1,,,22224,U,0,2113.0,
14335,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,BAO_0000218,CHEMBL629152,13257,,Autocuration,1,,,22224,U,0,2107.0,
14336,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,BAO_0000218,CHEMBL629153,13257,,Autocuration,1,,,22224,U,0,2048.0,
14337,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,BAO_0000218,CHEMBL629154,13257,,Autocuration,1,,,22224,U,0,2385.0,
14338,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,BAO_0000218,CHEMBL629155,13257,,Autocuration,1,,,22224,U,0,2367.0,
14339,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,BAO_0000218,CHEMBL629156,13257,,Autocuration,1,,,22224,U,0,2367.0,
14340,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,BAO_0000218,CHEMBL629157,13257,,Autocuration,1,,,22224,U,0,2385.0,
14341,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,BAO_0000218,CHEMBL629158,13257,,Autocuration,1,,,22224,U,0,2367.0,
14342,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,BAO_0000218,CHEMBL629159,13257,,Autocuration,1,,,22224,U,0,,
14343,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,BAO_0000218,CHEMBL629160,13257,,Autocuration,1,,,22224,U,0,2385.0,
14344,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,BAO_0000218,CHEMBL629161,13257,,Autocuration,1,,,22224,U,0,2106.0,
14345,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,BAO_0000218,CHEMBL629162,13257,,Autocuration,1,,,22224,U,0,1255.0,
14346,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,BAO_0000218,CHEMBL629163,13257,,Autocuration,1,,,22224,U,0,178.0,
14347,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,BAO_0000218,CHEMBL629164,13257,,Autocuration,1,,,22224,U,0,1474.0,
14348,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,BAO_0000218,CHEMBL629165,13257,,Autocuration,1,,,22224,U,0,,
14349,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,BAO_0000218,CHEMBL629166,13257,,Autocuration,1,,,22224,U,0,2107.0,
14350,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,BAO_0000218,CHEMBL629167,13257,,Autocuration,1,,,22224,U,0,2048.0,
14351,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,BAO_0000218,CHEMBL629168,13257,,Autocuration,1,,,22224,U,0,2385.0,
14352,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,BAO_0000019,CHEMBL629169,2193,,Autocuration,1,,,22224,U,0,,
14353,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,BAO_0000019,CHEMBL629170,2193,,Autocuration,1,,,22224,U,0,,
14354,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,BAO_0000019,CHEMBL631153,2193,,Autocuration,1,,,22224,U,0,,
14355,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,BAO_0000019,CHEMBL875121,2193,,Autocuration,1,,,22224,U,0,,
14356,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,BAO_0000019,CHEMBL631154,2193,,Autocuration,1,,,22224,U,0,,
14357,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,BAO_0000019,CHEMBL631155,2193,,Autocuration,1,,,22224,U,0,,
14358,,Hydrolysis rate constant was determined,,BAO_0000019,CHEMBL631156,568,,Autocuration,1,,,22224,U,0,,
14359,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,BAO_0000019,CHEMBL631157,9680,,Autocuration,1,,,22224,U,0,,
14360,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,BAO_0000019,CHEMBL631158,9680,,Autocuration,1,,,22224,U,0,,
14361,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,BAO_0000019,CHEMBL631159,9680,,Autocuration,1,,,22224,U,0,,
14362,,Observed second order rate constant,,BAO_0000019,CHEMBL631160,10026,,Autocuration,1,,,22224,U,0,,
14363,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,BAO_0000019,CHEMBL631161,10281,,Autocuration,1,,,22224,U,0,,
14364,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,BAO_0000019,CHEMBL631162,10014,,Autocuration,1,,,22224,U,0,,
14365,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,BAO_0000019,CHEMBL630313,10014,,Autocuration,1,,,22224,U,0,,
14366,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,BAO_0000019,CHEMBL630314,9680,,Autocuration,1,,,22224,U,0,,
14367,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,BAO_0000019,CHEMBL630315,9680,,Autocuration,1,,,22224,U,0,,
14368,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630316,13028,,Autocuration,1,,,22224,U,0,,
14369,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630986,13028,,Autocuration,1,,,22224,U,0,,
14370,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630987,13028,,Autocuration,1,,,22224,U,0,,
14371,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630988,13028,,Autocuration,1,,,22224,U,0,,
14372,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630989,13028,,Autocuration,1,,,22224,U,0,,
14373,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630990,13028,,Autocuration,1,,,22224,U,0,,
14374,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630991,13028,,Autocuration,1,,,22224,U,0,,
14375,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630992,13028,,Autocuration,1,,,22224,U,0,,
14376,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630993,13028,,Autocuration,1,,,22224,U,0,,
14377,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,BAO_0000019,CHEMBL630994,13028,,Autocuration,1,,,22224,U,0,,
14378,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,BAO_0000218,CHEMBL630995,10014,10116.0,Intermediate,1,,,50597,N,1,,
14379,,Association constant for compound at 31 degree C was determined,,BAO_0000019,CHEMBL629252,9962,,Autocuration,1,,,22224,U,0,,
14380,,Calculated antagonist equilibrium dissociation constant of the compound,,BAO_0000019,CHEMBL629253,12029,,Autocuration,1,,,22224,U,0,,
14381,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,BAO_0000019,CHEMBL629944,12029,,Autocuration,1,,,22224,U,0,,
14382,,Dissociation constants vs LTE4 on guinea pig trachea,,BAO_0000218,CHEMBL629945,10583,10141.0,Intermediate,1,,,50512,N,1,3126.0,
14383,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,BAO_0000019,CHEMBL629946,568,,Autocuration,1,,,22224,U,0,,
14384,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,BAO_0000019,CHEMBL629947,568,,Autocuration,1,,,22224,U,0,,
14385,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,BAO_0000019,CHEMBL629948,568,,Autocuration,1,,,22224,U,0,,
14386,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,BAO_0000019,CHEMBL856024,568,,Autocuration,1,,,22224,U,0,,
14387,,Affinity constant KD value was derived from TMP,,BAO_0000019,CHEMBL629949,7493,,Autocuration,1,,,22224,U,0,,
14388,,Apparent dissociation (binding) rate constant was evaluated,,BAO_0000019,CHEMBL629950,8371,,Autocuration,1,,,22224,U,0,,
14389,,Dissociation constant (KD) of the compound,,BAO_0000100,CHEMBL630127,13114,,Autocuration,1,,,22224,U,0,,
14390,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,BAO_0000100,CHEMBL630128,15515,,Autocuration,1,,,22224,U,0,,
14391,,Dissociation constant from ESR titration experiments,,BAO_0000100,CHEMBL630129,522,,Autocuration,1,,,22224,U,0,,
14392,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,BAO_0000019,CHEMBL630130,13888,,Autocuration,1,,,22224,U,0,,
14393,,Dissociation constant was evaluated.,,BAO_0000100,CHEMBL875234,2616,,Autocuration,1,,,22224,U,0,,
14394,,Dissociation constant was reported,,BAO_0000100,CHEMBL630131,3798,,Autocuration,1,,,22224,U,0,,
14395,,Dissociation constant was determined in rat pituitary cells.,,BAO_0000218,CHEMBL630132,8731,10116.0,Intermediate,1,,,50597,N,1,,
14396,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,BAO_0000019,CHEMBL630133,11892,,Autocuration,1,,,22224,U,0,,
14397,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,BAO_0000019,CHEMBL630134,11892,,Autocuration,1,,,22224,U,0,,
14398,,Equilibrium dissociation constant of the compound,,BAO_0000019,CHEMBL630135,2582,,Autocuration,1,,,22224,U,0,,
14399,,Equilibrium dissociation constant was determined,,BAO_0000019,CHEMBL630136,11892,,Autocuration,1,,,22224,U,0,,
14400,,Kinetic constant KD was evaluated,,BAO_0000019,CHEMBL630137,13396,,Autocuration,1,,,22224,U,0,,
14401,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,BAO_0000019,CHEMBL630138,603,,Autocuration,1,,,22224,U,0,,
14402,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,BAO_0000019,CHEMBL630139,15673,,Autocuration,1,,,22224,U,0,,
14403,,Rate constant for hydrolysis in aqueous acetone.,,BAO_0000019,CHEMBL630140,10368,,Autocuration,1,,,22224,U,0,,
14404,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,BAO_0000019,CHEMBL875235,14228,,Autocuration,1,,,22224,U,0,,
14405,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,BAO_0000218,CHEMBL876439,11510,10116.0,Intermediate,1,,,50597,N,1,,
14406,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,BAO_0000218,CHEMBL630605,11510,10116.0,Intermediate,1,,,50597,N,1,,
14407,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,BAO_0000218,CHEMBL630606,11510,10116.0,Intermediate,1,,,50597,N,1,,
14408,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,BAO_0000218,CHEMBL630607,11510,10116.0,Intermediate,1,,,50597,N,1,,
14409,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,BAO_0000218,CHEMBL630608,11510,10116.0,Intermediate,1,,,50597,N,1,,
14410,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,BAO_0000218,CHEMBL630609,11510,10116.0,Intermediate,1,,,50597,N,1,,
14411,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,BAO_0000218,CHEMBL630610,11510,10116.0,Intermediate,1,,,50597,N,1,,
14412,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,BAO_0000218,CHEMBL630611,11510,10116.0,Intermediate,1,,,50597,N,1,,
14413,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,BAO_0000218,CHEMBL629552,11510,10116.0,Intermediate,1,,,50597,N,1,,
14414,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,BAO_0000218,CHEMBL629733,11510,10116.0,Intermediate,1,,,50597,N,1,,
14415,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,BAO_0000218,CHEMBL629734,11510,10116.0,Intermediate,1,,,50597,N,1,,
14416,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,BAO_0000218,CHEMBL629735,11510,10116.0,Intermediate,1,,,50597,N,1,,
14417,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,BAO_0000218,CHEMBL629736,11510,10116.0,Intermediate,1,,,50597,N,1,,
14418,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,BAO_0000218,CHEMBL629737,11510,10116.0,Intermediate,1,,,50597,N,1,,
14419,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,BAO_0000218,CHEMBL629738,11510,10116.0,Intermediate,1,,,50597,N,1,,
14420,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,BAO_0000218,CHEMBL629739,11510,10116.0,Intermediate,1,,,50597,N,1,,
14421,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,BAO_0000218,CHEMBL629740,11510,10116.0,Intermediate,1,,,50597,N,1,,
14422,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,BAO_0000218,CHEMBL629741,11510,10116.0,Intermediate,1,,,50597,N,1,,
14423,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,BAO_0000218,CHEMBL629742,11510,10116.0,Intermediate,1,,,50597,N,1,,
14424,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,BAO_0000218,CHEMBL629743,11510,10116.0,Intermediate,1,,,50597,N,1,,
14425,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,BAO_0000218,CHEMBL629744,11510,10116.0,Intermediate,1,,,50597,N,1,,
14426,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,BAO_0000218,CHEMBL629745,11510,10116.0,Intermediate,1,,,50597,N,1,,
14427,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,BAO_0000218,CHEMBL629746,11510,10116.0,Intermediate,1,,,50597,N,1,,
14428,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,BAO_0000218,CHEMBL629747,11510,10116.0,Intermediate,1,,,50597,N,1,,
14429,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,BAO_0000218,CHEMBL629748,11510,10116.0,Intermediate,1,,,50597,N,1,,
14430,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,BAO_0000218,CHEMBL629749,11510,10116.0,Intermediate,1,,,50597,N,1,,
14431,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,BAO_0000218,CHEMBL629750,11510,10116.0,Intermediate,1,,,50597,N,1,,
14432,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,BAO_0000218,CHEMBL629751,11510,10116.0,Intermediate,1,,,50597,N,1,,
14433,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,BAO_0000218,CHEMBL629752,11510,10116.0,Intermediate,1,,,50597,N,1,,
14434,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,BAO_0000218,CHEMBL629753,11510,10116.0,Intermediate,1,,,50597,N,1,,
14435,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,BAO_0000218,CHEMBL629754,11510,10116.0,Intermediate,1,,,50597,N,1,,
14436,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,BAO_0000218,CHEMBL629755,11510,10116.0,Intermediate,1,,,50597,N,1,,
14437,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,BAO_0000218,CHEMBL629756,11510,10116.0,Intermediate,1,,,50597,N,1,,
14438,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,BAO_0000218,CHEMBL629757,11510,10116.0,Intermediate,1,,,50597,N,1,,
14439,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,BAO_0000218,CHEMBL629758,11510,10116.0,Intermediate,1,,,50597,N,1,,
14440,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,BAO_0000218,CHEMBL629759,11510,10116.0,Intermediate,1,,,50597,N,1,,
14441,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,BAO_0000218,CHEMBL629760,11510,10116.0,Intermediate,1,,,50597,N,1,,
14442,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,BAO_0000218,CHEMBL876443,11510,10116.0,Intermediate,1,,,50597,N,1,,
14443,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,CHEMBL629761,8310,9615.0,Intermediate,1,,,50588,N,1,,
14444,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,CHEMBL629762,8310,9615.0,Intermediate,1,,,50588,N,1,,
14445,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,CHEMBL629763,8310,10090.0,Intermediate,1,,,50594,N,1,,
14446,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,BAO_0000218,CHEMBL629764,8310,10090.0,Intermediate,1,,,50594,N,1,,
14447,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,BAO_0000218,CHEMBL629765,8310,10090.0,Intermediate,1,,,50594,N,1,,
14448,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,BAO_0000218,CHEMBL629766,8310,10090.0,Intermediate,1,,,50594,N,1,,
14449,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,CHEMBL629767,8310,10090.0,Intermediate,1,,,50594,N,1,,
14450,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,CHEMBL629768,8310,9615.0,Intermediate,1,,,50588,N,1,,
14451,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,BAO_0000218,CHEMBL629769,8310,10090.0,Intermediate,1,,,50594,N,1,,
14452,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,BAO_0000218,CHEMBL629770,8310,9615.0,Intermediate,1,,,50588,N,1,,
14453,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,BAO_0000218,CHEMBL629771,8310,9615.0,Intermediate,1,,,50588,N,1,,
14454,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,CHEMBL629772,8310,10090.0,Intermediate,1,,,50594,N,1,,
14455,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,BAO_0000218,CHEMBL629773,8310,10090.0,Intermediate,1,,,50594,N,1,,
14456,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,BAO_0000218,CHEMBL625455,8310,10090.0,Intermediate,1,,,50594,N,1,,
14457,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,BAO_0000218,CHEMBL625456,8310,10090.0,Intermediate,1,,,50594,N,1,,
14458,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,BAO_0000218,CHEMBL625457,8310,10090.0,Intermediate,1,,,50594,N,1,,
14459,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,BAO_0000218,CHEMBL625458,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14460,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,BAO_0000218,CHEMBL625459,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14461,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,BAO_0000218,CHEMBL875483,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14462,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,BAO_0000218,CHEMBL634779,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14463,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,BAO_0000218,CHEMBL625460,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14464,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,BAO_0000218,CHEMBL626117,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14465,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,BAO_0000218,CHEMBL626118,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14466,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,BAO_0000218,CHEMBL628342,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14467,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,BAO_0000218,CHEMBL628343,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14468,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,BAO_0000218,CHEMBL628344,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14469,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,BAO_0000218,CHEMBL628345,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14470,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,BAO_0000218,CHEMBL628346,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14471,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,BAO_0000218,CHEMBL628347,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14472,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,CHEMBL628348,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14473,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,CHEMBL628349,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14474,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,BAO_0000218,CHEMBL875611,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14475,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,BAO_0000218,CHEMBL628350,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14476,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,BAO_0000218,CHEMBL628351,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14477,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,BAO_0000218,CHEMBL628352,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14478,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,BAO_0000218,CHEMBL628353,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14479,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,BAO_0000218,CHEMBL628354,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14480,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,BAO_0000218,CHEMBL626667,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14481,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL626668,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14482,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,BAO_0000218,CHEMBL626669,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14483,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,BAO_0000218,CHEMBL626670,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14484,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,BAO_0000218,CHEMBL626671,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14485,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,BAO_0000218,CHEMBL626672,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14486,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,BAO_0000218,CHEMBL626673,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14487,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,BAO_0000218,CHEMBL626674,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14488,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,BAO_0000218,CHEMBL626675,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14489,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,BAO_0000218,CHEMBL626676,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14490,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,BAO_0000218,CHEMBL626677,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14491,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,BAO_0000218,CHEMBL626678,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14492,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,BAO_0000218,CHEMBL626679,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14493,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,BAO_0000218,CHEMBL875612,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14494,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,BAO_0000218,CHEMBL626680,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14495,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,BAO_0000218,CHEMBL626681,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14496,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,BAO_0000218,CHEMBL626682,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14497,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,BAO_0000218,CHEMBL626683,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14498,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,BAO_0000218,CHEMBL626684,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14499,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,BAO_0000218,CHEMBL626685,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14500,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,BAO_0000218,CHEMBL626686,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14501,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,BAO_0000218,CHEMBL626687,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14502,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,CHEMBL624978,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14503,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,BAO_0000218,CHEMBL624979,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14504,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,BAO_0000218,CHEMBL624980,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14505,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,BAO_0000218,CHEMBL624981,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14506,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,BAO_0000218,CHEMBL624982,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14507,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,BAO_0000218,CHEMBL627564,13257,,Autocuration,1,,,22224,U,0,2367.0,
14508,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,BAO_0000218,CHEMBL627565,13257,,Autocuration,1,,,22224,U,0,2367.0,
14509,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,BAO_0000218,CHEMBL627566,13257,,Autocuration,1,,,22224,U,0,,
14510,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,BAO_0000218,CHEMBL627567,13257,,Autocuration,1,,,22224,U,0,2385.0,
14511,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,BAO_0000218,CHEMBL627568,13257,,Autocuration,1,,,22224,U,0,2106.0,
14512,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,BAO_0000218,CHEMBL627569,13257,,Autocuration,1,,,22224,U,0,2113.0,
14513,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,BAO_0000218,CHEMBL627570,13257,,Autocuration,1,,,22224,U,0,1255.0,
14514,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,BAO_0000218,CHEMBL627571,13257,,Autocuration,1,,,22224,U,0,178.0,
14515,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,BAO_0000218,CHEMBL627572,13257,,Autocuration,1,,,22224,U,0,1474.0,
14516,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,BAO_0000218,CHEMBL627573,13257,,Autocuration,1,,,22224,U,0,,
14517,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,BAO_0000218,CHEMBL627574,13257,,Autocuration,1,,,22224,U,0,2113.0,
14518,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,BAO_0000218,CHEMBL627575,13257,,Autocuration,1,,,22224,U,0,2107.0,
14519,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,BAO_0000218,CHEMBL627576,13257,,Autocuration,1,,,22224,U,0,2048.0,
14520,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,BAO_0000218,CHEMBL627577,13257,,Autocuration,1,,,22224,U,0,2385.0,
14521,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,BAO_0000218,CHEMBL627578,13257,,Autocuration,1,,,22224,U,0,2367.0,
14522,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,BAO_0000218,CHEMBL627579,13257,,Autocuration,1,,,22224,U,0,2367.0,
14523,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,BAO_0000218,CHEMBL627580,13257,,Autocuration,1,,,22224,U,0,2385.0,
14524,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,BAO_0000218,CHEMBL627581,13257,,Autocuration,1,,,22224,U,0,2367.0,
14525,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,BAO_0000218,CHEMBL627582,13257,,Autocuration,1,,,22224,U,0,,
14526,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,BAO_0000218,CHEMBL627583,13257,,Autocuration,1,,,22224,U,0,2385.0,
14527,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,BAO_0000218,CHEMBL627584,13257,,Autocuration,1,,,22224,U,0,2106.0,
14528,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,BAO_0000218,CHEMBL627585,13257,,Autocuration,1,,,22224,U,0,2367.0,
14529,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,BAO_0000218,CHEMBL627586,13257,,Autocuration,1,,,22224,U,0,2385.0,
14530,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,CHEMBL627587,15413,10116.0,Intermediate,1,,,50597,N,1,,
14531,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL627588,15413,10116.0,Intermediate,1,,,50597,N,1,,
14532,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,CHEMBL628250,15413,10116.0,Intermediate,1,,,50597,N,1,,
14533,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628251,15413,10116.0,Intermediate,1,,,50597,N,1,,
14534,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,CHEMBL628252,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14535,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628253,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14536,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,BAO_0000218,CHEMBL628254,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14537,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL877493,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14538,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628255,15413,10116.0,Intermediate,1,,,50597,N,1,,
14539,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628256,15413,10116.0,Intermediate,1,,,50597,N,1,,
14540,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628257,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14541,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628258,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14542,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628259,15413,10116.0,Intermediate,1,,,50597,N,1,,
14543,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL628429,15413,10116.0,Intermediate,1,,,50597,N,1,,
14544,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,BAO_0000218,CHEMBL626862,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14545,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,BAO_0000218,CHEMBL626863,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14546,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,BAO_0000218,CHEMBL625886,15413,10116.0,Intermediate,1,,,50597,N,1,2037.0,
14547,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,BAO_0000218,CHEMBL625887,15413,10116.0,Intermediate,1,,,50597,N,1,2037.0,
14548,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,BAO_0000218,CHEMBL625888,15413,10116.0,Intermediate,1,,,50597,N,1,,
14549,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,BAO_0000218,CHEMBL625889,15413,10116.0,Intermediate,1,,,50597,N,1,,
14550,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,BAO_0000218,CHEMBL625890,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14551,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,BAO_0000218,CHEMBL625891,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14552,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,BAO_0000218,CHEMBL625892,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14553,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,BAO_0000218,CHEMBL625893,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14554,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,BAO_0000218,CHEMBL625894,15413,10116.0,Intermediate,1,,,50597,N,1,2037.0,
14555,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,BAO_0000218,CHEMBL625895,15413,10116.0,Intermediate,1,,,50597,N,1,,
14556,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,BAO_0000019,CHEMBL625896,12404,,Autocuration,1,,,22224,U,0,,
14557,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,BAO_0000019,CHEMBL625897,568,,Autocuration,1,,,22224,U,0,,
14558,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,BAO_0000019,CHEMBL625898,568,,Autocuration,1,,,22224,U,0,,
14559,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,BAO_0000019,CHEMBL625899,568,,Autocuration,1,,,22224,U,0,,
14560,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,BAO_0000019,CHEMBL626124,12404,,Autocuration,1,,,22224,U,0,,
14561,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,BAO_0000218,CHEMBL628500,7624,562.0,Intermediate,1,,,50212,N,1,,
14562,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,BAO_0000218,CHEMBL857856,7624,10116.0,Intermediate,1,,,50597,N,1,,
14563,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,BAO_0000218,CHEMBL628501,7624,10116.0,Intermediate,1,,,50597,N,1,,
14564,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,BAO_0000019,CHEMBL628502,4643,,Autocuration,1,,,22224,U,0,,
14565,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,BAO_0000019,CHEMBL628503,11532,,Autocuration,1,,,22224,U,0,,
14566,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,BAO_0000019,CHEMBL628504,11018,,Autocuration,1,,,22224,U,0,,
14567,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,BAO_0000019,CHEMBL628505,2276,,Autocuration,1,,,22224,U,0,,
14568,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,BAO_0000019,CHEMBL874452,2276,,Autocuration,1,,,22224,U,0,,
14569,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,BAO_0000019,CHEMBL628506,2276,,Autocuration,1,,,22224,U,0,,
14570,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,BAO_0000019,CHEMBL628507,2276,,Autocuration,1,,,22224,U,0,,
14571,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,BAO_0000019,CHEMBL628508,2276,,Autocuration,1,,,22224,U,0,,
14572,,Michaelis constant (KM) was evaluated,,BAO_0000019,CHEMBL628509,8949,,Autocuration,1,,,22224,U,0,,
14573,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,BAO_0000019,CHEMBL628510,12404,,Autocuration,1,,,22224,U,0,,
14574,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,BAO_0000019,CHEMBL628511,7625,,Autocuration,1,,,22224,U,0,,
14575,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,BAO_0000019,CHEMBL628512,7625,,Autocuration,1,,,22224,U,0,,
14576,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,BAO_0000019,CHEMBL628513,7625,,Autocuration,1,,,22224,U,0,,
14577,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,BAO_0000019,CHEMBL628514,7625,,Autocuration,1,,,22224,U,0,,
14578,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,BAO_0000019,CHEMBL628515,12908,,Autocuration,1,,,22224,U,0,,
14579,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,BAO_0000019,CHEMBL628516,10368,,Autocuration,1,,,22224,U,0,,
14580,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,BAO_0000019,CHEMBL628517,13108,,Autocuration,1,,,22224,U,0,,
14581,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,BAO_0000019,CHEMBL628518,13108,,Autocuration,1,,,22224,U,0,,
14582,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,BAO_0000019,CHEMBL628519,15217,,Autocuration,1,,,22224,U,0,,
14583,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,BAO_0000019,CHEMBL628520,15217,,Autocuration,1,,,22224,U,0,,
14584,,Binding constant was determined,,BAO_0000019,CHEMBL628521,10933,,Autocuration,1,,,22224,U,0,,
14585,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,BAO_0000019,CHEMBL630443,2363,,Autocuration,1,,,22224,U,0,,
14586,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,BAO_0000019,CHEMBL630444,2363,,Autocuration,1,,,22224,U,0,,
14587,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,BAO_0000019,CHEMBL857732,2276,,Autocuration,1,,,22224,U,0,,
14588,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,BAO_0000100,CHEMBL630445,14915,,Autocuration,1,,,22224,U,0,,
14589,,Catalytic rate constant of the compound,,BAO_0000019,CHEMBL630446,8847,,Autocuration,1,,,22224,U,0,,
14590,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,BAO_0000019,CHEMBL630447,15357,,Autocuration,1,,,22224,U,0,,
14591,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,BAO_0000019,CHEMBL630448,2869,,Autocuration,1,,,22224,U,0,,
14592,,Catalytic rate constant against phospholipase A2 was determined,,BAO_0000019,CHEMBL630449,3484,,Autocuration,1,,,22224,U,0,,
14593,,"Compound was evaluated for catalytic constant, Kcat",,BAO_0000019,CHEMBL630450,1373,,Autocuration,1,,,22224,U,0,,
14594,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,BAO_0000019,CHEMBL630451,8142,,Autocuration,1,,,22224,U,0,,
14595,,Kcat calculated from 0.693/T1/2,,BAO_0000019,CHEMBL630452,14131,,Autocuration,1,,,22224,U,0,,
14596,,Kcat was determined,,BAO_0000019,CHEMBL630453,17269,,Autocuration,1,,,22224,U,0,,
14597,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,BAO_0000019,CHEMBL630454,3485,,Autocuration,1,,,22224,U,0,,
14598,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,BAO_0000019,CHEMBL630455,3485,,Autocuration,1,,,22224,U,0,,
14599,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,BAO_0000019,CHEMBL631487,3485,,Autocuration,1,,,22224,U,0,,
14600,,Kcat value was determined,,BAO_0000019,CHEMBL631488,5962,,Autocuration,1,,,22224,U,0,,
14601,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,BAO_0000019,CHEMBL876440,3133,,Autocuration,1,,,22224,U,0,,
14602,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,BAO_0000019,CHEMBL631489,3133,,Autocuration,1,,,22224,U,0,,
14603,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,BAO_0000019,CHEMBL857742,2276,,Autocuration,1,,,22224,U,0,,
14604,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,BAO_0000019,CHEMBL631490,2276,,Autocuration,1,,,22224,U,0,,
14605,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,BAO_0000019,CHEMBL631491,2276,,Autocuration,1,,,22224,U,0,,
14606,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,BAO_0000019,CHEMBL631492,2276,,Autocuration,1,,,22224,U,0,,
14607,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,BAO_0000019,CHEMBL631493,2276,,Autocuration,1,,,22224,U,0,,
14608,,Kinetic parameter for rate of conversion to PABA was determined,,BAO_0000019,CHEMBL631494,4892,,Autocuration,1,,,22224,U,0,,
14609,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,BAO_0000019,CHEMBL631495,3133,,Autocuration,1,,,22224,U,0,,
14610,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,BAO_0000218,CHEMBL631496,11488,10116.0,Intermediate,1,,,50597,N,1,1988.0,
14611,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,CHEMBL631497,11488,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14612,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,CHEMBL631498,11488,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14613,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,BAO_0000218,CHEMBL629776,11488,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14614,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,BAO_0000218,CHEMBL629777,11488,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14615,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,BAO_0000218,CHEMBL629778,11488,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14616,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,BAO_0000218,CHEMBL630456,11488,10116.0,Intermediate,1,,,50597,N,1,,
14617,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,BAO_0000218,CHEMBL630457,11488,10116.0,Intermediate,1,,,50597,N,1,,
14618,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,BAO_0000218,CHEMBL630458,11488,10116.0,Intermediate,1,,,50597,N,1,,
14619,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,BAO_0000218,CHEMBL630459,11488,10116.0,Intermediate,1,,,50597,N,1,,
14620,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,BAO_0000218,CHEMBL630460,11488,10116.0,Intermediate,1,,,50597,N,1,,
14621,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,BAO_0000218,CHEMBL876550,11488,10116.0,Intermediate,1,,,50597,N,1,,
14622,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,BAO_0000218,CHEMBL630461,11488,10116.0,Intermediate,1,,,50597,N,1,,
14623,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,BAO_0000218,CHEMBL630462,11488,10116.0,Intermediate,1,,,50597,N,1,,
14624,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,BAO_0000218,CHEMBL630463,11488,10116.0,Intermediate,1,,,50597,N,1,,
14625,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,BAO_0000218,CHEMBL630464,11488,10116.0,Intermediate,1,,,50597,N,1,,
14626,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,BAO_0000218,CHEMBL630465,11488,10116.0,Intermediate,1,,,50597,N,1,,
14627,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,BAO_0000218,CHEMBL630466,11488,10116.0,Intermediate,1,,,50597,N,1,,
14628,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,BAO_0000218,CHEMBL630467,11488,10116.0,Intermediate,1,,,50597,N,1,,
14629,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,BAO_0000218,CHEMBL630633,11488,10116.0,Intermediate,1,,,50597,N,1,,
14630,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,BAO_0000218,CHEMBL630634,11488,10116.0,Intermediate,1,,,50597,N,1,,
14631,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,BAO_0000218,CHEMBL630635,11488,10116.0,Intermediate,1,,,50597,N,1,,
14632,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,BAO_0000218,CHEMBL630636,11488,10116.0,Intermediate,1,,,50597,N,1,,
14633,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,BAO_0000218,CHEMBL630637,11488,10116.0,Intermediate,1,,,50597,N,1,,
14634,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,BAO_0000218,CHEMBL630638,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14635,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,BAO_0000218,CHEMBL630639,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14636,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,BAO_0000218,CHEMBL630640,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14637,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,BAO_0000218,CHEMBL876551,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14638,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,BAO_0000218,CHEMBL630641,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14639,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,BAO_0000218,CHEMBL630642,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14640,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,CHEMBL630643,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14641,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,CHEMBL630644,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14642,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,BAO_0000218,CHEMBL630645,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14643,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,BAO_0000218,CHEMBL625599,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14644,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,BAO_0000218,CHEMBL625600,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14645,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,BAO_0000218,CHEMBL625601,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14646,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,BAO_0000218,CHEMBL625602,7132,9986.0,Intermediate,1,,,50592,N,1,1988.0,
14647,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,BAO_0000218,CHEMBL627470,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14648,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,BAO_0000218,CHEMBL627471,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14649,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,BAO_0000218,CHEMBL627472,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14650,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,BAO_0000218,CHEMBL627473,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14651,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,BAO_0000218,CHEMBL627474,7132,9986.0,Intermediate,1,,,50592,N,1,1088.0,
14652,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL627475,13925,10116.0,Intermediate,1,,,50597,N,1,178.0,
14653,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL627476,13925,10116.0,Intermediate,1,,,50597,N,1,178.0,
14654,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,BAO_0000218,CHEMBL627477,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14655,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,BAO_0000218,CHEMBL627478,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14656,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,BAO_0000218,CHEMBL627479,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14657,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,BAO_0000218,CHEMBL627480,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14658,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,BAO_0000218,CHEMBL627481,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14659,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL627482,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14660,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,BAO_0000218,CHEMBL627483,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14661,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,BAO_0000218,CHEMBL875636,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14662,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,BAO_0000218,CHEMBL625764,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14663,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,CHEMBL625765,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14664,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,BAO_0000218,CHEMBL625766,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14665,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,CHEMBL625767,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14666,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,CHEMBL625768,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14667,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL625769,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14668,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,BAO_0000218,CHEMBL625770,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14669,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,BAO_0000218,CHEMBL625771,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14670,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,BAO_0000218,CHEMBL625772,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14671,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,BAO_0000218,CHEMBL625773,12582,9615.0,Intermediate,1,,,50588,N,1,1088.0,
14672,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,BAO_0000218,CHEMBL625774,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14673,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,BAO_0000218,CHEMBL625775,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14674,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,BAO_0000218,CHEMBL625776,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14675,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,BAO_0000218,CHEMBL625777,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14676,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,BAO_0000218,CHEMBL625778,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14677,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,BAO_0000218,CHEMBL625779,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14678,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,BAO_0000218,CHEMBL625780,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14679,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,BAO_0000218,CHEMBL625781,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14680,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,BAO_0000218,CHEMBL875637,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14681,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,BAO_0000218,CHEMBL626473,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14682,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,BAO_0000218,CHEMBL626474,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14683,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,BAO_0000218,CHEMBL626475,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14684,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,BAO_0000218,CHEMBL626476,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14685,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,BAO_0000218,CHEMBL634397,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14686,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,BAO_0000218,CHEMBL626477,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14687,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,BAO_0000218,CHEMBL631069,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14688,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,BAO_0000218,CHEMBL631070,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14689,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,BAO_0000218,CHEMBL631071,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14690,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,BAO_0000218,CHEMBL631072,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14691,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,BAO_0000218,CHEMBL631073,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14692,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,BAO_0000218,CHEMBL631074,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14693,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,BAO_0000218,CHEMBL631075,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14694,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,BAO_0000218,CHEMBL631725,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14695,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,BAO_0000218,CHEMBL631726,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14696,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,BAO_0000218,CHEMBL631727,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14697,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,BAO_0000218,CHEMBL631728,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14698,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,BAO_0000218,CHEMBL631729,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14699,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,BAO_0000218,CHEMBL631730,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14700,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,BAO_0000218,CHEMBL631731,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14701,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,BAO_0000218,CHEMBL631910,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14702,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,BAO_0000218,CHEMBL631911,15413,10116.0,Intermediate,1,,,50597,N,1,10000000.0,
14703,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,BAO_0000218,CHEMBL631912,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14704,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,BAO_0000218,CHEMBL631913,15413,10116.0,Intermediate,1,,,50597,N,1,1898.0,
14705,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631914,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14706,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631915,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14707,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL875778,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14708,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631916,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14709,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631917,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14710,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631918,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14711,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631919,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14712,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL631920,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14713,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631921,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14714,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631922,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14715,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL631923,12017,10116.0,Intermediate,1,,,50597,N,1,178.0,
14716,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631924,12017,10116.0,Intermediate,1,,,50597,N,1,,
14717,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630234,12017,10116.0,Intermediate,1,,,50597,N,1,,
14718,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630235,12017,10116.0,Intermediate,1,,,50597,N,1,,
14719,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630236,12017,10116.0,Intermediate,1,,,50597,N,1,,
14720,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630237,12017,10116.0,Intermediate,1,,,50597,N,1,,
14721,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630238,12017,10116.0,Intermediate,1,,,50597,N,1,,
14722,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630239,12017,10116.0,Intermediate,1,,,50597,N,1,,
14723,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630303,12017,10116.0,Intermediate,1,,,50597,N,1,,
14724,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630304,12017,10116.0,Intermediate,1,,,50597,N,1,,
14725,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630305,12017,10116.0,Intermediate,1,,,50597,N,1,,
14726,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630306,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14727,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630307,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14728,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630308,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14729,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630309,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14730,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL629309,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14731,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL629993,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14732,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL629994,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14733,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL629995,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14734,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631993,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14735,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631994,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14736,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631995,12017,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14737,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL631996,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14738,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631997,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14739,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631998,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14740,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631999,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14741,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL632000,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14742,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL632001,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14743,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL874424,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14744,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL632002,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14745,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL632003,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14746,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,BAO_0000019,CHEMBL632004,3133,,Autocuration,1,,,22224,U,0,,
14747,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,BAO_0000019,CHEMBL632005,2742,,Autocuration,1,,,22224,U,0,,
14748,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,BAO_0000019,CHEMBL632006,2742,,Autocuration,1,,,22224,U,0,,
14749,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,BAO_0000019,CHEMBL632007,2742,,Autocuration,1,,,22224,U,0,,
14750,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,BAO_0000019,CHEMBL632008,2742,,Autocuration,1,,,22224,U,0,,
14751,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,BAO_0000019,CHEMBL632009,2742,,Autocuration,1,,,22224,U,0,,
14752,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,BAO_0000019,CHEMBL632010,2742,,Autocuration,1,,,22224,U,0,,
14753,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,BAO_0000019,CHEMBL857750,2742,,Autocuration,1,,,22224,U,0,,
14754,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,BAO_0000019,CHEMBL632011,2742,,Autocuration,1,,,22224,U,0,,
14755,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,CHEMBL632012,2276,,Autocuration,1,,,22224,U,0,,
14756,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,CHEMBL632013,2276,,Autocuration,1,,,22224,U,0,,
14757,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,BAO_0000019,CHEMBL632014,2276,,Autocuration,1,,,22224,U,0,,
14758,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,CHEMBL629622,2276,,Autocuration,1,,,22224,U,0,,
14759,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,BAO_0000019,CHEMBL629623,2276,,Autocuration,1,,,22224,U,0,,
14760,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,BAO_0000019,CHEMBL629624,2276,,Autocuration,1,,,22224,U,0,,
14761,,Ratio of Kcat to that of Km was determined,,BAO_0000019,CHEMBL629625,17269,,Autocuration,1,,,22224,U,0,,
14762,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,BAO_0000019,CHEMBL629626,2276,,Autocuration,1,,,22224,U,0,,
14763,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,BAO_0000019,CHEMBL629627,2276,,Autocuration,1,,,22224,U,0,,
14764,,"Compound was evaluated for constant, Kd",,BAO_0000019,CHEMBL629628,15917,,Autocuration,1,,,22224,U,0,,
14765,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,BAO_0000019,CHEMBL629629,10933,,Autocuration,1,,,22224,U,0,,
14766,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,BAO_0000019,CHEMBL629630,10933,,Autocuration,1,,,22224,U,0,,
14767,,Dissociation Constant of compound determined,,BAO_0000019,CHEMBL856030,14293,,Autocuration,1,,,22224,U,0,,
14768,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,BAO_0000019,CHEMBL629631,6698,,Autocuration,1,,,22224,U,0,,
14769,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,BAO_0000019,CHEMBL629632,6698,,Autocuration,1,,,22224,U,0,,
14770,,Dissociation constant of compound with Fructose was determined,,BAO_0000100,CHEMBL629633,4318,,Autocuration,1,,,22224,U,0,,
14771,,Dissociation constant of compound with Fructose was determined; Not determined,,BAO_0000100,CHEMBL629634,4318,,Autocuration,1,,,22224,U,0,,
14772,,Dissociation constant of compound with Lactulose was determined,,BAO_0000100,CHEMBL629635,4318,,Autocuration,1,,,22224,U,0,,
14773,,Dissociation constant of compound with Lactulose was determined; Not determined,,BAO_0000100,CHEMBL629636,4318,,Autocuration,1,,,22224,U,0,,
14774,,Dissociation constant of the Compound,,BAO_0000100,CHEMBL629637,14959,,Autocuration,1,,,22224,U,0,,
14775,,Dissociation constant by non-linear regression analysis,,BAO_0000100,CHEMBL629638,5913,,Autocuration,1,,,22224,U,0,,
14776,,Dissociation constant was determined,,BAO_0000100,CHEMBL629639,14218,,Autocuration,1,,,22224,U,0,,
14777,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,BAO_0000100,CHEMBL629640,10689,,Autocuration,1,,,22224,U,0,,
14778,,Dissociation constant was determined,,BAO_0000100,CHEMBL629641,13925,,Autocuration,1,,,22224,U,0,,
14779,,Dissociation constant was determined,,BAO_0000100,CHEMBL631344,16359,,Autocuration,1,,,22224,U,0,,
14780,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,BAO_0000218,CHEMBL631345,10944,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14781,,The dissociation constant determined by fluorescence displacement assay,,BAO_0000019,CHEMBL631346,11080,,Autocuration,1,,,22224,U,0,,
14782,,kd value surface plasmon resonance (SPR) method,,BAO_0000019,CHEMBL631524,17805,,Autocuration,1,,,22224,U,0,,
14783,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,BAO_0000218,CHEMBL631525,10944,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14784,,First dissociation constant of the binding of compound to V30M TTR,,BAO_0000019,CHEMBL631526,16645,,Autocuration,1,,,22224,U,0,,
14785,,Second dissociation constant of the binding of compound to V30M TTR,,BAO_0000019,CHEMBL631527,16645,,Autocuration,1,,,22224,U,0,,
14786,,"Compound was evaluated for equilibrium constant, Ke",,BAO_0000019,CHEMBL631528,7793,,Autocuration,1,,,22224,U,0,,
14787,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,BAO_0000019,CHEMBL631529,12199,,Autocuration,1,,,22224,U,0,1898.0,
14788,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,BAO_0000019,CHEMBL631530,12199,,Autocuration,1,,,22224,U,0,1898.0,
14789,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,BAO_0000019,CHEMBL631531,9680,,Autocuration,1,,,22224,U,0,,
14790,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,BAO_0000019,CHEMBL631532,9680,,Autocuration,1,,,22224,U,0,,
14791,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,BAO_0000019,CHEMBL631533,9680,,Autocuration,1,,,22224,U,0,,
14792,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,CHEMBL876552,13758,10090.0,Intermediate,1,,,50594,N,1,,
14793,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,BAO_0000218,CHEMBL631534,13758,10090.0,Intermediate,1,,,50594,N,1,,
14794,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,CHEMBL631535,13758,10090.0,Intermediate,1,,,50594,N,1,,
14795,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,CHEMBL631536,13758,10090.0,Intermediate,1,,,50594,N,1,,
14796,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,BAO_0000218,CHEMBL631537,13758,10090.0,Intermediate,1,,,50594,N,1,,
14797,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,BAO_0000218,CHEMBL631538,13758,10090.0,Intermediate,1,,,50594,N,1,,
14798,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,BAO_0000218,CHEMBL631539,13758,10090.0,Intermediate,1,,,50594,N,1,,
14799,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,BAO_0000218,CHEMBL631540,13758,10090.0,Intermediate,1,,,50594,N,1,,
14800,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,CHEMBL625637,14393,10116.0,Intermediate,1,,,50597,N,1,,
14801,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,BAO_0000218,CHEMBL625638,14393,10116.0,Intermediate,1,,,50597,N,1,,
14802,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,BAO_0000218,CHEMBL625639,15078,10116.0,Intermediate,1,,,50597,N,1,,
14803,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625640,13925,10116.0,Intermediate,1,,,50597,N,1,955.0,
14804,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625641,13925,10116.0,Intermediate,1,,,50597,N,1,955.0,
14805,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625642,13925,10116.0,Intermediate,1,,,50597,N,1,948.0,
14806,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625643,13925,10116.0,Intermediate,1,,,50597,N,1,948.0,
14807,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625644,13925,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14808,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625645,13925,10116.0,Intermediate,1,,,50597,N,1,2113.0,
14809,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625646,13925,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14810,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625647,13925,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14811,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625648,13925,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14812,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625649,13925,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14813,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625650,13925,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14814,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625651,13925,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14815,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625652,13925,10116.0,Intermediate,1,,,50597,N,1,14.0,
14816,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625653,13925,10116.0,Intermediate,1,,,50597,N,1,14.0,
14817,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625654,13925,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14818,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,BAO_0000218,CHEMBL625655,13925,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14819,,Biodistribution of Compound in rat blood after 15 minutes of administration,,BAO_0000218,CHEMBL625656,9712,10116.0,Intermediate,1,,,50597,N,1,178.0,
14820,,Biodistribution of Compound in rat blood after 2 minutes of administration,,BAO_0000218,CHEMBL625657,9712,10116.0,Intermediate,1,,,50597,N,1,178.0,
14821,,Biodistribution of Compound in rat brain after 15 minutes of administration,,BAO_0000218,CHEMBL625658,9712,10116.0,Intermediate,1,,,50597,N,1,955.0,
14822,,Biodistribution of Compound in rat brain after 2 minutes of administration,,BAO_0000218,CHEMBL625659,9712,10116.0,Intermediate,1,,,50597,N,1,955.0,
14823,,Biodistribution of Compound in rat heart after 15 minutes of administration,,BAO_0000218,CHEMBL625660,9712,10116.0,Intermediate,1,,,50597,N,1,948.0,
14824,,Biodistribution of Compound in rat heart after 2 minutes of administration,,BAO_0000218,CHEMBL625661,9712,10116.0,Intermediate,1,,,50597,N,1,948.0,
14825,,Biodistribution of Compound in rat liver after 15 minutes of administration,,BAO_0000218,CHEMBL625662,9712,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14826,,Biodistribution of Compound in rat liver after 2 minutes of administration,,BAO_0000218,CHEMBL625663,9712,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14827,,Biodistribution of Compound in rat lung after 15 minutes of administration,,BAO_0000218,CHEMBL875621,9712,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14828,,Biodistribution of Compound in rat lung after 2 minutes of administration,,BAO_0000218,CHEMBL628382,9712,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14829,,Biodistribution of Compound in rat muscle after 15 minutes of administration,,BAO_0000218,CHEMBL628383,9712,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14830,,Biodistribution of Compound in rat muscle after 2 minutes of administration,,BAO_0000218,CHEMBL628384,9712,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14831,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,BAO_0000218,CHEMBL628385,13925,10116.0,Intermediate,1,,,50597,N,1,,
14832,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,BAO_0000218,CHEMBL875753,13925,10116.0,Intermediate,1,,,50597,N,1,,
14833,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,BAO_0000218,CHEMBL628386,13925,10116.0,Intermediate,1,,,50597,N,1,,
14834,,Organ distribution in rat blood 2 minutes after intravenous injection,,BAO_0000218,CHEMBL628387,6941,10116.0,Intermediate,1,,,50597,N,1,,
14835,,Organ distribution in rat blood 2 hr after intravenous injection,,BAO_0000218,CHEMBL628388,6941,10116.0,Intermediate,1,,,50597,N,1,,
14836,,Organ distribution in rat blood 30 minutes after intravenous injection,,BAO_0000218,CHEMBL628389,6941,10116.0,Intermediate,1,,,50597,N,1,,
14837,,Organ distribution in rat blood 30 min after intravenous injection,,BAO_0000218,CHEMBL632756,6941,10116.0,Intermediate,1,,,50597,N,1,,
14838,,Organ distribution in rat brain 2 minutes after intravenous injection,,BAO_0000218,CHEMBL628390,6941,10116.0,Intermediate,1,,,50597,N,1,,
14839,,Organ distribution in rat brain 2 hr after intravenous injection,,BAO_0000218,CHEMBL631811,6941,10116.0,Intermediate,1,,,50597,N,1,,
14840,,Organ distribution in rat brain 30 minutes after intravenous injection,,BAO_0000218,CHEMBL631812,6941,10116.0,Intermediate,1,,,50597,N,1,,
14841,,Organ distribution in rat heart 2 minutes after intravenous injection,,BAO_0000218,CHEMBL631813,6941,10116.0,Intermediate,1,,,50597,N,1,,
14842,,Organ distribution in rat heart 2 hr after intravenous injection,,BAO_0000218,CHEMBL631814,6941,10116.0,Intermediate,1,,,50597,N,1,,
14843,,Organ distribution in rat heart 30 minutes after intravenous injection,,BAO_0000218,CHEMBL631815,6941,10116.0,Intermediate,1,,,50597,N,1,,
14844,,Organ distribution in rat kidney 2 minutes after intravenous injection,,BAO_0000218,CHEMBL631816,6941,10116.0,Intermediate,1,,,50597,N,1,,
14845,,Organ distribution in rat kidney 2 hr after intravenous injection,,BAO_0000218,CHEMBL875758,6941,10116.0,Intermediate,1,,,50597,N,1,,
14846,,Organ distribution in rat kidney 30 minutes after intravenous injection,,BAO_0000218,CHEMBL631817,6941,10116.0,Intermediate,1,,,50597,N,1,,
14847,,Organ distribution in rat liver 2 minutes after intravenous injection,,BAO_0000218,CHEMBL631818,6941,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14848,,Organ distribution in rat liver 2 hr after intravenous injection,,BAO_0000218,CHEMBL631819,6941,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14849,,Organ distribution in rat liver 30 minutes after intravenous injection,,BAO_0000218,CHEMBL631820,6941,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14850,,Organ distribution in rat lung 2 minutes after intravenous injection,,BAO_0000218,CHEMBL631821,6941,10116.0,Intermediate,1,,,50597,N,1,,
14851,,Organ distribution in rat lung 2 hr after intravenous injection,,BAO_0000218,CHEMBL631822,6941,10116.0,Intermediate,1,,,50597,N,1,,
14852,,Organ distribution in rat lung 30 minutes after intravenous injection,,BAO_0000218,CHEMBL631823,6941,10116.0,Intermediate,1,,,50597,N,1,,
14853,,Organ distribution in rat muscle 2 minutes after intravenous injection,,BAO_0000218,CHEMBL631824,6941,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14854,,Organ distribution in rat muscle 2 hr after intravenous injection,,BAO_0000218,CHEMBL631825,6941,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14855,,Organ distribution in rat muscle 30 minutes after intravenous injection,,BAO_0000218,CHEMBL631826,6941,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14856,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,BAO_0000218,CHEMBL631827,14439,10090.0,Intermediate,1,,,50594,N,1,,
14857,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,BAO_0000218,CHEMBL631828,14439,10090.0,Intermediate,1,,,50594,N,1,,
14858,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,BAO_0000218,CHEMBL631829,14439,10090.0,Intermediate,1,,,50594,N,1,,
14859,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,BAO_0000218,CHEMBL875759,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14860,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,BAO_0000218,CHEMBL631830,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14861,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,BAO_0000218,CHEMBL631831,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14862,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,BAO_0000218,CHEMBL631832,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14863,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,BAO_0000218,CHEMBL631833,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14864,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,BAO_0000218,CHEMBL631834,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14865,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,BAO_0000218,CHEMBL631835,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14866,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,BAO_0000218,CHEMBL631836,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14867,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,BAO_0000218,CHEMBL631837,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14868,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,BAO_0000218,CHEMBL631838,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14869,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,BAO_0000218,CHEMBL631839,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14870,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,BAO_0000218,CHEMBL631840,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14871,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,BAO_0000218,CHEMBL631841,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14872,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,BAO_0000218,CHEMBL631842,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14873,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,BAO_0000218,CHEMBL631843,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14874,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,BAO_0000218,CHEMBL631844,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14875,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,BAO_0000218,CHEMBL631845,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14876,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,BAO_0000218,CHEMBL631846,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14877,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,BAO_0000218,CHEMBL875760,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14878,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,BAO_0000218,CHEMBL632199,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14879,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,BAO_0000218,CHEMBL631847,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14880,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,BAO_0000218,CHEMBL631848,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14881,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,BAO_0000218,CHEMBL628707,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14882,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,BAO_0000218,CHEMBL628708,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14883,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,BAO_0000218,CHEMBL628709,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14884,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,BAO_0000218,CHEMBL628710,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14885,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,BAO_0000218,CHEMBL628711,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14886,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,BAO_0000218,CHEMBL628712,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14887,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,BAO_0000218,CHEMBL628713,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14888,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,BAO_0000218,CHEMBL628714,12582,10116.0,Intermediate,1,,,50597,N,1,1088.0,
14889,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,BAO_0000218,CHEMBL628715,7415,10116.0,Intermediate,1,,,50597,N,1,,
14890,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,BAO_0000019,CHEMBL629179,7313,,Autocuration,1,,,22224,U,0,,
14891,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,BAO_0000019,CHEMBL629180,7313,,Autocuration,1,,,22224,U,0,,
14892,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,BAO_0000019,CHEMBL875108,7313,,Autocuration,1,,,22224,U,0,,
14893,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629181,7570,,Autocuration,1,,,22224,U,0,1235.0,
14894,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629182,7570,,Autocuration,1,,,22224,U,0,1235.0,
14895,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629183,7570,,Autocuration,1,,,22224,U,0,,
14896,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629184,7570,,Autocuration,1,,,22224,U,0,,
14897,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629185,7570,,Autocuration,1,,,22224,U,0,1235.0,
14898,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629186,7570,,Autocuration,1,,,22224,U,0,1235.0,
14899,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629187,7570,,Autocuration,1,,,22224,U,0,,
14900,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629887,7570,,Autocuration,1,,,22224,U,0,,
14901,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629888,7570,,Autocuration,1,,,22224,U,0,,
14902,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629889,7570,,Autocuration,1,,,22224,U,0,,
14903,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629890,7570,,Autocuration,1,,,22224,U,0,1235.0,
14904,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629891,7570,,Autocuration,1,,,22224,U,0,,
14905,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629892,7570,,Autocuration,1,,,22224,U,0,,
14906,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629893,7570,,Autocuration,1,,,22224,U,0,1235.0,
14907,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629894,7570,,Autocuration,1,,,22224,U,0,,
14908,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,BAO_0000019,CHEMBL629895,7570,,Autocuration,1,,,22224,U,0,,
14909,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,BAO_0000218,CHEMBL875109,14122,9615.0,Autocuration,1,,,22224,U,0,,
14910,,Absolute bioavailability in male cynomolgus monkeys,,BAO_0000218,CHEMBL629896,16449,9541.0,Autocuration,1,,,22224,U,0,,
14911,,Absolute bioavailability in maleSprague-Dawley rats,,BAO_0000218,CHEMBL629897,16449,10116.0,Autocuration,1,,,22224,U,0,,
14912,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL629898,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14913,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630057,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14914,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630058,12017,10116.0,Intermediate,1,,,50597,N,1,2107.0,
14915,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630059,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14916,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630060,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14917,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630061,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14918,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630062,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14919,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630063,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14920,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630064,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14921,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630065,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14922,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630066,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14923,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630067,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14924,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630068,12017,10116.0,Intermediate,1,,,50597,N,1,2048.0,
14925,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631113,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14926,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631114,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14927,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL631115,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14928,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL631116,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14929,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630528,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14930,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630529,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14931,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630530,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14932,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630531,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14933,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630532,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14934,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630533,12017,10116.0,Intermediate,1,,,50597,N,1,2385.0,
14935,,Biodistribution in normal mice blood after 120 hr,,BAO_0000218,CHEMBL630534,15045,10090.0,Intermediate,1,,,50594,N,1,178.0,
14936,,Biodistribution in normal mice blood after 24 hr,,BAO_0000218,CHEMBL630535,15045,10090.0,Intermediate,1,,,50594,N,1,178.0,
14937,,Biodistribution in normal mice blood after 4 hr,,BAO_0000218,CHEMBL630536,15045,10090.0,Intermediate,1,,,50594,N,1,178.0,
14938,,Biodistribution in normal mice bone after 120 hr,,BAO_0000218,CHEMBL630537,15045,10090.0,Intermediate,1,,,50594,N,1,10000001.0,
14939,,Biodistribution in normal mice bone after 24 hr,,BAO_0000218,CHEMBL630538,15045,10090.0,Intermediate,1,,,50594,N,1,10000001.0,
14940,,Biodistribution in normal mice bone after 4 hr,,BAO_0000218,CHEMBL630539,15045,10090.0,Intermediate,1,,,50594,N,1,10000001.0,
14941,,Biodistribution in normal mice heart after 120 hr,,BAO_0000218,CHEMBL630540,15045,10090.0,Intermediate,1,,,50594,N,1,948.0,
14942,,Biodistribution in normal mice heart after 24 hr,,BAO_0000218,CHEMBL630541,15045,10090.0,Intermediate,1,,,50594,N,1,948.0,
14943,,Biodistribution in normal mice heart after 4 hr,,BAO_0000218,CHEMBL630542,15045,10090.0,Intermediate,1,,,50594,N,1,948.0,
14944,,Biodistribution in normal mice kidney after 120 hr,,BAO_0000218,CHEMBL630543,15045,10090.0,Intermediate,1,,,50594,N,1,2113.0,
14945,,Biodistribution in normal mice kidney after 24 hr,,BAO_0000218,CHEMBL630544,15045,10090.0,Intermediate,1,,,50594,N,1,2113.0,
14946,,Biodistribution in normal mice kidney after 4 hr,,BAO_0000218,CHEMBL630545,15045,10090.0,Intermediate,1,,,50594,N,1,2113.0,
14947,,Biodistribution in normal mice liver after 120 hr,,BAO_0000218,CHEMBL630546,15045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14948,,Biodistribution in normal mice liver after 24 hr,,BAO_0000218,CHEMBL630547,15045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14949,,Biodistribution in normal mice liver after 4 hr,,BAO_0000218,CHEMBL630548,15045,10090.0,Intermediate,1,,,50594,N,1,2107.0,
14950,,Biodistribution in normal mice spleen after 120 hr,,BAO_0000218,CHEMBL630549,15045,10090.0,Intermediate,1,,,50594,N,1,2106.0,
14951,,Biodistribution in normal mice spleen after 24 hr,,BAO_0000218,CHEMBL630550,15045,10090.0,Intermediate,1,,,50594,N,1,2106.0,
14952,,Biodistribution in normal mice spleen after 4 hr,,BAO_0000218,CHEMBL876426,15045,10090.0,Intermediate,1,,,50594,N,1,2106.0,
14953,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630551,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14954,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630552,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14955,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630553,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14956,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630554,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14957,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630555,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14958,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630556,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14959,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630557,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14960,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,BAO_0000218,CHEMBL630558,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14961,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630559,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14962,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL630560,12017,10116.0,Intermediate,1,,,50597,N,1,2106.0,
14963,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,BAO_0000218,CHEMBL876427,12017,10116.0,Intermediate,1,,,50597,N,1,2046.0,
14964,,The Kel values in female wistar rats.,,BAO_0000218,CHEMBL630561,14941,10116.0,Intermediate,1,,,50597,N,1,,
14965,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,BAO_0000019,CHEMBL630562,4646,,Autocuration,1,,,22224,U,0,,
14966,,Hydrolysis rate constant of the compound,,BAO_0000019,CHEMBL630563,8847,,Autocuration,1,,,22224,U,0,,
14967,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,BAO_0000100,CHEMBL629673,11778,,Autocuration,1,,,22229,U,0,,
14968,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,BAO_0000019,CHEMBL629674,2363,,Autocuration,1,,,22224,U,0,,
14969,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,BAO_0000019,CHEMBL629675,2363,,Autocuration,1,,,22224,U,0,,
14970,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,BAO_0000019,CHEMBL629676,2363,,Autocuration,1,,,22224,U,0,,
14971,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,BAO_0000019,CHEMBL629677,2363,,Autocuration,1,,,22224,U,0,,
14972,,Apparent inactivation rate constant was evaluated,,BAO_0000019,CHEMBL629678,8371,,Autocuration,1,,,22224,U,0,,
14973,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,BAO_0000019,CHEMBL629679,14883,,Autocuration,1,,,22224,U,0,,
14974,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,BAO_0000019,CHEMBL629680,14883,,Autocuration,1,,,22224,U,0,,
14975,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,BAO_0000019,CHEMBL629681,4643,,Autocuration,1,,,22224,U,0,,
14976,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,BAO_0000019,CHEMBL629682,3519,,Autocuration,1,,,22224,U,0,,
14977,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,BAO_0000019,CHEMBL629683,10600,,Autocuration,1,,,22224,U,0,,
14978,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,BAO_0000019,CHEMBL629684,8501,,Autocuration,1,,,22224,U,0,,
14979,,Dissociation constant was determined,,BAO_0000100,CHEMBL629685,8505,,Autocuration,1,,,22224,U,0,,
14980,,Dissociation constant was determined,,BAO_0000100,CHEMBL629686,9778,,Autocuration,1,,,22224,U,0,,
14981,,Dissociation constant at pH 7.4,,BAO_0000100,CHEMBL872932,9778,,Autocuration,1,,,22224,U,0,,
14982,,Dissociation constant in presence of 1 mM dithiothreitol,,BAO_0000100,CHEMBL629687,9778,,Autocuration,1,,,22224,U,0,,
14983,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,BAO_0000019,CHEMBL872931,13007,,Autocuration,1,,,22224,U,0,,
14984,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,BAO_0000019,CHEMBL628151,13007,,Autocuration,1,,,22224,U,0,,
14985,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,BAO_0000019,CHEMBL628152,13007,,Autocuration,1,,,22224,U,0,,
14986,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,BAO_0000019,CHEMBL628153,13007,,Autocuration,1,,,22224,U,0,,
14987,,Kinetic constant for aromatization of androstenedione,,BAO_0000019,CHEMBL628154,11482,,Autocuration,1,,,22224,U,0,,
14988,,Kinetic constant for aromatization of testosterone,,BAO_0000019,CHEMBL628155,11482,,Autocuration,1,,,22224,U,0,,
14989,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,BAO_0000019,CHEMBL628156,2303,,Autocuration,1,,,22224,U,0,,
14990,,Local inhibition constant was determined,,BAO_0000019,CHEMBL628157,11964,,Autocuration,1,,,22224,U,0,,
14991,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,BAO_0000218,CHEMBL857533,3140,4932.0,Intermediate,1,,,50347,N,1,,
14992,,Dissociation constant value of the compound,,BAO_0000100,CHEMBL628158,10650,,Autocuration,1,,,22224,U,0,,
14993,,In vitro permeability through cornea without epithelium,,BAO_0000019,CHEMBL628159,4667,,Autocuration,1,,,22224,U,0,964.0,
14994,,In vitro permeability through intact cornea,,BAO_0000019,CHEMBL875616,4667,,Autocuration,1,,,22224,U,0,964.0,
14995,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,BAO_0000218,CHEMBL628160,9199,9986.0,Intermediate,1,,,50592,N,1,964.0,
14996,,Rate of enzyme inactivation for the compound was determined,,BAO_0000019,CHEMBL628161,11966,,Autocuration,1,,,22224,U,0,,
14997,,In vitro permeability through cornea without epithelium,,BAO_0000019,CHEMBL628162,4667,,Autocuration,1,,,22224,U,0,964.0,
14998,,In vitro permeability through intact cornea,,BAO_0000019,CHEMBL628163,4667,,Autocuration,1,,,22224,U,0,964.0,
14999,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628164,8354,,Autocuration,1,,,22224,U,0,,
15000,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628165,8354,,Autocuration,1,,,22224,U,0,,
15001,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628166,8354,,Autocuration,1,,,22224,U,0,,
15002,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628167,8354,,Autocuration,1,,,22224,U,0,,
15003,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628168,8354,,Autocuration,1,,,22224,U,0,,
15004,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628169,8354,,Autocuration,1,,,22224,U,0,,
15005,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628170,8354,,Autocuration,1,,,22224,U,0,,
15006,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628171,8354,,Autocuration,1,,,22224,U,0,,
15007,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL627434,8354,,Autocuration,1,,,22224,U,0,,
15008,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL627435,8354,,Autocuration,1,,,22224,U,0,,
15009,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628110,8354,,Autocuration,1,,,22224,U,0,,
15010,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628111,8354,,Autocuration,1,,,22224,U,0,,
15011,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628112,8354,,Autocuration,1,,,22224,U,0,,
15012,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628260,8354,,Autocuration,1,,,22224,U,0,,
15013,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,BAO_0000019,CHEMBL628261,8354,,Autocuration,1,,,22224,U,0,,
15014,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,BAO_0000218,CHEMBL628262,14439,10090.0,Intermediate,1,,,50594,N,1,,
15015,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,BAO_0000218,CHEMBL628263,14439,9606.0,Intermediate,1,,,50587,N,1,,
15016,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,BAO_0000218,CHEMBL628264,14439,10090.0,Intermediate,1,,,50594,N,1,,
15017,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,BAO_0000218,CHEMBL628265,14439,10090.0,Intermediate,1,,,50594,N,1,,
15018,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,BAO_0000218,CHEMBL628266,14439,10090.0,Intermediate,1,,,50594,N,1,,
15019,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,BAO_0000218,CHEMBL628267,14439,10090.0,Intermediate,1,,,50594,N,1,,
15020,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,BAO_0000218,CHEMBL628268,14439,10090.0,Intermediate,1,,,50594,N,1,,
15021,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,BAO_0000218,CHEMBL628269,14439,10090.0,Intermediate,1,,,50594,N,1,,
15022,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,BAO_0000218,CHEMBL628270,14439,10090.0,Intermediate,1,,,50594,N,1,,
15023,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,BAO_0000218,CHEMBL628271,14439,10090.0,Intermediate,1,,,50594,N,1,,
15024,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,BAO_0000218,CHEMBL628272,14439,10090.0,Intermediate,1,,,50594,N,1,,
